primaryid,caseid,brand_name,prod_ai,route,dechal,rechal,dose_amt,dose_unit,dose_form,dose_freq,reaction,rpsr_cod,age,age_cod,gender,i_f_cod,fda_dt,event_dt,rept_cod_exp,rept_cod_per,outc_cod,indication,country_name,adverse_event,manufacturer,event_seriousness,case_seriousness,uspi_listedness
2016-001482,2016-001482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,48,Years,Male,I,2/25/2016,2/24/2016,,,,BACK PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-001482,2016-001482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,48,Years,Male,I,2/25/2016,2/24/2016,,,,BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-001482,2016-001482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,48,Years,Male,I,2/25/2016,2/24/2016,,,,BACK PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-001769,2016-001769,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Physician,,Unknown,UNK,I,3/8/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-001772,2016-001772,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Physician,,Unknown,UNK,I,3/8/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-001951,2016-001951,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Physician,,Unknown,Female,F,4/12/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-001952,2016-001952,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug hypersensitivity,Physician,,Unknown,Female,I,3/15/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Drug hypersensitivity,,NO,NO,Unlisted
2016-001952,2016-001952,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,,Unknown,Female,I,3/15/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Lethargy,Physician,58,Years,Female,I,3/16/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Lethargy,,YES,YES,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pruritus,Physician,58,Years,Female,I,3/16/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Pruritus,,YES,YES,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental overdose,Physician,58,Years,Female,I,3/16/2016,3/9/2016,,,Other,CHRONIC PAIN,UNITED STATES,Accidental overdose,,YES,YES,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Physician,58,Years,Female,I,3/16/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,58,Years,Female,I,3/16/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Headache,,YES,YES,Listed
2016-001993,2016-001993,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dispensing error,Physician,58,Years,Female,I,3/16/2016,3/9/2016,,,Other,CHRONIC PAIN,UNITED STATES,Drug dispensing error,,YES,YES,Unlisted
2016-002018,2016-002018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Palpitations,Physician,51,Years,Male,F,5/26/2016,3/1/2016,,,,PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-002018,2016-002018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dyspnoea,Physician,51,Years,Male,F,5/26/2016,3/1/2016,,,,PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-002018,2016-002018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Drug ineffective,Physician,51,Years,Male,F,5/26/2016,3/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002018,2016-002018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Migration of implanted drug,Physician,51,Years,Male,F,5/26/2016,3/1/2016,,,,PAIN,UNITED STATES,Migration of implanted drug,,NO,NO,Unlisted
2016-002018,2016-002018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Physician,51,Years,Male,F,5/26/2016,3/1/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-002034,2016-002034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,67,Years,Female,F,5/9/2016,3/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-002034,2016-002034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,67,Years,Female,F,5/9/2016,3/1/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002320,2016-002320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Nausea,Physician,,Unknown,Female,I,3/24/2016,3/1/2016,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-002340,2016-002340,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Unknown,,Tremor,Physician,,Unknown,Female,I,3/25/2016,3/1/2016,,,,PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2016-002353,2016-002353,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Chest pain,Other Health Professional,,Unknown,Female,I,3/29/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Chest pain,,NO,NO,Listed
2016-002370,2016-002370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Sedation,Physician,,Unknown,Female,I,3/28/2016,,,,,PAIN,UNITED STATES,Sedation,,NO,NO,Listed
2016-002403,2016-002403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Mouth swelling,Physician,53,Years,Female,I,3/29/2016,3/26/2016,,,Other,PAIN,UNITED STATES,Mouth swelling,,YES,YES,Unlisted
2016-002403,2016-002403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Lip swelling,Physician,53,Years,Female,I,3/29/2016,3/26/2016,,,Other,PAIN,UNITED STATES,Lip swelling,,YES,YES,Unlisted
2016-002410,2016-002410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Throat tightness,Physician,,Unknown,Female,F,6/3/2016,3/1/2016,,,,CHRONIC PAIN,UNITED STATES,Throat tightness,,NO,NO,Unlisted
2016-002415,2016-002415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pain,Non-Health Professional,,Unknown,Female,F,5/27/2016,1/1/2016,,,,PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-002415,2016-002415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Female,F,5/27/2016,1/1/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002437,2016-002437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dizziness,Physician,19,Years,Female,I,3/30/2016,2/1/2016,,,,CHRONIC PAIN MANAGEMENT,UNITED STATES,Dizziness,,NO,NO,Listed
2016-002448,2016-002448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Hypersensitivity,Physician,28,Years,Male,I,4/1/2016,3/1/2016,,,,PAIN,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2016-002448,2016-002448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Erythema,Physician,28,Years,Male,I,4/1/2016,3/1/2016,,,,PAIN,UNITED STATES,Erythema,,NO,NO,Unlisted
2016-002458,2016-002458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Urinary retention,Physician,56,Years,Male,F,4/25/2016,3/1/2016,,,,PAIN,UNITED STATES,Urinary retention,,NO,NO,Unlisted
2016-002458,2016-002458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Abdominal pain upper,Physician,56,Years,Male,F,4/25/2016,3/1/2016,,,,PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2016-002478,2016-002478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,67,Years,Female,I,4/1/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-002478,2016-002478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Other Health Professional,67,Years,Female,I,4/1/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-002478,2016-002478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Anxiety,Other Health Professional,67,Years,Female,I,4/1/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Anxiety,,NO,NO,Listed
2016-002480,2016-002480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Unknown,,Feeling abnormal,Physician,,Unknown,Female,I,4/4/2016,3/1/2016,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-002501,2016-002501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug hypersensitivity,Physician,48,Years,Male,I,4/4/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Drug hypersensitivity,,YES,YES,Listed
2016-002501,2016-002501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chest discomfort,Physician,48,Years,Male,I,4/4/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Chest discomfort,,YES,YES,Listed
2016-002501,2016-002501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,48,Years,Male,I,4/4/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Headache,,YES,YES,Listed
2016-002501,2016-002501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hypoaesthesia oral,Physician,48,Years,Male,I,4/4/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,YES,YES,Unlisted
2016-002501,2016-002501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Physician,48,Years,Male,I,4/4/2016,3/1/2016,,,Other,CHRONIC PAIN,UNITED STATES,Pain,,YES,YES,Unlisted
2016-002533,2016-002533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Unknown,,Drug ineffective,Nurse,,Unknown,Female,I,4/5/2016,3/31/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002536,2016-002536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Oral mucosal eruption,Physician,,Unknown,Female,I,4/5/2016,3/1/2016,,,,UNKNOWN,UNITED STATES,Oral mucosal eruption,,NO,NO,Unlisted
2016-002582,2016-002582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,6/8/2016,3/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002589,2016-002589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,66,Years,Female,F,6/3/2016,3/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002589,2016-002589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Physician,66,Years,Female,F,6/3/2016,3/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002591,2016-002591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Abdominal pain,Physician,4,Decades,Male,I,4/7/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2016-002597,2016-002597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,I,4/7/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002597,2016-002597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Withdrawal syndrome,Physician,,Unknown,Female,I,4/7/2016,1/1/2016,,,,PAIN,UNITED STATES,Withdrawal syndrome,,NO,NO,Listed
2016-002604,2016-002604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,59,Years,Female,I,4/8/2016,3/12/2016,,,,PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2016-002604,2016-002604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dose omission,Non-Health Professional,59,Years,Female,I,4/8/2016,4/4/2016,,,,PAIN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-002604,2016-002604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,59,Years,Female,I,4/8/2016,4/4/2016,,,,PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-002604,2016-002604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Foreign body,Non-Health Professional,59,Years,Female,I,4/8/2016,4/2/2016,,,,PAIN,UNITED STATES,Foreign body,,NO,NO,Unlisted
2016-002641,2016-002641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Other Health Professional,,Unknown,Female,I,4/8/2016,1/1/2016,,,,PAIN RELIEF,UNITED STATES,Nausea,,NO,NO,Listed
2016-002710,2016-002710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Product adhesion issue,Physician,36,Years,Female,F,5/9/2016,3/2/2016,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-002710,2016-002710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Underdose,Physician,36,Years,Female,F,5/9/2016,3/2/2016,,,,CHRONIC PAIN,UNITED STATES,Underdose,,NO,NO,Unlisted
2016-002721,2016-002721,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling abnormal,Physician,,Unknown,Female,I,4/13/2016,3/31/2016,,,Other,PAIN RELIEF,UNITED STATES,Feeling abnormal,,YES,YES,Unlisted
2016-002721,2016-002721,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dispensing error,Physician,,Unknown,Female,I,4/13/2016,3/31/2016,,,Other,PAIN RELIEF,UNITED STATES,Drug dispensing error,,YES,YES,Unlisted
2016-002721,2016-002721,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental overdose,Physician,,Unknown,Female,I,4/13/2016,3/31/2016,,,Other,PAIN RELIEF,UNITED STATES,Accidental overdose,,YES,YES,Listed
2016-002721,2016-002721,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,,Unknown,Female,I,4/13/2016,3/31/2016,,,Other,PAIN RELIEF,UNITED STATES,Nausea,,YES,YES,Listed
2016-002727,2016-002727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Physician,,Unknown,UNK,I,4/13/2016,3/1/2016,,,,PAIN MANAGEMENT,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002727,2016-002727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Physician,,Unknown,UNK,I,4/13/2016,3/1/2016,,,,PAIN MANAGEMENT,UNITED STATES,Nausea,,NO,NO,Listed
2016-002766,2016-002766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Nurse,71,Years,Female,F,6/16/2016,4/10/2016,,,,CHRONIC NEUROPATHY PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002766,2016-002766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Nurse,71,Years,Female,F,6/16/2016,4/1/2016,,,,CHRONIC NEUROPATHY PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002777,2016-002777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Nurse,,Unknown,Female,F,5/18/2016,4/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002797,2016-002797,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Oral mucosal blistering,Physician,,Unknown,UNK,I,4/19/2016,,,,,UNKNOWN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2016-002798,2016-002798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Swelling face,Physician,,Unknown,Male,I,4/19/2016,,,,,UNKNOWN,UNITED STATES,Swelling face,,NO,NO,Unlisted
2016-002799,2016-002799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vein disorder,Non-Health Professional,78,Years,Male,I,4/19/2016,4/1/2016,,,,PAIN,UNITED STATES,Vein disorder,,NO,NO,Unlisted
2016-002799,2016-002799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,78,Years,Male,I,4/19/2016,2/20/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002799,2016-002799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,78,Years,Male,I,4/19/2016,2/20/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-002799,2016-002799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,78,Years,Male,I,4/19/2016,2/20/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-002817,2016-002817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Completed suicide,Physician,58,Years,Male,I,4/20/2016,1/1/2016,,,Death,CHRONIC PAIN,UNITED STATES,Completed suicide,,YES,YES,Unlisted
2016-002817,2016-002817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Intentional overdose,Physician,58,Years,Male,I,4/20/2016,1/1/2016,,,Death,CHRONIC PAIN,UNITED STATES,Intentional overdose,,YES,YES,Listed
2016-002826,2016-002826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,54,Years,Female,F,6/27/2016,4/20/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002826,2016-002826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,54,Years,Female,F,6/27/2016,4/20/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-002841,2016-002841,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Physician,,Unknown,Male,F,6/27/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-002863,2016-002863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Alopecia,Physician,53,Years,Female,F,5/11/2016,3/7/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2016-002939,2016-002939,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Anaphylactic reaction,Physician,41,Years,Female,I,4/25/2016,4/1/2016,,,Other,UNKNOWN,UNITED STATES,Anaphylactic reaction,,YES,YES,Listed
2016-002961,2016-002961,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dizziness,Physician,54,Years,Male,F,6/20/2016,4/13/2016,,,,UNKNOWN,UNITED STATES,Dizziness,,NO,NO,Listed
2016-002961,2016-002961,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Disorientation,Physician,54,Years,Male,F,6/20/2016,4/13/2016,,,,UNKNOWN,UNITED STATES,Disorientation,,NO,NO,Unlisted
2016-002961,2016-002961,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Ill-defined disorder,Physician,54,Years,Male,F,6/20/2016,4/1/2016,,,,UNKNOWN,UNITED STATES,Ill-defined disorder,,NO,NO,Unlisted
2016-002961,2016-002961,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,54,Years,Male,F,6/20/2016,4/13/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-002961,2016-002961,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Activities of daily living impaired,Physician,54,Years,Male,F,6/20/2016,4/1/2016,,,,UNKNOWN,UNITED STATES,Activities of daily living impaired,,NO,NO,Unlisted
2016-002964,2016-002964,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,,Unknown,Female,I,4/25/2016,,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-002964,2016-002964,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Malaise,Non-Health Professional,,Unknown,Female,I,4/25/2016,,,,,PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2016-002968,2016-002968,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Male,I,4/26/2016,4/21/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-002968,2016-002968,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,68,Years,Male,I,4/26/2016,4/21/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-002970,2016-002970,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,Unknown,Female,I,4/25/2016,4/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-003025,2016-003025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Disorientation,Physician,,Unknown,Female,I,4/28/2016,4/1/2016,,,,UNKNOWN,UNITED STATES,Disorientation,,NO,NO,Unlisted
2016-003025,2016-003025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dizziness,Physician,,Unknown,Female,I,4/28/2016,4/1/2016,,,,UNKNOWN,UNITED STATES,Dizziness,,NO,NO,Listed
2016-003027,2016-003027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Other Health Professional,48,Years,Male,I,4/27/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-003046,2016-003046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Hallucination,Physician,45,Years,Female,I,4/28/2016,1/1/2016,,,Other,UNKNOWN,UNITED STATES,Hallucination,,YES,YES,Unlisted
2016-003046,2016-003046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Pharyngeal oedema,Physician,45,Years,Female,I,4/28/2016,1/1/2016,,,Other,UNKNOWN,UNITED STATES,Pharyngeal oedema,,YES,YES,Listed
2016-003053,2016-003053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Physician,,Unknown,UNK,I,4/29/2016,,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-003053,2016-003053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Breakthrough pain,Physician,,Unknown,UNK,I,4/29/2016,,,,,PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Unlisted
2016-003053,2016-003053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Physician,,Unknown,UNK,I,4/29/2016,,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-003054,2016-003054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Ill-defined disorder,Non-Health Professional,70,Years,Male,F,7/1/2016,4/25/2016,,,,TREAT ADDICTION TO PAIN MEDICATION (PAIN MANAGEMENT),UNITED STATES,Ill-defined disorder,,NO,NO,Unlisted
2016-003054,2016-003054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,70,Years,Male,F,7/1/2016,4/25/2016,,,,TREAT ADDICTION TO PAIN MEDICATION (PAIN MANAGEMENT),UNITED STATES,Fatigue,,NO,NO,Listed
2016-003054,2016-003054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,70,Years,Male,F,7/1/2016,4/25/2016,,,,TREAT ADDICTION TO PAIN MEDICATION (PAIN MANAGEMENT),UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2016-003054,2016-003054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,70,Years,Male,F,7/1/2016,4/25/2016,,,,TREAT ADDICTION TO PAIN MEDICATION (PAIN MANAGEMENT),UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003054,2016-003054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,F,7/1/2016,4/26/2016,,,,TREAT ADDICTION TO PAIN MEDICATION (PAIN MANAGEMENT),UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003055,2016-003055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Tachycardia,Nurse,68,Years,Female,F,7/1/2016,4/22/2016,,,,PAIN,UNITED STATES,Tachycardia,,NO,NO,Unlisted
2016-003055,2016-003055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Nurse,68,Years,Female,F,7/1/2016,3/23/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-003055,2016-003055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product packaging issue,Nurse,68,Years,Female,F,7/1/2016,3/23/2016,,,,PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016-003113,2016-003113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Rash,Other Health Professional,,Unknown,Female,I,5/2/2016,4/1/2016,,,,PAIN,UNITED STATES,Rash,,NO,NO,Listed
2016-003133,2016-003133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dyspnoea,Physician,,Unknown,Male,I,5/3/2016,4/1/2016,,,,PAIN MANAGEMENT,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-003141,2016-003141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Other Health Professional,46,Years,Female,I,5/3/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-003141,2016-003141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Other Health Professional,46,Years,Female,I,5/3/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-003161,2016-003161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Rash generalised,Physician,,Unknown,Female,I,5/5/2016,,,,Other,UNKNOWN,UNITED STATES,Rash generalised,,YES,YES,Listed
2016-003182,2016-003182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Migraine,Physician,32,Years,Male,F,5/20/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-003182,2016-003182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral discomfort,Physician,32,Years,Male,F,5/20/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2016-003222,2016-003222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Female,F,7/4/2016,,,,,LOW BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003222,2016-003222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Female,F,7/4/2016,5/4/2016,,,,LOW BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-003222,2016-003222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,73,Years,Female,F,7/4/2016,5/4/2016,,,,LOW BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003223,2016-003223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Accidental exposure to product,Non-Health Professional,,Unknown,Male,I,5/5/2016,5/4/2016,,,,UNKNOWN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-003224,2016-003224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Nausea,Physician,,Unknown,Female,I,5/5/2016,,,,,PAIN MANAGEMENT,UNITED STATES,Nausea,,NO,NO,Listed
2016-003234,2016-003234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Nurse,,Unknown,Male,I,5/5/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-003235,2016-003235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Toothache,Nurse,,Unknown,Female,I,5/5/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Toothache,,NO,NO,Unlisted
2016-003238,2016-003238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,52,Years,Female,I,5/6/2016,5/6/2016,,,,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003269,2016-003269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Activities of daily living impaired,Physician,58,Years,Female,F,9/28/2016,3/13/2016,,,,CERVICAL SPONDYLOSIS,UNITED STATES,Activities of daily living impaired,,NO,NO,Unlisted
2016-003269,2016-003269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Aura,Physician,58,Years,Female,F,9/28/2016,3/13/2016,,,,CERVICAL SPONDYLOSIS,UNITED STATES,Aura,,NO,NO,Unlisted
2016-003269,2016-003269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dizziness,Physician,58,Years,Female,F,9/28/2016,3/13/2016,,,,CERVICAL SPONDYLOSIS,UNITED STATES,Dizziness,,NO,NO,Listed
2016-003269,2016-003269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Physician,58,Years,Female,F,9/28/2016,3/13/2016,,,,CERVICAL SPONDYLOSIS,UNITED STATES,Headache,,NO,NO,Listed
2016-003273,2016-003273,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chest pain,Physician,39,Years,Male,I,5/10/2016,4/25/2016,,,Other,UNKNOWN,UNITED STATES,Chest pain,,NO,YES,Unlisted
2016-003279,2016-003279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Nurse,58,Years,Female,I,5/10/2016,3/11/2016,,,,HERNIATED DISC IN BACK,UNITED STATES,Headache,,NO,NO,Listed
2016-003280,2016-003280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Migraine,Nurse,33,Years,Female,I,5/10/2016,4/28/2016,,,,CHRONIC SPINE PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-003295,2016-003295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Product adhesion issue,Non-Health Professional,55,Years,Female,F,7/8/2016,5/10/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003328,2016-003328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,56,Years,Female,F,10/18/2016,5/10/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-003328,2016-003328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,56,Years,Female,F,10/18/2016,5/4/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-003328,2016-003328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Female,F,10/18/2016,5/4/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003348,2016-003348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Other Health Professional,,Unknown,Male,I,5/13/2016,,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-003348,2016-003348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Urticaria,Other Health Professional,,Unknown,Male,I,5/13/2016,,,,,UNKNOWN,UNITED STATES,Urticaria,,NO,NO,Unlisted
2016-003348,2016-003348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Palpitations,Other Health Professional,,Unknown,Male,I,5/13/2016,,,,,UNKNOWN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-003388,2016-003388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,47,Years,Female,I,5/16/2016,5/3/2016,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2016-003388,2016-003388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Constipation,Non-Health Professional,47,Years,Female,I,5/16/2016,5/10/2016,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2016-003388,2016-003388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Female,I,5/16/2016,4/30/2016,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003398,2016-003398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,69,Years,Female,F,7/14/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-003398,2016-003398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,F,7/14/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003413,2016-003413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,62,Years,Male,F,6/27/2016,5/13/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-003413,2016-003413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,62,Years,Male,F,6/27/2016,5/13/2016,,,,PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2016-003413,2016-003413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,62,Years,Male,F,6/27/2016,5/13/2016,,,,PAIN,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2016-003413,2016-003413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Ill-defined disorder,Non-Health Professional,62,Years,Male,F,6/27/2016,,,,,PAIN,UNITED STATES,Ill-defined disorder,,NO,NO,Unlisted
2016-003413,2016-003413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,62,Years,Male,F,6/27/2016,1/1/2016,,,,PAIN,UNITED STATES,Sleep disorder,,NO,NO,
2016-003424,2016-003424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Overdose,Physician,,Unknown,Male,I,5/17/2016,5/1/2016,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Overdose,,YES,YES,Listed
2016-003484,2016-003484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Seizure,Physician,,Unknown,Female,I,5/20/2016,1/1/2016,,,Other,PAIN,UNITED STATES,Seizure,,YES,YES,Unlisted
2016-003492,2016-003492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Negative,,microgram,Buccal film,,Drug ineffective,Physician,68,Years,Male,F,11/14/2016,5/26/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003492,2016-003492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Negative,,microgram,Buccal film,,Product adhesion issue,Physician,68,Years,Male,F,11/14/2016,5/20/2016,,,,BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003492,2016-003492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Negative,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,68,Years,Male,F,11/14/2016,5/25/2016,,,,BACK PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003492,2016-003492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Negative,,microgram,Buccal film,,Wrong technique in product usage process,Physician,68,Years,Male,F,11/14/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Sneezing,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Sneezing,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,48,Years,Female,F,7/18/2016,5/1/2016,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-003510,2016-003510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,48,Years,Female,F,7/18/2016,5/9/2016,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2016-003550,2016-003550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,5/24/2016,4/1/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003550,2016-003550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,59,Years,Female,I,5/24/2016,4/1/2016,,,,BACK PAIN,UNITED STATES,Muscle spasms,,NO,NO,Listed
2016-003596,2016-003596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Constipation,Physician,,Unknown,UNK,I,5/25/2016,,,,,UNKNOWN,UNITED STATES,Constipation,,NO,NO,Listed
2016-003596,2016-003596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Breakthrough pain,Physician,,Unknown,UNK,I,5/25/2016,,,,,UNKNOWN,UNITED STATES,Breakthrough pain,,NO,NO,Unlisted
2016-003624,2016-003624,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Breakthrough pain,Physician,,Unknown,UNK,I,5/27/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Breakthrough pain,,NO,NO,Unlisted
2016-003649,2016-003649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Physician,,Unknown,UNK,I,5/31/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-003651,2016-003651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,62,Years,Male,I,5/24/2016,5/22/2016,,,,NEUROPATHY,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003651,2016-003651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,62,Years,Male,I,5/24/2016,5/22/2016,,,,NEUROPATHY,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-003651,2016-003651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Male,I,5/24/2016,1/1/2016,,,,NEUROPATHY,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003679,2016-003679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,UNK,I,6/1/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003680,2016-003680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Physician,,Unknown,Female,I,5/31/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-003683,2016-003683,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,,,Female,F,6/14/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-003706,2016-003706,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,45,Years,Female,I,6/1/2016,5/20/2016,,,,CHRONIC MIGRAINES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-003706,2016-003706,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,45,Years,Female,I,6/1/2016,5/27/2016,,,,CHRONIC MIGRAINES,UNITED STATES,Somnolence,,NO,NO,Listed
2016-003711,2016-003711,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Physician,,Unknown,UNK,I,6/1/2016,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003712,2016-003712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Feeling abnormal,Physician,,Unknown,UNK,I,6/1/2016,,,,,PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-003712,2016-003712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Physician,,Unknown,UNK,I,6/1/2016,,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-003712,2016-003712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Somnolence,Physician,,Unknown,UNK,I,6/1/2016,,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-003714,2016-003714,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Muscle twitching,Non-Health Professional,,Unknown,Female,I,6/2/2016,5/26/2016,,,,UNKNOWN,UNITED STATES,Muscle twitching,,NO,NO,Unlisted
2016-003718,2016-003718,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,,Unknown,Male,I,6/1/2016,,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-003754,2016-003754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,6/3/2016,5/19/2016,,,,ABDOMINAL PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003754,2016-003754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,59,Years,Female,I,6/3/2016,5/19/2016,,,,ABDOMINAL PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-003770,2016-003770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Loss of consciousness,Non-Health Professional,,Unknown,Female,I,6/6/2016,6/3/2016,,,Other,BODY PAIN,UNITED STATES,Loss of consciousness,,YES,YES,Unlisted
2016-003770,2016-003770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,Unknown,Female,I,6/6/2016,6/3/2016,,,,BODY PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2016-003770,2016-003770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,Unknown,Female,I,6/6/2016,6/3/2016,,,,BODY PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2016-003770,2016-003770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,,Unknown,Female,I,6/6/2016,6/3/2016,,,,BODY PAIN,UNITED STATES,Headache,,NO,YES,Listed
2016-003770,2016-003770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,,Unknown,Female,I,6/6/2016,6/3/2016,,,,BODY PAIN,UNITED STATES,Dyspnoea,,NO,YES,Listed
2016-003818,2016-003818,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,43,Years,Male,I,6/7/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-003833,2016-003833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hospitalisation,Pharmacist,,Unknown,UNK,I,6/8/2016,1/1/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Hospitalisation,,YES,YES,Unlisted
2016-003864,2016-003864,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,Unknown,Male,F,8/22/2016,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-003864,2016-003864,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Product use issue,Non-Health Professional,,Unknown,Male,F,8/22/2016,,,,,CHRONIC PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016-003877,2016-003877,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Loss of consciousness,Non-Health Professional,,Unknown,Female,I,6/9/2016,6/1/2016,,,Other,UNKNOWN,UNITED STATES,Loss of consciousness,,YES,YES,Unlisted
2016-003884,2016-003884,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,35,Years,Female,F,9/16/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003884,2016-003884,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Other Health Professional,35,Years,Female,F,9/16/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-003886,2016-003886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Mouth ulceration,Physician,,Unknown,Male,F,9/16/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2016-003906,2016-003906,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Drug withdrawal syndrome,Physician,,Unknown,Female,I,6/13/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003907,2016-003907,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Oropharyngeal pain,Physician,,Unknown,Male,I,6/13/2016,1/1/2016,,,,PAIN,UNITED STATES,Oropharyngeal pain,,NO,NO,Listed
2016-003908,2016-003908,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,57,Years,Male,F,8/16/2016,6/11/2016,,,,PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-003908,2016-003908,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product formulation issue,Non-Health Professional,57,Years,Male,F,8/16/2016,1/1/2016,,,,PAIN,UNITED STATES,Product formulation issue,,NO,NO,Unlisted
2016-003908,2016-003908,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Male,F,8/16/2016,5/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-003929,2016-003929,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,45,Years,Female,F,8/22/2016,5/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-003929,2016-003929,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,45,Years,Female,F,8/22/2016,5/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004046,2016-004046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Physician,,Unknown,Male,F,8/17/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-004046,2016-004046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Male,F,8/17/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004056,2016-004056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Anger,Physician,62,Years,Male,I,6/17/2016,6/1/2016,,,,PAIN MANAGEMENT,UNITED STATES,Anger,,NO,NO,Unlisted
2016-004060,2016-004060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,8/29/2016,,,,,PAIN CONTROL,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004068,2016-004068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Bladder pain,Nurse,60,Years,Female,I,6/17/2016,6/1/2016,,,,FIBROMYALGIA,UNITED STATES,Bladder pain,,NO,NO,Unlisted
2016-004095,2016-004095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,52,Years,Female,F,8/16/2016,5/18/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-004095,2016-004095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,52,Years,Female,F,8/16/2016,5/20/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2016-004095,2016-004095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dysphonia,Non-Health Professional,52,Years,Female,F,8/16/2016,1/1/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Dysphonia,,NO,NO,Unlisted
2016-004095,2016-004095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,52,Years,Female,F,8/16/2016,1/1/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Pain,,NO,NO,Listed
2016-004095,2016-004095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Non-Health Professional,52,Years,Female,F,8/16/2016,5/18/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004118,2016-004118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Headache,Physician,,Unknown,Male,I,6/21/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-004120,2016-004120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Anxiety,Physician,,Unknown,Female,I,6/21/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2016-004121,2016-004121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Stomatitis,Physician,,Unknown,Female,I,6/21/2016,5/1/2016,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-004155,2016-004155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Malaise,Non-Health Professional,36,Years,Female,I,6/22/2016,6/15/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2016-004155,2016-004155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Euphoric mood,Non-Health Professional,36,Years,Female,I,6/22/2016,6/15/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Euphoric mood,,NO,NO,Unlisted
2016-004165,2016-004165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,72,Years,Male,F,8/26/2016,6/16/2016,,,,FRACTURED SPINE PAIN NEXT TO PINCHED NERVE,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-004165,2016-004165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Underdose,Non-Health Professional,72,Years,Male,F,8/26/2016,6/16/2016,,,,FRACTURED SPINE PAIN NEXT TO PINCHED NERVE,UNITED STATES,Underdose,,NO,NO,Unlisted
2016-004165,2016-004165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Male,F,8/26/2016,6/16/2016,,,,FRACTURED SPINE PAIN NEXT TO PINCHED NERVE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016-004165,2016-004165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,72,Years,Male,F,8/26/2016,6/16/2016,,,,FRACTURED SPINE PAIN NEXT TO PINCHED NERVE,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2016-004174,2016-004174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Non-Health Professional,,Unknown,UNK,I,6/24/2016,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004174,2016-004174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Vomiting,Non-Health Professional,,Unknown,UNK,I,6/24/2016,,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-004211,2016-004211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Feeling abnormal,Physician,,Unknown,Male,I,6/27/2016,,,,,UNKNOWN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-004213,2016-004213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Application site irritation,Other Health Professional,,Adult,Female,I,6/27/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Application site irritation,,NO,NO,Unlisted
2016-004215,2016-004215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Physician,,Unknown,Male,I,6/27/2016,6/1/2016,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-004215,2016-004215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling abnormal,Physician,,Unknown,Male,I,6/27/2016,6/1/2016,,,,PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-004216,2016-004216,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,8/26/2016,6/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004250,2016-004250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Atrial fibrillation,Other Health Professional,58,Years,Male,F,9/12/2016,6/25/2016,,,Other,CHRONIC PAIN,UNITED STATES,Atrial fibrillation,,YES,YES,Listed
2016-004252,2016-004252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Male,F,8/26/2016,,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004252,2016-004252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Male,F,8/26/2016,6/27/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-004252,2016-004252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,60,Years,Male,F,8/26/2016,6/28/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Listed
2016-004252,2016-004252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,60,Years,Male,F,8/26/2016,6/27/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-004257,2016-004257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,,Unknown,Male,I,6/28/2016,6/28/2016,,,,UNKNOWN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-004257,2016-004257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Irritability,Non-Health Professional,,Unknown,Male,I,6/28/2016,6/28/2016,,,,UNKNOWN,UNITED STATES,Irritability,,NO,NO,Unlisted
2016-004257,2016-004257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,,Unknown,Male,I,6/28/2016,6/28/2016,,,,UNKNOWN,UNITED STATES,Chest discomfort,,NO,NO,Listed
2016-004276,2016-004276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Blood pressure increased,Physician,69,Years,Male,I,6/29/2016,6/1/2016,,,Other,"PAIN, NOT SPECIFIED",UNITED STATES,Blood pressure increased,,YES,YES,Listed
2016-004276,2016-004276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Physician,69,Years,Male,I,6/29/2016,6/1/2016,,,,"PAIN, NOT SPECIFIED",UNITED STATES,Headache,,NO,YES,Listed
2016-004298,2016-004298,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,,Unknown,Female,I,6/29/2016,6/1/2016,,,,PAIN RELIEF,UNITED STATES,Headache,,NO,NO,Listed
2016-004305,2016-004305,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Drug effect decreased,Physician,,Unknown,UNK,I,6/30/2016,,,,,UNKNOWN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-004308,2016-004308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,Unknown,Female,F,8/26/2016,6/1/2015,,,,UNKNOWN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-004308,2016-004308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Thirst,Non-Health Professional,,Unknown,Female,F,8/26/2016,6/1/2015,,,,UNKNOWN,UNITED STATES,Thirst,,NO,NO,Unlisted
2016-004320,2016-004320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Other Health Professional,,Adult,Male,F,8/26/2016,6/27/2016,,,,CHRONIC PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-004320,2016-004320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Other Health Professional,,Adult,Male,F,8/26/2016,6/27/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004320,2016-004320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,,Adult,Male,F,8/26/2016,6/27/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004321,2016-004321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,47,Years,Female,F,9/5/2016,6/30/2016,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2016-004321,2016-004321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Female,F,9/5/2016,6/30/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004321,2016-004321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,47,Years,Female,F,9/5/2016,6/30/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004325,2016-004325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Wrong technique in product usage process,Non-Health Professional,,Unknown,Male,I,7/1/2016,,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004325,2016-004325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Product quality issue,Non-Health Professional,,Unknown,Male,I,7/1/2016,,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Listed
2016-004326,2016-004326,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Lymphadenopathy,Physician,,Unknown,Female,I,7/1/2016,,,,,CHRONIC PAIN,UNITED STATES,Lymphadenopathy,,NO,NO,Unlisted
2016-004344,2016-004344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Muscle spasms,Other Health Professional,53,Years,Female,I,7/1/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,NO,Listed
2016-004344,2016-004344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Decreased appetite,Other Health Professional,53,Years,Female,I,7/1/2016,6/14/2016,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2016-004344,2016-004344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Asthenia,Other Health Professional,53,Years,Female,I,7/1/2016,6/14/2016,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,NO,Listed
2016-004344,2016-004344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Withdrawal syndrome,Other Health Professional,53,Years,Female,I,7/1/2016,6/14/2016,,,,CHRONIC PAIN,UNITED STATES,Withdrawal syndrome,,NO,NO,Listed
2016-004344,2016-004344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chills,Other Health Professional,53,Years,Female,I,7/1/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Chills,,NO,NO,Listed
2016-004394,2016-004394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dispensing error,Non-Health Professional,,Unknown,Female,I,6/30/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dispensing error,,NO,NO,Unlisted
2016-004420,2016-004420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Application site swelling,Physician,,,Female,I,7/7/2016,7/1/2016,,,,UNKNOWN,UNITED STATES,Application site swelling,,NO,NO,Unlisted
2016-004430,2016-004430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,63,Years,Male,F,9/5/2016,7/7/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004430,2016-004430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Male,F,9/5/2016,7/7/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004431,2016-004431,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Female,I,7/7/2016,,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004441,2016-004441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Physician,,,Male,I,7/8/2016,,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004478,2016-004478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,35,Years,Male,I,7/11/2016,7/11/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004489,2016-004489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,No adverse event,Physician,,Unknown,UNK,F,7/18/2016,,,,,UNKNOWN,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-004504,2016-004504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Nurse,,Unknown,Male,I,7/12/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004504,2016-004504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Nurse,,Unknown,Male,I,7/12/2016,4/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-004513,2016-004513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dizziness,Physician,,Unknown,Female,I,7/11/2016,6/1/2016,,,,UNKNOWN,UNITED STATES,Dizziness,,NO,NO,Listed
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Somnolence,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Hyperaesthesia,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Hyperaesthesia,,NO,NO,Unlisted
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Motion sickness,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Motion sickness,,NO,NO,Unlisted
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Drug ineffective,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-004525,2016-004525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Dyspnoea,Non-Health Professional,56,Years,Female,F,9/12/2016,6/29/2016,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-004544,2016-004544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Sinusitis,Nurse,52,Years,Female,F,8/22/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Sinusitis,,NO,NO,Listed
2016-004544,2016-004544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dysgeusia,Nurse,52,Years,Female,F,8/22/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016-004544,2016-004544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Nurse,52,Years,Female,F,8/22/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004544,2016-004544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Parosmia,Nurse,52,Years,Female,F,8/22/2016,6/16/2016,,,,CHRONIC PAIN,UNITED STATES,Parosmia,,NO,NO,Unlisted
2016-004561,2016-004561,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Other Health Professional,,Unknown,Female,I,7/14/2016,7/1/2016,,,,CHRONIC PAIN MANAGEMENT,UNITED STATES,Nausea,,NO,NO,Listed
2016-004586,2016-004586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,Unknown,Male,I,7/15/2016,,,,,UNKNOWN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-004599,2016-004599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pharyngitis,Physician,,Unknown,Male,I,7/18/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Pharyngitis,,NO,NO,Unlisted
2016-004602,2016-004602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,51,Years,Female,I,7/15/2016,7/10/2016,,,,PAIN,CANADA,Drug effect decreased,,NO,NO,Listed
2016-004602,2016-004602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Unevaluable event,Non-Health Professional,51,Years,Female,I,7/15/2016,7/10/2016,,,,PAIN,CANADA,Unevaluable event,,NO,NO,Unlisted
2016-004613,2016-004613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Insomnia,Physician,,Unknown,Male,I,7/18/2016,7/16/2016,,,,CHRONIC LONG TERM PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2016-004613,2016-004613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Suicidal ideation,Physician,,Unknown,Male,I,7/18/2016,7/1/2016,,,Other,CHRONIC LONG TERM PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2016-004613,2016-004613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Depression,Physician,,Unknown,Male,I,7/18/2016,7/1/2016,,,,CHRONIC LONG TERM PAIN,UNITED STATES,Depression,,NO,YES,Listed
2016-004641,2016-004641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Nausea,Physician,,Unknown,Female,I,7/19/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004641,2016-004641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Somnolence,Physician,,Unknown,Female,I,7/19/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-004642,2016-004642,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Anaphylactic reaction,Physician,55,Years,Female,F,8/15/2016,5/27/2016,,,Other,CHRONIC PAIN SYNDROME,UNITED STATES,Anaphylactic reaction,,YES,YES,Listed
2016-004686,2016-004686,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hepatitis,Physician,,Unknown,Female,I,7/21/2016,1/1/2016,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hepatitis,,YES,YES,Unlisted
2016-004696,2016-004696,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Atrial fibrillation,Non-Health Professional,58,Years,Male,I,7/25/2016,4/1/2016,,,Other,OPIOID DEPENDENCE,UNITED STATES,Atrial fibrillation,,YES,YES,Listed
2016-004696,2016-004696,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Cardiac ablation,Non-Health Professional,58,Years,Male,I,7/25/2016,6/20/2016,,,Hospitalisation,OPIOID DEPENDENCE,UNITED STATES,Cardiac ablation,,YES,YES,Unlisted
2016-004696,2016-004696,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Off label use,Non-Health Professional,58,Years,Male,I,7/25/2016,4/1/2016,,,,OPIOID DEPENDENCE,UNITED STATES,Off label use,,NO,YES,Unlisted
2016-004722,2016-004722,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Application site pain,Nurse,,Unknown,UNK,F,7/26/2016,,,,,UNKNOWN,UNITED STATES,Application site pain,,NO,NO,Listed
2016-004753,2016-004753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Toothache,Non-Health Professional,46,Years,Female,F,9/23/2016,7/1/2016,,,,VERTEBRAE PAIN,UNITED STATES,Toothache,,NO,NO,Listed
2016-004753,2016-004753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,46,Years,Female,F,9/23/2016,1/1/2016,,,,VERTEBRAE PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-004753,2016-004753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,F,9/23/2016,1/1/2016,,,,VERTEBRAE PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004753,2016-004753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,F,9/23/2016,1/1/2016,,,,VERTEBRAE PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-004753,2016-004753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug dose omission,Non-Health Professional,46,Years,Female,F,9/23/2016,1/1/2016,,,,VERTEBRAE PAIN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-004787,2016-004787,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,51,Years,Female,F,8/22/2016,6/1/2016,,,,BACK PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004787,2016-004787,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,51,Years,Female,F,8/22/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-004787,2016-004787,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,51,Years,Female,F,8/22/2016,6/1/2016,,,,BACK PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-004825,2016-004825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Therapeutic response unexpected,Non-Health Professional,67,Years,Female,F,7/27/2016,1/1/2016,,,,PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2016-004825,2016-004825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Female,F,7/27/2016,7/24/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-004846,2016-004846,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,34,Years,Female,I,7/28/2016,7/28/2016,,,,POSSIBLE FIBROMYALGIA,UNITED STATES,Pain,,NO,NO,Listed
2016-004848,2016-004848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,60,Years,Female,F,8/22/2016,7/25/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004848,2016-004848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Female,F,8/22/2016,7/25/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004869,2016-004869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Diarrhoea,Physician,,Unknown,Male,I,7/29/2016,7/1/2016,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2016-004903,2016-004903,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Somnolence,Physician,,Unknown,Male,I,8/1/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-004910,2016-004910,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Drug withdrawal syndrome,Physician,,Unknown,UNK,I,8/1/2016,,,,,UNKNOWN,UNITED STATES,Drug withdrawal syndrome,,NO,NO,Listed
2016-004911,2016-004911,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Nurse,4,Decades,Female,I,8/2/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004951,2016-004951,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Toothache,Non-Health Professional,46,Years,Female,I,8/2/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,NO,Unlisted
2016-004951,2016-004951,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Sensitivity of teeth,Non-Health Professional,46,Years,Female,I,8/2/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Sensitivity of teeth,,NO,NO,Unlisted
2016-004975,2016-004975,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Female,F,8/22/2016,,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004975,2016-004975,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dry mouth,Non-Health Professional,,Unknown,Female,F,8/22/2016,,,,,UNKNOWN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-004976,2016-004976,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Headache,Physician,,Unknown,UNK,I,8/2/2016,,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-004976,2016-004976,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Drug screen negative,Physician,,Unknown,UNK,I,8/2/2016,,,,,UNKNOWN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2016-004976,2016-004976,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Nausea,Physician,,Unknown,UNK,I,8/2/2016,,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-004977,2016-004977,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,No adverse event,Non-Health Professional,,Unknown,UNK,I,8/3/2016,,,,,UNKNOWN,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-004978,2016-004978,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Male,F,11/21/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004978,2016-004978,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Male,F,11/21/2016,1/1/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004979,2016-004979,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,59,Years,Female,F,10/3/2016,5/1/2016,,,,EHLERS-DANLOS TYPE III,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-004979,2016-004979,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,F,10/3/2016,5/1/2016,,,,EHLERS-DANLOS TYPE III,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004994,2016-004994,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Stomatitis,Physician,,Unknown,Male,I,8/4/2016,7/29/2016,,,Other,CHRONIC PAIN,UNITED STATES,Stomatitis,,YES,YES,Unlisted
2016-004994,2016-004994,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Mouth swelling,Physician,,Unknown,Male,I,8/4/2016,7/29/2016,,,Other,CHRONIC PAIN,UNITED STATES,Mouth swelling,,YES,YES,Unlisted
2016-004997,2016-004997,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,10/18/2016,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-004997,2016-004997,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Physician,,Unknown,Female,F,10/18/2016,,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005013,2016-005013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,I,8/3/2016,7/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005024,2016-005024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,24,Years,Female,I,8/5/2016,1/1/2016,,,,LOW BACK PAIN OF LUMBAR SPINE,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005024,2016-005024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Physician,24,Years,Female,I,8/5/2016,1/1/2016,,,,LOW BACK PAIN OF LUMBAR SPINE,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/2/2016,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/2/2016,,,,PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/2/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/2/2016,,,,PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/1/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005025,2016-005025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,F,8/22/2016,8/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005026,2016-005026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Tooth deposit,Physician,61,Years,Female,F,1/9/2017,7/1/2016,,,,PAIN,UNITED STATES,Tooth deposit,,NO,NO,Unlisted
2016-005086,2016-005086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug screen negative,Other Health Professional,,Unknown,Female,I,8/9/2016,,,,,UNKNOWN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2016-005091,2016-005091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Pruritus,Physician,4,Decades,Female,I,8/9/2016,6/1/2016,,,,PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2016-005114,2016-005114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling drunk,Nurse,,Unknown,Female,I,8/10/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Feeling drunk,,NO,NO,Unlisted
2016-005115,2016-005115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Arthralgia,Nurse,,Unknown,Female,I,8/10/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Arthralgia,,NO,NO,Unlisted
2016-005121,2016-005121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hot flush,Physician,52,Years,Male,I,8/10/2016,5/1/2016,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2016-005139,2016-005139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,I,8/11/2016,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005142,2016-005142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Application site swelling,Other Health Professional,,Unknown,Female,I,8/11/2016,7/1/2016,,,,PAIN,UNITED STATES,Application site swelling,,NO,NO,Unlisted
2016-005142,2016-005142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hypersensitivity,Other Health Professional,,Unknown,Female,I,8/11/2016,7/1/2016,,,,PAIN,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2016-005146,2016-005146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,,Unknown,Female,I,8/11/2016,7/1/2016,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-005169,2016-005169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,60,Years,Male,F,10/18/2016,1/1/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005169,2016-005169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,60,Years,Male,F,10/18/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-005170,2016-005170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Accidental exposure to product,Physician,51,Years,Female,F,9/12/2016,8/15/2016,,,,UNKNOWN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-005170,2016-005170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product use issue,Physician,51,Years,Female,F,9/12/2016,8/15/2016,,,,UNKNOWN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016-005219,2016-005219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Lethargy,Physician,52,Years,Female,I,8/16/2016,8/1/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Lethargy,,YES,YES,Listed
2016-005219,2016-005219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Confusional state,Physician,52,Years,Female,I,8/16/2016,8/1/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Confusional state,,YES,YES,Unlisted
2016-005224,2016-005224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Male,F,8/26/2016,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005225,2016-005225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,8/26/2016,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005227,2016-005227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Physician,55,Years,Female,I,8/16/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-005227,2016-005227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Nausea,Physician,55,Years,Female,I,8/16/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-005228,2016-005228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,Unknown,Female,I,8/16/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-005229,2016-005229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,Unknown,Male,I,8/16/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-005252,2016-005252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Rash,Other Health Professional,,Unknown,Female,I,8/17/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Rash,,NO,NO,Listed
2016-005269,2016-005269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pollakiuria,Non-Health Professional,63,Years,Female,F,10/13/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Pollakiuria,,NO,NO,Unlisted
2016-005273,2016-005273,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Other Health Professional,,Unknown,Female,I,8/18/2016,8/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-005286,2016-005286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Swelling face,Physician,,Unknown,Female,I,8/19/2016,1/1/2016,,,,PAIN,UNITED STATES,Swelling face,,NO,NO,Unlisted
2016-005343,2016-005343,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,47,Years,Male,F,11/18/2016,7/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-005343,2016-005343,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,47,Years,Male,F,11/18/2016,8/25/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005354,2016-005354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Gingival bleeding,Physician,36,Years,Male,I,8/24/2016,7/1/2016,,,,UNKNOWN,UNITED STATES,Gingival bleeding,,NO,NO,Unlisted
2016-005354,2016-005354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hypertension,Physician,36,Years,Male,I,8/24/2016,7/1/2016,,,,UNKNOWN,UNITED STATES,Hypertension,,NO,NO,Unlisted
2016-005354,2016-005354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Physician,36,Years,Male,I,8/24/2016,7/1/2016,,,,UNKNOWN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-005358,2016-005358,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,76,Years,Female,I,8/24/2016,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-005360,2016-005360,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Migraine,Physician,32,Years,Male,I,8/24/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-005361,2016-005361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Physician,,Unknown,Female,F,10/18/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005361,2016-005361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Physician,,Unknown,Female,F,10/18/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-005361,2016-005361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug dose omission,Physician,,Unknown,Female,F,10/18/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-005372,2016-005372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pancreatitis,Physician,,Unknown,Female,I,8/25/2016,,,,Other,CHRONIC PAIN,UNITED STATES,Pancreatitis,,YES,YES,Unlisted
2016-005372,2016-005372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intestinal obstruction,Physician,,Unknown,Female,I,8/25/2016,,,,Other,CHRONIC PAIN,UNITED STATES,Intestinal obstruction,,YES,YES,Unlisted
2016-005372,2016-005372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Gastrointestinal disorder,Physician,,Unknown,Female,I,8/25/2016,,,,,CHRONIC PAIN,UNITED STATES,Gastrointestinal disorder,,NO,YES,Unlisted
2016-005397,2016-005397,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Peripheral swelling,Non-Health Professional,78,Years,Female,I,8/26/2016,1/1/2016,,,Other,SEVERE SPINAL STENOSIS,UNITED STATES,Peripheral swelling,,YES,YES,Listed
2016-005398,2016-005398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Anaphylactic reaction,Non-Health Professional,46,Years,Female,I,8/25/2016,8/1/2016,,,Other,PAIN,UNITED STATES,Anaphylactic reaction,,YES,YES,Listed
2016-005398,2016-005398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,I,8/25/2016,7/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2016-005398,2016-005398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,46,Years,Female,I,8/25/2016,1/1/2016,,,,PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2016-005398,2016-005398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Rash,Non-Health Professional,46,Years,Female,I,8/25/2016,1/1/2016,,,,PAIN,UNITED STATES,Rash,,NO,YES,Listed
2016-005401,2016-005401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Male,F,10/21/2016,1/1/2016,,,,OSTEOARTHRITIS PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005401,2016-005401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Male,F,10/21/2016,1/1/2016,,,,OSTEOARTHRITIS PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Malaise,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Musculoskeletal disorder,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal disorder,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Contusion,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Contusion,,NO,YES,Listed
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Physician,49,Years,Female,F,10/21/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug effect decreased,,NO,YES,Listed
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Fall,Physician,49,Years,Female,F,10/21/2016,8/22/2016,,,Other,CHRONIC PAIN,UNITED STATES,Fall,,YES,YES,Listed
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Muscle strain,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Muscle strain,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Physician,49,Years,Female,F,10/21/2016,7/22/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response unexpected,Physician,49,Years,Female,F,10/21/2016,6/1/2016,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Mobility decreased,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Mobility decreased,,NO,YES,Unlisted
2016-005429,2016-005429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Insomnia,Physician,49,Years,Female,F,10/21/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2016-005460,2016-005460,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Migraine,Non-Health Professional,,Unknown,Female,I,8/30/2016,8/17/2016,,,,PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-005460,2016-005460,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,,Unknown,Female,I,8/30/2016,8/1/2016,,,,PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2016-005470,2016-005470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pruritus,Physician,,Unknown,Female,I,8/31/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Pruritus,,NO,NO,Listed
2016-005487,2016-005487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Mouth swelling,Physician,,Unknown,Female,I,8/31/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Mouth swelling,,NO,NO,Unlisted
2016-005505,2016-005505,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Nurse,64,Years,Female,F,9/12/2016,1/1/2016,,,,"PAIN FROM SEVERE NERVE DAMAGE IN HER BACK, LEFT HIP AND LEFT LEG AND SCIATICA",UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005505,2016-005505,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Nurse,64,Years,Female,F,9/12/2016,1/1/2016,,,,"PAIN FROM SEVERE NERVE DAMAGE IN HER BACK, LEFT HIP AND LEFT LEG AND SCIATICA",UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-005513,2016-005513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Other Health Professional,,Unknown,Female,I,9/1/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-005513,2016-005513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Paraesthesia oral,Other Health Professional,,Unknown,Female,I,9/1/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Paraesthesia oral,,NO,NO,Unlisted
2016-005583,2016-005583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,74,Years,Male,I,9/6/2016,9/2/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005583,2016-005583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Pharmacist,74,Years,Male,I,9/6/2016,9/3/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005583,2016-005583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Pharmacist,74,Years,Male,I,9/6/2016,9/2/2016,,,,PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-005583,2016-005583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,74,Years,Male,I,9/6/2016,9/2/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005591,2016-005591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Physician,,Unknown,Male,F,11/21/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-005598,2016-005598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,,Unknown,Female,F,10/3/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-005599,2016-005599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,Unknown,Male,I,9/7/2016,,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-005600,2016-005600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Abdominal pain,Other Health Professional,70,Years,Female,I,9/7/2016,9/1/2016,,,,RIGHT HIP PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2016-005600,2016-005600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Other Health Professional,70,Years,Female,I,9/7/2016,9/1/2016,,,,RIGHT HIP PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-005600,2016-005600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Other Health Professional,70,Years,Female,I,9/7/2016,8/31/2016,,,,RIGHT HIP PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-005600,2016-005600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pruritus,Other Health Professional,70,Years,Female,I,9/7/2016,8/30/2016,,,,RIGHT HIP PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2016-005600,2016-005600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,70,Years,Female,I,9/7/2016,8/30/2016,,,,RIGHT HIP PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005607,2016-005607,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Stomatitis,Physician,37,Years,Female,F,11/2/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-005614,2016-005614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Insomnia,Physician,,Unknown,Female,I,9/8/2016,1/1/2016,,,,PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2016-005614,2016-005614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Headache,Physician,,Unknown,Female,I,9/8/2016,1/1/2016,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-005655,2016-005655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Laryngitis,Pharmacist,53,Years,Female,F,10/3/2016,9/8/2016,,,,FIBROMYALGIA,UNITED STATES,Laryngitis,,NO,NO,Unlisted
2016-005655,2016-005655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Pharmacist,53,Years,Female,F,10/3/2016,1/1/2016,,,,FIBROMYALGIA,UNITED STATES,Somnolence,,NO,NO,Listed
2016-005655,2016-005655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,53,Years,Female,F,10/3/2016,1/1/2016,,,,FIBROMYALGIA,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005655,2016-005655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oropharyngeal pain,Pharmacist,53,Years,Female,F,10/3/2016,9/7/2016,,,,FIBROMYALGIA,UNITED STATES,Oropharyngeal pain,,NO,NO,Listed
2016-005663,2016-005663,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Pharmacist,83,Years,Male,F,11/4/2016,8/30/2016,,,,NERVE PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-005692,2016-005692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Other Health Professional,,Unknown,Female,I,9/12/2016,1/1/2016,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Visual acuity reduced,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Visual acuity reduced,,NO,NO,Unlisted
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Activities of daily living impaired,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Activities of daily living impaired,,NO,NO,Unlisted
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2016-005707,2016-005707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,46,Years,Female,F,11/4/2016,8/1/2016,,,,NEUROPATHY PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-005722,2016-005722,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Alopecia,Other Health Professional,,Adult,Female,I,9/13/2016,,,,,PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2016-005728,2016-005728,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hypoglycaemia,Nurse,,Unknown,UNK,I,9/13/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Hypoglycaemia,,NO,NO,Unlisted
2016-005728,2016-005728,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Nurse,,Unknown,UNK,I,9/13/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005728,2016-005728,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Migraine,Nurse,,Unknown,UNK,I,9/13/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Migraine,,NO,NO,Listed
2016-005738,2016-005738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Sexual dysfunction,Other Health Professional,24,Years,Male,F,10/21/2016,8/1/2016,,,,CHRONIC LOW BACK PAIN,UNITED STATES,Sexual dysfunction,,NO,NO,Unlisted
2016-005746,2016-005746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Diarrhoea,Physician,,Unknown,Female,I,9/15/2016,1/1/2016,,,,PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2016-005757,2016-005757,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Underdose,Other Health Professional,29,Years,Female,F,11/14/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Underdose,,NO,NO,Unlisted
2016-005757,2016-005757,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,29,Years,Female,F,11/14/2016,9/7/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005757,2016-005757,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,29,Years,Female,F,11/14/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-005757,2016-005757,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Other Health Professional,29,Years,Female,F,11/14/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005757,2016-005757,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Other Health Professional,29,Years,Female,F,11/14/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-005766,2016-005766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Anger,Other Health Professional,68,Years,Male,I,9/15/2016,1/1/2016,,,,PAIN,UNITED STATES,Anger,,NO,NO,Unlisted
2016-005766,2016-005766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Mood altered,Other Health Professional,68,Years,Male,I,9/15/2016,1/1/2016,,,,PAIN,UNITED STATES,Mood altered,,NO,NO,Unlisted
2016-005766,2016-005766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Aggression,Other Health Professional,68,Years,Male,I,9/15/2016,1/1/2016,,,,PAIN,UNITED STATES,Aggression,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Application site swelling,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Application site swelling,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Application site irritation,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Application site irritation,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2016-005777,2016-005777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,56,Years,Male,F,11/21/2016,8/1/2016,,,,LOWER BACK PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016-005778,2016-005778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Liver function test increased,Other Health Professional,,Unknown,Male,I,9/15/2016,9/1/2016,,,,UNKNOWN,UNITED STATES,Liver function test increased,,NO,NO,Unlisted
2016-005778,2016-005778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Back pain,Other Health Professional,,Unknown,Male,I,9/15/2016,9/1/2016,,,,UNKNOWN,UNITED STATES,Back pain,,NO,NO,Listed
2016-005795,2016-005795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Drug screen negative,Physician,,Unknown,UNK,I,9/16/2016,,,,,UNKNOWN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2016-005796,2016-005796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Pharmacist,66,Years,Male,F,11/18/2016,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-005804,2016-005804,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Respiratory depression,Physician,,Unknown,Female,I,9/15/2016,,,,Other,CHRONIC PAIN,UNITED STATES,Respiratory depression,,YES,YES,Listed
2016-005813,2016-005813,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Oral discomfort,Nurse,,Unknown,UNK,I,9/19/2016,,,,,UNKNOWN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2016-005832,2016-005832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Other Health Professional,54,Years,Female,F,11/21/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005832,2016-005832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Other Health Professional,54,Years,Female,F,11/21/2016,9/16/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005832,2016-005832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Other Health Professional,54,Years,Female,F,11/21/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-005858,2016-005858,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,,Unknown,UNK,I,9/20/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-005858,2016-005858,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Diarrhoea,Physician,,Unknown,UNK,I,9/20/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2016-005859,2016-005859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Carpal tunnel syndrome,Non-Health Professional,58,Years,Female,F,1/3/2017,9/13/2016,,,,CHRONIC BACK AND LEG PAIN,UNITED STATES,Carpal tunnel syndrome,,NO,NO,Unlisted
2016-005859,2016-005859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,F,1/3/2017,9/1/2016,,,,CHRONIC BACK AND LEG PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005859,2016-005859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,58,Years,Female,F,1/3/2017,9/1/2016,,,,CHRONIC BACK AND LEG PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005869,2016-005869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Physician,,Unknown,UNK,F,11/18/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-005869,2016-005869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,,Unknown,UNK,F,11/18/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-005900,2016-005900,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Nurse,26,Years,Female,F,10/21/2016,1/1/2016,,,,PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-005904,2016-005904,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product packaging issue,Physician,77,Years,Female,F,11/24/2016,1/1/2016,,,,PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016-005904,2016-005904,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Physician,77,Years,Female,F,11/24/2016,9/20/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-005904,2016-005904,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Physician,77,Years,Female,F,11/24/2016,9/20/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005915,2016-005915,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Constipation,Other Health Professional,,Unknown,Female,I,9/22/2016,,,,,UNKNOWN,UNITED STATES,Constipation,,NO,NO,Listed
2016-005948,2016-005948,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Application site swelling,Physician,,Unknown,Female,I,9/26/2016,1/1/2016,,,,PAIN,UNITED STATES,Application site swelling,,NO,NO,Unlisted
2016-005948,2016-005948,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Application site hypersensitivity,Physician,,Unknown,Female,I,9/26/2016,1/1/2016,,,,PAIN,UNITED STATES,Application site hypersensitivity,,NO,NO,Unlisted
2016-005948,2016-005948,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hypersensitivity,Physician,,Unknown,Female,I,9/26/2016,1/1/2016,,,,PAIN,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2016-005960,2016-005960,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Female,F,11/21/2016,8/25/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-005960,2016-005960,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,66,Years,Female,F,11/21/2016,9/1/2016,,,,PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-005960,2016-005960,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,66,Years,Female,F,11/21/2016,8/25/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-005960,2016-005960,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Incorrect route of drug administration,Non-Health Professional,66,Years,Female,F,11/21/2016,1/1/2016,,,,PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2016-005971,2016-005971,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,39,Years,Female,F,10/18/2016,7/1/2016,,,,SEVERE ABDOMINAL PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2016-006004,2016-006004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,Unknown,Male,F,1/4/2017,1/1/2016,,,,UNKNOWN,UNITED STATES,Breakthrough pain,,NO,NO,Unlisted
2016-006004,2016-006004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Ill-defined disorder,Non-Health Professional,,Unknown,Male,F,1/4/2017,1/1/2016,,,,UNKNOWN,UNITED STATES,Ill-defined disorder,,NO,NO,Unlisted
2016-006005,2016-006005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Physician,,,UNK,I,9/28/2016,,,,,UNKNOWN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006013,2016-006013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,45,Years,Female,F,10/21/2016,9/17/2016,,,,CHRONIC PAIN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-006013,2016-006013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,45,Years,Female,F,10/21/2016,9/17/2016,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006030,2016-006030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Dehydration,Non-Health Professional,46,Years,Female,F,12/7/2016,9/19/2016,,,,CHRONIC PAIN,UNITED STATES,Dehydration,,NO,NO,Unlisted
2016-006030,2016-006030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,F,12/7/2016,9/19/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006030,2016-006030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Diarrhoea,Non-Health Professional,46,Years,Female,F,12/7/2016,9/19/2016,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2016-006030,2016-006030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Buccal film,,Vomiting,Non-Health Professional,46,Years,Female,F,12/7/2016,9/19/2016,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-006032,2016-006032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Palpitations,Physician,59,Years,Female,I,9/28/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-006032,2016-006032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Fall,Physician,59,Years,Female,I,9/28/2016,8/1/2016,,,,CHRONIC PAIN,UNITED STATES,Fall,,NO,NO,Unlisted
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Muscle spasms,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Muscle spasms,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug effect decreased,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Insomnia,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Insomnia,,NO,NO,Unlisted
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Malaise,Non-Health Professional,57,Years,Female,I,9/29/2016,1/1/2016,,,,PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Vomiting,Non-Health Professional,57,Years,Female,I,9/29/2016,1/1/2016,,,,PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Non-Health Professional,57,Years,Female,I,9/29/2016,1/1/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Asthenia,Non-Health Professional,57,Years,Female,I,9/29/2016,1/1/2016,,,,PAIN,UNITED STATES,Asthenia,,NO,NO,Listed
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pain in extremity,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pain,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-006051,2016-006051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Non-Health Professional,57,Years,Female,I,9/29/2016,7/1/2016,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-006085,2016-006085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Blood glucose increased,Non-Health Professional,55,Years,Female,I,9/30/2016,9/30/2016,,,Other,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,YES,YES,Unlisted
2016-006101,2016-006101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Oral pruritus,Other Health Professional,49,Years,Female,F,11/24/2016,9/1/2016,,,,PAIN,UNITED STATES,Oral pruritus,,NO,NO,Unlisted
2016-006101,2016-006101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,49,Years,Female,F,11/24/2016,9/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006106,2016-006106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,43,Years,Female,F,11/24/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006106,2016-006106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,43,Years,Female,F,11/24/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016-006106,2016-006106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,43,Years,Female,F,11/24/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pain,Other Health Professional,43,Years,Female,F,12/7/2016,1/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Pain,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Weight decreased,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Depression,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Depression,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Mobility decreased,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Mobility decreased,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Orthostatic hypotension,Other Health Professional,43,Years,Female,F,12/7/2016,9/28/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Orthostatic hypotension,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dizziness,Other Health Professional,43,Years,Female,F,12/7/2016,9/28/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Dizziness,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Heart rate increased,Other Health Professional,43,Years,Female,F,12/7/2016,9/28/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Other Health Professional,43,Years,Female,F,12/7/2016,1/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hypertension,Other Health Professional,43,Years,Female,F,12/7/2016,9/28/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Hypertension,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Back pain,Other Health Professional,43,Years,Female,F,12/7/2016,9/20/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Back pain,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug effect decreased,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Breakthrough pain,Other Health Professional,43,Years,Female,F,12/7/2016,1/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Breakthrough pain,,NO,NO,Unlisted
2016-006109,2016-006109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Withdrawal syndrome,Other Health Professional,43,Years,Female,F,12/7/2016,8/1/2016,,,,INTERSTITIAL CYSTITIS,UNITED STATES,Withdrawal syndrome,,NO,NO,Listed
2016-006120,2016-006120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug screen negative,Other Health Professional,,Unknown,UNK,I,10/4/2016,,,,,UNKNOWN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2016-006149,2016-006149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dose omission,Pharmacist,35,Years,Female,F,1/4/2017,9/27/2016,,,,PAIN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-006149,2016-006149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Pharmacist,35,Years,Female,F,1/4/2017,9/27/2016,,,,PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006149,2016-006149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Pharmacist,35,Years,Female,F,1/4/2017,1/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-006159,2016-006159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,77,Years,Female,F,1/4/2017,10/5/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-006159,2016-006159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,77,Years,Female,F,1/4/2017,10/5/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006176,2016-006176,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,No adverse event,Non-Health Professional,44,Years,Female,I,10/6/2016,,,,,UNKNOWN,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-006178,2016-006178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Migraine,Other Health Professional,,Unknown,Female,I,10/5/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Migraine,,NO,NO,Listed
2016-006189,2016-006189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Oral discomfort,Physician,,Unknown,Female,F,1/3/2017,10/5/2016,,,,PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2016-006216,2016-006216,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Depression,Other Health Professional,,Unknown,Female,I,10/10/2016,9/1/2016,,,,UNKNOWN,UNITED STATES,Depression,,NO,NO,Listed
2016-006224,2016-006224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Accidental exposure to product,Pharmacist,24,Years,Male,I,10/11/2016,10/11/2016,,,,,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-006230,2016-006230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Dyspnoea,Physician,,Unknown,UNK,I,10/11/2016,1/1/2016,,,,PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-006244,2016-006244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Nausea,Physician,,Unknown,UNK,I,10/12/2016,,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006246,2016-006246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Unknown,,Unevaluable event,Pharmacist,,Unknown,Female,I,10/12/2016,,,,,UNKNOWN,UNITED STATES,Unevaluable event,,NO,NO,Unlisted
2016-006250,2016-006250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Palpitations,Physician,64,Years,Male,F,11/3/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-006251,2016-006251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,64,Years,Female,I,10/11/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006251,2016-006251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Diarrhoea,Physician,64,Years,Female,I,10/11/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2016-006310,2016-006310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,51,Years,Female,F,11/8/2016,9/1/2016,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016-006313,2016-006313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug dose omission,Non-Health Professional,82,Years,Female,F,12/22/2016,10/12/2016,,,,BACK PAIN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-006313,2016-006313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,82,Years,Female,F,12/22/2016,10/12/2016,,,,BACK PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006323,2016-006323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,Unknown,Female,F,12/22/2016,,,,,UNKNOWN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006323,2016-006323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,Unknown,Female,F,12/22/2016,,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-006324,2016-006324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Anger,Other Health Professional,,Unknown,Male,I,10/14/2016,10/1/2016,,,,CHRONIC LOW BACK PAIN,UNITED STATES,Anger,,NO,NO,Unlisted
2016-006324,2016-006324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Irritability,Other Health Professional,,Unknown,Male,I,10/14/2016,10/1/2016,,,,CHRONIC LOW BACK PAIN,UNITED STATES,Irritability,,NO,NO,Unlisted
2016-006342,2016-006342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Chest pain,Physician,,Unknown,Female,I,10/17/2016,10/1/2016,,,,UNKNOWN,UNITED STATES,Chest pain,,NO,NO,Listed
2016-006342,2016-006342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Joint swelling,Physician,,Unknown,Female,I,10/17/2016,10/1/2016,,,,UNKNOWN,UNITED STATES,Joint swelling,,NO,NO,Unlisted
2016-006344,2016-006344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,F,12/22/2016,10/14/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006344,2016-006344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Female,F,12/22/2016,10/14/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006344,2016-006344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,F,12/22/2016,1/1/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-006346,2016-006346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Migraine,Physician,8,Decades,Female,I,10/17/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-006399,2016-006399,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,,Unknown,Female,F,12/22/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-006414,2016-006414,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,F,12/22/2016,10/12/2016,,,,MS,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006414,2016-006414,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect delayed,Non-Health Professional,46,Years,Female,F,12/22/2016,10/12/2016,,,,MS,UNITED STATES,Drug effect delayed,,NO,NO,Unlisted
2016-006414,2016-006414,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect incomplete,Non-Health Professional,46,Years,Female,F,12/22/2016,10/12/2016,,,,MS,UNITED STATES,Drug effect incomplete,,NO,NO,Unlisted
2016-006415,2016-006415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,F,12/22/2016,10/19/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006418,2016-006418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting projectile,Non-Health Professional,52,Years,Female,I,10/20/2016,10/6/2016,,,Other,PAIN,UNITED STATES,Vomiting projectile,,YES,YES,Listed
2016-006418,2016-006418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dehydration,Non-Health Professional,52,Years,Female,I,10/20/2016,10/6/2016,,,Other,PAIN,UNITED STATES,Dehydration,,YES,YES,Listed
2016-006425,2016-006425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Palpitations,Non-Health Professional,,Unknown,Female,I,10/19/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-006447,2016-006447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,64,Years,Female,F,1/16/2017,10/20/2016,,,,BACK PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-006447,2016-006447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,64,Years,Female,F,1/16/2017,,,,,BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-006447,2016-006447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,64,Years,Female,F,1/16/2017,10/20/2016,,,,BACK PAIN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016-006480,2016-006480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Rash,Physician,,Unknown,Female,I,10/24/2016,,,,,UNKNOWN,UNITED STATES,Rash,,NO,NO,Listed
2016-006480,2016-006480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Fatigue,Physician,,Unknown,Female,I,10/24/2016,,,,,UNKNOWN,UNITED STATES,Fatigue,,NO,NO,Listed
2016-006489,2016-006489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,Unknown,Female,I,10/24/2016,10/24/2016,,,,PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2016-006489,2016-006489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vision blurred,Non-Health Professional,,Unknown,Female,I,10/24/2016,10/24/2016,,,,PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2016-006489,2016-006489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,Unknown,Female,I,10/24/2016,10/24/2016,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-006514,2016-006514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Enzyme level increased,Nurse,,Unknown,Female,F,1/13/2017,,,,,UNKNOWN,UNITED STATES,Enzyme level increased,,NO,NO,Unlisted
2016-006514,2016-006514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Nurse,,Unknown,Female,F,1/13/2017,,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006514,2016-006514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral candidiasis,Nurse,,Unknown,Female,F,1/13/2017,,,,,UNKNOWN,UNITED STATES,Oral candidiasis,,NO,NO,Unlisted
2016-006537,2016-006537,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Physician,,Unknown,Female,F,12/22/2016,,,,,LOWER BACK PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006537,2016-006537,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,F,12/22/2016,,,,,LOWER BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006541,2016-006541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,,Unknown,Male,F,12/22/2016,10/26/2016,,,,UNKNOWN,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-006563,2016-006563,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Swelling,Physician,,Unknown,Female,I,10/27/2016,10/1/2016,,,,UNKNOWN,UNITED STATES,Swelling,,NO,NO,Unlisted
2016-006568,2016-006568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,68,Years,Female,I,10/28/2016,10/28/2016,,,,LOW BACK PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-006568,2016-006568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Skin irritation,Non-Health Professional,68,Years,Female,I,10/28/2016,10/28/2016,,,,LOW BACK PAIN,UNITED STATES,Skin irritation,,NO,NO,Listed
2016-006568,2016-006568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hot flush,Non-Health Professional,68,Years,Female,I,10/28/2016,10/28/2016,,,,LOW BACK PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2016-006568,2016-006568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,68,Years,Female,I,10/28/2016,10/27/2016,,,,LOW BACK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-006615,2016-006615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,55,Years,Female,F,1/9/2017,10/28/2016,,,,BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006615,2016-006615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,55,Years,Female,F,1/9/2017,10/29/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006615,2016-006615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Non-Health Professional,55,Years,Female,F,1/9/2017,11/4/2016,,,,BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-006630,2016-006630,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,60,Years,Male,I,11/2/2016,10/1/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006633,2016-006633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Non-Health Professional,63,Years,Male,F,12/22/2016,9/1/2016,,,,ALL OVER PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-006633,2016-006633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Male,F,12/22/2016,9/1/2016,,,,ALL OVER PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006634,2016-006634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Nausea,Physician,80,Years,Female,I,11/2/2016,1/1/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006649,2016-006649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Abnormal dreams,Nurse,7,Decades,Female,I,11/3/2016,1/1/2016,,,,,UNITED STATES,Abnormal dreams,,NO,NO,Unlisted
2016-006650,2016-006650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Urinary retention,Physician,,Unknown,Male,I,11/3/2016,,,,,PAIN,UNITED STATES,Urinary retention,,NO,NO,Unlisted
2016-006654,2016-006654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Oral pruritus,Nurse,40,Years,Female,I,11/3/2016,1/1/2016,,,,PAIN,UNITED STATES,Oral pruritus,,NO,NO,Unlisted
2016-006709,2016-006709,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Physician,58,Years,Female,I,11/7/2016,1/1/2016,,,,PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-006717,2016-006717,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,58,Years,Female,F,1/13/2017,1/1/2016,,,,PAIN FROM PRE-EXISTING CONDITIONS,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-006717,2016-006717,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,F,1/13/2017,1/1/2016,,,,PAIN FROM PRE-EXISTING CONDITIONS,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006729,2016-006729,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Heart rate increased,Nurse,,Unknown,Female,I,11/8/2016,,,,,CHRONIC PAIN,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2016-006734,2016-006734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Nurse,,Unknown,UNK,I,11/9/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006738,2016-006738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Unknown,,Drug dose omission,Non-Health Professional,,Unknown,Male,I,11/9/2016,11/9/2016,,,,UNKNOWN,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2016-006739,2016-006739,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product use issue,Pharmacist,54,Years,Female,F,1/16/2017,11/3/2016,,,,SEVERE CHRONIC PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016-006739,2016-006739,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,54,Years,Female,F,1/16/2017,11/3/2016,,,,SEVERE CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006750,2016-006750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,F,1/16/2017,11/8/2016,,,,FIBROMYALGIA,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006760,2016-006760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Application site haemorrhage,Nurse,,Unknown,Female,I,11/9/2016,1/1/2016,,,,PAIN,UNITED STATES,Application site haemorrhage,,NO,NO,Unlisted
2016-006763,2016-006763,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Nurse,,Unknown,UNK,I,11/9/2016,,,,,UNKNOWN,UNITED STATES,Headache,,NO,NO,Listed
2016-006782,2016-006782,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Nurse,,Unknown,Female,I,11/10/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-006782,2016-006782,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Mouth swelling,Nurse,,Unknown,Female,I,11/10/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Mouth swelling,,NO,NO,Unlisted
2016-006784,2016-006784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Weight decreased,Other Health Professional,31,Years,Female,I,11/10/2016,,,,,UNKNOWN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2016-006784,2016-006784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Stomatitis,Other Health Professional,31,Years,Female,I,11/10/2016,,,,,UNKNOWN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-006784,2016-006784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Sensitivity of teeth,Other Health Professional,31,Years,Female,I,11/10/2016,,,,,UNKNOWN,UNITED STATES,Sensitivity of teeth,,NO,NO,Unlisted
2016-006784,2016-006784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Other Health Professional,31,Years,Female,I,11/10/2016,,,,,UNKNOWN,UNITED STATES,Nausea,,NO,NO,Unlisted
2016-006796,2016-006796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Speech disorder,Physician,,Unknown,Female,I,11/10/2016,11/1/2016,,,,PAIN,UNITED STATES,Speech disorder,,NO,NO,Unlisted
2016-006796,2016-006796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Asthenia,Physician,,Unknown,Female,I,11/10/2016,11/1/2016,,,,PAIN,UNITED STATES,Asthenia,,NO,NO,Listed
2016-006796,2016-006796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hypoaesthesia oral,Physician,,Unknown,Female,I,11/10/2016,11/1/2016,,,,PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2016-006796,2016-006796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Balance disorder,Physician,,Unknown,Female,I,11/10/2016,11/1/2016,,,,PAIN,UNITED STATES,Balance disorder,,NO,NO,Unlisted
2016-006798,2016-006798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Administration site irritation,Physician,,Unknown,Female,I,11/10/2016,1/1/2016,,,,PAIN,UNITED STATES,Administration site irritation,,NO,NO,Unlisted
2016-006798,2016-006798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,,Unknown,Female,I,11/10/2016,1/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-006855,2016-006855,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Physician,,Unknown,Female,I,11/15/2016,10/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006878,2016-006878,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,46,Years,Female,F,1/17/2017,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2016-006886,2016-006886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pruritus,Physician,,Unknown,Female,I,11/15/2016,11/1/2016,,,,PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2016-006886,2016-006886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Anxiety,Physician,,Unknown,Female,I,11/15/2016,11/1/2016,,,,PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2016-006886,2016-006886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hyperhidrosis,Physician,,Unknown,Female,I,11/15/2016,11/1/2016,,,,PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2016-006906,2016-006906,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Weight decreased,Nurse,,Unknown,Female,I,11/16/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2016-006906,2016-006906,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dysgeusia,Nurse,,Unknown,Female,I,11/16/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016-006909,2016-006909,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Alopecia,Physician,,Unknown,Female,I,11/16/2016,,,,,PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2016-006924,2016-006924,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,70,Years,Male,I,11/16/2016,11/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-006924,2016-006924,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Physician,70,Years,Male,I,11/16/2016,11/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006925,2016-006925,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Physician,70,Years,Male,I,11/16/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-006926,2016-006926,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Weight increased,Physician,,Adult,Female,I,11/16/2016,,,,,CHRONIC PAIN,UNITED STATES,Weight increased,,NO,NO,Unlisted
2016-006926,2016-006926,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Weight decreased,Physician,,Adult,Female,I,11/16/2016,,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2016-006926,2016-006926,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oedema peripheral,Physician,,Adult,Female,I,11/16/2016,,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2016-006927,2016-006927,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oedema peripheral,Physician,,Unknown,Female,I,11/16/2016,,,,,UNKNOWN,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2016-006927,2016-006927,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Weight increased,Physician,,Unknown,Female,I,11/16/2016,,,,,UNKNOWN,UNITED STATES,Weight increased,,NO,NO,Unlisted
2016-006928,2016-006928,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,,Buccal film,,Dysgeusia,Nurse,,Unknown,UNK,I,11/16/2016,,,,,UNKNOWN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chills,Non-Health Professional,59,Years,Male,F,1/17/2017,11/14/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Chills,,NO,NO,Listed
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,59,Years,Male,F,1/17/2017,11/14/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Salivary hypersecretion,Non-Health Professional,59,Years,Male,F,1/17/2017,11/14/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Salivary hypersecretion,,NO,NO,Unlisted
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product use issue,Non-Health Professional,59,Years,Male,F,1/17/2017,11/14/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oropharyngeal pain,Non-Health Professional,59,Years,Male,F,1/17/2017,11/14/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Oropharyngeal pain,,NO,NO,Unlisted
2016-006954,2016-006954,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect incomplete,Non-Health Professional,59,Years,Male,F,1/17/2017,11/1/2016,,,,CHRONIC NECK AND BACK PAIN,UNITED STATES,Drug effect incomplete,,NO,NO,Listed
2016-006997,2016-006997,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Heart rate increased,Nurse,,Unknown,Female,I,11/21/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2016-006998,2016-006998,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Rash,Nurse,,Unknown,Male,I,11/21/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2016-007003,2016-007003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Palpitations,Nurse,24,Years,Female,I,11/21/2016,,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2016-007013,2016-007013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Pruritus,Physician,75,Years,Female,I,11/21/2016,,,,,,UNITED STATES,Pruritus,,NO,NO,Unlisted
2016-007017,2016-007017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Aggression,Physician,66,Years,Female,F,1/17/2017,10/20/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Aggression,,YES,YES,Unlisted
2016-007017,2016-007017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Amnesia,Physician,66,Years,Female,F,1/17/2017,10/20/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Amnesia,,YES,YES,Unlisted
2016-007017,2016-007017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Headache,Physician,66,Years,Female,F,1/17/2017,10/20/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Headache,,YES,YES,Listed
2016-007027,2016-007027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,Unknown,Female,I,11/22/2016,11/1/2016,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-007027,2016-007027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,Unknown,Female,I,11/22/2016,11/1/2016,,,,PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-007027,2016-007027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,,Unknown,Female,I,11/22/2016,11/1/2016,,,,PAIN,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016-007027,2016-007027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,I,11/22/2016,11/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007027,2016-007027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,Unknown,Female,I,11/22/2016,11/1/2016,,,,PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2016-007046,2016-007046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,,Unknown,Female,I,11/22/2016,1/1/2016,,,,PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-007046,2016-007046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral disorder,Other Health Professional,,Unknown,Female,I,11/22/2016,1/1/2016,,,,PAIN,UNITED STATES,Oral disorder,,NO,NO,Unlisted
2016-007059,2016-007059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,50,Years,Male,F,1/16/2017,11/22/2016,,,,RSD PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007059,2016-007059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,50,Years,Male,F,1/16/2017,11/22/2016,,,,RSD PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2016-007076,2016-007076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hallucination,Nurse,,Unknown,Female,I,11/28/2016,1/1/2016,,,,PAIN,UNITED STATES,Hallucination,,NO,NO,Unlisted
2016-007133,2016-007133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Intentional product use issue,Physician,,Unknown,Female,I,11/30/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016-007133,2016-007133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Blood pressure decreased,Physician,,Unknown,Female,I,11/30/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Blood pressure decreased,,NO,NO,Listed
2016-007139,2016-007139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Application site irritation,Nurse,,Unknown,Female,I,11/29/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Application site irritation,,NO,NO,Unlisted
2016-007146,2016-007146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Migraine,Physician,,Unknown,Female,I,11/30/2016,11/1/2016,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2016-007152,2016-007152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Nurse,,Unknown,Male,I,12/1/2016,11/1/2016,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2016-007162,2016-007162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,62,Years,Female,I,12/2/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2016-007162,2016-007162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect increased,Non-Health Professional,62,Years,Female,I,12/2/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug effect increased,,NO,NO,Unlisted
2016-007162,2016-007162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,62,Years,Female,I,12/2/2016,9/1/2016,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-007218,2016-007218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Nurse,40,Years,Female,I,12/6/2016,1/1/2016,,,,FIBROMYALGIA,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-007218,2016-007218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Stomatitis,Nurse,40,Years,Female,I,12/6/2016,1/1/2016,,,,FIBROMYALGIA,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016-007219,2016-007219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,60,Years,Male,I,12/6/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-007219,2016-007219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,60,Years,Male,I,12/6/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016-007219,2016-007219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,60,Years,Male,I,12/6/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007219,2016-007219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Male,I,12/6/2016,1/1/2016,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007229,2016-007229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Non-Health Professional,50,Years,Female,I,12/8/2016,12/7/2016,,,,CHRONIC NERVE PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2016-007229,2016-007229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Vomiting,Non-Health Professional,50,Years,Female,I,12/8/2016,12/7/2016,,,,CHRONIC NERVE PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2016-007231,2016-007231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hospitalisation,Pharmacist,80,Years,Male,I,12/8/2016,1/1/2016,,,Hospitalisation,UNKNOWN,UNITED STATES,Hospitalisation,,YES,YES,Unlisted
2016-007258,2016-007258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,84,Years,Male,I,12/9/2016,11/18/2016,,,,"NECK STENOSIS, WITH VERTEBRAE",UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007258,2016-007258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,84,Years,Male,I,12/9/2016,1/1/2016,,,,"NECK STENOSIS, WITH VERTEBRAE",UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007314,2016-007314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,80,Years,Male,I,12/8/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016-007346,2016-007346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,I,12/15/2016,,,,,UNKNOWN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007401,2016-007401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,I,12/16/2016,12/16/2016,,,,SPINAL PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007465,2016-007465,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,55,Years,Male,I,12/20/2016,,,,,UNKNOWN,UNITED STATES,Dry mouth,,NO,NO,Listed
2016-007465,2016-007465,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,55,Years,Male,I,12/20/2016,,,,,UNKNOWN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016-007477,2016-007477,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Ill-defined disorder,Non-Health Professional,,Unknown,Male,I,12/21/2016,1/1/2016,,,,UNKNOWN,UNITED STATES,Ill-defined disorder,,NO,NO,Unlisted
2016-007510,2016-007510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dyspnoea,Non-Health Professional,,Unknown,Female,I,12/22/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2016-007510,2016-007510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Dizziness,Non-Health Professional,,Unknown,Female,I,12/22/2016,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2016-007510,2016-007510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Female,I,12/22/2016,,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007518,2016-007518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,UNK,F,12/29/2016,,,,,UNKNOWN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007518,2016-007518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,UNK,F,12/29/2016,,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007535,2016-007535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,55,Years,Female,I,12/27/2016,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007540,2016-007540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,53,Years,Male,I,12/28/2016,12/28/2016,,,,EXTREME ARTHRITIS IN LOWER BACK AND LEFT SHOULDER,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007540,2016-007540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,53,Years,Male,I,12/28/2016,1/1/2016,,,,EXTREME ARTHRITIS IN LOWER BACK AND LEFT SHOULDER,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2016-007540,2016-007540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Accidental exposure to product,Non-Health Professional,53,Years,Male,I,12/28/2016,1/1/2016,,,,EXTREME ARTHRITIS IN LOWER BACK AND LEFT SHOULDER,UNITED STATES,Accidental exposure to product,,NO,NO,Unlisted
2016-007572,2016-007572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,,Unknown,Female,I,12/29/2016,12/1/2016,,,,UNKNOWN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016-007572,2016-007572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,Unknown,Female,I,12/29/2016,12/29/2016,,,,UNKNOWN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016-007572,2016-007572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,Unknown,Female,I,12/29/2016,12/1/2016,,,,UNKNOWN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016-007575,2016-007575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nasopharyngitis,Non-Health Professional,54,Years,Male,I,12/29/2016,12/25/2016,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Nasopharyngitis,,NO,NO,Listed
2016-007575,2016-007575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug effect decreased,Non-Health Professional,54,Years,Male,I,12/29/2016,1/1/2016,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Myalgia,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Myalgia,,NO,NO,Unlisted
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Fatigue,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Fatigue,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Rhinorrhoea,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rhinorrhoea,,NO,NO,Unlisted
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Rhinorrhoea,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rhinorrhoea,,NO,NO,Unlisted
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Myalgia,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Myalgia,,NO,NO,Unlisted
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0002,2016BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Female,I,2/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Malaise,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product quality issue,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Malaise,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product solubility abnormal,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product solubility abnormal,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0003,2016BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product quality issue,Non-Health Professional,,,,I,2/12/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2016BDSI0004,2016BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Drug effect decreased,Other Health Professional,,,,I,2/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016BDSI0004,2016BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Drug effect decreased,Other Health Professional,,,,I,2/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Diarrhoea,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Diarrhoea,,NO,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Vomiting,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Vomiting,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Diarrhoea,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Diarrhoea,,NO,YES,Listed
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Product preparation error,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product preparation error,,NO,YES,Unlisted
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Product preparation error,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product preparation error,,NO,YES,Unlisted
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Haemorrhoidal haemorrhage,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Haemorrhoidal haemorrhage,,NO,YES,Unlisted
2016BDSI0005,2016BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,,,,milligram,,,Haemorrhoidal haemorrhage,Non-Health Professional,41,Years,Male,I,2/26/2016,2/4/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Haemorrhoidal haemorrhage,,NO,YES,Unlisted
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,,I,2/26/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,,I,2/26/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2016BDSI0006,2016BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,NO,NO,Unlisted
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,NO,NO,Unlisted
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0007,2016BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0008,2016BDSI0008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0008,2016BDSI0008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0008,2016BDSI0008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Intentional product use issue,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016BDSI0008,2016BDSI0008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Intentional product use issue,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2016BDSI0009,2016BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Drug ineffective,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0009,2016BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Adverse event,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Adverse event,,NO,NO,Unlisted
2016BDSI0009,2016BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Adverse event,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Adverse event,,NO,NO,Unlisted
2016BDSI0009,2016BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Drug ineffective,Physician,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0010,2016BDSI0010,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Stomatitis,Other Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016BDSI0010,2016BDSI0010,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Unknown,,Stomatitis,Other Health Professional,,,,I,2/26/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2016BDSI0011,2016BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,27,Years,Male,I,3/9/2016,3/5/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0011,2016BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,27,Years,Male,I,3/9/2016,3/5/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0012,2016BDSI0012,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,Positive,,,,,,Insomnia,Non-Health Professional,29,Years,Male,I,3/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Insomnia,,NO,NO,Listed
2016BDSI0012,2016BDSI0012,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,Positive,,,,,,Insomnia,Non-Health Professional,29,Years,Male,I,3/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Insomnia,,NO,NO,Listed
2016BDSI0012,2016BDSI0012,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,Positive,,,,,,Sleep terror,Non-Health Professional,29,Years,Male,I,3/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Sleep terror,,NO,NO,Unlisted
2016BDSI0012,2016BDSI0012,Bunavail,"BUPRENORPHINE,NALOXONE",Sublingual use,Positive,,,,,,Sleep terror,Non-Health Professional,29,Years,Male,I,3/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Sleep terror,,NO,NO,Unlisted
2016BDSI0013,2016BDSI0013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,,I,3/14/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0013,2016BDSI0013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,,I,3/14/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Abdominal discomfort,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Malaise,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Malaise,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Abdominal discomfort,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Nausea,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Nausea,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Malabsorption from application site,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malabsorption from application site,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Product solubility abnormal,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Product solubility abnormal,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Malabsorption from application site,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malabsorption from application site,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Drug ineffective for unapproved indication,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Drug ineffective for unapproved indication,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Feeding disorder,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Feeding disorder,,NO,NO,Unlisted
2016BDSI0014,2016BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",,Positive,,,,,,Feeding disorder,Physician,54,Years,Male,I,3/10/2016,2/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Feeding disorder,,NO,NO,Unlisted
2016BDSI0015,2016BDSI0015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral mucosal blistering,Non-Health Professional,,,Female,I,3/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2016BDSI0015,2016BDSI0015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral mucosal blistering,Non-Health Professional,,,Female,I,3/16/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Insomnia,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Insomnia,,NO,NO,Listed
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Constipation,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Constipation,,NO,NO,Listed
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal discomfort,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal discomfort,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Constipation,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Constipation,,NO,NO,Listed
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Insomnia,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Insomnia,,NO,NO,Listed
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0016,2016BDSI0016,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Non-Health Professional,49,Years,Female,I,3/29/2016,3/25/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0017,2016BDSI0017,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Non-Health Professional,,,Male,I,4/4/2016,3/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,NO,Unlisted
2016BDSI0017,2016BDSI0017,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Non-Health Professional,,,Male,I,4/4/2016,3/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,NO,Unlisted
2016BDSI0017,2016BDSI0017,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,,,Male,I,4/4/2016,3/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0017,2016BDSI0017,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,,,Male,I,4/4/2016,3/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0018,2016BDSI0018,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Malaise,Non-Health Professional,,,Female,I,4/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0018,2016BDSI0018,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Malaise,Non-Health Professional,,,Female,I,4/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0019,2016BDSI0019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,No adverse event,Pharmacist,,,Female,I,4/11/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,No adverse event,,NO,NO,Listed
2016BDSI0019,2016BDSI0019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,No adverse event,Pharmacist,,,Female,I,4/11/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,No adverse event,,NO,NO,Listed
2016BDSI0019,2016BDSI0019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug prescribing error,Pharmacist,,,Female,I,4/11/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2016BDSI0019,2016BDSI0019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug prescribing error,Pharmacist,,,Female,I,4/11/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2016BDSI0020,2016BDSI0020,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,4/14/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0020,2016BDSI0020,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,4/14/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0021,2016BDSI0021,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug effect decreased,Non-Health Professional,,,Female,I,4/22/2016,1/1/2016,,,,HEROIN ADDICTION,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016BDSI0021,2016BDSI0021,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug effect decreased,Non-Health Professional,,,Female,I,4/22/2016,1/1/2016,,,,HEROIN ADDICTION,UNITED STATES,Drug effect decreased,,NO,NO,Listed
2016BDSI0021,2016BDSI0021,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/22/2016,1/1/2016,,,,HEROIN ADDICTION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0021,2016BDSI0021,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/22/2016,1/1/2016,,,,HEROIN ADDICTION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Peripheral swelling,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Peripheral swelling,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pharyngeal oedema,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pharyngeal oedema,,NO,NO,Unlisted
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pharyngeal oedema,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pharyngeal oedema,,NO,NO,Unlisted
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Nausea,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0022,2016BDSI0022,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Nausea,Non-Health Professional,41,Years,Female,I,4/25/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Frustration,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Frustration,,NO,NO,Unlisted
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Tension,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Tension,,NO,NO,Unlisted
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Tension,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Tension,,NO,NO,Unlisted
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Anger,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anger,,NO,NO,Unlisted
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Anger,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anger,,NO,NO,Unlisted
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Anxiety,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Anxiety,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0023,2016BDSI0023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Frustration,Non-Health Professional,33,Years,Male,I,4/20/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Frustration,,NO,NO,Unlisted
2016BDSI0024,2016BDSI0024,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0024,2016BDSI0024,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0025,2016BDSI0025,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0025,2016BDSI0025,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0026,2016BDSI0026,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0026,2016BDSI0026,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Electrocardiogram QT prolonged,Physician,,,Male,I,4/25/2016,,,,Other,OPIOID DEPENDENCE,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Unlisted
2016BDSI0027,2016BDSI0027,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,44,Years,Female,I,4/22/2016,1/1/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0027,2016BDSI0027,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,44,Years,Female,I,4/22/2016,1/1/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0027,2016BDSI0027,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Pain,Non-Health Professional,44,Years,Female,I,4/22/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,YES,Listed
2016BDSI0027,2016BDSI0027,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Pain,Non-Health Professional,44,Years,Female,I,4/22/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,YES,Listed
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dry throat,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry throat,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dry throat,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry throat,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dry mouth,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dry mouth,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hypoaesthesia oral,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia oral,,NO,YES,Unlisted
2016BDSI0029,2016BDSI0029,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hypoaesthesia oral,Non-Health Professional,46,Years,Female,I,5/2/2016,4/30/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia oral,,NO,YES,Unlisted
2016BDSI0030,2016BDSI0030,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Physician,,,Male,I,5/2/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0030,2016BDSI0030,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Physician,,,Male,I,5/2/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0033,2016BDSI0033,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,5/13/2016,5/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2016BDSI0033,2016BDSI0033,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,5/13/2016,5/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dyspnoea,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dyspnoea,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Unlisted
2016BDSI0034,2016BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Physician,,,Male,I,6/6/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0035,2016BDSI0035,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,5/16/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0035,2016BDSI0035,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,5/16/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0037,2016BDSI0037,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,,,Female,I,5/19/2016,,,,,WITHDRAWAL,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0038,2016BDSI0038,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Heart rate increased,Non-Health Professional,27,Years,Female,I,5/20/2016,9/1/2015,,,,TO GET OFF OF MORPHINE,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2016BDSI0038,2016BDSI0038,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Heart rate increased,Non-Health Professional,27,Years,Female,I,5/20/2016,9/1/2015,,,,TO GET OFF OF MORPHINE,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2016BDSI0038,2016BDSI0038,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,27,Years,Female,I,5/20/2016,9/1/2015,,,,TO GET OFF OF MORPHINE,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0038,2016BDSI0038,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,27,Years,Female,I,5/20/2016,9/1/2015,,,,TO GET OFF OF MORPHINE,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0039,2016BDSI0039,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,,,Female,I,5/23/2016,,,,,CHRONIC BACK PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2016BDSI0039,2016BDSI0039,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,,,Female,I,5/23/2016,,,,,CHRONIC BACK PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2016BDSI0040,2016BDSI0040,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,,,,I,5/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0040,2016BDSI0040,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,,,,I,5/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0041,2016BDSI0041,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oedema,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Oedema,,NO,NO,Unlisted
2016BDSI0041,2016BDSI0041,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oedema,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Oedema,,NO,NO,Unlisted
2016BDSI0041,2016BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Tablet,,Off label use,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Off label use,,NO,NO,
2016BDSI0041,2016BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Tablet,,Oedema,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Oedema,,NO,NO,
2016BDSI0041,2016BDSI0041,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Off label use,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2016BDSI0041,2016BDSI0041,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Off label use,Physician,,,,I,5/28/2016,,,,,PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Fatigue,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Fatigue,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malabsorption from administration site,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malabsorption from administration site,,NO,NO,Unlisted
2016BDSI0042,2016BDSI0042,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malabsorption from administration site,Non-Health Professional,23,Years,Male,I,5/26/2016,4/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malabsorption from administration site,,NO,NO,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0043,2016BDSI0043,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,35,Years,Female,I,5/27/2016,5/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0045,2016BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,20,Years,Male,I,6/3/2016,5/20/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0045,2016BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product identification number issue,Non-Health Professional,20,Years,Male,I,6/3/2016,5/20/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product identification number issue,,NO,NO,Unlisted
2016BDSI0045,2016BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product identification number issue,Non-Health Professional,20,Years,Male,I,6/3/2016,5/20/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product identification number issue,,NO,NO,Unlisted
2016BDSI0045,2016BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,20,Years,Male,I,6/3/2016,5/20/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0046,2016BDSI0046,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical issue,Non-Health Professional,,,Male,I,5/31/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0046,2016BDSI0046,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical issue,Non-Health Professional,,,Male,I,5/31/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0047,2016BDSI0047,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/2/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0047,2016BDSI0047,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/2/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0047,2016BDSI0047,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/2/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0047,2016BDSI0047,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/2/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0048,2016BDSI0048,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Pharmacist,,,Female,I,6/3/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016BDSI0048,2016BDSI0048,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Pharmacist,,,Female,I,6/3/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016BDSI0048,2016BDSI0048,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Pharmacist,,,Female,I,6/3/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0048,2016BDSI0048,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Pharmacist,,,Female,I,6/3/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Wrong technique in product usage process,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0049,2016BDSI0049,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Wrong technique in product usage process,Other Health Professional,,,Female,I,6/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0050,2016BDSI0050,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Physician,,,Male,I,6/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0050,2016BDSI0050,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Physician,,,Male,I,6/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0051,2016BDSI0051,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,6/15/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0051,2016BDSI0051,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,6/15/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0052,2016BDSI0052,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Female,I,6/24/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0052,2016BDSI0052,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Female,I,6/24/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Product physical consistency issue,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Product physical consistency issue,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Fatigue,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Fatigue,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Fatigue,,NO,NO,Listed
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Product solubility abnormal,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0053,2016BDSI0053,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Product solubility abnormal,Non-Health Professional,61,Years,Male,I,6/27/2016,6/21/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Lacrimation increased,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lacrimation increased,,NO,NO,Listed
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Lacrimation increased,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lacrimation increased,,NO,NO,Listed
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Fatigue,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Unlisted
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Fatigue,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Unlisted
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Somnolence,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Unlisted
2016BDSI0054,2016BDSI0054,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Somnolence,Physician,,,Male,I,6/28/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Unlisted
2016BDSI0055,2016BDSI0055,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Anxiety,,,,Female,I,6/28/2016,10/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0055,2016BDSI0055,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Hypoaesthesia,,,,Female,I,6/28/2016,10/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2016BDSI0055,2016BDSI0055,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Hypoaesthesia,,,,Female,I,6/28/2016,10/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2016BDSI0055,2016BDSI0055,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Anxiety,,,,Female,I,6/28/2016,10/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2016BDSI0056,2016BDSI0056,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Hypoaesthesia,,,,Female,I,6/28/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2016BDSI0056,2016BDSI0056,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Hypoaesthesia,,,,Female,I,6/28/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2016BDSI0057,2016BDSI0057,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Vomiting,Physician,,,,I,7/11/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0057,2016BDSI0057,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dry mouth,Physician,,,,I,7/11/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,NO,Unlisted
2016BDSI0057,2016BDSI0057,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dry mouth,Physician,,,,I,7/11/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,NO,Unlisted
2016BDSI0057,2016BDSI0057,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Vomiting,Physician,,,,I,7/11/2016,6/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0067,2016BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,7/8/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0067,2016BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,7/8/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0067,2016BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product size issue,Non-Health Professional,,,Male,I,7/8/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product size issue,,NO,NO,Unlisted
2016BDSI0067,2016BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product size issue,Non-Health Professional,,,Male,I,7/8/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product size issue,,NO,NO,Unlisted
2016BDSI0068,2016BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug dispensing error,Non-Health Professional,,,Male,I,7/14/2016,7/14/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dispensing error,,NO,NO,Unlisted
2016BDSI0068,2016BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug dispensing error,Non-Health Professional,,,Male,I,7/14/2016,7/14/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dispensing error,,NO,NO,Unlisted
2016BDSI0069,2016BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Abnormal behaviour,Physician,58,Years,Female,I,7/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abnormal behaviour,,NO,NO,Unlisted
2016BDSI0069,2016BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Abnormal behaviour,Physician,58,Years,Female,I,7/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abnormal behaviour,,NO,NO,Unlisted
2016BDSI0069,2016BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Emotional disorder,Physician,58,Years,Female,I,7/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Emotional disorder,,NO,NO,Unlisted
2016BDSI0069,2016BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,,,milligram,,,Emotional disorder,Physician,58,Years,Female,I,7/14/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Emotional disorder,,NO,NO,Unlisted
2016BDSI0070,2016BDSI0070,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0070,2016BDSI0070,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0070,2016BDSI0070,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0070,2016BDSI0070,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0071,2016BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,NO,Unlisted
2016BDSI0071,2016BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,NO,Unlisted
2016BDSI0071,2016BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0071,2016BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0072,2016BDSI0072,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0072,2016BDSI0072,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0072,2016BDSI0072,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,YES,Unlisted
2016BDSI0072,2016BDSI0072,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,YES,Unlisted
2016BDSI0073,2016BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,YES,Unlisted
2016BDSI0073,2016BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0073,2016BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug effect increased,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug effect increased,,NO,YES,Unlisted
2016BDSI0073,2016BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug abuse,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug abuse,,YES,YES,Listed
2016BDSI0074,2016BDSI0074,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0074,2016BDSI0074,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0074,2016BDSI0074,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Other Health Professional,,,,I,7/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2016BDSI0074,2016BDSI0074,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Other Health Professional,,,,I,7/15/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0075,2016BDSI0075,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0083,2016BDSI0083,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Pharmacist,44,Years,Female,I,7/26/2016,7/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dyspepsia,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dyspepsia,,NO,NO,Listed
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dyspepsia,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dyspepsia,,NO,NO,Listed
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal distension,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal distension,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal distension,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal distension,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal pain upper,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Abdominal pain upper,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0086,2016BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/15/2016,6/26/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0087,2016BDSI0087,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/13/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2016BDSI0087,2016BDSI0087,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/13/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2016BDSI0088,2016BDSI0088,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,,,Female,I,8/19/2016,8/18/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0088,2016BDSI0088,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,,,Female,I,8/19/2016,8/18/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0089,2016BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Exposure during pregnancy,Non-Health Professional,,,Female,I,8/22/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Exposure during pregnancy,,NO,YES,Listed
2016BDSI0089,2016BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,8/22/2016,8/1/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0089,2016BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,8/22/2016,8/1/2016,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0089,2016BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Exposure during pregnancy,Non-Health Professional,,,Female,I,8/22/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Exposure during pregnancy,,NO,YES,Listed
2016BDSI0090,2016BDSI0090,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,8/23/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Listed
2016BDSI0090,2016BDSI0090,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,8/23/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Listed
2016BDSI0091,2016BDSI0091,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,Female,I,8/29/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2016BDSI0091,2016BDSI0091,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,Female,I,8/29/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product use issue,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product use issue,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product use issue,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0092,2016BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,,I,9/2/2016,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0093,2016BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dysgeusia,Non-Health Professional,,,Female,I,9/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016BDSI0093,2016BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dysgeusia,Non-Health Professional,,,Female,I,9/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2016BDSI0093,2016BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Constipation,Non-Health Professional,,,Female,I,9/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2016BDSI0093,2016BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Constipation,Non-Health Professional,,,Female,I,9/15/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2016BDSI0094,2016BDSI0094,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Seizure,Non-Health Professional,,,Female,I,9/22/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Seizure,,YES,YES,Unlisted
2016BDSI0094,2016BDSI0094,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Seizure,Non-Health Professional,,,Female,I,9/22/2016,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Seizure,,YES,YES,Unlisted
2016BDSI0095,2016BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/26/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0095,2016BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/26/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Pain of skin,Non-Health Professional,52,Years,Female,I,10/25/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Pain of skin,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hyperaesthesia,Non-Health Professional,52,Years,Female,I,10/25/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Hyperaesthesia,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hyperaesthesia,Non-Health Professional,52,Years,Female,I,10/25/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Hyperaesthesia,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,52,Years,Female,I,10/25/2016,5/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,52,Years,Female,I,10/25/2016,5/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,52,Years,Female,I,10/25/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Pain of skin,Non-Health Professional,52,Years,Female,I,10/25/2016,6/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Pain of skin,,NO,NO,Unlisted
2016BDSI0096,2016BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,52,Years,Female,I,10/25/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2016BDSI0097,2016BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,33,Years,Male,I,10/31/2016,10/31/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0097,2016BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,33,Years,Male,I,10/31/2016,10/31/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0098,2016BDSI0098,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Overdose,Other Health Professional,28,Years,Male,I,10/28/2016,10/4/2016,,,Death,DEPENDENCE ON OPIATES,UNITED STATES,Overdose,,YES,YES,Listed
2016BDSI0098,2016BDSI0098,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Overdose,Other Health Professional,28,Years,Male,I,10/28/2016,10/4/2016,,,Death,DEPENDENCE ON OPIATES,UNITED STATES,Overdose,,YES,YES,Listed
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Self-medication,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Self-medication,,NO,YES,Unlisted
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Self-medication,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Self-medication,,NO,YES,Unlisted
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,11/7/2016,10/2/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,11/7/2016,10/2/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Discomfort,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Discomfort,,NO,YES,Unlisted
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Discomfort,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Discomfort,,NO,YES,Unlisted
2016BDSI0099,2016BDSI0099,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/7/2016,4/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2016BDSI0100,2016BDSI0100,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Lower respiratory tract infection,,,,Female,I,11/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lower respiratory tract infection,,NO,YES,Unlisted
2016BDSI0100,2016BDSI0100,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Staphylococcal infection,,,,Female,I,11/7/2016,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Staphylococcal infection,,YES,YES,Unlisted
2016BDSI0100,2016BDSI0100,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Staphylococcal infection,,,,Female,I,11/7/2016,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Staphylococcal infection,,YES,YES,Unlisted
2016BDSI0100,2016BDSI0100,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Lower respiratory tract infection,,,,Female,I,11/7/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lower respiratory tract infection,,NO,YES,Unlisted
2016BDSI0101,2016BDSI0101,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,11/2/2016,1/1/2014,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0101,2016BDSI0101,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,11/2/2016,1/1/2014,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0101,2016BDSI0101,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Female,I,11/2/2016,1/1/2014,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0101,2016BDSI0101,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Female,I,11/2/2016,1/1/2014,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0102,2016BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,11/9/2016,10/8/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0102,2016BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Male,I,11/9/2016,10/8/2016,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0102,2016BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Male,I,11/9/2016,10/8/2016,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2016BDSI0102,2016BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,11/9/2016,10/8/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0103,2016BDSI0103,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/18/2016,9/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0103,2016BDSI0103,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/18/2016,9/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0103,2016BDSI0103,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/18/2016,9/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2016BDSI0103,2016BDSI0103,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/18/2016,9/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0104,2016BDSI0104,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,36,Years,Female,I,11/16/2016,11/2/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0104,2016BDSI0104,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,36,Years,Female,I,11/16/2016,11/2/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Pain,Non-Health Professional,29,Years,Male,I,11/17/2016,8/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Pain,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,29,Years,Male,I,11/17/2016,11/10/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,29,Years,Male,I,11/17/2016,11/10/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Headache,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Headache,,NO,NO,Listed
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Pain,Non-Health Professional,29,Years,Male,I,11/17/2016,8/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Pain,,NO,NO,Unlisted
2016BDSI0105,2016BDSI0105,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,29,Years,Male,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,Female,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Peripheral swelling,Non-Health Professional,,,Female,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oedema peripheral,Non-Health Professional,,,Female,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oedema peripheral,Non-Health Professional,,,Female,I,11/17/2016,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral mucosal eruption,Non-Health Professional,,,Female,I,11/17/2016,11/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral mucosal eruption,,NO,NO,Listed
2016BDSI0106,2016BDSI0106,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral mucosal eruption,Non-Health Professional,,,Female,I,11/17/2016,11/17/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral mucosal eruption,,NO,NO,Listed
2016BDSI0107,2016BDSI0107,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Non-Health Professional,24,Years,Male,I,11/21/2016,11/12/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0107,2016BDSI0107,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,24,Years,Male,I,11/21/2016,11/12/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0107,2016BDSI0107,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,24,Years,Male,I,11/21/2016,11/12/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0107,2016BDSI0107,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Non-Health Professional,24,Years,Male,I,11/21/2016,11/12/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Thirst,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Thirst,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Thirst,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Thirst,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2016BDSI0108,2016BDSI0108,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,55,Years,Male,I,11/18/2016,1/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2016BDSI0109,2016BDSI0109,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Pharmacist,,,Female,I,12/9/2016,12/9/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0109,2016BDSI0109,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Pharmacist,,,Female,I,12/9/2016,12/9/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2016BDSI0110,2016BDSI0110,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Exposure via partner,Non-Health Professional,,,Male,I,12/7/2016,11/29/2016,,,,UNINTENDED INGESTION OF PRODUCT,UNITED STATES,Exposure via partner,,NO,NO,Listed
2016BDSI0110,2016BDSI0110,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Exposure via partner,Non-Health Professional,,,Male,I,12/7/2016,11/29/2016,,,,UNINTENDED INGESTION OF PRODUCT,UNITED STATES,Exposure via partner,,NO,NO,Listed
2016BDSI0110,2016BDSI0110,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug screen positive,Non-Health Professional,,,Male,I,12/7/2016,11/29/2016,,,,UNINTENDED INGESTION OF PRODUCT,UNITED STATES,Drug screen positive,,NO,NO,Listed
2016BDSI0110,2016BDSI0110,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug screen positive,Non-Health Professional,,,Male,I,12/7/2016,11/29/2016,,,,UNINTENDED INGESTION OF PRODUCT,UNITED STATES,Drug screen positive,,NO,NO,Listed
2016BDSI0111,2016BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,12/19/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2016BDSI0111,2016BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,12/19/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017-000078,2017-000078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product quality issue,Non-Health Professional,,Unknown,Male,I,1/5/2017,,,,,,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2017-000078,2017-000078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,,Unknown,Male,I,1/5/2017,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2017-000100,2017-000100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hepatic enzyme increased,Non-Health Professional,61,Years,Female,I,1/9/2017,1/3/2017,,,,PAIN,UNITED STATES,Hepatic enzyme increased,,NO,NO,Listed
2017-000119,2017-000119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Non-Health Professional,72,Years,Female,I,1/12/2017,1/1/2016,,,,BACK PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2017-000119,2017-000119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Non-Health Professional,72,Years,Female,I,1/12/2017,1/1/2016,,,,BACK PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2017-000119,2017-000119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,72,Years,Female,I,1/12/2017,1/1/2016,,,,BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017-000120,2017-000120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,62,Years,Female,I,1/18/2017,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2017-000121,2017-000121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,,Unknown,Female,I,1/18/2017,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2017-000122,2017-000122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Non-Health Professional,,Unknown,Female,I,1/20/2017,,,,,,UNITED STATES,No adverse event,,NO,NO,Unlisted
2017-000123,2017-000123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Male,I,1/20/2017,1/17/2017,,,,BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017-000123,2017-000123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Male,I,1/20/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0001,2017BDSI0001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Feeling abnormal,Non-Health Professional,45,Years,Male,I,1/12/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2017BDSI0001,2017BDSI0001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Feeling abnormal,Non-Health Professional,45,Years,Male,I,1/12/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2017BDSI0002,2017BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Somnolence,,,,Male,I,1/12/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0002,2017BDSI0002,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Somnolence,,,,Male,I,1/12/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0003,2017BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,47,Years,Female,I,1/17/2017,1/6/2017,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0003,2017BDSI0003,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,47,Years,Female,I,1/17/2017,1/6/2017,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0004,2017BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,25,Years,Male,I,1/17/2017,12/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0004,2017BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,25,Years,Male,I,1/17/2017,12/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0004,2017BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,25,Years,Male,I,1/17/2017,12/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0004,2017BDSI0004,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,25,Years,Male,I,1/17/2017,12/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0005,2017BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,39,Years,Female,I,1/18/2017,1/18/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0005,2017BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,39,Years,Female,I,1/18/2017,1/18/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0005,2017BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,39,Years,Female,I,1/18/2017,1/18/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0005,2017BDSI0005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,39,Years,Female,I,1/18/2017,1/18/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0006,2017BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,61,Years,Male,I,1/23/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0006,2017BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,61,Years,Male,I,1/23/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0006,2017BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,61,Years,Male,I,1/23/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0006,2017BDSI0006,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,61,Years,Male,I,1/23/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0007,2017BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,,I,1/23/2017,1/23/2017,,,,,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0007,2017BDSI0007,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,,I,1/23/2017,1/23/2017,,,,,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0009,2017BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/24/2017,1/24/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0009,2017BDSI0009,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/24/2017,1/24/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0010,2017BDSI0010,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,,,Male,I,1/25/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2017BDSI0010,2017BDSI0010,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Malaise,Non-Health Professional,,,Male,I,1/25/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Retching,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Retching,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Retching,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Retching,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Vomiting,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Impatience,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Impatience,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Breath odour,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Breath odour,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Breath odour,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Breath odour,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anxiety,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Impatience,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Impatience,,NO,NO,Unlisted
2017BDSI0011,2017BDSI0011,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,,,Male,I,1/25/2017,11/1/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Anxiety,,NO,NO,Unlisted
2017BDSI0012,2017BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,1/25/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0013,2017BDSI0013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,1/27/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0014,2017BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Pharmacist,31,Years,Male,I,1/30/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0014,2017BDSI0014,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Pharmacist,31,Years,Male,I,1/30/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0022,2017BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Headache,Non-Health Professional,,,Female,I,2/6/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0023,2017BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Pharmacist,,,,I,2/6/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0024,2017BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Drug screen negative,,,,Male,I,2/6/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2017BDSI0025,2017BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Male,I,2/10/2017,2/8/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0025,2017BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,2/10/2017,2/8/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0025,2017BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/10/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,
2017BDSI0026,2017BDSI0026,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Non-Health Professional,,,Male,I,2/8/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0026,2017BDSI0026,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical issue,Non-Health Professional,,,Male,I,2/8/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0027,2017BDSI0027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging issue,Non-Health Professional,,,Female,I,2/7/2017,1/6/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0028,2017BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response shortened,Non-Health Professional,,,Female,I,2/9/2017,,,,,PAIN,UNITED STATES,Therapeutic response shortened,,NO,NO,Listed
2017BDSI0028,2017BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/9/2017,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0028,2017BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Female,I,2/9/2017,,,,,PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0030,2017BDSI0030,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Tablet,,Pregnancy test positive,Other Health Professional,33,Years,Female,F,3/13/2017,2/6/2017,,,Other,PHARMACOKINETIC STUDY,UNITED STATES,Pregnancy test positive,,YES,YES,Unlisted
2017BDSI0030,2017BDSI0030,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Tablet,,Pregnancy test positive,Other Health Professional,33,Years,Female,F,3/13/2017,2/6/2017,,,Other,PHARMACOKINETIC STUDY,UNITED STATES,Pregnancy test positive,,YES,YES,Unlisted
2017BDSI0031,2017BDSI0031,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,40,Years,Female,I,2/14/2017,2/1/2017,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0031,2017BDSI0031,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Feeling abnormal,Non-Health Professional,40,Years,Female,I,2/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2017BDSI0031,2017BDSI0031,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Feeling abnormal,Non-Health Professional,40,Years,Female,I,2/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2017BDSI0031,2017BDSI0031,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,40,Years,Female,I,2/14/2017,2/1/2017,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0032,2017BDSI0032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Male,I,2/14/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0033,2017BDSI0033,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product packaging issue,Non-Health Professional,,,Female,I,2/14/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0034,2017BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/14/2017,2/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0034,2017BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,2/14/2017,2/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0034,2017BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,2/14/2017,2/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0034,2017BDSI0034,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/14/2017,2/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0035,2017BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,64,Years,Female,I,3/1/2017,2/1/2017,,,,NECK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0036,2017BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product solubility abnormal,Physician,,,Female,I,2/22/2017,,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0036,2017BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Therapeutic response decreased,Physician,,,Female,I,2/22/2017,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0036,2017BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral administration complication,Physician,,,Female,I,2/22/2017,,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0037,2017BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product physical issue,Non-Health Professional,,,Female,I,2/16/2017,,,,,PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0037,2017BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product outer packaging issue,Non-Health Professional,,,Female,I,2/16/2017,,,,,PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Product physical issue,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Product packaging quantity issue,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Product solubility abnormal,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Somnolence,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Fatigue,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2017BDSI0038,2017BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,,,Product physical consistency issue,Non-Health Professional,65,Years,Female,I,2/21/2017,1/1/2017,,,,BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0040,2017BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,4/17/2017,1/6/2017,,,,ANKYLOSING SPONDYLITIS,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0040,2017BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,4/17/2017,1/6/2017,,,,ANKYLOSING SPONDYLITIS,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0041,2017BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Oral administration complication,Non-Health Professional,42,Years,Female,I,2/24/2017,6/27/2016,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0041,2017BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product adhesion issue,Non-Health Professional,42,Years,Female,I,2/24/2017,6/27/2016,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0041,2017BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Drug ineffective,Non-Health Professional,42,Years,Female,I,2/24/2017,6/27/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0041,2017BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product solubility abnormal,Non-Health Professional,42,Years,Female,I,2/24/2017,6/27/2016,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0041,2017BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product physical consistency issue,Non-Health Professional,42,Years,Female,I,2/24/2017,6/27/2016,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0042,2017BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,,92,Years,Male,I,2/23/2017,2/1/2017,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0043,2017BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Migraine,Physician,43,Years,Male,I,3/1/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,NO,Listed
2017BDSI0044,2017BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Dyspnoea,Non-Health Professional,,,Female,I,3/2/2017,2/28/2017,,,,PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2017BDSI0044,2017BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Throat irritation,Non-Health Professional,,,Female,I,3/2/2017,2/28/2017,,,,PAIN,UNITED STATES,Throat irritation,,NO,NO,Unlisted
2017BDSI0056,2017BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/24/2017,1/1/2017,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0056,2017BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,2/24/2017,1/1/2017,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0056,2017BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/24/2017,1/1/2017,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0057,2017BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Pharmacist,,,Female,I,3/6/2017,,,,,BACK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0058,2017BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Physician,,,Female,I,3/6/2017,2/24/2017,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0058,2017BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Physician,,,Female,I,3/6/2017,2/24/2017,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0058,2017BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Physician,,,Female,I,3/6/2017,2/24/2017,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0058,2017BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Physician,,,Female,I,3/6/2017,2/24/2017,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0059,2017BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,66,Years,Female,I,3/9/2017,3/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0059,2017BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,66,Years,Female,I,3/9/2017,3/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0060,2017BDSI0060,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,,,,I,3/14/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0060,2017BDSI0060,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Non-Health Professional,,,,I,3/14/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug dependence,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug dependence,,NO,NO,Unlisted
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Gait disturbance,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Gait disturbance,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Vomiting,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Vomiting,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dizziness,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dizziness,,NO,NO,Unlisted
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Dizziness,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dizziness,,NO,NO,Unlisted
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug ineffective,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0061,2017BDSI0061,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Drug dependence,Non-Health Professional,,,Male,I,3/14/2017,2/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug dependence,,NO,NO,Unlisted
2017BDSI0062,2017BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,37,Years,Female,I,3/13/2017,2/1/2017,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0062,2017BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,37,Years,Female,I,3/13/2017,3/1/2017,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0062,2017BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,37,Years,Female,I,3/13/2017,3/1/2017,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0062,2017BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,37,Years,Female,I,3/13/2017,3/1/2017,,,,RHEUMATOID ARTHRITIS,UNITED STATES,Product physical issue,,NO,NO,
2017BDSI0063,2017BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Pharmacist,,,Female,I,3/22/2017,1/1/2017,,,,PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0064,2017BDSI0064,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Generalised tonic-clonic seizure,Non-Health Professional,55,Years,Female,I,3/23/2017,1/1/2017,,,Hospitalisation,OPIOID DEPENDENCE,UNITED STATES,Generalised tonic-clonic seizure,,YES,YES,Unlisted
2017BDSI0064,2017BDSI0064,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Generalised tonic-clonic seizure,Non-Health Professional,55,Years,Female,I,3/23/2017,1/1/2017,,,Hospitalisation,OPIOID DEPENDENCE,UNITED STATES,Generalised tonic-clonic seizure,,YES,YES,Unlisted
2017BDSI0065,2017BDSI0065,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug screen negative,Other Health Professional,29,Years,Male,I,3/23/2017,3/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2017BDSI0065,2017BDSI0065,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug screen negative,Other Health Professional,29,Years,Male,I,3/23/2017,3/14/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2017BDSI0066,2017BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,No adverse event,Pharmacist,51,Years,Female,I,3/23/2017,3/23/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,No adverse event,,NO,NO,Listed
2017BDSI0066,2017BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Wrong technique in product usage process,Pharmacist,51,Years,Female,I,3/23/2017,3/23/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0067,2017BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product packaging quantity issue,Pharmacist,,,Male,I,3/24/2017,3/21/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0067,2017BDSI0067,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Product packaging quantity issue,Pharmacist,,,Male,I,3/24/2017,3/21/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0068,2017BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Agitation,Non-Health Professional,,,Male,I,3/23/2017,3/15/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Agitation,,NO,NO,Unlisted
2017BDSI0068,2017BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Male,I,3/23/2017,1/1/2016,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0068,2017BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,,,Male,I,3/23/2017,3/15/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0068,2017BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Feeling jittery,Non-Health Professional,,,Male,I,3/23/2017,3/15/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Feeling jittery,,NO,NO,Unlisted
2017BDSI0068,2017BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nervousness,Non-Health Professional,,,Male,I,3/23/2017,3/15/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Nervousness,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Weight increased,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Weight increased,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Food craving,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Food craving,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Food craving,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Food craving,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug administration error,Non-Health Professional,61,Years,Male,I,3/27/2017,3/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug administration error,Non-Health Professional,61,Years,Male,I,3/27/2017,3/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Weight increased,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Weight increased,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0069,2017BDSI0069,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,3/27/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Incorrect dose administered,Non-Health Professional,56,Years,Female,I,3/30/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Incorrect dose administered,,NO,YES,Unlisted
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Incorrect dose administered,Non-Health Professional,56,Years,Female,I,3/30/2017,3/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Incorrect dose administered,,NO,YES,Unlisted
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Non-Health Professional,56,Years,Female,I,3/30/2017,3/1/2017,,,Other,OPIOID DEPENDENCE,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Non-Health Professional,56,Years,Female,I,3/30/2017,3/1/2017,,,Other,OPIOID DEPENDENCE,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,56,Years,Female,I,3/30/2017,3/14/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug ineffective,,NO,YES,Listed
2017BDSI0071,2017BDSI0071,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,56,Years,Female,I,3/30/2017,3/14/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug ineffective,,NO,YES,Listed
2017BDSI0073,2017BDSI0073,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,33,Years,Female,I,3/31/2017,3/30/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0074,2017BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Neck pain,Non-Health Professional,,,Male,I,3/22/2017,,,,,CHRONIC PAIN,UNITED STATES,Neck pain,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral administration complication,Non-Health Professional,36,Years,Male,I,4/10/2017,4/8/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Gingival disorder,Non-Health Professional,36,Years,Male,I,4/10/2017,4/8/2017,,,,CHRONIC PAIN,UNITED STATES,Gingival disorder,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,36,Years,Male,I,4/10/2017,4/5/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,36,Years,Male,I,4/10/2017,4/5/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,36,Years,Male,I,4/10/2017,4/5/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Feeling abnormal,Non-Health Professional,36,Years,Male,I,4/10/2017,4/5/2017,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Nightmare,Non-Health Professional,36,Years,Male,I,4/10/2017,4/5/2017,,,,CHRONIC PAIN,UNITED STATES,Nightmare,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Dental caries,Non-Health Professional,36,Years,Male,I,4/10/2017,4/8/2017,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Malaise,Non-Health Professional,36,Years,Male,I,4/10/2017,4/10/2017,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Throat irritation,Non-Health Professional,36,Years,Male,I,4/10/2017,4/9/2017,,,,CHRONIC PAIN,UNITED STATES,Throat irritation,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Cough,Non-Health Professional,36,Years,Male,I,4/10/2017,4/9/2017,,,,CHRONIC PAIN,UNITED STATES,Cough,,NO,NO,Listed
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Dyspnoea,Non-Health Professional,36,Years,Male,I,4/10/2017,4/9/2017,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral administration complication,Non-Health Professional,36,Years,Male,I,4/10/2017,4/9/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral mucosal discolouration,Non-Health Professional,36,Years,Male,I,4/10/2017,4/8/2017,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal discolouration,,NO,NO,Unlisted
2017BDSI0075,2017BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Dry mouth,Non-Health Professional,36,Years,Male,I,4/10/2017,4/8/2017,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Unlisted
2017BDSI0076,2017BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,4/7/2017,4/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0077,2017BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,57,Years,Male,I,4/13/2017,4/7/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0077,2017BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,57,Years,Male,I,4/13/2017,4/7/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0077,2017BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,57,Years,Male,I,4/13/2017,4/7/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0077,2017BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,57,Years,Male,I,4/13/2017,4/7/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0078,2017BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,52,Years,Male,I,4/12/2017,4/11/2017,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0079,2017BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Physician,,,Male,I,4/26/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0079,2017BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Physician,,,Male,I,4/26/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0080,2017BDSI0080,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,59,Years,Male,I,4/26/2017,2/1/2017,,,,ARTHRITIS,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0080,2017BDSI0080,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,59,Years,Male,I,4/26/2017,2/1/2017,,,,ARTHRITIS,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0081,2017BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Physician,,,Female,I,4/26/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0081,2017BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Physician,,,Female,I,4/26/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0082,2017BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Drug ineffective,Non-Health Professional,48,Years,Male,I,4/27/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0083,2017BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,55,Years,Female,I,4/27/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0084,2017BDSI0084,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,4/28/2017,4/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0084,2017BDSI0084,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,4/28/2017,4/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0084,2017BDSI0084,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,4/28/2017,4/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0084,2017BDSI0084,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,4/28/2017,4/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0085,2017BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Drug prescribing error,Physician,,,Female,I,4/28/2017,9/30/2016,,,,PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0085,2017BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product size issue,Physician,,,Female,I,4/28/2017,1/1/2017,,,,PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2017BDSI0086,2017BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Non-Health Professional,,,Female,I,4/28/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0086,2017BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging issue,Non-Health Professional,,,Female,I,4/28/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0086,2017BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product use complaint,Non-Health Professional,,,Female,I,4/28/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0086,2017BDSI0086,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product use complaint,Non-Health Professional,,,Female,I,4/28/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0087,2017BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Drug ineffective,Non-Health Professional,54,Years,Female,I,5/4/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0087,2017BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product solubility abnormal,Non-Health Professional,54,Years,Female,I,5/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0087,2017BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Oral administration complication,Non-Health Professional,54,Years,Female,I,5/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0087,2017BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product adhesion issue,Non-Health Professional,54,Years,Female,I,5/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0088,2017BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product packaging quantity issue,Pharmacist,62,Years,Male,I,5/2/2017,5/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0089,2017BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,1/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0089,2017BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,1/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0090,2017BDSI0090,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0090,2017BDSI0090,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0091,2017BDSI0091,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0091,2017BDSI0091,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0092,2017BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,1/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0092,2017BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,1/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0093,2017BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0093,2017BDSI0093,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0094,2017BDSI0094,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0094,2017BDSI0094,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Physician,,,,I,5/8/2017,8/1/2015,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0095,2017BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Road traffic accident,Physician,,,,I,5/8/2017,1/1/2015,,,Hospitalisation,DEPENDENCE ON OPIATES,UNITED STATES,Road traffic accident,,YES,YES,Listed
2017BDSI0095,2017BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Facial operation,Physician,,,,I,5/8/2017,1/1/2015,,,Hospitalisation,DEPENDENCE ON OPIATES,UNITED STATES,Facial operation,,YES,YES,Unlisted
2017BDSI0095,2017BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Road traffic accident,Physician,,,,I,5/8/2017,1/1/2015,,,Hospitalisation,DEPENDENCE ON OPIATES,UNITED STATES,Road traffic accident,,YES,YES,Listed
2017BDSI0095,2017BDSI0095,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Facial operation,Physician,,,,I,5/8/2017,1/1/2015,,,Hospitalisation,DEPENDENCE ON OPIATES,UNITED STATES,Facial operation,,YES,YES,Unlisted
2017BDSI0096,2017BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,56,Years,Male,I,5/9/2017,9/1/2016,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0097,2017BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dysuria,Non-Health Professional,,,Male,I,5/11/2017,5/8/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dysuria,,NO,NO,Unlisted
2017BDSI0097,2017BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Chromaturia,Non-Health Professional,,,Male,I,5/11/2017,5/8/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Chromaturia,,NO,NO,Unlisted
2017BDSI0097,2017BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Chromaturia,Non-Health Professional,,,Male,I,5/11/2017,5/8/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Chromaturia,,NO,NO,Unlisted
2017BDSI0097,2017BDSI0097,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dysuria,Non-Health Professional,,,Male,I,5/11/2017,5/8/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dysuria,,NO,NO,Unlisted
2017BDSI0098,2017BDSI0098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Physician,,,,I,5/11/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0099,2017BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Pharmacist,46,Years,Female,I,5/15/2017,5/10/2017,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0099,2017BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,46,Years,Female,I,5/15/2017,5/10/2017,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0099,2017BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Pharmacist,46,Years,Female,I,5/15/2017,5/10/2017,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0099,2017BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Pharmacist,46,Years,Female,I,5/15/2017,5/10/2017,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0100,2017BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,83,Years,Male,I,5/15/2017,1/1/2016,,,,POST HERPETIC NEURALGIA,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0101,2017BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,,,Female,I,5/17/2017,5/17/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2017BDSI0102,2017BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response unexpected,Non-Health Professional,,,Female,I,5/17/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2017BDSI0102,2017BDSI0102,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response unexpected,Non-Health Professional,,,Female,I,5/17/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2017BDSI0103,2017BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,68,Years,Female,I,5/18/2017,5/11/2017,,,,ARACHNOIDITIS,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0103,2017BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,68,Years,Female,I,5/18/2017,5/11/2017,,,,ARACHNOIDITIS,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0103,2017BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,68,Years,Female,I,5/18/2017,5/11/2017,,,,ARACHNOIDITIS,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0104,2017BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,68,Years,Male,I,5/19/2017,4/1/2017,,,,FIBROMYALGIA,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0104,2017BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,68,Years,Male,I,5/19/2017,4/1/2017,,,,FIBROMYALGIA,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0104,2017BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,68,Years,Male,I,5/19/2017,4/1/2017,,,,FIBROMYALGIA,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0105,2017BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Positive,,microgram,,,Vomiting,Other Health Professional,,,Male,I,5/23/2017,5/1/2017,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0106,2017BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal tablet,,Headache,Pharmacist,30,Years,Male,I,6/6/2017,6/6/2017,,,Hospitalisation,DRUG ABUSE,UNITED STATES,Headache,,YES,YES,Listed
2017BDSI0106,2017BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal tablet,,Product adhesion issue,Pharmacist,30,Years,Male,I,6/6/2017,,,,,DRUG ABUSE,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2017BDSI0106,2017BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal tablet,,Vomiting,Pharmacist,30,Years,Male,I,6/6/2017,,,,Hospitalisation,DRUG ABUSE,UNITED STATES,Vomiting,,YES,YES,Unlisted
2017BDSI0107,2017BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Palpitations,Other Health Professional,,,,I,6/6/2017,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Palpitations,,YES,YES,Unlisted
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug dose omission,Other Health Professional,53,Years,Male,I,6/6/2017,5/26/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug dose omission,Other Health Professional,53,Years,Male,I,6/6/2017,5/26/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Other Health Professional,53,Years,Male,I,6/6/2017,5/1/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Other Health Professional,53,Years,Male,I,6/6/2017,5/1/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Other Health Professional,53,Years,Male,I,6/6/2017,5/1/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0108,2017BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Other Health Professional,53,Years,Male,I,6/6/2017,5/1/2017,,,,POST LAMINECTOMY SYNDROME,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0109,2017BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,,,Female,I,6/6/2017,9/12/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0109,2017BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Pharmacist,,,Female,I,6/6/2017,12/9/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0110,2017BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Non-Health Professional,55,Years,Male,I,6/8/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0110,2017BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Non-Health Professional,55,Years,Male,I,6/8/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0111,2017BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,6/9/2017,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0111,2017BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,6/9/2017,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0111,2017BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Male,I,6/9/2017,6/6/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0111,2017BDSI0111,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Male,I,6/9/2017,6/6/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0112,2017BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/12/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0113,2017BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,6/12/2017,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0113,2017BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/12/2017,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0114,2017BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Tooth loss,Non-Health Professional,,,Male,I,6/9/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tooth loss,,NO,NO,Unlisted
2017BDSI0116,2017BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Incorrect route of drug administration,Pharmacist,,,Female,I,6/14/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2017BDSI0117,2017BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Pharmacist,,,Female,I,6/16/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0118,2017BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product quality issue,Non-Health Professional,69,Years,Male,I,6/19/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2017BDSI0118,2017BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,69,Years,Male,I,6/19/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0118,2017BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,69,Years,Male,I,6/19/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0119,2017BDSI0119,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Road traffic accident,Other Health Professional,34,Years,Female,I,6/23/2017,5/25/2017,,,Death,DEPENDENCE ON OPIATES,UNITED STATES,Road traffic accident,,YES,YES,Unlisted
2017BDSI0119,2017BDSI0119,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,,,Road traffic accident,Other Health Professional,34,Years,Female,I,6/23/2017,5/25/2017,,,Death,DEPENDENCE ON OPIATES,UNITED STATES,Road traffic accident,,YES,YES,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Asthenia,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Limb injury,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Limb injury,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Cystitis interstitial,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Cystitis interstitial,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug screen negative,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Inappropriate schedule of drug administration,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2017BDSI0120,2017BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Incorrect route of drug administration,Non-Health Professional,53,Years,Female,I,6/20/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,55,Years,Female,I,6/23/2017,6/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Non-Health Professional,55,Years,Female,I,6/23/2017,6/21/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Non-Health Professional,55,Years,Female,I,6/23/2017,6/21/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,55,Years,Female,I,6/23/2017,6/21/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0121,2017BDSI0121,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,55,Years,Female,I,6/23/2017,6/21/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0122,2017BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,,,Male,I,6/23/2017,6/23/2017,,,,PAIN DUE TO BURNING MOUTH SYNDROME,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0123,2017BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,,Non-Health Professional,,,Female,I,6/29/2017,,,,,CHRONIC PAIN,UNITED STATES,nan,,NO,NO,Unlisted
2017BDSI0124,2017BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,71,Years,Male,I,7/19/2017,6/29/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0124,2017BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,71,Years,Male,I,7/19/2017,6/29/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0124,2017BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,71,Years,Male,I,7/19/2017,6/29/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0124,2017BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,71,Years,Male,I,7/19/2017,6/29/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0124,2017BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,71,Years,Male,I,7/19/2017,6/28/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0127,2017BDSI0127,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Adverse reaction,Non-Health Professional,,,Female,I,6/22/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Adverse reaction,,NO,NO,Listed
2017BDSI0128,2017BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product packaging quantity issue,Pharmacist,,,Female,I,6/28/2017,5/15/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0129,2017BDSI0129,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,35,Years,Male,I,7/6/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2017BDSI0129,2017BDSI0129,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,35,Years,Male,I,7/6/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2017BDSI0130,2017BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,69,Years,Female,I,7/6/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0130,2017BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,7/6/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0130,2017BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,69,Years,Female,I,7/6/2017,5/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0131,2017BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/12/2017,7/10/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0131,2017BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/12/2017,7/10/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0131,2017BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,7/12/2017,7/10/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0131,2017BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,7/12/2017,7/10/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0132,2017BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Non-Health Professional,55,Years,Male,I,7/17/2017,7/14/2017,,,,CHRONIC PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0133,2017BDSI0133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,7/17/2017,7/17/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0134,2017BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,54,Years,Male,I,7/17/2017,7/7/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0135,2017BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Rash pruritic,Other Health Professional,,,Female,I,7/19/2017,6/19/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash pruritic,,NO,NO,Listed
2017BDSI0136,2017BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,70,Years,Female,I,7/19/2017,7/17/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0136,2017BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Hypoaesthesia oral,Non-Health Professional,70,Years,Female,I,7/19/2017,7/17/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2017BDSI0136,2017BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dysgeusia,Non-Health Professional,70,Years,Female,I,7/19/2017,7/17/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Incorrect route of drug administration,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Underdose,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Underdose,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Incorrect route of drug administration,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0137,2017BDSI0137,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Underdose,Non-Health Professional,,,Female,I,7/19/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Underdose,,NO,NO,Unlisted
2017BDSI0138,2017BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,,,Male,I,7/20/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0138,2017BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Constipation,Non-Health Professional,,,Male,I,7/20/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2017BDSI0138,2017BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Headache,Non-Health Professional,,,Male,I,7/20/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0138,2017BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Somnolence,Non-Health Professional,,,Male,I,7/20/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0138,2017BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Influenza like illness,Non-Health Professional,,,Male,I,7/20/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Influenza like illness,,NO,NO,Unlisted
2017BDSI0139,2017BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Throat tightness,Other Health Professional,,,Female,I,7/20/2017,7/1/2017,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Throat tightness,,NO,NO,Unlisted
2017BDSI0140,2017BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,,,Drug ineffective,Non-Health Professional,53,Years,Female,I,7/26/2017,7/24/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0140,2017BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,,,Incorrect dose administered,Non-Health Professional,53,Years,Female,I,7/26/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Incorrect dose administered,,NO,NO,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Peripheral swelling,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Peripheral swelling,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Anxiety,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,YES,Listed
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Anxiety,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,YES,Listed
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Skin disorder,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Skin disorder,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Skin disorder,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Skin disorder,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Intentional product misuse,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,YES,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Dry skin,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry skin,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Intentional product misuse,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,YES,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Dry skin,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry skin,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Skin discolouration,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Skin discolouration,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Skin discolouration,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Skin discolouration,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Hypoaesthesia,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Hypoaesthesia,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Dysgeusia,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Dysgeusia,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Emotional distress,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Emotional distress,,NO,YES,Unlisted
2017BDSI0142,2017BDSI0142,Bunavail,"BUPRENORPHINE,NALOXONE",Intravenous use,,,,,,,Emotional distress,Non-Health Professional,,,Male,I,7/28/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Emotional distress,,NO,YES,Unlisted
2017BDSI0143,2017BDSI0143,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Constipation,Non-Health Professional,,,Male,I,7/28/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2017BDSI0143,2017BDSI0143,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Constipation,Non-Health Professional,,,Male,I,7/28/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2017BDSI0144,2017BDSI0144,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dysuria,Non-Health Professional,,,Male,I,7/28/2017,7/27/2017,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,NO,Unlisted
2017BDSI0145,2017BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,47,Years,Female,I,7/29/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0145,2017BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,47,Years,Female,I,7/29/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0145,2017BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,47,Years,Female,I,7/29/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0146,2017BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,43,Years,Male,I,7/31/2017,6/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Unlisted
2017BDSI0146,2017BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,43,Years,Male,I,7/31/2017,7/18/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2017BDSI0146,2017BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,43,Years,Male,I,7/31/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0146,2017BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,43,Years,Male,I,7/31/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0147,2017BDSI0147,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Pharmacist,,,Female,I,7/31/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0147,2017BDSI0147,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Pharmacist,,,Female,I,7/31/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0147,2017BDSI0147,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Pharmacist,,,Female,I,7/31/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0147,2017BDSI0147,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Pharmacist,,,Female,I,7/31/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0148,2017BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Suicidal ideation,Physician,,,Male,I,8/2/2017,7/28/2017,,,Other,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2017BDSI0148,2017BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Feeling abnormal,Physician,,,Male,I,8/2/2017,7/1/2017,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2017BDSI0149,2017BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Pharmacist,,,Female,I,8/4/2017,,,,,PAIN IN FEET,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0150,2017BDSI0150,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Overdose,Non-Health Professional,,,Female,I,8/7/2017,8/1/2017,,,Death,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Overdose,,YES,YES,Unlisted
2017BDSI0150,2017BDSI0150,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Overdose,Non-Health Professional,,,Female,I,8/7/2017,8/1/2017,,,Death,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Overdose,,YES,YES,Unlisted
2017BDSI0151,2017BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Blood pressure increased,Other Health Professional,,,Male,I,8/7/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blood pressure increased,,YES,YES,Listed
2017BDSI0152,2017BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Non-Health Professional,47,Years,Female,I,8/7/2017,8/3/2017,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0152,2017BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,47,Years,Female,I,8/7/2017,8/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,
2017BDSI0152,2017BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,47,Years,Female,I,8/7/2017,8/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,
2017BDSI0152,2017BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,47,Years,Female,I,8/7/2017,8/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,
2017BDSI0154,2017BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product adhesion issue,Physician,,,Female,I,8/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0154,2017BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Wrong technique in product usage process,Physician,,,Female,I,8/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0154,2017BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product solubility abnormal,Physician,,,Female,I,8/4/2017,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0155,2017BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,42,Years,Female,I,8/8/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0155,2017BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,42,Years,Female,I,8/8/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0155,2017BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,42,Years,Female,I,8/8/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0155,2017BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,42,Years,Female,I,8/8/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0155,2017BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,42,Years,Female,I,8/8/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0157,2017BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Death,Physician,,,,I,8/10/2017,1/1/2017,,,Death,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Death,,YES,YES,Listed
2017BDSI0158,2017BDSI0158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Seizure,Non-Health Professional,,,Female,I,8/14/2017,8/11/2017,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Seizure,,YES,YES,Unlisted
2017BDSI0159,2017BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Mouth ulceration,Physician,,,Female,I,8/11/2017,8/1/2017,,,,PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2017BDSI0160,2017BDSI0160,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Drug withdrawal syndrome,Physician,,,,I,8/14/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0160,2017BDSI0160,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Therapeutic response unexpected,Physician,,,,I,8/14/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,YES,Unlisted
2017BDSI0160,2017BDSI0160,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Therapeutic response unexpected,Physician,,,,I,8/14/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,YES,Unlisted
2017BDSI0160,2017BDSI0160,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,,,Drug withdrawal syndrome,Physician,,,,I,8/14/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0161,2017BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Nausea,Non-Health Professional,56,Years,Female,I,8/21/2017,4/29/2017,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Medication residue present,,NO,NO,
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral discomfort,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oral discomfort,,NO,NO,
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Aphonia,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Aphonia,,NO,NO,Unlisted
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,8/22/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0162,2017BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Female,I,8/22/2017,7/18/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Unlisted
2017BDSI0164,2017BDSI0164,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,25,Years,Male,I,8/23/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0164,2017BDSI0164,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,25,Years,Male,I,8/23/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2017BDSI0164,2017BDSI0164,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,25,Years,Male,I,8/23/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2017BDSI0164,2017BDSI0164,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,25,Years,Male,I,8/23/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Anger,Physician,54,Years,Female,I,8/22/2017,8/10/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Anger,,NO,NO,
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Agitation,Physician,54,Years,Female,I,8/22/2017,8/11/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Agitation,,NO,NO,
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Physician,54,Years,Female,I,8/22/2017,8/8/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Anger,Physician,54,Years,Female,I,8/22/2017,8/10/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Anger,,NO,NO,Unlisted
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Therapeutic response decreased,Physician,54,Years,Female,I,8/22/2017,8/8/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Therapeutic response decreased,,NO,NO,
2017BDSI0165,2017BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Agitation,Physician,54,Years,Female,I,8/22/2017,8/11/2017,,,,PAIN IN RIGHT SHOULDER,UNITED STATES,Agitation,,NO,NO,Unlisted
2017BDSI0166,2017BDSI0166,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapy cessation,Non-Health Professional,70,Years,Female,I,8/25/2017,8/12/2017,,,,LEG PAIN,UNITED STATES,Therapy cessation,,NO,NO,Unlisted
2017BDSI0166,2017BDSI0166,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,8/25/2017,8/1/2017,,,,LEG PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0166,2017BDSI0166,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,70,Years,Female,I,8/25/2017,8/1/2017,,,,LEG PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0167,2017BDSI0167,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/28/2017,8/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0167,2017BDSI0167,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/28/2017,8/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0168,2017BDSI0168,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,8/28/2017,8/25/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0169,2017BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,8/28/2017,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0170,2017BDSI0170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,8/28/2017,8/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0170,2017BDSI0170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/28/2017,8/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0171,2017BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Fatigue,Non-Health Professional,,,Female,I,8/30/2017,8/1/2017,,,,INTRACTABLE SEVERE PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2017BDSI0171,2017BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,,,Female,I,8/30/2017,8/1/2017,,,,INTRACTABLE SEVERE PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0171,2017BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Somnolence,Non-Health Professional,,,Female,I,8/30/2017,8/1/2017,,,,INTRACTABLE SEVERE PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0171,2017BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging issue,Non-Health Professional,,,Female,I,8/30/2017,8/1/2017,,,,INTRACTABLE SEVERE PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0171,2017BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Breakthrough pain,Non-Health Professional,,,Female,I,8/30/2017,8/30/2017,,,,INTRACTABLE SEVERE PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2017BDSI0172,2017BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Malaise,,,,Female,I,8/30/2017,8/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2017BDSI0172,2017BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Body temperature decreased,,,,Female,I,8/30/2017,8/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Body temperature decreased,,NO,NO,Unlisted
2017BDSI0172,2017BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,,,,Female,I,8/30/2017,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0173,2017BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Headache,Non-Health Professional,63,Years,Male,I,9/6/2017,8/16/2017,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0174,2017BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Dyspnoea,Physician,,,Female,I,9/7/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,YES,YES,Listed
2017BDSI0174,2017BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Chest pain,Physician,,,Female,I,9/7/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest pain,,YES,YES,Listed
2017BDSI0174,2017BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Electrocardiogram QT prolonged,Physician,,,Female,I,9/7/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2017BDSI0175,2017BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,52,Years,Female,I,9/8/2017,9/7/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0178,2017BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,48,Years,Female,I,9/8/2017,1/1/2016,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Unlisted
2017BDSI0178,2017BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,48,Years,Female,I,9/8/2017,8/14/2017,,,,CHRONIC ABDOMINAL PAIN,UNITED STATES,Product packaging quantity issue,,NO,YES,Unlisted
2017BDSI0178,2017BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Osteonecrosis,Non-Health Professional,48,Years,Female,I,9/8/2017,7/1/2017,,,Hospitalisation,CHRONIC ABDOMINAL PAIN,UNITED STATES,Osteonecrosis,,YES,YES,Unlisted
2017BDSI0179,2017BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,68,Years,Female,I,9/12/2017,8/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0179,2017BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging issue,Non-Health Professional,68,Years,Female,I,9/12/2017,9/10/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0179,2017BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,68,Years,Female,I,9/12/2017,9/10/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0179,2017BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,68,Years,Female,I,9/12/2017,6/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0180,2017BDSI0180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product outer packaging issue,Non-Health Professional,,,Male,I,9/13/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2017BDSI0180,2017BDSI0180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Male,I,9/13/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0180,2017BDSI0180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,,,Male,I,9/13/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,35,Years,Male,I,9/14/2017,1/1/2015,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug screen negative,Non-Health Professional,35,Years,Male,I,9/14/2017,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug screen negative,Non-Health Professional,35,Years,Male,I,9/14/2017,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,35,Years,Male,I,9/14/2017,1/1/2015,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,35,Years,Male,I,9/14/2017,1/1/2015,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Non-Health Professional,35,Years,Male,I,9/14/2017,1/1/2015,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Withdrawal syndrome,Non-Health Professional,35,Years,Male,I,9/14/2017,,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2017BDSI0182,2017BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Withdrawal syndrome,Non-Health Professional,35,Years,Male,I,9/14/2017,,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2017BDSI0183,2017BDSI0183,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Insomnia,Non-Health Professional,64,Years,Female,I,9/12/2017,9/11/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2017BDSI0183,2017BDSI0183,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Somnolence,Non-Health Professional,64,Years,Female,I,9/12/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,59,Years,Female,I,9/18/2017,9/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,59,Years,Female,I,9/18/2017,9/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Throat tightness,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Throat tightness,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Abdominal distension,Non-Health Professional,59,Years,Female,I,9/18/2017,9/17/2017,,,,CHRONIC PAIN,UNITED STATES,Abdominal distension,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Throat irritation,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Throat irritation,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dysphagia,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Dysphagia,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Chest discomfort,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Chest discomfort,,NO,YES,Unlisted
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2017BDSI0184,2017BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Withdrawal syndrome,Non-Health Professional,59,Years,Female,I,9/18/2017,9/10/2017,,,Other,CHRONIC PAIN,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2017BDSI0185,2017BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/18/2017,7/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0185,2017BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,9/18/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0187,2017BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,9/21/2017,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0189,2017BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Abdominal pain,Physician,,,Female,I,9/25/2017,9/23/2017,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abdominal pain,,YES,YES,Listed
2017BDSI0189,2017BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Electrocardiogram QT prolonged,Physician,,,Female,I,9/25/2017,9/24/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2017BDSI0191,2017BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Drug ineffective,Non-Health Professional,,,Male,I,9/28/2017,9/25/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0191,2017BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,9/28/2017,9/25/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0191,2017BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Male,I,9/28/2017,9/25/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0192,2017BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug screen negative,Non-Health Professional,34,Years,Male,I,9/29/2017,4/1/2017,,,,LOW BACK PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2017BDSI0193,2017BDSI0193,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug dose omission,Non-Health Professional,,,Female,I,10/2/2017,9/29/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2017BDSI0193,2017BDSI0193,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Cold sweat,Non-Health Professional,,,Female,I,10/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Cold sweat,,NO,NO,Listed
2017BDSI0193,2017BDSI0193,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug dose omission,Non-Health Professional,,,Female,I,10/2/2017,9/29/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug dose omission,,NO,NO,Unlisted
2017BDSI0193,2017BDSI0193,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Cold sweat,Non-Health Professional,,,Female,I,10/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Cold sweat,,NO,NO,Listed
2017BDSI0194,2017BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Breakthrough pain,Non-Health Professional,,,Male,I,10/2/2017,9/1/2017,,,,CHRONIC SCIATIC LOWER BACK PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2017BDSI0194,2017BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Sleep disorder,Non-Health Professional,,,Male,I,10/2/2017,9/1/2017,,,,CHRONIC SCIATIC LOWER BACK PAIN,UNITED STATES,Sleep disorder,,NO,YES,Unlisted
2017BDSI0194,2017BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,10/2/2017,9/1/2017,,,Other,CHRONIC SCIATIC LOWER BACK PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0194,2017BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Visual impairment,Non-Health Professional,,,Male,I,10/2/2017,1/1/2017,,,,CHRONIC SCIATIC LOWER BACK PAIN,UNITED STATES,Visual impairment,,NO,YES,Unlisted
2017BDSI0195,2017BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,10/3/2017,4/2/2016,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0195,2017BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Breakthrough pain,Non-Health Professional,,,Male,I,10/3/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2017BDSI0195,2017BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Muscle tightness,Non-Health Professional,,,Male,I,10/3/2017,10/2/2017,,,,CHRONIC PAIN,UNITED STATES,Muscle tightness,,NO,NO,Unlisted
2017BDSI0195,2017BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Pain in jaw,Non-Health Professional,,,Male,I,10/3/2017,10/2/2017,,,,CHRONIC PAIN,UNITED STATES,Pain in jaw,,NO,NO,Unlisted
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oedema peripheral,Pharmacist,39,Years,Female,I,10/4/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,YES,Listed
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Gait disturbance,Pharmacist,39,Years,Female,I,10/4/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,YES,Unlisted
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Conversion disorder,Pharmacist,39,Years,Female,I,10/4/2017,10/6/2017,,,,CHRONIC PAIN,UNITED STATES,Conversion disorder,,NO,YES,Unlisted
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,39,Years,Female,I,10/4/2017,10/3/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Pharmacist,39,Years,Female,I,10/4/2017,10/7/2017,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0196,2017BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product size issue,Pharmacist,39,Years,Female,I,10/4/2017,10/3/2017,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,YES,Unlisted
2017BDSI0197,2017BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,53,Years,Female,I,10/4/2017,10/3/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0197,2017BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,53,Years,Female,I,10/4/2017,10/3/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0197,2017BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,53,Years,Female,I,10/4/2017,10/3/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0198,2017BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,62,Years,Female,I,10/4/2017,9/18/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0198,2017BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Feeling abnormal,Non-Health Professional,62,Years,Female,I,10/4/2017,9/18/2017,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2017BDSI0198,2017BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,62,Years,Female,I,10/4/2017,9/18/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0198,2017BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,62,Years,Female,I,10/4/2017,9/18/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0198,2017BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,62,Years,Female,I,10/4/2017,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2017BDSI0199,2017BDSI0199,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,61,Years,Female,I,10/9/2017,10/6/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0200,2017BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,10/6/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0200,2017BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,10/6/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0200,2017BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,10/6/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0201,2017BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Euphoric mood,Other Health Professional,,,,I,10/10/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Euphoric mood,,NO,NO,Listed
2017BDSI0202,2017BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product adhesion issue,Physician,,,,I,10/10/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0203,2017BDSI0203,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Non-Health Professional,,,Male,I,10/6/2017,5/8/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0203,2017BDSI0203,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug prescribing error,Non-Health Professional,,,Male,I,10/6/2017,5/8/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,56,Years,Male,I,10/9/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,56,Years,Male,I,10/9/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,56,Years,Male,I,10/9/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,56,Years,Male,I,10/9/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Insomnia,Non-Health Professional,56,Years,Male,I,10/9/2017,8/18/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,56,Years,Male,I,10/9/2017,8/18/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Headache,Non-Health Professional,56,Years,Male,I,10/9/2017,8/18/2017,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0204,2017BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,56,Years,Male,I,10/9/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,57,Years,Female,I,10/10/2017,1/1/2017,,,,PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Off label use,Non-Health Professional,57,Years,Female,I,10/10/2017,1/1/2017,,,,PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective for unapproved indication,Non-Health Professional,57,Years,Female,I,10/10/2017,1/1/2017,,,,PAIN,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective for unapproved indication,Non-Health Professional,57,Years,Female,I,10/10/2017,1/1/2017,,,,PAIN,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Condition aggravated,Non-Health Professional,57,Years,Female,I,10/10/2017,7/1/2017,,,,PAIN,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2017BDSI0205,2017BDSI0205,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Condition aggravated,Non-Health Professional,57,Years,Female,I,10/10/2017,7/1/2017,,,,PAIN,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2017BDSI0206,2017BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Pharmacist,,,Female,I,10/11/2017,10/11/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0206,2017BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Pharmacist,,,Female,I,10/11/2017,10/11/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0209,2017BDSI0209,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Adrenal insufficiency,Physician,,,,I,10/4/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Adrenal insufficiency,,YES,YES,Listed
2017BDSI0209,2017BDSI0209,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Adrenal insufficiency,Physician,,,,I,10/4/2017,1/1/2017,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Adrenal insufficiency,,YES,YES,Listed
2017BDSI0210,2017BDSI0210,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product availability issue,Non-Health Professional,62,Years,Female,I,10/13/2017,10/13/2017,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,YES,Unlisted
2017BDSI0210,2017BDSI0210,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Non-Health Professional,62,Years,Female,I,10/13/2017,10/13/2017,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2017BDSI0216,2017BDSI0216,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Condition aggravated,Non-Health Professional,45,Years,Female,I,10/13/2017,10/11/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Condition aggravated,,NO,NO,Listed
2017BDSI0216,2017BDSI0216,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dyspnoea,Non-Health Professional,45,Years,Female,I,10/13/2017,10/11/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dyspnoea,,NO,NO,Listed
2017BDSI0216,2017BDSI0216,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Dyspnoea,Non-Health Professional,45,Years,Female,I,10/13/2017,10/11/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Dyspnoea,,NO,NO,Listed
2017BDSI0216,2017BDSI0216,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Condition aggravated,Non-Health Professional,45,Years,Female,I,10/13/2017,10/11/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Condition aggravated,,NO,NO,Listed
2017BDSI0217,2017BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Somnolence,Non-Health Professional,,,Male,I,10/15/2017,10/15/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0217,2017BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Narcolepsy,Non-Health Professional,,,Male,I,10/15/2017,10/15/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Narcolepsy,,NO,NO,Unlisted
2017BDSI0219,2017BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,58,Years,Male,I,10/16/2017,9/27/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0219,2017BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Inappropriate schedule of drug administration,Non-Health Professional,58,Years,Male,I,10/16/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2017BDSI0219,2017BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,58,Years,Male,I,10/16/2017,10/16/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0219,2017BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,58,Years,Male,I,10/16/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Vomiting,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Vomiting,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Vomiting,,NO,NO,Listed
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Nausea,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Nausea,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Oral administration complication,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Oral administration complication,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Product adhesion issue,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Product adhesion issue,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Product physical consistency issue,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0220,2017BDSI0220,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Negative,,,,,Product physical consistency issue,Non-Health Professional,61,Years,Female,I,10/17/2017,10/11/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0221,2017BDSI0221,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Other Health Professional,,,Male,I,10/19/2017,6/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hypoaesthesia oral,Non-Health Professional,30,Years,Female,I,10/20/2017,10/15/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Hypoaesthesia oral,Non-Health Professional,30,Years,Female,I,10/20/2017,10/15/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,30,Years,Female,I,10/20/2017,1/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,30,Years,Female,I,10/20/2017,1/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug administration error,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug administration error,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product taste abnormal,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2017BDSI0222,2017BDSI0222,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Wrong technique in product usage process,Non-Health Professional,30,Years,Female,I,10/20/2017,9/23/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0224,2017BDSI0224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Pharmacist,,,Female,I,10/24/2017,10/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2017BDSI0226,2017BDSI0226,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product physical issue,Pharmacist,,,Female,I,10/24/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0228,2017BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,10/27/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0229,2017BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Hiccups,Non-Health Professional,,,Female,I,10/31/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Hiccups,,NO,NO,Unlisted
2017BDSI0229,2017BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Female,I,10/31/2017,10/18/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0229,2017BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Hypersomnia,Non-Health Professional,,,Female,I,10/31/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Hypersomnia,,NO,NO,Listed
2017BDSI0230,2017BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Male,I,10/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0230,2017BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging issue,Non-Health Professional,,,Male,I,10/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2017BDSI0231,2017BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Condition aggravated,Non-Health Professional,40,Years,Female,I,10/31/2017,10/23/2017,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2017BDSI0231,2017BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Headache,Non-Health Professional,40,Years,Female,I,10/31/2017,10/23/2017,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0235,2017BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Stomatitis,Other Health Professional,,,Female,I,11/1/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2017BDSI0236,2017BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,,,Nausea,Pharmacist,,,Male,I,11/3/2017,1/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Nausea,,YES,YES,Listed
2017BDSI0236,2017BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Vomiting,Pharmacist,,,Male,I,11/3/2017,1/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2017BDSI0236,2017BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Nausea,Pharmacist,,,Male,I,11/3/2017,1/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Nausea,,YES,YES,Listed
2017BDSI0236,2017BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,,,Vomiting,Pharmacist,,,Male,I,11/3/2017,1/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2017BDSI0237,2017BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,11/3/2017,1/1/2017,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2017BDSI0237,2017BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Therapeutic response decreased,Non-Health Professional,,,Male,I,11/3/2017,1/1/2017,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0238,2017BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Tongue discolouration,Physician,,,,I,11/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tongue discolouration,,NO,NO,Unlisted
2017BDSI0238,2017BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral mucosal erythema,Physician,,,,I,11/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal erythema,,NO,NO,Unlisted
2017BDSI0241,2017BDSI0241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,11/13/2017,1/1/2017,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0241,2017BDSI0241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oral administration complication,Non-Health Professional,,,Male,I,11/13/2017,1/1/2017,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0245,2017BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Other Health Professional,,,UNK,I,11/13/2017,11/13/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0246,2017BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Female,I,11/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0246,2017BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,11/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0246,2017BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Non-Health Professional,,,Female,I,11/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2017BDSI0246,2017BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,,,Female,I,11/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2017BDSI0247,2017BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Stomatitis,Physician,,,,I,11/16/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2017BDSI0249,2017BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Anaphylactic shock,Physician,,,Female,I,11/16/2017,11/11/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Anaphylactic shock,,YES,YES,Listed
2017BDSI0250,2017BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Drug ineffective,Non-Health Professional,35,Years,Female,I,11/21/2017,1/1/2017,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0250,2017BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Sensitivity of teeth,Non-Health Professional,35,Years,Female,I,11/21/2017,1/1/2017,,,,PAIN,UNITED STATES,Sensitivity of teeth,,NO,NO,Unlisted
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Vomiting,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Oral pain,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Oral pain,,YES,YES,Unlisted
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Noninfective gingivitis,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Noninfective gingivitis,,YES,YES,Unlisted
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Insomnia,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Stomatitis,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Stomatitis,,YES,YES,Unlisted
2017BDSI0251,2017BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Mouth haemorrhage,Physician,58,Years,Female,I,11/20/2017,11/1/2017,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Mouth haemorrhage,,YES,YES,Unlisted
2017BDSI0254,2017BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Noninfective gingivitis,Physician,61,Years,Male,I,11/20/2017,11/20/2017,,,,CHRONIC PAIN,UNITED STATES,Noninfective gingivitis,,NO,NO,Unlisted
2017BDSI0254,2017BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Stomatitis,Physician,61,Years,Male,I,11/20/2017,11/20/2017,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2017BDSI0256,2017BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Insomnia,Non-Health Professional,,,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2017BDSI0256,2017BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Affect lability,Non-Health Professional,,,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Affect lability,,NO,NO,Unlisted
2017BDSI0256,2017BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Anxiety,Non-Health Professional,,,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Unlisted
2017BDSI0256,2017BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Intentional dose omission,Non-Health Professional,,,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2017BDSI0256,2017BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,11/20/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product use in unapproved indication,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Product use in unapproved indication,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product use in unapproved indication,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Product use in unapproved indication,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Inappropriate schedule of drug administration,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Inappropriate schedule of drug administration,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Inappropriate schedule of drug administration,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Inappropriate schedule of drug administration,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Glucocorticoid deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Glucocorticoid deficiency,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Glucocorticoid deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Glucocorticoid deficiency,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Pain,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Pain,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Pain,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Pain,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Intentional device misuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Intentional device misuse,,NO,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Intentional device misuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Intentional device misuse,,NO,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Overdose,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Overdose,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Off label use,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Off label use,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Off label use,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Off label use,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hypogonadism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypogonadism,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Fatigue,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Headache,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Asthenia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product use in unapproved indication,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Product use in unapproved indication,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Inappropriate schedule of drug administration,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Inappropriate schedule of drug administration,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Glucocorticoid deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Glucocorticoid deficiency,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Pain,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Pain,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Intentional device misuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Intentional device misuse,,NO,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Alcohol abuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Alcohol abuse,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Gonadotrophin deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Gonadotrophin deficiency,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Overdose,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Off label use,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Off label use,,YES,YES,
2017BDSI0258,2017BDSI0258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hypogonadism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypogonadism,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hypogonadism,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypogonadism,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Headache,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Headache,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Condition aggravated,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Condition aggravated,,YES,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Alcohol abuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Alcohol abuse,,YES,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Alcohol abuse,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Alcohol abuse,,YES,YES,
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Gonadotrophin deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Gonadotrophin deficiency,,YES,YES,Unlisted
2017BDSI0258,2017BDSI0258,Bunavail,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Gonadotrophin deficiency,Other Health Professional,35,Years,Male,F,8/1/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Gonadotrophin deficiency,,YES,YES,Unlisted
2017BDSI0259,2017BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/21/2017,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0260,2017BDSI0260,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,Female,I,11/22/2017,11/19/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0260,2017BDSI0260,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Pharmacist,,,Female,I,11/22/2017,11/19/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2017BDSI0261,2017BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Rash pustular,Other Health Professional,59,Years,Female,I,11/21/2017,9/1/2017,,,,CHRONIC PAIN,UNITED STATES,Rash pustular,,NO,NO,Listed
2017BDSI0261,2017BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Pruritus,Other Health Professional,59,Years,Female,I,11/21/2017,9/1/2017,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Unlisted
2017BDSI0263,2017BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Somnolence,Non-Health Professional,63,Years,Female,I,11/29/2017,9/15/2017,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2017BDSI0263,2017BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Yawning,Non-Health Professional,63,Years,Female,I,11/29/2017,9/15/2017,,,,CHRONIC PAIN,UNITED STATES,Yawning,,NO,NO,Unlisted
2017BDSI0263,2017BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Drug ineffective,Non-Health Professional,63,Years,Female,I,11/29/2017,9/15/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Unlisted
2017BDSI0264,2017BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,11/27/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0264,2017BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,11/27/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0264,2017BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/27/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Physician,83,Years,Female,I,11/30/2017,8/30/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Mouth swelling,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Mouth swelling,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Discomfort,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Discomfort,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Sleep disorder,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Lip pain,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Lip pain,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Glossodynia,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Glossodynia,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Swollen tongue,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Swollen tongue,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral discomfort,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2017BDSI0265,2017BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Tongue discomfort,Physician,83,Years,Female,I,11/30/2017,10/1/2017,,,,CHRONIC PAIN,UNITED STATES,Tongue discomfort,,NO,NO,Unlisted
2017BDSI0267,2017BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Tongue discolouration,Physician,,,,I,11/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tongue discolouration,,NO,NO,Unlisted
2017BDSI0267,2017BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Oral mucosal erythema,Physician,,,,I,11/2/2017,1/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal erythema,,NO,NO,Unlisted
2017BDSI0268,2017BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Female,I,12/1/2017,10/22/2017,,,,MIGRAINE HEADACHE,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0269,2017BDSI0269,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Other Health Professional,,,Male,I,12/1/2017,11/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0269,2017BDSI0269,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Other Health Professional,,,Male,I,12/1/2017,11/1/2017,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0270,2017BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Alopecia,Physician,43,Years,Male,I,12/6/2017,12/5/2017,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product adhesion issue,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0271,2017BDSI0271,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product physical consistency issue,Pharmacist,,,Male,I,12/6/2017,1/1/2017,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0272,2017BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,66,Years,Male,I,12/7/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0274,2017BDSI0274,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,12/11/2017,12/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0274,2017BDSI0274,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,12/11/2017,12/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0275,2017BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,53,Years,Female,I,12/14/2017,12/6/2017,,,,COMPLEX REGIONAL PAIN SYNDROME,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0275,2017BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,53,Years,Female,I,12/14/2017,12/6/2017,,,,COMPLEX REGIONAL PAIN SYNDROME,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2017BDSI0276,2017BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Oral administration complication,Non-Health Professional,,,Female,I,12/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0276,2017BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Female,I,12/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0276,2017BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0276,2017BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product physical issue,Non-Health Professional,,,Female,I,12/14/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Diarrhoea,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Restless legs syndrome,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Restless legs syndrome,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dysuria,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Headache,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nervousness,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Nervousness,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Insomnia,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Fatigue,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0277,2017BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Heart rate increased,Non-Health Professional,73,Years,Female,I,12/14/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2017BDSI0283,2017BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,90,Years,Female,I,12/18/2017,12/1/2017,,,,LEG PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2017BDSI0283,2017BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,90,Years,Female,I,12/18/2017,12/11/2017,,,,LEG PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0283,2017BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,90,Years,Female,I,12/18/2017,12/1/2017,,,,LEG PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0283,2017BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,90,Years,Female,I,12/18/2017,12/1/2017,,,,LEG PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0283,2017BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,90,Years,Female,I,12/18/2017,12/1/2017,,,,LEG PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0284,2017BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,12/19/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2017BDSI0284,2017BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/19/2017,12/13/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product colour issue,Other Health Professional,60,Years,Female,I,12/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Other Health Professional,60,Years,Female,I,12/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Other Health Professional,60,Years,Female,I,12/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Other Health Professional,60,Years,Female,I,12/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Other Health Professional,60,Years,Female,I,12/20/2017,12/19/2017,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2017BDSI0286,2017BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Other Health Professional,60,Years,Female,I,12/20/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Overdose,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Off label use,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Off label use,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Off label use,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Off label use,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypogonadism,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypogonadism,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypogonadism,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypogonadism,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product use in unapproved indication,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Product use in unapproved indication,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product use in unapproved indication,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Product use in unapproved indication,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Inappropriate schedule of drug administration,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Inappropriate schedule of drug administration,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Inappropriate schedule of drug administration,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Inappropriate schedule of drug administration,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2017BDSI0293,2017BDSI0293,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Overdose,Other Health Professional,35,Years,Male,F,2/15/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,Unlisted
2018BDSI0003,2018BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,,,Female,I,12/26/2017,9/29/2017,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0003,2018BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Pharmacist,,,Female,I,12/26/2017,12/1/2017,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0003,2018BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product colour issue,Pharmacist,,,Female,I,12/26/2017,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2018BDSI0003,2018BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product taste abnormal,Pharmacist,,,Female,I,12/26/2017,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2018BDSI0003,2018BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product size issue,Pharmacist,,,Female,I,12/26/2017,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2018BDSI0004,2018BDSI0004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/2/2018,12/29/2017,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0004,2018BDSI0004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,,,Female,I,1/2/2018,12/29/2017,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0006,2018BDSI0006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Pharmacist,,,Male,I,12/29/2017,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0010,2018BDSI0010,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,1/5/2018,1/2/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0010,2018BDSI0010,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,57,Years,Female,I,1/5/2018,1/2/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0011,2018BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Therapeutic response decreased,Non-Health Professional,,,,I,1/8/2018,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,1/9/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Palpitations,Non-Health Professional,,,Female,I,1/9/2018,1/8/2018,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Heart rate increased,Non-Health Professional,,,Female,I,1/9/2018,1/8/2018,,,,CHRONIC PAIN,UNITED STATES,Heart rate increased,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Tremor,Non-Health Professional,,,Female,I,1/9/2018,1/9/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Vision blurred,Non-Health Professional,,,Female,I,1/9/2018,1/9/2018,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dysuria,Non-Health Professional,,,Female,I,1/9/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Migraine,Non-Health Professional,,,Female,I,1/9/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,YES,Unlisted
2018BDSI0014,2018BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Seizure,Non-Health Professional,,,Female,I,1/9/2018,12/1/2017,,,Other,CHRONIC PAIN,UNITED STATES,Seizure,,YES,YES,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Dizziness,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Dry mouth,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Oropharyngeal pain,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oropharyngeal pain,,NO,NO,Unlisted
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Hypertension,Non-Health Professional,80,Years,Female,I,1/19/2018,1/11/2018,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Drug ineffective,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Tongue haemorrhage,Non-Health Professional,80,Years,Female,I,1/19/2018,1/8/2018,,,,CHRONIC PAIN,UNITED STATES,Tongue haemorrhage,,NO,NO,Unlisted
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Candida infection,Non-Health Professional,80,Years,Female,I,1/19/2018,1/8/2018,,,,CHRONIC PAIN,UNITED STATES,Candida infection,,NO,NO,Unlisted
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Dizziness,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Fatigue,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Disturbance in attention,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2018BDSI0016,2018BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Insomnia,Non-Health Professional,80,Years,Female,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0017,2018BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,65,Years,Female,I,1/12/2018,12/1/2017,,,,HEADACHE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0017,2018BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,65,Years,Female,I,1/12/2018,12/1/2017,,,,HEADACHE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0017,2018BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective for unapproved indication,Non-Health Professional,65,Years,Female,I,1/12/2018,12/19/2017,,,,HEADACHE,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2018BDSI0017,2018BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Intentional product use issue,Non-Health Professional,65,Years,Female,I,1/12/2018,12/19/2017,,,,HEADACHE,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2018BDSI0017,2018BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,65,Years,Female,I,1/12/2018,12/1/2017,,,,HEADACHE,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0022,2018BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,1/19/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0022,2018BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,,,Male,I,1/19/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Listed
2018BDSI0022,2018BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,1/19/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0023,2018BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Weight decreased,Non-Health Professional,51,Years,Male,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2018BDSI0023,2018BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Decreased appetite,Non-Health Professional,51,Years,Male,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2018BDSI0023,2018BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Vomiting,Non-Health Professional,51,Years,Male,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0023,2018BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Blood glucose increased,Non-Health Professional,51,Years,Male,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,NO,NO,Unlisted
2018BDSI0023,2018BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Vision blurred,Non-Health Professional,51,Years,Male,I,1/19/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2018BDSI0024,2018BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0024,2018BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0026,2018BDSI0026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,1/20/2018,1/20/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0026,2018BDSI0026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0027,2018BDSI0027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Male,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Heart rate irregular,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Heart rate irregular,,NO,NO,Unlisted
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Headache,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0028,2018BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Diarrhoea,Non-Health Professional,,,Female,I,1/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0033,2018BDSI0033,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,1/23/2018,1/23/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0036,2018BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,67,Years,Male,I,1/25/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0036,2018BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,67,Years,Male,I,1/25/2018,12/26/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0036,2018BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,67,Years,Male,I,1/25/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0037,2018BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,60,Years,Female,I,1/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0037,2018BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral discomfort,Non-Health Professional,60,Years,Female,I,1/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2018BDSI0037,2018BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,1/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0037,2018BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,1/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0045,2018BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Pharmacist,21,Years,Male,I,2/1/2018,1/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0045,2018BDSI0045,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Pharmacist,21,Years,Male,I,2/1/2018,1/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0046,2018BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Off label use,Non-Health Professional,56,Years,Female,I,2/1/2018,1/25/2017,,,,MIGRAINE,UNITED STATES,Off label use,,NO,NO,Unlisted
2018BDSI0046,2018BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Inability to afford medication,Non-Health Professional,56,Years,Female,I,2/1/2018,1/1/2018,,,,MIGRAINE,UNITED STATES,Inability to afford medication,,NO,NO,Unlisted
2018BDSI0047,2018BDSI0047,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Female,I,2/2/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/5/2018,12/1/2017,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/5/2018,12/1/2017,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Non-Health Professional,,,Female,I,2/5/2018,,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/5/2018,,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,,,Female,I,2/5/2018,,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0053,2018BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/5/2018,,,,,SEVERE ARTHRITIS PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0054,2018BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Pharmacist,,,Male,I,2/5/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0060,2018BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Seizure,Other Health Professional,46,Years,Male,I,2/6/2018,2/5/2018,,,Other,CHRONIC PAIN,UNITED STATES,Seizure,,YES,YES,Unlisted
2018BDSI0060,2018BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug withdrawal syndrome,Other Health Professional,46,Years,Male,I,2/6/2018,2/5/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Diarrhoea,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Mydriasis,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Mydriasis,,NO,NO,Unlisted
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Hyperhidrosis,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0061,2018BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,64,Years,Female,I,2/7/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0063,2018BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,3/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0063,2018BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Female,I,3/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0063,2018BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Somnolence,Non-Health Professional,,,Female,I,3/29/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0063,2018BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,3/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0066,2018BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Butterfly rash,Physician,56,Years,Male,I,2/8/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Butterfly rash,,NO,NO,Unlisted
2018BDSI0066,2018BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Rash,Physician,56,Years,Male,I,2/8/2018,12/4/2017,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2018BDSI0066,2018BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Physician,56,Years,Male,I,2/8/2018,12/1/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Headache,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fatigue,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Fatigue,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypopituitarism,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hypopituitarism,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Disturbance in attention,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Disturbance in attention,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Libido decreased,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Libido decreased,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Thermophobia,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Thermophobia,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Hyperhidrosis,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Asthenia,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asthenia,,YES,YES,Listed
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Memory impairment,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Memory impairment,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling cold,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Feeling cold,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2018BDSI0068,2018BDSI0068,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Adrenocorticotropic hormone deficiency,Other Health Professional,35,Years,Male,I,2/14/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,Unlisted
2018BDSI0069,2018BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Other Health Professional,,,Female,I,2/8/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0070,2018BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,,,Female,I,2/12/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0070,2018BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/12/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0070,2018BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,2/12/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0070,2018BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/12/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0073,2018BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/15/2018,2/15/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0073,2018BDSI0073,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/15/2018,2/15/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0074,2018BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,2/20/2018,2/20/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0074,2018BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/20/2018,2/20/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0075,2018BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Dysphagia,Non-Health Professional,,,Female,I,2/20/2018,2/17/2018,,,,CHRONIC PSORIATIC ARTHRITIS PAIN,UNITED STATES,Dysphagia,,NO,NO,Unlisted
2018BDSI0075,2018BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Peripheral swelling,Non-Health Professional,,,Female,I,2/20/2018,2/17/2018,,,,CHRONIC PSORIATIC ARTHRITIS PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2018BDSI0075,2018BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Swelling face,Non-Health Professional,,,Female,I,2/20/2018,2/17/2018,,,,CHRONIC PSORIATIC ARTHRITIS PAIN,UNITED STATES,Swelling face,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/21/2018,2/21/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/21/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0076,2018BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/21/2018,2/21/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0077,2018BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging issue,Pharmacist,44,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0077,2018BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,44,Years,Female,I,2/23/2018,2/16/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0078,2018BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Somnolence,Non-Health Professional,72,Years,Female,I,2/23/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0079,2018BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Diarrhoea,Non-Health Professional,,,Male,I,2/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dry mouth,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dry mouth,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0081,2018BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,I,2/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0082,2018BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,,,Male,I,2/26/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0085,2018BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Panic attack,Non-Health Professional,75,Years,Female,I,2/27/2018,2/26/2018,,,,CHRONIC PAIN,UNITED STATES,Panic attack,,NO,NO,Unlisted
2018BDSI0085,2018BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Tremor,Non-Health Professional,75,Years,Female,I,2/27/2018,2/26/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,
2018BDSI0085,2018BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,75,Years,Female,I,2/27/2018,2/26/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,
2018BDSI0085,2018BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,75,Years,Female,I,2/27/2018,2/26/2018,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,
2018BDSI0085,2018BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Hyperhidrosis,Non-Health Professional,75,Years,Female,I,2/27/2018,2/26/2018,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,
2018BDSI0086,2018BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Migraine,Physician,,,Female,I,3/20/2018,2/1/2018,,,,PAIN,CANADA,Migraine,,NO,NO,Listed
2018BDSI0087,2018BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Tooth fracture,Non-Health Professional,,,Male,I,2/28/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tooth fracture,,NO,NO,Unlisted
2018BDSI0087,2018BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Tooth erosion,Non-Health Professional,,,Male,I,2/28/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tooth erosion,,NO,NO,Unlisted
2018BDSI0089,2018BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,3/1/2018,2/25/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0090,2018BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,,,Male,I,3/1/2018,1/1/2017,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0090,2018BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product outer packaging issue,Non-Health Professional,,,Male,I,3/1/2018,1/1/2017,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2018BDSI0091,2018BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,72,Years,Female,I,3/2/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0091,2018BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Non-Health Professional,72,Years,Female,I,3/2/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0091,2018BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,3/2/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0091,2018BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,72,Years,Female,I,3/2/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0091,2018BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical issue,Non-Health Professional,72,Years,Female,I,3/2/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0092,2018BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/5/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lethargy,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Lethargy,,NO,NO,Listed
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Malaise,,NO,NO,Unlisted
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0093,2018BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,3/5/2018,2/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product use complaint,,NO,NO,Unlisted
2018BDSI0094,2018BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/8/2018,3/7/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0094,2018BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,3/8/2018,3/8/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0095,2018BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Pharmacist,,,Female,I,3/9/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0096,2018BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/11/2018,3/11/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0096,2018BDSI0096,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/11/2018,3/11/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0099,2018BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Other Health Professional,,,Female,I,3/8/2018,3/1/2018,,,,CERVICAL LUMBAR AND HIP PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0099,2018BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Heart rate increased,Other Health Professional,,,Female,I,3/8/2018,3/1/2018,,,,CERVICAL LUMBAR AND HIP PAIN,UNITED STATES,Heart rate increased,,NO,NO,Listed
2018BDSI0100,2018BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Other Health Professional,,,,I,2/5/2018,2/5/2018,,,,,CANADA,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0101,2018BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Pharmacist,,,,I,2/27/2018,2/27/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product use complaint,,NO,NO,Unlisted
2018BDSI0102,2018BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Chest pain,Non-Health Professional,45,Years,Male,I,3/13/2018,3/12/2018,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2018BDSI0102,2018BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Palpitations,Non-Health Professional,45,Years,Male,I,3/13/2018,3/12/2018,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Listed
2018BDSI0102,2018BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Dizziness,Non-Health Professional,45,Years,Male,I,3/13/2018,3/12/2018,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0102,2018BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Abdominal pain upper,Non-Health Professional,45,Years,Male,I,3/13/2018,3/12/2018,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2018BDSI0102,2018BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Pain,Non-Health Professional,45,Years,Male,I,3/13/2018,3/12/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0103,2018BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Mouth ulceration,Other Health Professional,,,Female,I,3/13/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/14/2018,3/14/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/14/2018,3/14/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/14/2018,3/14/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/14/2018,3/14/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,3/14/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2018BDSI0104,2018BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,,,Female,I,3/14/2018,3/14/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0105,2018BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Dry mouth,Pharmacist,,,Female,I,3/14/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,NO,Listed
2018BDSI0105,2018BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Salivary hypersecretion,Pharmacist,,,Female,I,3/14/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Salivary hypersecretion,,NO,NO,Unlisted
2018BDSI0105,2018BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Product adhesion issue,Pharmacist,,,Female,I,3/14/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0105,2018BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Wrong technique in product usage process,Pharmacist,,,Female,I,3/14/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0106,2018BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Nausea,Other Health Professional,39,Years,Male,I,3/14/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0106,2018BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Other Health Professional,39,Years,Male,I,3/14/2018,2/6/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0106,2018BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Other Health Professional,39,Years,Male,I,3/14/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0106,2018BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Other Health Professional,39,Years,Male,I,3/14/2018,2/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0107,2018BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Dysgeusia,Non-Health Professional,,,Male,I,3/13/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2018BDSI0107,2018BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Medication residue present,Non-Health Professional,,,Male,I,3/13/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Thermophobia,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Thermophobia,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Headache,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Headache,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Glucocorticoid deficiency,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Glucocorticoid deficiency,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Fatigue,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Fatigue,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Hypopituitarism,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Hypopituitarism,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Drug dependence,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Drug dependence,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Libido decreased,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Libido decreased,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Hypogonadism,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Hypogonadism,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Inappropriate schedule of drug administration,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Inappropriate schedule of drug administration,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Gonadotrophin deficiency,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Gonadotrophin deficiency,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Overdose,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Overdose,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Product use in unapproved indication,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Product use in unapproved indication,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Off label use,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Off label use,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Pain,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Pain,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Feeling cold,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Feeling cold,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Asthenia,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Asthenia,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Adrenocorticotropic hormone deficiency,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Adrenocorticotropic hormone deficiency,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Disturbance in attention,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Disturbance in attention,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Memory impairment,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Memory impairment,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Condition aggravated,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Condition aggravated,,YES,YES,
2018BDSI0109,2018BDSI0109,BUPRENORPHINE NALOXONE,nan,,,,,,,,Hyperhidrosis,Physician,35,Years,Male,F,10/11/2018,,,,Other,OPIOID TYPE DEPENDENCE,FRANCE,Hyperhidrosis,,YES,YES,
2018BDSI0110,2018BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Muscle spasms,Physician,69,Years,Female,I,3/15/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Muscle spasms,,NO,NO,Unlisted
2018BDSI0111,2018BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,57,Years,Female,I,3/14/2018,3/3/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0111,2018BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Non-Health Professional,57,Years,Female,I,3/14/2018,3/7/2018,,,,CHRONIC PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0111,2018BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,57,Years,Female,I,3/14/2018,3/3/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0111,2018BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,3/14/2018,3/3/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0112,2018BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,3/16/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0112,2018BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/16/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0113,2018BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/19/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0115,2018BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product adhesion issue,Pharmacist,,,Female,I,3/21/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0115,2018BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product adhesion issue,Pharmacist,,,Female,I,3/21/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0115,2018BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Wrong technique in product usage process,Pharmacist,,,Female,I,3/21/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0115,2018BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Wrong technique in product usage process,Pharmacist,,,Female,I,3/21/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0116,2018BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,,,Product adhesion issue,Pharmacist,,,UNK,I,3/21/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0117,2018BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Paraesthesia,Physician,68,Years,Female,I,3/22/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2018BDSI0117,2018BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Physician,68,Years,Female,I,3/22/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0117,2018BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Insomnia,Physician,68,Years,Female,I,3/22/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0118,2018BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Physician,,,,I,3/14/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0119,2018BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oedema,Physician,,,Male,I,3/21/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oedema,,NO,NO,Listed
2018BDSI0119,2018BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Physician,,,Male,I,3/21/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0120,2018BDSI0120,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Male,I,3/22/2018,1/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0120,2018BDSI0120,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Product packaging quantity issue,Non-Health Professional,,,Male,I,3/22/2018,1/1/2017,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug administration error,Non-Health Professional,72,Years,Female,I,3/23/2018,3/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,72,Years,Female,I,3/23/2018,3/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,3/23/2018,3/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Intentional dose omission,Non-Health Professional,72,Years,Female,I,3/23/2018,3/23/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Abdominal pain upper,Non-Health Professional,72,Years,Female,I,3/23/2018,3/23/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Unlisted
2018BDSI0121,2018BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Headache,Non-Health Professional,72,Years,Female,I,3/23/2018,3/23/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0122,2018BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,49,Years,Male,I,3/27/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0122,2018BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,49,Years,Male,I,3/27/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0122,2018BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,49,Years,Male,I,3/27/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0122,2018BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,49,Years,Male,I,3/27/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0123,2018BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Joint swelling,Non-Health Professional,29,Years,Male,I,3/27/2018,3/24/2018,,,,CHRONIC PAIN,UNITED STATES,Joint swelling,,NO,NO,Unlisted
2018BDSI0123,2018BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Joint swelling,Non-Health Professional,29,Years,Male,I,3/27/2018,3/24/2018,,,,CHRONIC PAIN,UNITED STATES,Joint swelling,,NO,NO,Unlisted
2018BDSI0126,2018BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Stomatitis,Other Health Professional,51,Years,Female,I,3/26/2018,3/26/2018,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2018BDSI0126,2018BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Condition aggravated,Other Health Professional,51,Years,Female,I,3/26/2018,3/26/2018,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2018BDSI0134,2018BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Medication residue present,Non-Health Professional,80,Years,Female,I,4/2/2018,3/29/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0134,2018BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,80,Years,Female,I,4/2/2018,3/29/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0134,2018BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,80,Years,Female,I,4/2/2018,3/29/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0135,2018BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product adhesion issue,Physician,,,Female,I,3/28/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0135,2018BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product physical consistency issue,Physician,,,Female,I,3/28/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0135,2018BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product solubility abnormal,Physician,,,Female,I,3/28/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0136,2018BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/5/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0136,2018BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,4/5/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0136,2018BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/5/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0137,2018BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,4/4/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0137,2018BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,4/4/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0137,2018BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,4/4/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0138,2018BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mouth ulceration,Other Health Professional,,,Female,I,4/4/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2018BDSI0139,2018BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,4/5/2018,4/5/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0140,2018BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/9/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0141,2018BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Palpitations,Other Health Professional,61,Years,Female,I,4/5/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2018BDSI0143,2018BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,I,4/11/2018,3/19/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0143,2018BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,69,Years,Female,I,4/11/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0143,2018BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,69,Years,Female,I,4/11/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0143,2018BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,69,Years,Female,I,4/11/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0144,2018BDSI0144,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,3/24/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0144,2018BDSI0144,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,3/24/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0146,2018BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hallucination,Physician,,,Male,I,4/13/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hallucination,,NO,NO,Unlisted
2018BDSI0146,2018BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Physician,,,Male,I,4/13/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0146,2018BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hallucination,Physician,,,Male,I,4/13/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hallucination,,NO,NO,Unlisted
2018BDSI0146,2018BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Physician,,,Male,I,4/13/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0147,2018BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Male,I,4/13/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0148,2018BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Physician,,,,I,4/13/2018,4/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0148,2018BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Physician,,,,I,4/13/2018,4/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0149,2018BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Male,I,4/16/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0149,2018BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,58,Years,Male,I,4/16/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0149,2018BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Male,I,4/16/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0149,2018BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Male,I,4/16/2018,4/13/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0149,2018BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,58,Years,Male,I,4/16/2018,4/15/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0152,2018BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,45,Years,Male,I,4/17/2018,1/1/2015,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2018BDSI0152,2018BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Teeth brittle,Non-Health Professional,45,Years,Male,I,4/17/2018,1/1/2015,,,,CHRONIC PAIN,UNITED STATES,Teeth brittle,,NO,NO,Unlisted
2018BDSI0153,2018BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Pharmacist,,,Male,I,4/18/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0154,2018BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,4/18/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0154,2018BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,4/18/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0154,2018BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/18/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0155,2018BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug prescribing error,Pharmacist,60,Years,Male,I,4/19/2018,4/19/2018,,,,CHRONIC PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0156,2018BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,4/18/2018,4/18/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0156,2018BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Pharmacist,,,Female,I,4/18/2018,4/18/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0157,2018BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Other Health Professional,,,Female,I,4/23/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0158,2018BDSI0158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/23/2018,4/22/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal pain,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal pain,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal stiffness,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal stiffness,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling jittery,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Feeling jittery,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,76,Years,Female,I,4/19/2018,4/4/2018,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mental impairment,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Mental impairment,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Myalgia,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Myalgia,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,76,Years,Female,I,4/19/2018,4/4/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Suicidal ideation,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,76,Years,Female,I,4/19/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0159,2018BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Agitation,Non-Health Professional,76,Years,Female,I,4/19/2018,4/4/2018,,,,CHRONIC PAIN,UNITED STATES,Agitation,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,65,Years,Female,I,4/23/2018,4/12/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Visual brightness,Non-Health Professional,65,Years,Female,I,4/23/2018,4/12/2018,,,,CHRONIC PAIN,UNITED STATES,Visual brightness,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Platelet count decreased,Non-Health Professional,65,Years,Female,I,4/23/2018,,,,,CHRONIC PAIN,UNITED STATES,Platelet count decreased,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Haematochezia,Non-Health Professional,65,Years,Female,I,4/23/2018,4/21/2018,,,,CHRONIC PAIN,UNITED STATES,Haematochezia,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Bronchitis,Non-Health Professional,65,Years,Female,I,4/23/2018,4/13/2018,,,,CHRONIC PAIN,UNITED STATES,Bronchitis,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Non-Health Professional,65,Years,Female,I,4/23/2018,4/13/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,4/23/2018,4/13/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0161,2018BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Neuralgia,Non-Health Professional,65,Years,Female,I,4/23/2018,4/12/2018,,,,CHRONIC PAIN,UNITED STATES,Neuralgia,,NO,NO,Unlisted
2018BDSI0164,2018BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Accidental overdose,Pharmacist,,,Male,I,4/20/2018,,,,Other,ANALGESIC THERAPY,UNITED KINGDOM,Accidental overdose,,YES,YES,
2018BDSI0164,2018BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Confusional state,Pharmacist,,,Male,I,4/20/2018,,,,Other,ANALGESIC THERAPY,UNITED KINGDOM,Confusional state,,YES,YES,
2018BDSI0164,2018BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Oxygen saturation decreased,Pharmacist,,,Male,I,4/20/2018,,,,Other,ANALGESIC THERAPY,UNITED KINGDOM,Oxygen saturation decreased,,YES,YES,
2018BDSI0164,2018BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug administration error,Pharmacist,,,Male,I,4/20/2018,,,,Other,ANALGESIC THERAPY,UNITED KINGDOM,Drug administration error,,YES,YES,
2018BDSI0164,2018BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Somnolence,Pharmacist,,,Male,I,4/20/2018,,,,Other,ANALGESIC THERAPY,UNITED KINGDOM,Somnolence,,YES,YES,
2018BDSI0165,2018BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Male,I,4/23/2018,1/12/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0165,2018BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,54,Years,Male,I,4/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0182,2018BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use in unapproved indication,Non-Health Professional,,,Female,I,4/27/2018,4/24/2018,,,,SEVERE MIGRAINE,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0182,2018BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective for unapproved indication,Non-Health Professional,,,Female,I,4/27/2018,4/26/2018,,,,SEVERE MIGRAINE,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Listed
2018BDSI0182,2018BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/27/2018,4/1/2018,,,,SEVERE MIGRAINE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0182,2018BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/27/2018,4/1/2018,,,,SEVERE MIGRAINE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0182,2018BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,4/27/2018,4/1/2018,,,,SEVERE MIGRAINE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,35,Years,Female,I,5/1/2018,4/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,35,Years,Female,I,5/1/2018,9/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,35,Years,Female,I,5/1/2018,1/1/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inability to afford medication,Non-Health Professional,35,Years,Female,I,5/1/2018,4/30/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Inability to afford medication,,NO,NO,Listed
2018BDSI0190,2018BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,35,Years,Female,I,5/1/2018,3/30/2018,,,,CHRONIC PAIN DUE TO CHEMOTHERAPY,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood potassium increased,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,Other,CHRONIC BACK PAIN,UNITED STATES,Blood potassium increased,,YES,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,5/1/2018,,,,,CHRONIC BACK PAIN,UNITED STATES,Dry mouth,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Oedema peripheral,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Paraesthesia,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Burning sensation,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Burning sensation,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Potentiating drug interaction,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,Other,CHRONIC BACK PAIN,UNITED STATES,Potentiating drug interaction,,YES,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Pain,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Blood pressure increased,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Back pain,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Back pain,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,,,Female,I,5/1/2018,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Abdominal discomfort,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastric dilatation,Non-Health Professional,,,Female,I,5/1/2018,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Gastric dilatation,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Female,I,5/1/2018,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Constipation,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug prescribing error,Non-Health Professional,,,Female,I,5/1/2018,4/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Drug prescribing error,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/1/2018,5/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,Other,CHRONIC BACK PAIN,UNITED STATES,Oedema peripheral,,YES,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,,,Female,I,5/1/2018,4/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Decreased appetite,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Capillary fragility,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Capillary fragility,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,,CHRONIC BACK PAIN,UNITED STATES,Tremor,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood thyroid stimulating hormone increased,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,Other,CHRONIC BACK PAIN,UNITED STATES,Blood thyroid stimulating hormone increased,,YES,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,5/1/2018,,,,,CHRONIC BACK PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/1/2018,,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2018BDSI0191,2018BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of consciousness,Non-Health Professional,,,Female,I,5/1/2018,1/1/2017,,,Hospitalisation,CHRONIC BACK PAIN,UNITED STATES,Loss of consciousness,,YES,YES,Unlisted
2018BDSI0192,2018BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Consumer,77,Years,Female,I,5/2/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0192,2018BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Consumer,77,Years,Female,I,5/2/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0192,2018BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Consumer,77,Years,Female,I,5/2/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0192,2018BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Consumer,77,Years,Female,I,5/2/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0192,2018BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Diarrhoea,Consumer,77,Years,Female,I,5/2/2018,5/2/2018,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0194,2018BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,5/3/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0194,2018BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,57,Years,Female,I,5/3/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0195,2018BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Depression,Physician,46,Years,Male,I,5/3/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2018BDSI0195,2018BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Anxiety,Physician,46,Years,Male,I,5/3/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2018BDSI0198,2018BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Chest pain,Other Health Professional,,,,I,5/3/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest pain,,NO,NO,Listed
2018BDSI0199,2018BDSI0199,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Electrocardiogram QT prolonged,Physician,48,Years,Female,I,5/4/2018,3/16/2018,,,Other,CHRONIC BACK PAIN,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2018BDSI0200,2018BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/7/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0200,2018BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/7/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0200,2018BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/7/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0200,2018BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/7/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0200,2018BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/7/2018,5/2/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,61,Years,Female,I,5/8/2018,4/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Product physical issue,,NO,YES,Unlisted
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysstasia,Non-Health Professional,61,Years,Female,I,5/8/2018,12/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Dysstasia,,NO,YES,Unlisted
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,61,Years,Female,I,5/8/2018,12/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Gait disturbance,,NO,YES,Unlisted
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Bone development abnormal,Non-Health Professional,61,Years,Female,I,5/8/2018,11/1/2017,,,Hospitalisation,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Bone development abnormal,,YES,YES,Unlisted
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,61,Years,Female,I,5/8/2018,11/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Pain,,NO,YES,Listed
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,61,Years,Female,I,5/8/2018,4/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0201,2018BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,5/8/2018,4/1/2017,,,,CHRONIC PAIN IN SPINAL AND ANKLE REGION,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2018BDSI0202,2018BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,56,Years,Female,I,5/8/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0202,2018BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral disorder,Other Health Professional,56,Years,Female,I,5/8/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral disorder,,NO,NO,Unlisted
2018BDSI0204,2018BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Nervousness,Non-Health Professional,70,Years,Male,I,5/10/2018,5/6/2018,,,,CHRONIC PAIN,UNITED STATES,Nervousness,,NO,NO,Unlisted
2018BDSI0204,2018BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Asthenia,Non-Health Professional,70,Years,Male,I,5/10/2018,5/10/2018,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,NO,Listed
2018BDSI0204,2018BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,70,Years,Male,I,5/10/2018,5/6/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0204,2018BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,70,Years,Male,I,5/10/2018,5/6/2018,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2018BDSI0204,2018BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Pain,Non-Health Professional,70,Years,Male,I,5/10/2018,5/6/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0205,2018BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,,,Male,I,5/11/2018,5/11/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0205,2018BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Male,I,5/11/2018,5/11/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0208,2018BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,53,Years,Male,I,5/14/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0208,2018BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Male,I,5/14/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0208,2018BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Male,I,5/14/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0208,2018BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Male,I,5/14/2018,5/9/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0209,2018BDSI0209,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Night sweats,Non-Health Professional,,,Female,I,5/14/2017,,,,,CHRONIC PAIN,UNITED STATES,Night sweats,,NO,NO,Listed
2018BDSI0209,2018BDSI0209,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,5/14/2017,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0209,2018BDSI0209,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,,,Female,I,5/14/2017,,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2018BDSI0213,2018BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Female,I,5/15/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0213,2018BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,62,Years,Female,I,5/15/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0213,2018BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,62,Years,Female,I,5/15/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0213,2018BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,62,Years,Female,I,5/15/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0213,2018BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,62,Years,Female,I,5/15/2018,3/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0214,2018BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,,,Male,I,5/16/2018,5/16/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0215,2018BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,53,Years,Female,I,5/16/2018,5/14/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0215,2018BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,53,Years,Female,I,5/16/2018,5/14/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0215,2018BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Female,I,5/16/2018,5/14/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0215,2018BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,53,Years,Female,I,5/16/2018,5/14/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0216,2018BDSI0216,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug abuse,Other Health Professional,36,Years,Male,I,5/17/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,DENMARK,Drug abuse,,YES,YES,
2018BDSI0216,2018BDSI0216,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,No adverse event,Other Health Professional,36,Years,Male,I,5/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,DENMARK,No adverse event,,NO,YES,
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Throat tightness,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Throat tightness,,NO,YES,Unlisted
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,YES,Listed
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,YES,Listed
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,YES,Listed
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,YES,Unlisted
2018BDSI0220,2018BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,5/17/2018,5/15/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0225,2018BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Female,I,5/17/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0225,2018BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,66,Years,Female,I,5/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2018BDSI0225,2018BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Female,I,5/17/2018,4/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0229,2018BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/17/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0230,2018BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Asthenia,Non-Health Professional,,,Male,I,5/18/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Asthenia,,NO,NO,Listed
2018BDSI0230,2018BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,5/18/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0230,2018BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Weight decreased,Non-Health Professional,,,Male,I,5/18/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2018BDSI0232,2018BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Pharmacist,30,Years,Female,I,5/18/2018,4/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2018BDSI0234,2018BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Male,I,5/22/2018,4/25/2018,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0234,2018BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective for unapproved indication,Non-Health Professional,57,Years,Male,I,5/22/2018,4/25/2018,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Unlisted
2018BDSI0234,2018BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug prescribing error,Non-Health Professional,57,Years,Male,I,5/22/2018,5/21/2018,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0234,2018BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,57,Years,Male,I,5/22/2018,5/1/2018,,,,BREAKTHROUGH PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0238,2018BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug dispensing error,Non-Health Professional,,,Male,I,5/22/2018,5/22/2018,,,,CHRONIC NEUROPATHY PAIN,UNITED STATES,Drug dispensing error,,NO,NO,Unlisted
2018BDSI0238,2018BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,5/22/2018,5/22/2018,,,,CHRONIC NEUROPATHY PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0239,2018BDSI0239,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/25/2018,5/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0239,2018BDSI0239,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/25/2018,5/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0239,2018BDSI0239,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug prescribing error,Non-Health Professional,,,Male,I,6/25/2018,1/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0239,2018BDSI0239,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug prescribing error,Non-Health Professional,,,Male,I,6/25/2018,1/1/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0240,2018BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Nausea,Other Health Professional,37,Years,Male,I,5/22/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0240,2018BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Vomiting,Other Health Professional,37,Years,Male,I,5/22/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,,,Female,I,5/24/2018,5/11/2018,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0242,2018BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0243,2018BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,63,Years,Female,I,5/24/2018,1/1/2018,,,,PAIN DUE TO FIBROMYALGIA AND NEUROPATHY,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0243,2018BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Female,I,5/24/2018,1/1/2018,,,,PAIN DUE TO FIBROMYALGIA AND NEUROPATHY,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0243,2018BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Female,I,5/24/2018,1/1/2018,,,,PAIN DUE TO FIBROMYALGIA AND NEUROPATHY,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0243,2018BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,63,Years,Female,I,5/24/2018,1/1/2018,,,,PAIN DUE TO FIBROMYALGIA AND NEUROPATHY,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0244,2018BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,80,Years,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0244,2018BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,80,Years,Female,I,5/24/2018,5/23/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0244,2018BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,80,Years,Female,I,5/24/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0245,2018BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,57,Years,Female,I,5/30/2018,5/27/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0245,2018BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pain,Non-Health Professional,57,Years,Female,I,5/30/2018,5/27/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0245,2018BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,5/30/2018,5/26/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0246,2018BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/25/2018,1/1/2018,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0246,2018BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/25/2018,1/1/2018,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0246,2018BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/25/2018,1/1/2018,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0246,2018BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/25/2018,4/24/2018,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0246,2018BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/25/2018,1/1/2018,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0247,2018BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/30/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0247,2018BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,5/30/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0247,2018BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/30/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Drug ineffective,,NO,NO,Listed
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Malaise,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Malaise,,NO,NO,Unlisted
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Memory impairment,,NO,NO,Unlisted
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0249,2018BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Female,I,5/31/2018,5/29/2018,,,,CHRONIC PAIN,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0250,2018BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Product use in unapproved indication,Non-Health Professional,69,Years,Female,I,6/7/2018,5/14/2018,,,,HEADACHE,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0250,2018BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Dizziness,Non-Health Professional,69,Years,Female,I,6/7/2018,5/14/2018,,,,HEADACHE,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0250,2018BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Nausea,Non-Health Professional,69,Years,Female,I,6/7/2018,5/14/2018,,,,HEADACHE,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0250,2018BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,,,Nocturnal dyspnoea,Non-Health Professional,69,Years,Female,I,6/7/2018,5/14/2018,,,,HEADACHE,UNITED STATES,Nocturnal dyspnoea,,NO,NO,Listed
2018BDSI0261,2018BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Male,I,6/5/2018,6/4/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0263,2018BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,58,Years,Male,I,6/5/2018,3/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,57,Years,Female,F,8/20/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,57,Years,Female,F,8/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,F,8/20/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,F,8/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,57,Years,Female,F,8/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,57,Years,Female,F,8/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2018BDSI0264,2018BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,57,Years,Female,F,8/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0265,2018BDSI0265,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/7/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0265,2018BDSI0265,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/7/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0265,2018BDSI0265,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/7/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0265,2018BDSI0265,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/7/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Non-Health Professional,52,Years,Female,I,6/7/2018,5/1/2016,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Non-Health Professional,52,Years,Female,I,6/7/2018,5/1/2016,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging issue,Non-Health Professional,52,Years,Female,I,6/7/2018,,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug administration error,Non-Health Professional,52,Years,Female,I,6/7/2018,5/1/2016,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging issue,Non-Health Professional,52,Years,Female,I,6/7/2018,,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug administration error,Non-Health Professional,52,Years,Female,I,6/7/2018,5/1/2016,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,52,Years,Female,I,6/7/2018,,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,52,Years,Female,I,6/7/2018,,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Pain,Non-Health Professional,52,Years,Female,I,6/7/2018,4/1/2017,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0266,2018BDSI0266,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Pain,Non-Health Professional,52,Years,Female,I,6/7/2018,4/1/2017,,,,PSORIATIC ARTHRITIS PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0267,2018BDSI0267,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,6/7/2018,5/30/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0267,2018BDSI0267,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,6/7/2018,5/30/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0268,2018BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,54,Years,Female,I,6/7/2018,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2018BDSI0268,2018BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug administration error,Non-Health Professional,54,Years,Female,I,6/7/2018,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0268,2018BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,54,Years,Female,I,6/7/2018,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0285,2018BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Male,I,6/8/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0285,2018BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,59,Years,Male,I,6/8/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0285,2018BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Male,I,6/8/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0285,2018BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Male,I,6/8/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0291,2018BDSI0291,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,,,Female,I,6/11/2018,1/1/2018,,,,PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2018BDSI0291,2018BDSI0291,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/11/2018,1/1/2018,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0293,2018BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Other Health Professional,,,Male,I,6/12/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0293,2018BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pain,Other Health Professional,,,Male,I,6/12/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0293,2018BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Disorientation,Other Health Professional,,,Male,I,6/12/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Disorientation,,NO,NO,Unlisted
2018BDSI0293,2018BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug prescribing error,Other Health Professional,,,Male,I,6/12/2018,6/6/2018,,,,CHRONIC PAIN,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0294,2018BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,67,Years,Female,I,6/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0294,2018BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,67,Years,Female,I,6/13/2018,5/10/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0295,2018BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/14/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0295,2018BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/14/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0297,2018BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Physician,,,Female,I,4/26/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0298,2018BDSI0298,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,3/8/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0320,2018BDSI0320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Back pain,Non-Health Professional,,,Male,I,6/18/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Back pain,,NO,NO,Listed
2018BDSI0321,2018BDSI0321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,6/19/2018,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0322,2018BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,59,Years,Male,I,6/22/2018,1/1/2018,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0322,2018BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyskinesia,Physician,59,Years,Male,I,6/22/2018,1/1/2018,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyskinesia,,YES,YES,Unlisted
2018BDSI0322,2018BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chorea,Physician,59,Years,Male,I,6/22/2018,1/1/2018,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chorea,,YES,YES,Unlisted
2018BDSI0323,2018BDSI0323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dyspnoea,Physician,,,,I,5/19/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2018BDSI0323,2018BDSI0323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug interaction,Physician,,,,I,5/19/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2018BDSI0325,2018BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product use complaint,Non-Health Professional,,,Female,I,4/16/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product use complaint,,NO,NO,Unlisted
2018BDSI0326,2018BDSI0326,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Other Health Professional,,,,I,4/25/2018,4/25/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0327,2018BDSI0327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,,I,5/3/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0327,2018BDSI0327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Physician,,,,I,5/3/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0329,2018BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Physician,,,,I,5/4/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0330,2018BDSI0330,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Physician,,,,I,5/25/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0331,2018BDSI0331,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Physician,,,Male,I,5/29/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0332,2018BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Physician,,,,I,5/31/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Oral administration complication,,NO,NO,Unlisted
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0335,2018BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus generalised,Non-Health Professional,,,Female,I,6/25/2018,6/20/2018,,,,CHRONIC PAIN,UNITED STATES,Pruritus generalised,,NO,NO,Listed
2018BDSI0336,2018BDSI0336,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response shortened,Other Health Professional,,,Female,I,7/23/2018,,,,,PAIN MANAGEMENT,UNITED STATES,Therapeutic response shortened,,NO,NO,Listed
2018BDSI0337,2018BDSI0337,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Teeth brittle,Non-Health Professional,34,Years,Female,I,6/25/2018,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Teeth brittle,,NO,NO,Unlisted
2018BDSI0337,2018BDSI0337,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,34,Years,Female,I,6/25/2018,,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0337,2018BDSI0337,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth erosion,Non-Health Professional,34,Years,Female,I,6/25/2018,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Tooth erosion,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mood swings,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Mood swings,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2018BDSI0338,2018BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,60,Years,Female,I,6/26/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2018BDSI0342,2018BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,I,6/27/2018,6/27/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0342,2018BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Female,I,6/27/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0342,2018BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Female,I,6/27/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0351,2018BDSI0351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,38,Years,Female,I,7/3/2018,7/2/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0351,2018BDSI0351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,38,Years,Female,I,7/3/2018,7/2/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0351,2018BDSI0351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,38,Years,Female,I,7/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0351,2018BDSI0351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Female,I,7/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0354,2018BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,,I,6/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Female,I,8/3/2018,7/3/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Salivary hypersecretion,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Salivary hypersecretion,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased activity,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Decreased activity,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2018BDSI0355,2018BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ageusia,Non-Health Professional,65,Years,Female,I,8/3/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Ageusia,,NO,NO,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth fracture,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tooth fracture,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,48,Years,Female,F,7/16/2018,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Complication associated with device,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Complication associated with device,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingival disorder,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Gingival disorder,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth erosion,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tooth erosion,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth discolouration,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tooth discolouration,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Toothache,Non-Health Professional,48,Years,Female,F,7/16/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cerebrospinal fluid leakage,Non-Health Professional,48,Years,Female,F,7/16/2018,4/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Cerebrospinal fluid leakage,,YES,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,48,Years,Female,F,7/16/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight fluctuation,Non-Health Professional,48,Years,Female,F,7/16/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Weight fluctuation,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,48,Years,Female,F,7/16/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,YES,Unlisted
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,48,Years,Female,F,7/16/2018,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,48,Years,Female,F,7/16/2018,11/1/2017,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,48,Years,Female,F,7/16/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2018BDSI0356,2018BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,48,Years,Female,F,7/16/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2018BDSI0357,2018BDSI0357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,56,Years,Female,I,7/9/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0357,2018BDSI0357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,56,Years,Female,I,7/9/2018,7/6/2018,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Incorrect route of drug administration,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product colour issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product colour issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Incorrect route of drug administration,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0359,2018BDSI0359,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Male,I,7/9/2018,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0361,2018BDSI0361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Physician,,,,I,6/6/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0362,2018BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/11/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0362,2018BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/11/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0362,2018BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/11/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0365,2018BDSI0365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Deep vein thrombosis,Physician,,,Female,I,7/11/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Deep vein thrombosis,,NO,NO,Unlisted
2018BDSI0365,2018BDSI0365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Oedema peripheral,Physician,,,Female,I,7/11/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2018BDSI0374,2018BDSI0374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Incorrect route of drug administration,Non-Health Professional,62,Years,Female,I,7/11/2018,7/11/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0379,2018BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Withdrawal syndrome,Non-Health Professional,67,Years,Male,I,7/16/2018,7/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2018BDSI0379,2018BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Male,I,7/16/2018,7/12/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0379,2018BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Male,I,7/16/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2018BDSI0379,2018BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Male,I,7/16/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2018BDSI0387,2018BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,43,Years,Female,I,7/16/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0388,2018BDSI0388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,,,Female,I,7/15/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,
2018BDSI0388,2018BDSI0388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/15/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,
2018BDSI0388,2018BDSI0388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/15/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0390,2018BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,86,Years,Male,I,7/16/2018,1/1/2018,,,,CHRONIC PAIN IN LEFT SIDE OF THE BODY,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0390,2018BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,86,Years,Male,I,7/16/2018,,,,,CHRONIC PAIN IN LEFT SIDE OF THE BODY,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Fatigue,Non-Health Professional,72,Years,Male,I,7/16/2018,7/13/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,72,Years,Male,I,7/16/2018,7/13/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,72,Years,Male,I,7/16/2018,7/13/2018,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,72,Years,Male,I,7/16/2018,7/14/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,72,Years,Male,I,7/16/2018,7/14/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Drug effect increased,Non-Health Professional,72,Years,Male,I,7/16/2018,7/13/2018,,,,CHRONIC PAIN,UNITED STATES,Drug effect increased,,NO,NO,Listed
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Vertigo,Non-Health Professional,72,Years,Male,I,7/16/2018,7/13/2018,,,,CHRONIC PAIN,UNITED STATES,Vertigo,,NO,NO,Unlisted
2018BDSI0391,2018BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,,,microgram,Buccal film,,Retching,Non-Health Professional,72,Years,Male,I,7/16/2018,7/14/2018,,,,CHRONIC PAIN,UNITED STATES,Retching,,NO,NO,Unlisted
2018BDSI0392,2018BDSI0392,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/17/2018,7/17/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0392,2018BDSI0392,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/17/2018,7/17/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0392,2018BDSI0392,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/17/2018,7/17/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0393,2018BDSI0393,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,7/17/2018,7/16/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0394,2018BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Stomatitis,Other Health Professional,,,Female,I,7/16/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,7/17/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alopecia,Non-Health Professional,,,Female,I,7/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alopecia,Non-Health Professional,,,Female,I,7/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alopecia,Non-Health Professional,,,Female,I,7/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/17/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/17/2018,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0395,2018BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,,,Female,I,7/17/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2018BDSI0400,2018BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Nausea,Physician,,,,I,7/20/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0400,2018BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Vomiting,Physician,,,,I,7/20/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pollakiuria,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Pollakiuria,,NO,YES,Unlisted
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,YES,Unlisted
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anger,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Anger,,NO,YES,Unlisted
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Discomfort,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Discomfort,,NO,YES,Unlisted
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,YES,Listed
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0401,2018BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,78,Years,Male,I,7/19/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2018BDSI0403,2018BDSI0403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,,Oral discomfort,Non-Health Professional,50,Years,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2018BDSI0403,2018BDSI0403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,,Oral administration complication,Non-Health Professional,50,Years,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0403,2018BDSI0403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,,Glossodynia,Non-Health Professional,50,Years,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Glossodynia,,NO,NO,Unlisted
2018BDSI0404,2018BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0404,2018BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0404,2018BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/20/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0407,2018BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/23/2018,7/22/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0407,2018BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,7/23/2018,7/23/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hot flush,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nervousness,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Nervousness,,NO,NO,Unlisted
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mood altered,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Mood altered,,NO,NO,Unlisted
2018BDSI0410,2018BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vision blurred,Non-Health Professional,,,Male,I,7/23/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2018BDSI0412,2018BDSI0412,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,,,Rash,Other Health Professional,29,Years,Female,I,7/24/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash,,NO,NO,Listed
2018BDSI0415,2018BDSI0415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/23/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0416,2018BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,7/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0416,2018BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Male,I,7/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0416,2018BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Male,I,7/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0418,2018BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,43,Years,Female,I,7/26/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2018BDSI0418,2018BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,43,Years,Female,I,7/26/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Unlisted
2018BDSI0418,2018BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,43,Years,Female,I,7/26/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0418,2018BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,43,Years,Female,I,7/26/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2018BDSI0418,2018BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,43,Years,Female,I,7/26/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0419,2018BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Other Health Professional,65,Years,Female,I,7/26/2018,,,,Other,BREAKTHROUGH CANCER PAIN,SPAIN,Drug dependence,,YES,YES,
2018BDSI0419,2018BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug diversion,Other Health Professional,65,Years,Female,I,7/26/2018,,,,,BREAKTHROUGH CANCER PAIN,SPAIN,Drug diversion,,NO,YES,
2018BDSI0428,2018BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing issue,Pharmacist,67,Years,Male,I,7/27/2018,7/27/2018,,,,PAIN AFTER ORAL SURGERY,UNITED STATES,Product prescribing issue,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0429,2018BDSI0429,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/27/2018,7/27/2018,,,,OPIOID DEPENDENCE,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0430,2018BDSI0430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/27/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0430,2018BDSI0430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/27/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0434,2018BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug prescribing error,Pharmacist,,,,I,7/30/2018,7/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,63,Years,Female,I,7/30/2018,7/19/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,63,Years,Female,I,7/30/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional product misuse,,NO,YES,Unlisted
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,63,Years,Female,I,7/30/2018,7/28/2018,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,YES,Listed
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,63,Years,Female,I,7/30/2018,7/28/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,63,Years,Female,I,7/30/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,YES,Listed
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,63,Years,Female,I,7/30/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Drug withdrawal syndrome,Non-Health Professional,63,Years,Female,I,7/30/2018,7/19/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Intentional product misuse,Non-Health Professional,63,Years,Female,I,7/30/2018,7/19/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional product misuse,,NO,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Muscle spasms,Non-Health Professional,63,Years,Female,I,7/30/2018,7/28/2018,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Insomnia,Non-Health Professional,63,Years,Female,I,7/30/2018,7/28/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Oedema peripheral,Non-Health Professional,63,Years,Female,I,7/30/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,YES,
2018BDSI0438,2018BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Oedema peripheral,Non-Health Professional,63,Years,Female,I,7/30/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,YES,
2018BDSI0439,2018BDSI0439,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,50,Years,Male,I,7/31/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,NO,Unlisted
2018BDSI0439,2018BDSI0439,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,50,Years,Male,I,7/31/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0440,2018BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,I,8/1/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0440,2018BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,51,Years,Female,I,8/1/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0443,2018BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/2/2018,7/30/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0443,2018BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Discomfort,Non-Health Professional,,,Male,I,8/2/2018,7/30/2018,,,,CHRONIC PAIN,UNITED STATES,Discomfort,,NO,NO,Unlisted
2018BDSI0443,2018BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,8/2/2018,7/30/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0443,2018BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,8/2/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0443,2018BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/2/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0446,2018BDSI0446,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hypertension,Other Health Professional,,,Female,I,8/6/2018,7/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypertension,,NO,NO,Listed
2018BDSI0447,2018BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0447,2018BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,8/6/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0448,2018BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,73,Years,Female,I,8/6/2018,8/3/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0448,2018BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Female,I,8/6/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0448,2018BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,73,Years,Female,I,8/6/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0448,2018BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Female,I,8/6/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0449,2018BDSI0449,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/8/2018,8/7/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0449,2018BDSI0449,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/8/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0453,2018BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/9/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0453,2018BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/9/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0454,2018BDSI0454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/10/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2018BDSI0454,2018BDSI0454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product label confusion,Non-Health Professional,,,Female,I,8/10/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product label confusion,,NO,NO,Unlisted
2018BDSI0454,2018BDSI0454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/10/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,57,Years,Female,I,8/13/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,YES,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry eye,Non-Health Professional,57,Years,Female,I,8/13/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dry eye,,NO,YES,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Non-Health Professional,57,Years,Female,I,8/13/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,YES,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,57,Years,Female,I,8/13/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Balance disorder,,NO,YES,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Speech disorder,Non-Health Professional,57,Years,Female,I,8/13/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Speech disorder,,NO,YES,Unlisted
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,8/13/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0457,2018BDSI0457,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,57,Years,Female,I,8/13/2018,,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0458,2018BDSI0458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,54,Years,Female,I,8/11/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2018BDSI0458,2018BDSI0458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Female,I,8/11/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0458,2018BDSI0458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,54,Years,Female,I,8/11/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0460,2018BDSI0460,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Off label use,Non-Health Professional,,,Female,I,8/15/2018,1/1/2018,,,,PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2018BDSI0461,2018BDSI0461,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/16/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0462,2018BDSI0462,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug prescribing error,Pharmacist,,,Male,I,8/15/2018,4/3/2018,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0462,2018BDSI0462,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug prescribing error,Pharmacist,,,Male,I,8/15/2018,4/3/2018,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug prescribing error,,NO,NO,Unlisted
2018BDSI0463,2018BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/16/2018,8/16/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of drug administration,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,8/17/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/17/2018,7/25/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0464,2018BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/17/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0465,2018BDSI0465,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood glucose increased,Non-Health Professional,,,Female,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,NO,NO,Unlisted
2018BDSI0467,2018BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,62,Years,Female,I,8/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0467,2018BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,62,Years,Female,I,8/17/2018,6/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swollen tongue,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Swollen tongue,,NO,NO,Unlisted
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0469,2018BDSI0469,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Pharmacist,70,Years,Female,I,8/20/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,67,Years,Male,I,9/7/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Male,I,9/7/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Male,I,9/7/2018,6/29/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Male,I,9/7/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Male,I,9/7/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0470,2018BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,67,Years,Male,I,9/7/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0471,2018BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,mega-international unit per litre,Buccal film,,Product packaging issue,Pharmacist,,,Male,I,8/21/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Vomiting,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Nausea,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Malaise,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Decreased appetite,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Decreased appetite,,NO,NO,Listed
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Blood pressure increased,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2018BDSI0472,2018BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Constipation,Other Health Professional,42,Years,Female,I,8/17/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2018BDSI0473,2018BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug administration error,Non-Health Professional,60,Years,Male,I,8/18/2018,8/20/2018,,,,CHRONIC PAIN,UNITED STATES,Drug administration error,,NO,NO,Unlisted
2018BDSI0473,2018BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Male,I,8/18/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0473,2018BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Male,I,8/18/2018,8/17/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0473,2018BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Male,I,8/18/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0474,2018BDSI0474,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0474,2018BDSI0474,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0474,2018BDSI0474,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Male,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2018BDSI0474,2018BDSI0474,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0474,2018BDSI0474,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/20/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0475,2018BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/22/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0475,2018BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,8/22/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2018BDSI0476,2018BDSI0476,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/24/2018,8/24/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0477,2018BDSI0477,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/24/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0478,2018BDSI0478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Female,I,8/24/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0478,2018BDSI0478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,8/24/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0479,2018BDSI0479,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,,I,8/8/2018,8/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0480,2018BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/20/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0481,2018BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Male,I,8/27/2018,8/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0481,2018BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/27/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0481,2018BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Male,I,8/27/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2018BDSI0482,2018BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/29/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0482,2018BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/29/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0483,2018BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,8/30/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0483,2018BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,8/30/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0483,2018BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,8/30/2018,8/29/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0485,2018BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/31/2018,8/17/2018,,,,CHRONIC PAIN IN STOMACH,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0486,2018BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,42,Years,Male,I,8/31/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0486,2018BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,42,Years,Male,I,8/31/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0486,2018BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,42,Years,Male,I,8/31/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0486,2018BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,42,Years,Male,I,8/31/2018,8/30/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0487,2018BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,59,Years,Male,I,9/6/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0488,2018BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Other Health Professional,79,Years,Male,I,9/4/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0488,2018BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Muscular weakness,Other Health Professional,79,Years,Male,I,9/4/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Muscular weakness,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Restless legs syndrome,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Restless legs syndrome,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling of body temperature change,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Feeling of body temperature change,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,,,Female,I,9/4/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,9/4/2018,8/24/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0489,2018BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,9/4/2018,8/24/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Salivary hypersecretion,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Salivary hypersecretion,,NO,NO,Unlisted
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastrointestinal tract irritation,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Gastrointestinal tract irritation,,NO,NO,Unlisted
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Facial neuralgia,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Facial neuralgia,,NO,NO,Unlisted
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of drug administration,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0490,2018BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Female,I,9/4/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0493,2018BDSI0493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Swollen tongue,Physician,,,Female,I,9/5/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Swollen tongue,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,59,Years,Female,I,9/18/2018,9/18/2018,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0496,2018BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,I,9/18/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0497,2018BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of drug administration,Non-Health Professional,57,Years,Female,I,9/11/2018,9/11/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Incorrect route of drug administration,Non-Health Professional,,,Female,I,9/12/2018,7/1/2018,,,,PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Incorrect route of drug administration,Non-Health Professional,,,Female,I,9/12/2018,7/1/2018,,,,PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Non-Health Professional,,,Female,I,9/12/2018,7/1/2018,,,,PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Non-Health Professional,,,Female,I,9/12/2018,7/1/2018,,,,PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0499,2018BDSI0499,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0501,2018BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Pharmacist,,,Female,I,9/14/2018,1/1/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,YES,YES,Unlisted
2018BDSI0501,2018BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cerebrovascular accident,Pharmacist,,,Female,I,9/14/2018,8/29/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Cerebrovascular accident,,YES,YES,Unlisted
2018BDSI0501,2018BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysarthria,Pharmacist,,,Female,I,9/14/2018,1/1/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dysarthria,,YES,YES,Unlisted
2018BDSI0501,2018BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Facial paralysis,Pharmacist,,,Female,I,9/14/2018,1/1/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Facial paralysis,,YES,YES,Unlisted
2018BDSI0502,2018BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,51,Years,Female,I,9/13/2018,7/11/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0502,2018BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of drug administration,Non-Health Professional,51,Years,Female,I,9/13/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0502,2018BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,51,Years,Female,I,9/13/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0502,2018BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,51,Years,Female,I,9/13/2018,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0505,2018BDSI0505,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0505,2018BDSI0505,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/17/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0505,2018BDSI0505,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/17/2018,9/16/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0506,2018BDSI0506,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/12/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0508,2018BDSI0508,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,61,Years,Male,I,9/20/2018,9/14/2018,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2018BDSI0508,2018BDSI0508,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,61,Years,Male,I,9/20/2018,9/14/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0511,2018BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug abuse,Other Health Professional,36,Years,Male,I,9/24/2018,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED KINGDOM,Drug abuse,,YES,YES,
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Palpitations,,NO,YES,Listed
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Chest discomfort,,NO,YES,Unlisted
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Therapeutic response decreased,,NO,YES,Unlisted
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2018BDSI0513,2018BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,39,Years,Female,I,9/25/2018,9/1/2018,,,Other,REFLEX SYMPATHETIC DYSTROPHY,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0514,2018BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product lot number issue,Other Health Professional,,,,I,9/24/2018,8/1/2018,,,,NO ADVERSE EVENT,UNITED STATES,Product lot number issue,,NO,NO,Unlisted
2018BDSI0514,2018BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product expiration date issue,Other Health Professional,,,,I,9/24/2018,8/1/2018,,,,NO ADVERSE EVENT,UNITED STATES,Product expiration date issue,,NO,NO,Unlisted
2018BDSI0515,2018BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0515,2018BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0515,2018BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2018BDSI0517,2018BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,9/25/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0518,2018BDSI0518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,9/26/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0518,2018BDSI0518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,9/26/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0518,2018BDSI0518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,,,Male,I,9/26/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2018BDSI0520,2018BDSI0520,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,9/28/2018,9/28/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0521,2018BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,57,Years,Female,I,9/28/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0521,2018BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,57,Years,Female,I,9/28/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0521,2018BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,9/28/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0522,2018BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,9/26/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0522,2018BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pyrexia,Non-Health Professional,59,Years,Female,I,9/26/2018,9/25/2018,,,,CHRONIC PAIN,UNITED STATES,Pyrexia,,NO,NO,Listed
2018BDSI0522,2018BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,59,Years,Female,I,9/26/2018,9/25/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0522,2018BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,59,Years,Female,I,9/26/2018,9/25/2018,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Unlisted
2018BDSI0522,2018BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,59,Years,Female,I,9/26/2018,9/25/2018,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2018BDSI0523,2018BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,73,Years,Female,I,10/3/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Unlisted
2018BDSI0523,2018BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,73,Years,Female,I,10/3/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0523,2018BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0523,2018BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0524,2018BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,9/28/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0524,2018BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,9/28/2018,9/25/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0524,2018BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,9/28/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0526,2018BDSI0526,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arrhythmia,Non-Health Professional,84,Years,Female,I,10/1/2018,10/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Arrhythmia,,NO,NO,Unlisted
2018BDSI0526,2018BDSI0526,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,84,Years,Female,I,10/1/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0526,2018BDSI0526,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,84,Years,Female,I,10/1/2018,9/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0527,2018BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nightmare,Other Health Professional,56,Years,Female,I,10/1/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nightmare,,NO,NO,Unlisted
2018BDSI0528,2018BDSI0528,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/2/2018,10/1/2018,,,,CHRONIC SHOULDER PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0529,2018BDSI0529,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,,,Female,I,10/2/2018,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0530,2018BDSI0530,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Other Health Professional,,,Female,I,10/2/2018,,,,,CHRONIC PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0530,2018BDSI0530,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product use in unapproved indication,Other Health Professional,,,Female,I,10/2/2018,,,,,CHRONIC PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2018BDSI0530,2018BDSI0530,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Nausea,Other Health Professional,,,Female,I,10/2/2018,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0530,2018BDSI0530,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Nausea,Other Health Professional,,,Female,I,10/2/2018,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product label issue,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product label issue,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rhinalgia,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Rhinalgia,,NO,NO,Unlisted
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cough,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Cough,,NO,NO,Listed
2018BDSI0532,2018BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sinus disorder,Non-Health Professional,48,Years,Female,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Sinus disorder,,NO,NO,Listed
2018BDSI0539,2018BDSI0539,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,10/3/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0541,2018BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,10/8/2018,9/1/2018,,,,CHRONIC PAIN IN THE PELVIS,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0541,2018BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,10/8/2018,9/1/2018,,,,CHRONIC PAIN IN THE PELVIS,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0541,2018BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,,Male,I,10/8/2018,9/1/2018,,,,CHRONIC PAIN IN THE PELVIS,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2018BDSI0541,2018BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Male,I,10/8/2018,9/1/2018,,,,CHRONIC PAIN IN THE PELVIS,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0547,2018BDSI0547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Male,I,10/7/2018,,,,Other,HERNIATED DISC,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0547,2018BDSI0547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,,,Male,I,10/7/2018,,,,,HERNIATED DISC,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2018BDSI0549,2018BDSI0549,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Female,I,10/8/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2018BDSI0549,2018BDSI0549,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,10/8/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,54,Years,Female,I,10/9/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,YES,Listed
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,54,Years,Female,I,10/9/2018,8/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,54,Years,Female,I,10/9/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,54,Years,Female,I,10/9/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,54,Years,Female,I,10/9/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2018BDSI0551,2018BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Female,I,10/9/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site irritation,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Application site irritation,,NO,NO,Unlisted
2018BDSI0552,2018BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site pain,Non-Health Professional,69,Years,Female,I,10/8/2018,10/8/2018,,,,CHRONIC PAIN,UNITED STATES,Application site pain,,NO,NO,Unlisted
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,69,Years,Male,I,10/10/2018,10/22/2018,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,NO,
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,
2018BDSI0554,2018BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Male,I,10/10/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0559,2018BDSI0559,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Male,I,10/11/2018,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0565,2018BDSI0565,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,62,Years,Female,I,10/15/2018,9/20/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0565,2018BDSI0565,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Female,I,10/15/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2018BDSI0565,2018BDSI0565,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,62,Years,Female,I,10/15/2018,9/20/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Unlisted
2018BDSI0565,2018BDSI0565,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,62,Years,Female,I,10/15/2018,8/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2018BDSI0565,2018BDSI0565,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,62,Years,Female,I,10/15/2018,,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2018BDSI0567,2018BDSI0567,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/15/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0567,2018BDSI0567,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,10/15/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0567,2018BDSI0567,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/15/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0567,2018BDSI0567,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/15/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0570,2018BDSI0570,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,10/15/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0570,2018BDSI0570,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/15/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0570,2018BDSI0570,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,10/15/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2018BDSI0571,2018BDSI0571,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/17/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0571,2018BDSI0571,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/17/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0576,2018BDSI0576,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Pharmacist,,,,I,10/22/2018,10/2/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0577,2018BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,10/22/2018,10/18/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0577,2018BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Male,I,10/22/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0578,2018BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Heart rate increased,Other Health Professional,57,Years,Female,I,10/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Heart rate increased,,NO,NO,Listed
2018BDSI0578,2018BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mouth swelling,Other Health Professional,57,Years,Female,I,10/22/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Mouth swelling,,NO,NO,Unlisted
2018BDSI0579,2018BDSI0579,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Burning sensation,Other Health Professional,45,Years,Female,I,10/23/2018,10/21/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2018BDSI0579,2018BDSI0579,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swelling face,Other Health Professional,45,Years,Female,I,10/23/2018,10/21/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Swelling face,,NO,NO,Unlisted
2018BDSI0579,2018BDSI0579,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Other Health Professional,45,Years,Female,I,10/23/2018,10/21/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Unlisted
2018BDSI0581,2018BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Transdermal patch,,Hyperaesthesia,Other Health Professional,81,Years,Female,I,10/25/2018,,,,Hospitalisation,DORSAL PAIN,SPAIN,Hyperaesthesia,,YES,YES,
2018BDSI0581,2018BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Transdermal patch,,Poor quality sleep,Other Health Professional,81,Years,Female,I,10/25/2018,,,,Hospitalisation,DORSAL PAIN,SPAIN,Poor quality sleep,,YES,YES,
2018BDSI0583,2018BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,56,Years,Male,I,10/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0583,2018BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,56,Years,Male,I,10/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0583,2018BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Male,I,10/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0583,2018BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Male,I,10/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0583,2018BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,56,Years,Male,I,10/22/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0584,2018BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tongue ulceration,Other Health Professional,57,Years,Male,I,10/23/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Tongue ulceration,,NO,NO,Unlisted
2018BDSI0585,2018BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pain,Physician,,,Female,I,10/23/2018,10/22/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Unlisted
2018BDSI0585,2018BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Bradycardia,Physician,,,Female,I,10/23/2018,10/22/2018,,,Other,CHRONIC PAIN,UNITED STATES,Bradycardia,,YES,YES,Listed
2018BDSI0585,2018BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Physician,,,Female,I,10/23/2018,10/22/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2018BDSI0585,2018BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Irritability,Physician,,,Female,I,10/23/2018,10/22/2018,,,,CHRONIC PAIN,UNITED STATES,Irritability,,NO,YES,Listed
2018BDSI0585,2018BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Vomiting,Physician,,,Female,I,10/23/2018,10/22/2018,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,YES,Listed
2018BDSI0586,2018BDSI0586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Glossodynia,Other Health Professional,,,Female,I,10/23/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Glossodynia,,NO,NO,Unlisted
2018BDSI0587,2018BDSI0587,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/23/2018,9/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Blood creatine phosphokinase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blood creatine phosphokinase increased,,YES,YES,Unlisted
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Aspartate aminotransferase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Aspartate aminotransferase increased,,NO,YES,Listed
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Alanine aminotransferase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Alanine aminotransferase increased,,NO,YES,Listed
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Tablet,,Aspartate aminotransferase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Aspartate aminotransferase increased,,NO,YES,
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Tablet,,Blood creatine phosphokinase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Blood creatine phosphokinase increased,,YES,YES,
2018BDSI0588,2018BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,milligram,Tablet,,Alanine aminotransferase increased,Other Health Professional,68,Years,Female,I,10/24/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Alanine aminotransferase increased,,NO,YES,
2018BDSI0592,2018BDSI0592,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,38,Years,Male,I,10/29/2018,10/28/2018,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,YES,Unlisted
2018BDSI0592,2018BDSI0592,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,38,Years,Male,I,10/29/2018,10/28/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0595,2018BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/24/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0595,2018BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,10/24/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0595,2018BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,10/24/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0595,2018BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,10/24/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0595,2018BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Male,I,10/24/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2018BDSI0596,2018BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,10/24/2018,10/23/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0597,2018BDSI0597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,49,Years,Female,I,10/26/2018,10/26/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0597,2018BDSI0597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,49,Years,Female,I,10/26/2018,10/26/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0598,2018BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,10/26/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0599,2018BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,10/26/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0599,2018BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,10/26/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2018BDSI0605,2018BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,10/30/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0605,2018BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,10/30/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0607,2018BDSI0607,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of drug administration,Pharmacist,,,Female,I,10/31/2018,10/31/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of drug administration,,NO,NO,Unlisted
2018BDSI0612,2018BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vision blurred,Physician,64,Years,Male,I,11/2/2018,9/14/2018,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,
2018BDSI0613,2018BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sinus congestion,Physician,73,Years,Female,I,11/5/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Sinus congestion,,NO,NO,Listed
2018BDSI0613,2018BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Physician,73,Years,Female,I,11/5/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0613,2018BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Physician,73,Years,Female,I,11/5/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0613,2018BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Physician,73,Years,Female,I,11/5/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2018BDSI0614,2018BDSI0614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/6/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0620,2018BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,11/6/2018,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0621,2018BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,11/6/2018,11/6/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0621,2018BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/6/2018,11/6/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0621,2018BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,11/6/2018,11/6/2018,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0623,2018BDSI0623,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Female,I,11/6/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0624,2018BDSI0624,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,82,Years,Female,I,11/9/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0624,2018BDSI0624,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,82,Years,Female,I,11/9/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0625,2018BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Pharmacist,,,,I,11/12/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0626,2018BDSI0626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Male,I,11/7/2018,10/29/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0626,2018BDSI0626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,58,Years,Male,I,11/7/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0628,2018BDSI0628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0628,2018BDSI0628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0628,2018BDSI0628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,11/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0628,2018BDSI0628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,11/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0630,2018BDSI0630,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Physician,,,Male,I,11/15/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0630,2018BDSI0630,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Physician,,,Male,I,11/15/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0631,2018BDSI0631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,11/16/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2018BDSI0631,2018BDSI0631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,11/16/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0632,2018BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Gynaecomastia,Physician,,,Male,I,11/15/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Gynaecomastia,,NO,NO,Unlisted
2018BDSI0633,2018BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,32,Years,Female,I,11/19/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0633,2018BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,32,Years,Female,I,11/19/2018,10/23/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0633,2018BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,32,Years,Female,I,11/19/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0633,2018BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,32,Years,Female,I,11/19/2018,11/16/2018,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0633,2018BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,11/19/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0634,2018BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/16/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0635,2018BDSI0635,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,11/16/2018,11/16/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0636,2018BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Blood thyroid stimulating hormone increased,Non-Health Professional,,,Male,I,11/15/2018,11/15/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blood thyroid stimulating hormone increased,,NO,NO,Unlisted
2018BDSI0637,2018BDSI0637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/19/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0637,2018BDSI0637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/19/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0637,2018BDSI0637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/19/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0637,2018BDSI0637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hypoaesthesia oral,Non-Health Professional,,,Male,I,11/19/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2018BDSI0638,2018BDSI0638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,11/19/2018,11/19/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0639,2018BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral discomfort,Non-Health Professional,,,Female,I,11/20/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2018BDSI0640,2018BDSI0640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Breakthrough pain,Pharmacist,,,,I,11/20/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2018BDSI0644,2018BDSI0644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,11/21/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0644,2018BDSI0644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,11/21/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0644,2018BDSI0644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,11/21/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0645,2018BDSI0645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Small intestinal obstruction,Physician,68,Years,Male,F,12/11/2018,11/19/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Small intestinal obstruction,,YES,YES,Unlisted
2018BDSI0645,2018BDSI0645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Physician,68,Years,Male,F,12/11/2018,11/19/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Headache,,YES,YES,Listed
2018BDSI0645,2018BDSI0645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Asthenia,Physician,68,Years,Male,F,12/11/2018,11/1/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Asthenia,,YES,YES,Listed
2018BDSI0645,2018BDSI0645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Fatigue,Physician,68,Years,Male,F,12/11/2018,11/1/2018,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Fatigue,,YES,YES,Listed
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral coldness,Non-Health Professional,80,Years,Female,I,11/27/2018,11/24/2018,,,,CHRONIC PAIN,UNITED STATES,Peripheral coldness,,NO,NO,Unlisted
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral coldness,Non-Health Professional,80,Years,Female,I,11/27/2018,11/24/2018,,,,CHRONIC PAIN,UNITED STATES,Peripheral coldness,,NO,NO,Unlisted
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abnormal sensation in eye,Non-Health Professional,80,Years,Female,I,11/27/2018,11/24/2018,,,,CHRONIC PAIN,UNITED STATES,Abnormal sensation in eye,,NO,NO,Unlisted
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,80,Years,Female,I,11/27/2018,11/24/2018,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,80,Years,Female,I,11/27/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0647,2018BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,80,Years,Female,I,11/27/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0648,2018BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Stomatitis,Physician,37,Years,Female,I,11/26/2018,11/7/2018,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2018BDSI0648,2018BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tongue eruption,Physician,37,Years,Female,I,11/26/2018,11/7/2018,,,,CHRONIC PAIN,UNITED STATES,Tongue eruption,,NO,NO,Unlisted
2018BDSI0648,2018BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Noninfective gingivitis,Physician,37,Years,Female,I,11/26/2018,11/7/2018,,,,CHRONIC PAIN,UNITED STATES,Noninfective gingivitis,,NO,NO,Unlisted
2018BDSI0648,2018BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Swollen tongue,Physician,37,Years,Female,I,11/26/2018,11/7/2018,,,,CHRONIC PAIN,UNITED STATES,Swollen tongue,,NO,NO,Unlisted
2018BDSI0649,2018BDSI0649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,11/29/2018,11/9/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0650,2018BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,,,Female,I,11/30/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abdominal pain,,NO,NO,Listed
2018BDSI0650,2018BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,,,Female,I,11/30/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2018BDSI0650,2018BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sinus disorder,Non-Health Professional,,,Female,I,11/30/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Sinus disorder,,NO,NO,Listed
2018BDSI0650,2018BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,,,Female,I,11/30/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Decreased appetite,,NO,NO,Listed
2018BDSI0650,2018BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Myalgia,Non-Health Professional,,,Female,I,11/30/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Myalgia,,NO,NO,Listed
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Unlisted
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response delayed,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response delayed,,NO,NO,Unlisted
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,68,Years,Male,I,11/29/2018,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Akathisia,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Akathisia,,NO,NO,Unlisted
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0653,2018BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,68,Years,Male,I,11/29/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0654,2018BDSI0654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of drug administration,Non-Health Professional,,,Female,I,12/3/2018,,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of drug administration,,NO,NO,Unlisted
2018BDSI0654,2018BDSI0654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,12/3/2018,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0656,2018BDSI0656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,12/4/2018,12/1/2018,,,,CHRONIC PAIN IN NECK,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0658,2018BDSI0658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,12/6/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2018BDSI0658,2018BDSI0658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,12/6/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2018BDSI0659,2018BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Headache,Other Health Professional,,,Male,I,12/6/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0660,2018BDSI0660,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,12/6/2018,11/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2018BDSI0661,2018BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/7/2018,12/7/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0661,2018BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,12/7/2018,12/7/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0661,2018BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/7/2018,12/7/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0662,2018BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,12/6/2018,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0663,2018BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical issue,Pharmacist,,,Male,I,12/7/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0663,2018BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical issue,Pharmacist,,,Male,I,12/7/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2018BDSI0664,2018BDSI0664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,12/7/2018,11/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0667,2018BDSI0667,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,12/7/2018,12/7/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0668,2018BDSI0668,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arrhythmia,Physician,,,Male,F,12/13/2018,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Arrhythmia,,YES,YES,Unlisted
2018BDSI0669,2018BDSI0669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,69,Years,Female,I,12/11/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2018BDSI0671,2018BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/11/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0671,2018BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Medication residue present,Non-Health Professional,,,Female,I,12/11/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Medication residue present,,NO,NO,Unlisted
2018BDSI0671,2018BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/11/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0676,2018BDSI0676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Road traffic accident,Pharmacist,,,Male,I,12/13/2018,12/1/2018,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Road traffic accident,,YES,YES,Unlisted
2018BDSI0677,2018BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,12/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0677,2018BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,12/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0677,2018BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0677,2018BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2018BDSI0677,2018BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/13/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0678,2018BDSI0678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Physician,,,Male,I,12/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Confusional state,,NO,NO,Unlisted
2018BDSI0678,2018BDSI0678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Physician,,,Male,I,12/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0678,2018BDSI0678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Physician,,,Male,I,12/13/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0680,2018BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,12/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2018BDSI0680,2018BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,12/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2018BDSI0680,2018BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,12/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2018BDSI0680,2018BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,12/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2018BDSI0680,2018BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypervigilance,Non-Health Professional,,,Female,I,12/17/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypervigilance,,NO,NO,Unlisted
2018BDSI0681,2018BDSI0681,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/14/2018,12/14/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2018BDSI0682,2018BDSI0682,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal blistering,Physician,56,Years,Female,I,12/19/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2018BDSI0683,2018BDSI0683,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,12/5/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2018BDSI0684,2018BDSI0684,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal blistering,Physician,49,Years,Female,I,12/19/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2018BDSI0684,2018BDSI0684,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug hypersensitivity,Physician,49,Years,Female,I,12/19/2018,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug hypersensitivity,,NO,NO,Listed
2018BDSI0689,2018BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,12/19/2018,12/16/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2018BDSI0690,2018BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,64,Years,Male,I,12/21/2018,12/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2018BDSI0690,2018BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response shortened,Non-Health Professional,64,Years,Male,I,12/21/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response shortened,,NO,YES,Listed
2018BDSI0690,2018BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Male,I,12/21/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2018BDSI0690,2018BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Male,I,12/21/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2018BDSI0690,2018BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,64,Years,Male,I,12/21/2018,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2018BDSI0692,2018BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,61,Years,Female,I,12/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2018BDSI0692,2018BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,61,Years,Female,I,12/20/2018,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2018BDSI0696,2018BDSI0696,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/26/2018,12/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2018BDSI0696,2018BDSI0696,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/26/2018,12/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0003,2019BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Pharmacist,,,Female,I,12/26/2018,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0004,2019BDSI0004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Consumer,,,Female,I,12/28/2018,12/28/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0004,2019BDSI0004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Consumer,,,Female,I,12/28/2018,12/28/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0005,2019BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,12/26/2018,12/26/2018,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0008,2019BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/2/2019,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0008,2019BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,,Female,I,1/2/2019,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2019BDSI0008,2019BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/2/2019,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0008,2019BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/2/2019,12/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0009,2019BDSI0009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,12/31/2018,12/29/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0009,2019BDSI0009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,12/31/2018,12/29/2018,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0012,2019BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,1/2/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0012,2019BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,1/2/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0012,2019BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,1/2/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0012,2019BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/2/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0013,2019BDSI0013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,1/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0014,2019BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Male,I,1/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2019BDSI0014,2019BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,1/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0014,2019BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,1/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0014,2019BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0015,2019BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,1/7/2019,11/1/2018,,,,KNEE PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0016,2019BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/8/2019,1/6/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0016,2019BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/8/2019,1/6/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0016,2019BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/8/2019,1/6/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0017,2019BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/8/2019,1/8/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0018,2019BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,,,Male,I,1/7/2019,1/1/2018,,,,SPINAL STENOSIS,UNITED STATES,Drug tolerance,,NO,NO,Listed
2019BDSI0018,2019BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lethargy,Non-Health Professional,,,Male,I,1/7/2019,1/1/2018,,,,SPINAL STENOSIS,UNITED STATES,Lethargy,,NO,NO,Listed
2019BDSI0018,2019BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,1/7/2019,1/1/2018,,,,SPINAL STENOSIS,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0023,2019BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,1/9/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0024,2019BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0025,2019BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Male,I,1/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0025,2019BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,1/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0025,2019BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Male,I,1/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0028,2019BDSI0028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Other Health Professional,,,Male,I,1/9/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0029,2019BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,74,Years,Female,I,1/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2019BDSI0031,2019BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product size issue,Non-Health Professional,,,Female,I,1/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product size issue,,NO,NO,Unlisted
2019BDSI0031,2019BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,1/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2019BDSI0031,2019BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Suspected product tampering,Non-Health Professional,,,Female,I,1/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Suspected product tampering,,NO,NO,Unlisted
2019BDSI0032,2019BDSI0032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Acute cardiac event,Physician,43,Years,Male,I,1/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Acute cardiac event,,NO,NO,Unlisted
2019BDSI0038,2019BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,63,Years,Male,I,1/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0038,2019BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal stiffness,Non-Health Professional,63,Years,Male,I,1/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal stiffness,,NO,NO,Unlisted
2019BDSI0042,2019BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cough,Non-Health Professional,,,Female,I,1/17/2019,,,,,CHRONIC PAIN,UNITED STATES,Cough,,NO,NO,Unlisted
2019BDSI0043,2019BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,1/17/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0043,2019BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,1/17/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0044,2019BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/18/2019,1/7/2019,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0044,2019BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/18/2019,1/7/2019,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0044,2019BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/18/2019,1/7/2019,,,,PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0044,2019BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,1/18/2019,1/7/2019,,,,PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0044,2019BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/18/2019,1/7/2019,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0045,2019BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,74,Years,Female,I,1/18/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0046,2019BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,1/19/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0047,2019BDSI0047,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal chest pain,Non-Health Professional,69,Years,Female,I,1/21/2019,1/19/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Musculoskeletal chest pain,,NO,NO,Unlisted
2019BDSI0047,2019BDSI0047,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,69,Years,Female,I,1/21/2019,1/19/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0048,2019BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,55,Years,Male,I,1/21/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0049,2019BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,1/22/2019,,,,Other,PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0050,2019BDSI0050,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Physician,,,Female,I,1/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
2019BDSI0056,2019BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,50,Years,Male,I,1/22/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0056,2019BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling abnormal,Other Health Professional,50,Years,Male,I,1/22/2019,1/15/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0056,2019BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,50,Years,Male,I,1/22/2019,1/15/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0056,2019BDSI0056,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal discomfort,Other Health Professional,50,Years,Male,I,1/22/2019,,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2019BDSI0057,2019BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,55,Years,Male,I,9/23/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0057,2019BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,55,Years,Male,I,9/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0057,2019BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep paralysis,Non-Health Professional,55,Years,Male,I,9/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Sleep paralysis,,NO,YES,Unlisted
2019BDSI0058,2019BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,1/22/2019,1/21/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0059,2019BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,1/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0060,2019BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,84,Years,Female,I,1/22/2019,1/19/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0060,2019BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,84,Years,Female,I,1/22/2019,1/19/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0060,2019BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,84,Years,Female,I,1/22/2019,1/19/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0060,2019BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,84,Years,Female,I,1/22/2019,1/19/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0062,2019BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0064,2019BDSI0064,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0065,2019BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Abnormal dreams,Physician,,,Female,I,1/21/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abnormal dreams,,NO,NO,Unlisted
2019BDSI0066,2019BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,46,Years,Female,I,1/24/2019,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0066,2019BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,46,Years,Female,I,1/24/2019,10/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0066,2019BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,46,Years,Female,I,1/24/2019,,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0068,2019BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,1/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0070,2019BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hyperhidrosis,Physician,80,Years,Female,I,1/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2019BDSI0071,2019BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/25/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0076,2019BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/28/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,1/29/2019,1/29/2018,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,1/29/2019,1/29/2018,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0079,2019BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product complaint,Non-Health Professional,,,Female,I,1/29/2019,1/29/2019,,,,PAIN,UNITED STATES,Product complaint,,NO,NO,Unlisted
2019BDSI0080,2019BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,53,Years,Male,I,1/29/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood iron decreased,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Blood iron decreased,,NO,NO,Unlisted
2019BDSI0082,2019BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,63,Years,Female,I,1/28/2019,,,,,CHRONIC ARTHRITIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0084,2019BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Palpitations,Physician,,,Female,I,1/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Palpitations,,NO,NO,Unlisted
2019BDSI0085,2019BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dyspnoea,Physician,,,Female,I,1/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0086,2019BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dyspnoea,Physician,,,Female,I,1/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0087,2019BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dyspnoea,Physician,,,Female,I,1/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0088,2019BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Physician,,,Female,I,1/30/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical consistency issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug screen negative,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug screen negative,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0089,2019BDSI0089,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product physical issue,Other Health Professional,,,Female,I,1/29/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0090,2019BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,1/30/2019,1/29/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Unlisted
2019BDSI0090,2019BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,1/30/2019,1/29/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0090,2019BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product prescribing error,Non-Health Professional,70,Years,Female,I,1/30/2019,1/29/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0090,2019BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,70,Years,Female,I,1/30/2019,1/29/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0091,2019BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/6/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0091,2019BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0091,2019BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/6/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0092,2019BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Other Health Professional,70,Years,Male,I,1/31/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypertension,,NO,NO,Listed
2019BDSI0092,2019BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Other Health Professional,70,Years,Male,I,1/31/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2019BDSI0093,2019BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,79,Years,Female,I,2/1/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0093,2019BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,79,Years,Female,I,2/1/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0093,2019BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,79,Years,Female,I,2/1/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0093,2019BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,79,Years,Female,I,2/1/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0094,2019BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0095,2019BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response shortened,Non-Health Professional,,,Female,I,2/1/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response shortened,,NO,NO,Listed
2019BDSI0095,2019BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,2/1/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0096,2019BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,55,Years,Male,I,2/2/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0097,2019BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,2/4/2019,2/4/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0097,2019BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Female,I,2/4/2019,2/4/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0097,2019BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,2/4/2019,2/4/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0098,2019BDSI0098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,49,Years,Female,I,2/6/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0099,2019BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Female,I,2/5/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0099,2019BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,65,Years,Female,I,2/5/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0099,2019BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,65,Years,Female,I,2/5/2019,2/5/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0099,2019BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,65,Years,Female,I,2/5/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0099,2019BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Female,I,2/5/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0100,2019BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dispensing error,Non-Health Professional,,,Female,I,2/7/2019,1/1/2019,,,,BACK PAIN,UNITED STATES,Product dispensing error,,NO,NO,Unlisted
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Retching,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,,CHRONIC PAIN,UNITED STATES,Retching,,NO,YES,Unlisted
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,YES,Listed
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2019BDSI0101,2019BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Loss of consciousness,Non-Health Professional,58,Years,Female,I,2/13/2019,2/5/2019,,,Other,CHRONIC PAIN,UNITED STATES,Loss of consciousness,,YES,YES,Unlisted
2019BDSI0103,2019BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,69,Years,Male,I,2/9/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0103,2019BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Male,I,2/9/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0103,2019BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Male,I,2/9/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0103,2019BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,69,Years,Male,I,2/9/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0106,2019BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/11/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0107,2019BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Chest pain,Physician,40,Years,Male,I,2/12/2019,,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Eye irritation,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Eye irritation,,NO,NO,Unlisted
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lacrimation increased,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Lacrimation increased,,NO,NO,Unlisted
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0108,2019BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,61,Years,Male,I,2/11/2019,2/1/2019,,,,BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0109,2019BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,2/13/2019,,,,Other,BREAKTHROUGH PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0109,2019BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,2/13/2019,,,,,BREAKTHROUGH PAIN,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2019BDSI0109,2019BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use in unapproved indication,Non-Health Professional,,,Female,I,2/13/2019,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product use in unapproved indication,,NO,YES,Unlisted
2019BDSI0112,2019BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,2/13/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0112,2019BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,2/13/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0114,2019BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,2/14/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0116,2019BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Menstruation irregular,Other Health Professional,,,Female,I,2/13/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Menstruation irregular,,NO,NO,Unlisted
2019BDSI0117,2019BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Female,I,2/14/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0117,2019BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,63,Years,Female,I,2/14/2019,2/11/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0117,2019BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Female,I,2/14/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0119,2019BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,,Buccal film,,Rash generalised,Other Health Professional,82,Years,Female,I,2/15/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash generalised,,NO,NO,Listed
2019BDSI0119,2019BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,,Buccal film,,Urticaria,Other Health Professional,82,Years,Female,I,2/15/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Urticaria,,NO,NO,Listed
2019BDSI0123,2019BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,2/18/2019,2/14/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0124,2019BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Application site haemorrhage,Other Health Professional,86,Years,Female,I,2/15/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Application site haemorrhage,,NO,NO,Unlisted
2019BDSI0127,2019BDSI0127,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,59,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0129,2019BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/19/2019,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0129,2019BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/19/2019,,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0129,2019BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/19/2019,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0129,2019BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/19/2019,,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0130,2019BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral mucosal blistering,Physician,70,Years,Female,I,2/20/2019,2/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2019BDSI0131,2019BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,36,Years,Female,I,2/21/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0132,2019BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral mucosal blistering,Physician,25,Years,Male,I,2/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2019BDSI0135,2019BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Female,I,2/20/2019,2/20/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0135,2019BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Female,I,2/20/2019,2/20/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0135,2019BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,2/20/2019,2/20/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0135,2019BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,67,Years,Female,I,2/20/2019,2/20/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0136,2019BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/20/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0137,2019BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,72,Years,Male,I,2/20/2019,2/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0138,2019BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,2/21/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0139,2019BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Other Health Professional,62,Years,Male,I,2/22/2019,2/22/2019,,,,CHRONIC NECK PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2019BDSI0139,2019BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Other Health Professional,62,Years,Male,I,2/22/2019,2/22/2019,,,,CHRONIC NECK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0139,2019BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Other Health Professional,62,Years,Male,I,2/22/2019,2/22/2019,,,,CHRONIC NECK PAIN,UNITED STATES,Confusional state,,NO,NO,Listed
2019BDSI0139,2019BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Other Health Professional,62,Years,Male,I,2/22/2019,2/22/2019,,,,CHRONIC NECK PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0139,2019BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Other Health Professional,62,Years,Male,I,2/22/2019,2/1/2019,,,,CHRONIC NECK PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0142,2019BDSI0142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/25/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0142,2019BDSI0142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/25/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0142,2019BDSI0142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/25/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0143,2019BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,2/22/2019,,,,,SPINAL PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0144,2019BDSI0144,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,2/25/2019,2/25/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0145,2019BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,62,Years,Male,I,2/20/2019,9/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0145,2019BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Amnesia,Other Health Professional,62,Years,Male,I,2/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Amnesia,,NO,NO,Unlisted
2019BDSI0146,2019BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/22/2019,2/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0146,2019BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,2/22/2019,2/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0148,2019BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,35,Years,Female,I,2/26/2019,2/18/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0149,2019BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Female,I,2/26/2019,2/16/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0149,2019BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,2/26/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0150,2019BDSI0150,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Anaphylactic reaction,Other Health Professional,35,Years,Female,I,2/26/2019,1/29/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Anaphylactic reaction,,YES,YES,Listed
2019BDSI0151,2019BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,2/26/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0153,2019BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/26/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0153,2019BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/26/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0154,2019BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Cellulitis,Non-Health Professional,72,Years,Male,I,2/28/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Cellulitis,,NO,NO,Unlisted
2019BDSI0155,2019BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0156,2019BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0157,2019BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0158,2019BDSI0158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0159,2019BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0160,2019BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0160,2019BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0161,2019BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,2/28/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Agitation,Non-Health Professional,79,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Agitation,,NO,NO,Listed
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,79,Years,Female,I,2/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,79,Years,Female,I,2/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,79,Years,Female,I,2/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,79,Years,Female,I,2/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Visual impairment,Non-Health Professional,79,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,79,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oropharyngeal pain,Non-Health Professional,79,Years,Female,I,2/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oropharyngeal pain,,NO,NO,Unlisted
2019BDSI0162,2019BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,79,Years,Female,I,2/26/2019,2/26/2019,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Listed
2019BDSI0163,2019BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Hyperhidrosis,Other Health Professional,,,Female,I,2/28/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Unlisted
2019BDSI0163,2019BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Mood swings,Other Health Professional,,,Female,I,2/28/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Mood swings,,NO,NO,Listed
2019BDSI0163,2019BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Stomatitis,Other Health Professional,,,Female,I,2/28/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anger,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Anger,,NO,NO,Unlisted
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality sleep,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Poor quality sleep,,NO,NO,Listed
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,52,Years,Female,I,3/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,52,Years,Female,I,3/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,52,Years,Female,I,3/1/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0164,2019BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,52,Years,Female,I,3/1/2019,2/7/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0170,2019BDSI0170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,3/4/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,66,Years,Male,I,3/4/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Male,I,3/4/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,66,Years,Male,I,3/4/2019,7/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Male,I,3/4/2019,7/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0171,2019BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Male,I,3/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0172,2019BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/4/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0172,2019BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/4/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0172,2019BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,3/4/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0173,2019BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Off label use,Physician,81,Years,Female,I,3/5/2019,,,,Hospitalisation,PAIN,SPAIN,Off label use,,YES,YES,
2019BDSI0173,2019BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hyperaesthesia,Physician,81,Years,Female,I,3/5/2019,,,,Hospitalisation,PAIN,SPAIN,Hyperaesthesia,,YES,YES,
2019BDSI0177,2019BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,53,Years,Female,I,3/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0177,2019BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Choking sensation,Non-Health Professional,53,Years,Female,I,3/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Choking sensation,,NO,NO,Unlisted
2019BDSI0177,2019BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Female,I,3/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0178,2019BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,74,Years,Female,I,3/5/2019,2/16/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0179,2019BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,3/6/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0179,2019BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/6/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0179,2019BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,3/6/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug ineffective,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug ineffective,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product taste abnormal,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,YES,Unlisted
2019BDSI0180,2019BDSI0180,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product taste abnormal,Pharmacist,40,Years,Female,I,3/8/2019,3/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product taste abnormal,,NO,YES,Unlisted
2019BDSI0181,2019BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Other Health Professional,,,Female,I,3/8/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0185,2019BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,86,Years,Male,I,3/8/2019,3/7/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0185,2019BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,86,Years,Male,I,3/8/2019,3/7/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0186,2019BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,3/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0186,2019BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,3/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0187,2019BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,3/8/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0187,2019BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0187,2019BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0187,2019BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0190,2019BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/11/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0190,2019BDSI0190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/11/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0191,2019BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,3/11/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0192,2019BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,88,Years,Female,I,3/11/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2019BDSI0192,2019BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,88,Years,Female,I,3/11/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0192,2019BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,88,Years,Female,I,3/11/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0192,2019BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,88,Years,Female,I,3/11/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0193,2019BDSI0193,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,Buccal film,,Therapeutic response decreased,Non-Health Professional,72,Years,Male,I,3/12/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0194,2019BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,,,Female,I,3/12/2019,,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0195,2019BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,,Non-Health Professional,,,Female,I,3/12/2019,,,,,,UNITED STATES,nan,,NO,NO,
2019BDSI0196,2019BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/12/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0196,2019BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/12/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0196,2019BDSI0196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,3/12/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0198,2019BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/13/2019,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0199,2019BDSI0199,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/14/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0205,2019BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,52,Years,Female,I,3/14/2019,3/14/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0206,2019BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Female,I,3/15/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2019BDSI0206,2019BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,3/15/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Somnolence,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Nausea,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Vomiting,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Unlisted
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dizziness,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0207,2019BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,3/18/2019,3/17/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0208,2019BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Malaise,Non-Health Professional,,,Female,I,3/16/2019,3/1/2019,,,,PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0208,2019BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Pain,Non-Health Professional,,,Female,I,3/16/2019,3/1/2019,,,,PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0208,2019BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Product availability issue,Non-Health Professional,,,Female,I,3/16/2019,3/16/2019,,,,PAIN,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2019BDSI0209,2019BDSI0209,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,3/17/2019,3/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0210,2019BDSI0210,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,3/18/2019,3/18/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0210,2019BDSI0210,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/18/2019,3/18/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0210,2019BDSI0210,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/18/2019,3/18/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0212,2019BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait inability,Non-Health Professional,,,Female,I,3/19/2019,1/1/2019,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Gait inability,,YES,YES,Unlisted
2019BDSI0212,2019BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,,,Female,I,3/19/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product dose omission,,NO,YES,Unlisted
2019BDSI0213,2019BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,51,Years,Male,I,3/18/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0213,2019BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,51,Years,Male,I,3/18/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0214,2019BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Angioedema,Physician,49,Years,Male,I,3/18/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Angioedema,,YES,YES,Unlisted
2019BDSI0214,2019BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Angioedema,Physician,49,Years,Male,I,3/18/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Angioedema,,YES,YES,Unlisted
2019BDSI0215,2019BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Electrocardiogram QT prolonged,Physician,33,Years,,I,3/19/2019,7/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2019BDSI0217,2019BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,,,Female,I,3/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,NO,Unlisted
2019BDSI0217,2019BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0217,2019BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Bedridden,Non-Health Professional,,,Female,I,3/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Bedridden,,NO,NO,Unlisted
2019BDSI0218,2019BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0218,2019BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0218,2019BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of product administration,Non-Health Professional,,,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of product administration,,NO,NO,Unlisted
2019BDSI0218,2019BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0219,2019BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0219,2019BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0220,2019BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hypersensitivity,Non-Health Professional,,,Female,I,3/19/2019,3/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2019BDSI0221,2019BDSI0221,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/21/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0222,2019BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,62,Years,Female,I,3/21/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0222,2019BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,62,Years,Female,I,3/21/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hair disorder,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hair disorder,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle fatigue,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Muscle fatigue,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Erythema,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Erythema,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Burning sensation,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Burning sensation,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Spider vein,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Spider vein,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood glucose decreased,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Blood glucose decreased,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breath odour,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breath odour,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,53,Years,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,53,Years,Male,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2018,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,YES,Listed
2019BDSI0223,2019BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Bone pain,Non-Health Professional,53,Years,Male,I,3/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Bone pain,,NO,YES,Unlisted
2019BDSI0225,2019BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,3/20/2019,,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0226,2019BDSI0226,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Gingival recession,Other Health Professional,,,Male,I,3/21/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Gingival recession,,NO,NO,Unlisted
2019BDSI0227,2019BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/22/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0227,2019BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/22/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0228,2019BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/24/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0228,2019BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/24/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0228,2019BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/24/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0228,2019BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,3/24/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0229,2019BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,40,Years,Female,I,3/23/2019,3/20/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0229,2019BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,40,Years,Female,I,3/23/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0229,2019BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,40,Years,Female,I,3/23/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0230,2019BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,41,Years,Male,I,3/25/2019,3/23/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0231,2019BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Death,Physician,,,UNK,I,3/25/2019,,,,Death,DRUG USE FOR UNKNOWN INDICATION,DENMARK,Death,,YES,YES,
2019BDSI0231,2019BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Neoplasm malignant,Physician,,,UNK,I,3/25/2019,,,,Death,DRUG USE FOR UNKNOWN INDICATION,DENMARK,Neoplasm malignant,,YES,YES,
2019BDSI0231,2019BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Respiratory disorder,Physician,,,UNK,I,3/25/2019,,,,Death,DRUG USE FOR UNKNOWN INDICATION,DENMARK,Respiratory disorder,,YES,YES,
2019BDSI0231,2019BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Pneumonia,Physician,,,UNK,I,3/25/2019,,,,Death,DRUG USE FOR UNKNOWN INDICATION,DENMARK,Pneumonia,,YES,YES,
2019BDSI0232,2019BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mouth ulceration,Other Health Professional,55,Years,Female,I,3/26/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2019BDSI0234,2019BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,Female,I,3/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0234,2019BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Physician,,,Female,I,3/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0234,2019BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Physician,,,Female,I,3/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0236,2019BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,,Male,I,3/28/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Condition aggravated,,NO,NO,Listed
2019BDSI0236,2019BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/28/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0237,2019BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/27/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0237,2019BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/27/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0238,2019BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mouth ulceration,Other Health Professional,73,Years,Female,I,3/28/2019,2/8/2019,,,,CHRONIC PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2019BDSI0238,2019BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Stomatitis,Other Health Professional,73,Years,Female,I,3/28/2019,2/8/2019,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0242,2019BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Male,I,3/29/2019,3/28/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0244,2019BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,24,Years,Male,I,3/29/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0244,2019BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,24,Years,Male,I,3/29/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0244,2019BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,24,Years,Male,I,3/29/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2019BDSI0246,2019BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,70,Years,Female,I,3/31/2019,3/31/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0246,2019BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,70,Years,Female,I,3/31/2019,3/31/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,YES,Unlisted
2019BDSI0246,2019BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,3/31/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0246,2019BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,3/31/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0246,2019BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,70,Years,Female,I,3/31/2019,3/31/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Unlisted
2019BDSI0247,2019BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,85,Years,Female,I,4/1/2019,3/29/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0251,2019BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,40,Years,Female,I,4/2/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI0251,2019BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash generalised,Other Health Professional,40,Years,Female,I,4/2/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash generalised,,NO,YES,Listed
2019BDSI0251,2019BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash,Other Health Professional,40,Years,Female,I,4/2/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash,,NO,YES,Unlisted
2019BDSI0251,2019BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Electrocardiogram QT prolonged,Other Health Professional,40,Years,Female,I,4/2/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2019BDSI0252,2019BDSI0252,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,4/3/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0253,2019BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Alopecia,Non-Health Professional,45,Years,Male,I,4/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2019BDSI0253,2019BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival recession,Non-Health Professional,45,Years,Male,I,4/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Gingival recession,,NO,NO,Unlisted
2019BDSI0253,2019BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival pain,Non-Health Professional,45,Years,Male,I,4/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Gingival pain,,NO,NO,Unlisted
2019BDSI0253,2019BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival bleeding,Non-Health Professional,45,Years,Male,I,4/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Gingival bleeding,,NO,NO,Unlisted
2019BDSI0253,2019BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dental caries,Non-Health Professional,45,Years,Male,I,4/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2019BDSI0256,2019BDSI0256,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Food craving,Other Health Professional,30,Years,Female,I,4/5/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Food craving,,NO,NO,Unlisted
2019BDSI0256,2019BDSI0256,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Food craving,Other Health Professional,30,Years,Female,I,4/5/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Food craving,,NO,NO,Unlisted
2019BDSI0257,2019BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Other Health Professional,50,Years,Female,I,4/8/2019,3/19/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0257,2019BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Weight increased,Other Health Professional,50,Years,Female,I,4/8/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Weight increased,,NO,NO,Unlisted
2019BDSI0257,2019BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Generalised oedema,Other Health Professional,50,Years,Female,I,4/8/2019,3/19/2019,,,,CHRONIC PAIN,UNITED STATES,Generalised oedema,,NO,NO,Unlisted
2019BDSI0257,2019BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Other Health Professional,50,Years,Female,I,4/8/2019,3/19/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0265,2019BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Euphoric mood,Other Health Professional,68,Years,Male,I,4/5/2019,3/20/2019,,,,CHRONIC PAIN,UNITED STATES,Euphoric mood,,NO,NO,Unlisted
2019BDSI0265,2019BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Overdose,Other Health Professional,68,Years,Male,I,4/5/2019,3/20/2019,,,,CHRONIC PAIN,UNITED STATES,Overdose,,NO,NO,Unlisted
2019BDSI0265,2019BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mental impairment,Other Health Professional,68,Years,Male,I,4/5/2019,3/20/2019,,,,CHRONIC PAIN,UNITED STATES,Mental impairment,,NO,NO,Listed
2019BDSI0265,2019BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Fatigue,Other Health Professional,68,Years,Male,I,4/5/2019,3/20/2019,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0266,2019BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,4/8/2019,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0266,2019BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Male,I,4/8/2019,,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0267,2019BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,61,Years,Female,I,4/5/2019,4/5/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0270,2019BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,4/8/2019,3/28/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Red blood cell count decreased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Red blood cell count decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Mean cell volume abnormal,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Mean cell volume abnormal,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Mean cell haemoglobin decreased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Mean cell haemoglobin decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Red cell distribution width increased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Red cell distribution width increased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Platelet count decreased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Platelet count decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Antibody test abnormal,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Antibody test abnormal,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Aspartate aminotransferase increased,Non-Health Professional,,,Male,I,4/5/2019,4/2/2019,,,,MUSCLE SPASMS,UNITED STATES,Aspartate aminotransferase increased,,NO,NO,Listed
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Blood iron decreased,Non-Health Professional,,,Male,I,4/5/2019,4/2/2019,,,,MUSCLE SPASMS,UNITED STATES,Blood iron decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Vitamin B12 increased,Non-Health Professional,,,Male,I,4/5/2019,4/2/2019,,,,MUSCLE SPASMS,UNITED STATES,Vitamin B12 increased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Haemoglobin decreased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Haemoglobin decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Haematocrit decreased,Non-Health Professional,,,Male,I,4/5/2019,4/5/2019,,,,MUSCLE SPASMS,UNITED STATES,Haematocrit decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Serum ferritin decreased,Non-Health Professional,,,Male,I,4/5/2019,1/1/2019,,,,MUSCLE SPASMS,UNITED STATES,Serum ferritin decreased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,4/5/2019,1/1/2019,,,,MUSCLE SPASMS,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Weight increased,Non-Health Professional,,,Male,I,4/5/2019,1/1/2019,,,,MUSCLE SPASMS,UNITED STATES,Weight increased,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,,,Male,I,4/5/2019,,,,,MUSCLE SPASMS,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Anaemia,Non-Health Professional,,,Male,I,4/5/2019,1/1/2019,,,,MUSCLE SPASMS,UNITED STATES,Anaemia,,NO,NO,Listed
2019BDSI0271,2019BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,,,Male,I,4/5/2019,1/1/2019,,,,MUSCLE SPASMS,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2019BDSI0272,2019BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Unresponsive to stimuli,Other Health Professional,64,Years,Female,I,4/9/2019,4/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Unresponsive to stimuli,,YES,YES,Unlisted
2019BDSI0272,2019BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Amnesia,Other Health Professional,64,Years,Female,I,4/9/2019,4/8/2019,,,Other,CHRONIC PAIN,UNITED STATES,Amnesia,,YES,YES,Unlisted
2019BDSI0272,2019BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Intentional product misuse,Other Health Professional,64,Years,Female,I,4/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional product misuse,,NO,YES,Unlisted
2019BDSI0279,2019BDSI0279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Application site pain,Non-Health Professional,,,Female,I,4/12/2019,4/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Application site pain,,NO,NO,Unlisted
2019BDSI0281,2019BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,4/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0281,2019BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,4/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0281,2019BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,4/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0281,2019BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Malaise,Non-Health Professional,,,Female,I,4/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0282,2019BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0282,2019BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0294,2019BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,61,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0294,2019BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,61,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0294,2019BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,61,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Balance disorder,,NO,NO,Unlisted
2019BDSI0294,2019BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,61,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Listed
2019BDSI0294,2019BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,61,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,40,Years,Female,I,4/16/2019,4/2/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,40,Years,Female,I,4/16/2019,4/2/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Restless legs syndrome,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Restless legs syndrome,,NO,YES,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0295,2019BDSI0295,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,40,Years,Female,I,4/16/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,YES,Unlisted
2019BDSI0296,2019BDSI0296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,58,Years,Male,I,4/16/2019,4/14/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0296,2019BDSI0296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Inflammation,Non-Health Professional,58,Years,Male,I,4/16/2019,4/14/2019,,,,CHRONIC PAIN,UNITED STATES,Inflammation,,NO,YES,Unlisted
2019BDSI0296,2019BDSI0296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,58,Years,Male,I,4/16/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI0303,2019BDSI0303,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,4/17/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0304,2019BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Physician,,,,I,4/17/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0304,2019BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Diarrhoea,Physician,,,,I,4/17/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,YES,Unlisted
2019BDSI0304,2019BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Paraesthesia,Physician,,,,I,4/17/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Paraesthesia,,NO,YES,Unlisted
2019BDSI0304,2019BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Palpitations,Physician,,,,I,4/17/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Palpitations,,NO,YES,Unlisted
2019BDSI0310,2019BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,,,Female,I,4/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0310,2019BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product residue present,Other Health Professional,,,Female,I,4/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Product residue present,,NO,NO,Unlisted
2019BDSI0311,2019BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nasal congestion,Physician,,,Male,I,4/18/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nasal congestion,,NO,NO,Listed
2019BDSI0311,2019BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sinusitis,Physician,,,Male,I,4/18/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Sinusitis,,NO,NO,Listed
2019BDSI0312,2019BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dry skin,Other Health Professional,58,Years,Female,I,4/18/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dry skin,,NO,NO,Unlisted
2019BDSI0322,2019BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0322,2019BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0325,2019BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,4/23/2019,4/23/2019,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0325,2019BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disorientation,Non-Health Professional,,,Female,I,4/23/2019,4/23/2019,,,,CHRONIC PAIN,UNITED STATES,Disorientation,,NO,NO,Unlisted
2019BDSI0326,2019BDSI0326,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,76,Years,Male,I,4/24/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0327,2019BDSI0327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,4/24/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0329,2019BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,58,Years,Female,I,4/24/2019,4/24/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0329,2019BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,I,4/24/2019,3/11/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Oral administration complication,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Product solubility abnormal,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Product solubility abnormal,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Product physical consistency issue,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Drug ineffective,Non-Health Professional,38,Years,Female,I,4/23/2019,4/6/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Product physical consistency issue,Non-Health Professional,38,Years,Female,I,4/23/2019,4/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,38,Years,Female,I,4/23/2019,4/11/2019,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,38,Years,Female,I,4/23/2019,4/11/2019,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0331,2019BDSI0331,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Positive,Positive,,,Buccal film,,Drug ineffective,Non-Health Professional,38,Years,Female,I,4/23/2019,4/6/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Drug ineffective,,NO,YES,Unlisted
2019BDSI0332,2019BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Female,I,4/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0332,2019BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,4/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0332,2019BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Toothache,Non-Health Professional,67,Years,Female,I,4/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,NO,Listed
2019BDSI0334,2019BDSI0334,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Product prescribing error,Pharmacist,,,Female,I,4/23/2019,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0334,2019BDSI0334,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Product prescribing error,Pharmacist,,,Female,I,4/23/2019,,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,56,Years,Female,I,4/24/2019,4/21/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,56,Years,Female,I,4/24/2019,4/21/2019,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Listed
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Female,I,4/24/2019,4/21/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Respiratory rate decreased,Non-Health Professional,56,Years,Female,I,4/24/2019,4/21/2019,,,,CHRONIC PAIN,UNITED STATES,Respiratory rate decreased,,NO,NO,Unlisted
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,56,Years,Female,I,4/24/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,56,Years,Female,I,4/24/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,56,Years,Female,I,4/24/2019,4/21/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0335,2019BDSI0335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,56,Years,Female,I,4/24/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0336,2019BDSI0336,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,71,Years,Female,I,4/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0341,2019BDSI0341,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Toxicity to various agents,Other Health Professional,27,Years,Male,F,5/2/2019,,,,Death,DRUG USE FOR UNKNOWN INDICATION,NORWAY,Toxicity to various agents,,YES,YES,
2019BDSI0342,2019BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,31,Years,Female,I,4/26/2019,4/5/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0342,2019BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,31,Years,Female,I,4/26/2019,4/5/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0342,2019BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,31,Years,Female,I,4/26/2019,2/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0342,2019BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,31,Years,Female,I,4/26/2019,4/5/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0344,2019BDSI0344,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Non-Health Professional,79,Years,Female,I,4/26/2019,4/25/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0347,2019BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,43,Years,Female,I,4/30/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0348,2019BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,4/29/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0348,2019BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,4/29/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0348,2019BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/29/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0354,2019BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,4/30/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0354,2019BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/30/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0355,2019BDSI0355,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Pyrexia,Other Health Professional,,,Female,I,4/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pyrexia,,NO,NO,Listed
2019BDSI0355,2019BDSI0355,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Pyrexia,Other Health Professional,,,Female,I,4/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pyrexia,,NO,NO,Listed
2019BDSI0359,2019BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,81,Years,Female,I,5/3/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0359,2019BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,81,Years,Female,I,5/3/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0359,2019BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,81,Years,Female,I,5/3/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0369,2019BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,5/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0369,2019BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,70,Years,Male,I,5/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0369,2019BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Male,I,5/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0369,2019BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,5/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0369,2019BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,70,Years,Male,I,5/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0370,2019BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,5/9/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0370,2019BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/9/2019,5/9/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0370,2019BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,5/9/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0370,2019BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/9/2019,5/9/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0371,2019BDSI0371,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tinnitus,Physician,,,Male,I,5/9/2019,3/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Tinnitus,,NO,NO,Unlisted
2019BDSI0372,2019BDSI0372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/10/2019,5/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0372,2019BDSI0372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/10/2019,5/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0374,2019BDSI0374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,38,Years,Female,I,5/10/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0375,2019BDSI0375,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Chest pain,Other Health Professional,50,Years,Male,I,5/10/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0375,2019BDSI0375,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal pain,Other Health Professional,50,Years,Male,I,5/10/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,59,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,59,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,59,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,59,Years,Female,I,6/18/2019,5/7/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,59,Years,Female,I,6/18/2019,5/7/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nasopharyngitis,Non-Health Professional,59,Years,Female,I,6/18/2019,5/23/2019,,,,CHRONIC PAIN,UNITED STATES,Nasopharyngitis,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Joint swelling,Non-Health Professional,59,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Joint swelling,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,59,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,59,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,59,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,59,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,59,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,6/18/2019,5/7/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0379,2019BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysuria,Non-Health Professional,59,Years,Female,I,6/18/2019,5/7/2019,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,7/31/2019,5/12/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,7/31/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,7/31/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0380,2019BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0381,2019BDSI0381,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/13/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0381,2019BDSI0381,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/13/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0381,2019BDSI0381,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/13/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,55,Years,Female,I,5/27/2019,5/16/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapy change,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapy change,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ligament sprain,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Ligament sprain,,NO,NO,Unlisted
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0382,2019BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,55,Years,Female,I,5/27/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0383,2019BDSI0383,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/13/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0383,2019BDSI0383,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/13/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0384,2019BDSI0384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic product effect increased,Non-Health Professional,,,Male,I,5/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic product effect increased,,NO,NO,Unlisted
2019BDSI0384,2019BDSI0384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Feeling abnormal,Non-Health Professional,,,Male,I,5/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Malaise,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Vomiting,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0398,2019BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Asthma,Non-Health Professional,,,Male,I,5/20/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Asthma,,NO,NO,Unlisted
2019BDSI0403,2019BDSI0403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,46,Years,Female,I,5/16/2019,4/27/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0403,2019BDSI0403,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,46,Years,Female,I,5/16/2019,4/27/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0404,2019BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,58,Years,Male,I,5/17/2019,5/17/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0406,2019BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Other Health Professional,,,Male,I,5/24/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0410,2019BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,5/18/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0410,2019BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,5/18/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0413,2019BDSI0413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Consumer,80,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0413,2019BDSI0413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Consumer,80,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0413,2019BDSI0413,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Consumer,80,Years,Female,I,6/18/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0416,2019BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,5/21/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0416,2019BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,57,Years,Female,I,5/21/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0416,2019BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,5/21/2019,5/7/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0416,2019BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,57,Years,Female,I,5/21/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2019BDSI0417,2019BDSI0417,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tachycardia,Physician,49,Years,Male,I,5/21/2019,5/9/2019,,,,CHRONIC PAIN,UNITED STATES,Tachycardia,,NO,NO,Unlisted
2019BDSI0418,2019BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/24/2019,4/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0418,2019BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0418,2019BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,5/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0418,2019BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,5/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,
2019BDSI0420,2019BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,,,Female,I,5/22/2019,5/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,NO,Listed
2019BDSI0420,2019BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/22/2019,5/16/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0420,2019BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypotension,Non-Health Professional,,,Female,I,5/22/2019,5/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypotension,,NO,NO,Listed
2019BDSI0420,2019BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,5/22/2019,5/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0420,2019BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Heart rate increased,Non-Health Professional,,,Female,I,5/22/2019,5/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Heart rate increased,,NO,NO,Listed
2019BDSI0421,2019BDSI0421,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,5/22/2019,5/20/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0439,2019BDSI0439,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,5/28/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0439,2019BDSI0439,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/28/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0439,2019BDSI0439,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,5/28/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0440,2019BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,,I,5/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Other Health Professional,,,Female,I,5/31/2019,5/22/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Confusional state,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response increased,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Somnolence,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0442,2019BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,,,Female,I,5/31/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0443,2019BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Physician,61,Years,Female,I,5/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Depression,,NO,NO,Listed
2019BDSI0443,2019BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Physician,61,Years,Female,I,5/23/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Unlisted
2019BDSI0444,2019BDSI0444,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Male,I,6/6/2019,5/28/2019,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2019BDSI0445,2019BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,5/28/2019,,,,,ARTHRITIS,CANADA,Off label use,,NO,NO,Unlisted
2019BDSI0445,2019BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,5/28/2019,,,,,ARTHRITIS,CANADA,Product administration error,,NO,NO,Unlisted
2019BDSI0445,2019BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug effective for unapproved indication,Non-Health Professional,,,Male,I,5/28/2019,,,,,ARTHRITIS,CANADA,Drug effective for unapproved indication,,NO,NO,Unlisted
2019BDSI0446,2019BDSI0446,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Application site hypoaesthesia,Physician,66,Years,Male,I,5/28/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Application site hypoaesthesia,,NO,NO,Unlisted
2019BDSI0446,2019BDSI0446,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Physician,66,Years,Male,I,5/28/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/28/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,,,Female,I,5/28/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Unlisted
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/28/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/28/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/28/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,5/28/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0447,2019BDSI0447,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/28/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0448,2019BDSI0448,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,5/29/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0449,2019BDSI0449,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Other Health Professional,49,Years,Female,I,5/28/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0451,2019BDSI0451,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/29/2019,5/28/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0453,2019BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Euphoric mood,Non-Health Professional,70,Years,Female,I,6/4/2019,5/30/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Euphoric mood,,NO,NO,Unlisted
2019BDSI0455,2019BDSI0455,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,5/31/2019,5/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0458,2019BDSI0458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Pharmacist,,,Female,I,5/31/2019,,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2019BDSI0458,2019BDSI0458,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Pharmacist,,,Female,I,5/31/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0461,2019BDSI0461,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,69,Years,Female,I,6/3/2019,5/30/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0461,2019BDSI0461,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,69,Years,Female,I,6/3/2019,5/30/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0461,2019BDSI0461,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,I,6/3/2019,5/31/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0461,2019BDSI0461,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,69,Years,Female,I,6/3/2019,6/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0465,2019BDSI0465,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,6/7/2019,6/2/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0466,2019BDSI0466,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vision blurred,Other Health Professional,70,Years,Male,I,6/5/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2019BDSI0466,2019BDSI0466,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal discomfort,Other Health Professional,70,Years,Male,I,6/5/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2019BDSI0466,2019BDSI0466,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,70,Years,Male,I,6/5/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Unlisted
2019BDSI0467,2019BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oedema peripheral,Other Health Professional,,,Female,I,6/11/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2019BDSI0467,2019BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Peripheral swelling,Other Health Professional,,,Female,I,6/11/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2019BDSI0468,2019BDSI0468,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/4/2019,6/4/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0468,2019BDSI0468,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/4/2019,6/4/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0468,2019BDSI0468,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/4/2019,6/4/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0470,2019BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,6/21/2019,6/3/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Listed
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0471,2019BDSI0471,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Pharmacist,58,Years,Female,I,6/4/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0472,2019BDSI0472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,6/6/2019,5/13/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0473,2019BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,56,Years,Male,I,6/4/2019,5/30/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0473,2019BDSI0473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Male,I,6/4/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0480,2019BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Overdose,Non-Health Professional,,,Male,I,6/7/2019,6/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Overdose,,YES,YES,Listed
2019BDSI0480,2019BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,6/7/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0480,2019BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthma,Non-Health Professional,,,Male,I,6/7/2019,6/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Asthma,,YES,YES,Unlisted
2019BDSI0480,2019BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,,,Male,I,6/7/2019,6/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hypertension,,YES,YES,Listed
2019BDSI0480,2019BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,,Male,I,6/7/2019,6/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Condition aggravated,,YES,YES,Unlisted
2019BDSI0481,2019BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,6/7/2019,6/5/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2019BDSI0481,2019BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0481,2019BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0481,2019BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0481,2019BDSI0481,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0482,2019BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Feeling abnormal,Physician,,,Female,I,6/5/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0482,2019BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Physician,,,Female,I,6/5/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0482,2019BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Physician,,,Female,I,6/5/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0484,2019BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Vision blurred,Physician,,,Male,I,6/7/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2019BDSI0485,2019BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/7/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0485,2019BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,6/7/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0485,2019BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,6/7/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0486,2019BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,6/10/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0487,2019BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use issue,Pharmacist,40,Years,Female,I,6/10/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2019BDSI0487,2019BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Pharmacist,40,Years,Female,I,6/10/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0487,2019BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,40,Years,Female,I,6/10/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0487,2019BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Pharmacist,40,Years,Female,I,6/10/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0488,2019BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,50,Years,Female,I,6/10/2019,6/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2019BDSI0488,2019BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of product administration,Non-Health Professional,50,Years,Female,I,6/10/2019,,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of product administration,,NO,NO,Unlisted
2019BDSI0488,2019BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,50,Years,Female,I,6/10/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0489,2019BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/11/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0490,2019BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hypersensitivity,Other Health Professional,,,Male,I,6/11/2019,,,,,CHRONIC PAIN,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2019BDSI0491,2019BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,I,6/12/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0491,2019BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of product administration,Non-Health Professional,59,Years,Female,I,6/12/2019,,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of product administration,,NO,NO,Unlisted
2019BDSI0491,2019BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,59,Years,Female,I,6/12/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0491,2019BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,59,Years,Female,I,6/12/2019,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0491,2019BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,6/12/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0495,2019BDSI0495,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Male,I,6/12/2019,5/1/2019,,,,DRUG WITHDRAWAL SYNDROME,UNITED STATES,Constipation,,NO,NO,Listed
2019BDSI0495,2019BDSI0495,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,6/12/2019,5/1/2019,,,,DRUG WITHDRAWAL SYNDROME,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0496,2019BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0496,2019BDSI0496,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0497,2019BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,74,Years,Male,I,6/13/2019,6/10/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0507,2019BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyskinesia,Non-Health Professional,65,Years,Male,I,6/13/2019,6/11/2019,,,,CHRONIC PAIN,UNITED STATES,Dyskinesia,,NO,NO,Unlisted
2019BDSI0508,2019BDSI0508,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/14/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0513,2019BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Amnesia,Non-Health Professional,,,Male,I,6/14/2019,,,,,CHRONIC PAIN,UNITED STATES,Amnesia,,NO,NO,Unlisted
2019BDSI0514,2019BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0514,2019BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0514,2019BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0514,2019BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,6/18/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0516,2019BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,57,Years,Female,I,6/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0516,2019BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,57,Years,Female,I,6/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2019BDSI0516,2019BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,57,Years,Female,I,6/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2019BDSI0516,2019BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,6/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0519,2019BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,6/23/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product packaging issue,Pharmacist,,,Male,I,6/18/2019,6/18/2019,,,,OPIOID WITHDRAWAL,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical issue,Pharmacist,,,Male,I,6/18/2019,6/18/2019,,,,OPIOID WITHDRAWAL,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product use in unapproved indication,Pharmacist,,,Male,I,6/18/2019,,,,,OPIOID WITHDRAWAL,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product packaging issue,Pharmacist,,,Male,I,6/18/2019,6/18/2019,,,,OPIOID WITHDRAWAL,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical issue,Pharmacist,,,Male,I,6/18/2019,6/18/2019,,,,OPIOID WITHDRAWAL,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0520,2019BDSI0520,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product use in unapproved indication,Pharmacist,,,Male,I,6/18/2019,,,,,OPIOID WITHDRAWAL,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug ineffective,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug ineffective,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug withdrawal syndrome,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug withdrawal syndrome,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Weight decreased,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Weight decreased,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Weight decreased,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Weight decreased,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug dependence,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,General physical health deterioration,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,General physical health deterioration,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Vertigo,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Vertigo,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug ineffective,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug ineffective,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug withdrawal syndrome,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug withdrawal syndrome,,YES,YES,
2019BDSI0521,2019BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Weight decreased,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Weight decreased,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug ineffective,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug ineffective,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug dependence,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,General physical health deterioration,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,General physical health deterioration,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Vertigo,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Vertigo,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug ineffective,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug ineffective,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug withdrawal syndrome,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug withdrawal syndrome,,YES,YES,
2019BDSI0521,2019BDSI0521,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Weight decreased,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Weight decreased,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug dependence,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug dependence,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug dependence,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Drug dependence,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,General physical health deterioration,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,General physical health deterioration,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,General physical health deterioration,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,General physical health deterioration,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Vertigo,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Vertigo,,YES,YES,
2019BDSI0521,2019BDSI0521,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Vertigo,Other Health Professional,81,Years,Male,I,6/20/2019,,,,Other,PAIN,AUSTRIA,Vertigo,,YES,YES,
2019BDSI0523,2019BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,6/19/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0523,2019BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/19/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0523,2019BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/19/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0523,2019BDSI0523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/19/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0524,2019BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,67,Years,Female,I,6/21/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0524,2019BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,6/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0524,2019BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use issue,Non-Health Professional,67,Years,Female,I,6/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2019BDSI0524,2019BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Female,I,6/21/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0527,2019BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,26,Years,Female,I,6/20/2019,6/19/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,YES,Unlisted
2019BDSI0527,2019BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,26,Years,Female,I,6/20/2019,5/3/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0527,2019BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,26,Years,Female,I,6/20/2019,6/5/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,YES,Unlisted
2019BDSI0529,2019BDSI0529,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,6/24/2019,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0530,2019BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,6/24/2019,6/18/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0530,2019BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product label issue,Pharmacist,,,,I,6/24/2019,6/18/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product label issue,,NO,NO,Unlisted
2019BDSI0531,2019BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,6/21/2019,6/21/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0531,2019BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/21/2019,6/21/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0531,2019BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,,,Female,I,6/21/2019,6/21/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0531,2019BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Pharmacist,,,Female,I,6/21/2019,6/21/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0532,2019BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vertigo,Other Health Professional,72,Years,Female,I,6/24/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vertigo,,NO,NO,Unlisted
2019BDSI0533,2019BDSI0533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Depression,Other Health Professional,,,Male,I,6/21/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Depression,,NO,NO,Listed
2019BDSI0535,2019BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,65,Years,Female,I,6/25/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0535,2019BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Female,I,6/25/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0535,2019BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Female,I,6/25/2019,2/13/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0536,2019BDSI0536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,6/24/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0536,2019BDSI0536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,6/24/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0539,2019BDSI0539,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,6/25/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Dry mouth,,NO,NO,Listed
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Dry mouth,,NO,NO,Listed
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0540,2019BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,6/27/2019,1/1/2019,,,,NEUROPATHIC PAIN IN FEET,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0541,2019BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash,Non-Health Professional,46,Years,Female,I,6/26/2019,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2019BDSI0541,2019BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,46,Years,Female,I,6/26/2019,,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/26/2019,6/25/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,6/26/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,6/26/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Slow speech,Non-Health Professional,,,Female,I,6/26/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Slow speech,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/26/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling drunk,Non-Health Professional,,,Female,I,6/26/2019,6/25/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling drunk,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Speech disorder,Non-Health Professional,,,Female,I,6/26/2019,6/25/2019,,,,CHRONIC PAIN,UNITED STATES,Speech disorder,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,6/26/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,,,Female,I,6/26/2019,6/25/2019,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2019BDSI0542,2019BDSI0542,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,6/26/2019,6/25/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0543,2019BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Male,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0543,2019BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0543,2019BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0544,2019BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,56,Years,Female,I,6/27/2019,6/26/2019,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2019BDSI0544,2019BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,56,Years,Female,I,6/27/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0545,2019BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0545,2019BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0545,2019BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0545,2019BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,6/27/2019,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0548,2019BDSI0548,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/29/2019,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0548,2019BDSI0548,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,6/29/2019,,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0551,2019BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Consumer,,,Female,I,7/1/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0552,2019BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,40,Years,Male,I,7/11/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2019BDSI0553,2019BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/2/2019,1/1/2019,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0553,2019BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/2/2019,1/1/2019,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0553,2019BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,7/2/2019,1/1/2019,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0553,2019BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/2/2019,1/1/2019,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0554,2019BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/2/2019,6/27/2019,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0554,2019BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/2/2019,6/27/2019,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0554,2019BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/2/2019,6/27/2019,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0554,2019BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,7/2/2019,6/27/2019,,,,PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0555,2019BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,58,Years,Female,I,6/29/2019,6/24/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0555,2019BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,58,Years,Female,I,6/29/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0555,2019BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Female,I,6/29/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0555,2019BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,I,6/29/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0556,2019BDSI0556,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,7/11/2019,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,77,Years,Female,I,7/8/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,77,Years,Female,I,7/8/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,77,Years,Female,I,7/8/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,77,Years,Female,I,7/8/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,77,Years,Female,I,7/8/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral discomfort,Non-Health Professional,77,Years,Female,I,7/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral disorder,Non-Health Professional,77,Years,Female,I,7/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral disorder,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,77,Years,Female,I,7/8/2019,,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Initial insomnia,Non-Health Professional,77,Years,Female,I,7/8/2019,,,,,CHRONIC PAIN,UNITED STATES,Initial insomnia,,NO,NO,Listed
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,77,Years,Female,I,7/8/2019,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0557,2019BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,77,Years,Female,I,7/8/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0558,2019BDSI0558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,,,Female,I,7/2/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2019BDSI0560,2019BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,7/2/2019,,,,,PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0560,2019BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/2/2019,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0573,2019BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/8/2019,7/8/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0573,2019BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/8/2019,7/8/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0573,2019BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/8/2019,7/8/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0573,2019BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure decreased,Non-Health Professional,,,Female,I,7/8/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Blood pressure decreased,,NO,NO,Unlisted
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Discomfort,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Discomfort,,NO,NO,Unlisted
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2019BDSI0574,2019BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,7/4/2019,1/1/2019,,,,PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0576,2019BDSI0576,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Death,Other Health Professional,,,Male,F,7/12/2019,1/1/2019,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Death,,YES,YES,Unlisted
2019BDSI0577,2019BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,36,Years,Female,I,7/7/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0577,2019BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,36,Years,Female,I,7/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2019BDSI0577,2019BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,36,Years,Female,I,7/7/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0578,2019BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0578,2019BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Coating in mouth,Pharmacist,,,Female,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Coating in mouth,,NO,NO,Unlisted
2019BDSI0578,2019BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal discolouration,Pharmacist,,,Female,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal discolouration,,NO,NO,Unlisted
2019BDSI0581,2019BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,7/10/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0581,2019BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,7/10/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0581,2019BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,67,Years,Female,I,7/10/2019,7/10/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2019BDSI0581,2019BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,67,Years,Female,I,7/10/2019,7/10/2019,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2019BDSI0581,2019BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Female,I,7/10/2019,7/10/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0582,2019BDSI0582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/9/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0583,2019BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,49,Years,Female,I,7/10/2019,6/28/2019,,,,CHRONIC CRPS,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2019BDSI0583,2019BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,49,Years,Female,I,7/10/2019,6/1/2019,,,,CHRONIC CRPS,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal discomfort,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal discomfort,,NO,NO,Unlisted
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0584,2019BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,63,Years,Male,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2019BDSI0585,2019BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,,,,Female,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0585,2019BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,,,,Female,I,7/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0588,2019BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oedema peripheral,Other Health Professional,66,Years,Female,I,7/11/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2019BDSI0589,2019BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,7/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0589,2019BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0589,2019BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,7/10/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0590,2019BDSI0590,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,7/11/2019,7/11/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0590,2019BDSI0590,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/11/2019,7/11/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0590,2019BDSI0590,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/11/2019,7/11/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0590,2019BDSI0590,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/11/2019,7/11/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0593,2019BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0593,2019BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0595,2019BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,37,Years,Female,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0595,2019BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,37,Years,Female,I,7/12/2019,7/12/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2019BDSI0595,2019BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,37,Years,Female,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0595,2019BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,37,Years,Female,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0596,2019BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Male,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0596,2019BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0596,2019BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Male,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0596,2019BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0596,2019BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,70,Years,Male,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0597,2019BDSI0597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,57,Years,Female,I,7/15/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysstasia,Non-Health Professional,57,Years,Female,I,7/15/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dysstasia,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,7/15/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,57,Years,Female,I,7/15/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Back pain,Non-Health Professional,57,Years,Female,I,7/15/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Back pain,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,57,Years,Female,I,7/15/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0598,2019BDSI0598,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,7/15/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0599,2019BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/14/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong dose,Physician,66,Years,Male,I,7/12/2019,6/22/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong dose,,NO,NO,Unlisted
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dispensing error,Physician,66,Years,Male,I,7/12/2019,6/22/2019,,,,CHRONIC PAIN,UNITED STATES,Product dispensing error,,NO,NO,Unlisted
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depressed mood,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Depressed mood,,NO,NO,Listed
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0601,2019BDSI0601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Physician,66,Years,Male,I,7/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2019BDSI0602,2019BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product dose omission,Non-Health Professional,,,Female,I,7/17/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product dose omission,,NO,YES,Unlisted
2019BDSI0602,2019BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,7/17/2019,1/1/2019,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0602,2019BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product availability issue,Non-Health Professional,,,Female,I,7/17/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product availability issue,,NO,YES,Unlisted
2019BDSI0603,2019BDSI0603,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Physician,35,Years,Female,I,7/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0604,2019BDSI0604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,7/16/2019,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0605,2019BDSI0605,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,76,Years,Female,I,7/22/2019,7/16/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0606,2019BDSI0606,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug interaction,Other Health Professional,,,Male,I,7/16/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2019BDSI0606,2019BDSI0606,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Other Health Professional,,,Male,I,7/16/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0608,2019BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,57,Years,Male,I,8/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI0608,2019BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,57,Years,Male,I,8/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0608,2019BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,57,Years,Male,I,8/5/2019,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0608,2019BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Male,I,8/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0608,2019BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use issue,Non-Health Professional,57,Years,Male,I,8/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use issue,,NO,NO,Unlisted
2019BDSI0609,2019BDSI0609,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Female,I,8/5/2019,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2019BDSI0611,2019BDSI0611,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product residue present,Non-Health Professional,,,Male,I,7/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product residue present,,NO,NO,Unlisted
2019BDSI0611,2019BDSI0611,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,7/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0611,2019BDSI0611,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0612,2019BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/22/2019,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0612,2019BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/22/2019,,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0612,2019BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/22/2019,1/20/2019,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0612,2019BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/22/2019,,,,,PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0613,2019BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swelling face,Physician,86,Years,Female,I,7/22/2019,7/16/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Swelling face,,NO,NO,Unlisted
2019BDSI0616,2019BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Other Health Professional,,,,I,7/19/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0617,2019BDSI0617,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/22/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0617,2019BDSI0617,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/22/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0617,2019BDSI0617,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,7/22/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0617,2019BDSI0617,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,7/22/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0618,2019BDSI0618,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,7/22/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,83,Years,Female,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,83,Years,Female,I,7/24/2019,7/22/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,83,Years,Female,I,7/24/2019,7/22/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,83,Years,Female,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,83,Years,Female,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0622,2019BDSI0622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,83,Years,Female,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0625,2019BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,88,Years,Female,I,7/23/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0625,2019BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,88,Years,Female,I,7/23/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0625,2019BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,88,Years,Female,I,7/23/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0625,2019BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,88,Years,Female,I,7/23/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0626,2019BDSI0626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oropharyngeal pain,Physician,38,Years,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oropharyngeal pain,,NO,NO,Unlisted
2019BDSI0627,2019BDSI0627,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product solubility abnormal,Physician,,,Female,I,7/23/2019,7/1/2019,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0627,2019BDSI0627,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical consistency issue,Physician,,,Female,I,7/23/2019,7/1/2019,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0627,2019BDSI0627,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product solubility abnormal,Physician,,,Female,I,7/23/2019,7/1/2019,,,,OPIOID DEPENDENCE,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0627,2019BDSI0627,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,milligram,Buccal film,,Product physical consistency issue,Physician,,,Female,I,7/23/2019,7/1/2019,,,,OPIOID DEPENDENCE,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0628,2019BDSI0628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,68,Years,Male,I,7/23/2019,,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0629,2019BDSI0629,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,72,Years,Female,I,7/24/2019,7/22/2019,,,,"SPINAL STENOSIS, LUMBAR REGION WITH NEUROGENIC CLAUDICATION",UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0629,2019BDSI0629,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,72,Years,Female,I,7/24/2019,7/1/2019,,,,"SPINAL STENOSIS, LUMBAR REGION WITH NEUROGENIC CLAUDICATION",UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0629,2019BDSI0629,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Pharmacist,72,Years,Female,I,7/24/2019,7/22/2019,,,,"SPINAL STENOSIS, LUMBAR REGION WITH NEUROGENIC CLAUDICATION",UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0630,2019BDSI0630,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/24/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0631,2019BDSI0631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,71,Years,Female,I,7/24/2019,7/24/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0632,2019BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Male,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0632,2019BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,74,Years,Male,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0632,2019BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,74,Years,Male,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0632,2019BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,74,Years,Male,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0632,2019BDSI0632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,74,Years,Male,I,7/24/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0633,2019BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/24/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0633,2019BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/24/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0633,2019BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/24/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0633,2019BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/24/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Fatigue,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2019BDSI0634,2019BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Male,I,7/24/2019,7/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0635,2019BDSI0635,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lethargy,Other Health Professional,72,Years,Female,I,7/25/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lethargy,,NO,NO,Listed
2019BDSI0636,2019BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,65,Years,Female,I,7/26/2019,7/25/2019,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2019BDSI0636,2019BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Female,I,7/26/2019,7/25/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0636,2019BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,7/26/2019,7/25/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0636,2019BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,65,Years,Female,I,7/26/2019,7/25/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0637,2019BDSI0637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug withdrawal syndrome,Other Health Professional,,,Female,I,8/6/2019,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0638,2019BDSI0638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,7/26/2019,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0639,2019BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/1/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0649,2019BDSI0649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,,I,7/29/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,70,Years,Female,I,7/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Road traffic accident,Non-Health Professional,70,Years,Female,I,7/26/2019,5/21/2019,,,,CHRONIC PAIN,UNITED STATES,Road traffic accident,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,70,Years,Female,I,7/26/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,7/26/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,7/26/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,70,Years,Female,I,7/26/2019,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,70,Years,Female,I,7/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,70,Years,Female,I,7/26/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Female,I,7/26/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0650,2019BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,7/26/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0651,2019BDSI0651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Burn oral cavity,Physician,79,Years,Female,I,7/29/2019,,,,,CHRONIC PAIN,UNITED STATES,Burn oral cavity,,NO,NO,Unlisted
2019BDSI0651,2019BDSI0651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Physician,79,Years,Female,I,7/29/2019,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0654,2019BDSI0654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Myalgia,Non-Health Professional,,,Female,I,7/30/2019,,,,,PAIN,UNITED STATES,Myalgia,,NO,NO,Unlisted
2019BDSI0654,2019BDSI0654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pain,Non-Health Professional,,,Female,I,7/30/2019,,,,,PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2019BDSI0655,2019BDSI0655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/29/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0656,2019BDSI0656,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,7/30/2019,7/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0656,2019BDSI0656,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,7/30/2019,7/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0656,2019BDSI0656,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,7/30/2019,7/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0656,2019BDSI0656,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,7/30/2019,7/1/2019,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0660,2019BDSI0660,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,F,11/13/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0660,2019BDSI0660,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,F,11/13/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0660,2019BDSI0660,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,F,11/13/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0661,2019BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,45,Years,Male,I,8/1/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0661,2019BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,45,Years,Male,I,8/1/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0662,2019BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Non-Health Professional,,,Female,I,8/2/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0663,2019BDSI0663,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,8/2/2019,7/24/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0663,2019BDSI0663,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/2/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0665,2019BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingival pain,Non-Health Professional,73,Years,Female,I,8/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gingival pain,,NO,NO,Unlisted
2019BDSI0665,2019BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Noninfective gingivitis,Non-Health Professional,73,Years,Female,I,8/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Noninfective gingivitis,,NO,NO,Unlisted
2019BDSI0666,2019BDSI0666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,8/5/2019,8/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0666,2019BDSI0666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/5/2019,8/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0667,2019BDSI0667,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/5/2019,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0670,2019BDSI0670,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Other Health Professional,,,Female,I,8/6/2019,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0671,2019BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alcohol interaction,Non-Health Professional,,,Male,I,8/5/2019,5/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Alcohol interaction,,YES,YES,Listed
2019BDSI0671,2019BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ligament rupture,Non-Health Professional,,,Male,I,8/5/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Ligament rupture,,NO,YES,Unlisted
2019BDSI0672,2019BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,40,Years,Female,I,8/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0672,2019BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,40,Years,Female,I,8/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0672,2019BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,40,Years,Female,I,8/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0672,2019BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,40,Years,Female,I,8/8/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0673,2019BDSI0673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,8/5/2019,8/1/2019,,,,DETOXIFICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0674,2019BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Sinusitis,Other Health Professional,,,Female,I,8/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Sinusitis,,NO,YES,Listed
2019BDSI0674,2019BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product administration error,Other Health Professional,,,Female,I,8/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2019BDSI0674,2019BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Upper respiratory tract infection,Other Health Professional,,,Female,I,8/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Upper respiratory tract infection,,NO,YES,Listed
2019BDSI0674,2019BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Sinus pain,Other Health Professional,,,Female,I,8/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Sinus pain,,NO,YES,Unlisted
2019BDSI0674,2019BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug withdrawal syndrome,Other Health Professional,,,Female,I,8/6/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0675,2019BDSI0675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,79,Years,Female,I,8/7/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0675,2019BDSI0675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,79,Years,Female,I,8/7/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0675,2019BDSI0675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,79,Years,Female,I,8/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0676,2019BDSI0676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,80,Years,Female,I,8/9/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0677,2019BDSI0677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/7/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0679,2019BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Female,I,8/8/2019,3/6/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0679,2019BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,62,Years,Female,I,8/8/2019,3/6/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0679,2019BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,62,Years,Female,I,8/8/2019,8/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2019BDSI0679,2019BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,62,Years,Female,I,8/8/2019,3/19/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0679,2019BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,62,Years,Female,I,8/8/2019,1/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0682,2019BDSI0682,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Off label use,Non-Health Professional,,,Female,I,8/9/2019,,,,,MIGRAINES,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0682,2019BDSI0682,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective for unapproved indication,Non-Health Professional,,,Female,I,8/9/2019,,,,,MIGRAINES,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Unlisted
2019BDSI0684,2019BDSI0684,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Poor dental condition,Non-Health Professional,,,Male,I,8/9/2019,,,,,PAIN,UNITED STATES,Poor dental condition,,NO,NO,Unlisted
2019BDSI0684,2019BDSI0684,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Tooth injury,Non-Health Professional,,,Male,I,8/9/2019,,,,,PAIN,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2019BDSI0684,2019BDSI0684,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Teeth brittle,Non-Health Professional,,,Male,I,8/9/2019,,,,,PAIN,UNITED STATES,Teeth brittle,,NO,NO,Unlisted
2019BDSI0685,2019BDSI0685,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0685,2019BDSI0685,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/12/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0689,2019BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,8/13/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Chest pain,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Insomnia,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Impaired quality of life,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Impaired quality of life,,NO,NO,Unlisted
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Depression,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Depression,,NO,NO,Listed
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0690,2019BDSI0690,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Anxiety,Non-Health Professional,46,Years,Female,I,8/14/2019,8/1/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle fatigue,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Muscle fatigue,,NO,NO,Unlisted
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Muscle spasms,,NO,NO,Unlisted
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Neck pain,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Neck pain,,NO,NO,Listed
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal pain,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Musculoskeletal pain,,NO,NO,Unlisted
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Muscle spasms,,NO,NO,Listed
2019BDSI0691,2019BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Myalgia,Non-Health Professional,64,Years,Male,I,8/14/2019,7/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Myalgia,,NO,NO,Unlisted
2019BDSI0692,2019BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cerebrovascular accident,Other Health Professional,,,Female,I,8/14/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Cerebrovascular accident,,YES,YES,Listed
2019BDSI0693,2019BDSI0693,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/14/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0693,2019BDSI0693,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/14/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0694,2019BDSI0694,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,,,Female,I,8/14/2019,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0694,2019BDSI0694,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Other Health Professional,,,Female,I,8/14/2019,,,,,PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0694,2019BDSI0694,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Other Health Professional,,,Female,I,8/14/2019,,,,,PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0695,2019BDSI0695,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Product packaging quantity issue,Non-Health Professional,62,Years,Male,I,8/21/2019,8/15/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0697,2019BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental implantation,Non-Health Professional,67,Years,Male,I,8/15/2019,7/12/2019,,,,CHRONIC PAIN,UNITED STATES,Dental implantation,,NO,NO,Unlisted
2019BDSI0697,2019BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth loss,Non-Health Professional,67,Years,Male,I,8/15/2019,,,,,CHRONIC PAIN,UNITED STATES,Tooth loss,,NO,NO,Unlisted
2019BDSI0697,2019BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth fracture,Non-Health Professional,67,Years,Male,I,8/15/2019,,,,,CHRONIC PAIN,UNITED STATES,Tooth fracture,,NO,NO,Unlisted
2019BDSI0697,2019BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingivitis,Non-Health Professional,67,Years,Male,I,8/15/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gingivitis,,NO,NO,Unlisted
2019BDSI0697,2019BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth injury,Non-Health Professional,67,Years,Male,I,8/15/2019,,,,,CHRONIC PAIN,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2019BDSI0699,2019BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Cardiac failure,Other Health Professional,,,Female,I,8/15/2019,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Cardiac failure,,YES,YES,Unlisted
2019BDSI0699,2019BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Renal failure,Other Health Professional,,,Female,I,8/15/2019,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Renal failure,,YES,YES,Unlisted
2019BDSI0699,2019BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hepatic failure,Other Health Professional,,,Female,I,8/15/2019,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hepatic failure,,YES,YES,Unlisted
2019BDSI0700,2019BDSI0700,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mania,Physician,70,Years,,I,8/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Mania,,NO,NO,Unlisted
2019BDSI0701,2019BDSI0701,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mania,Physician,43,Years,,I,8/19/2019,,,,,CHRONIC PAIN,UNITED STATES,Mania,,NO,NO,Unlisted
2019BDSI0702,2019BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0702,2019BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0702,2019BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/19/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0703,2019BDSI0703,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Application site vesicles,Other Health Professional,,,Female,I,8/13/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Application site vesicles,,NO,NO,Unlisted
2019BDSI0704,2019BDSI0704,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Application site vesicles,Other Health Professional,,,Male,I,8/13/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Application site vesicles,,NO,NO,Unlisted
2019BDSI0705,2019BDSI0705,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Acne,Physician,,,Male,I,8/15/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Acne,,NO,NO,Unlisted
2019BDSI0706,2019BDSI0706,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cheilitis,Other Health Professional,,,Female,I,8/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Cheilitis,,NO,NO,Unlisted
2019BDSI0707,2019BDSI0707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/19/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0709,2019BDSI0709,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product residue present,Non-Health Professional,63,Years,Female,I,8/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Product residue present,,NO,NO,Unlisted
2019BDSI0709,2019BDSI0709,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Female,I,8/21/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Pharmacist,67,Years,Female,I,8/20/2019,8/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug hypersensitivity,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug hypersensitivity,,NO,NO,Listed
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product residue present,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product residue present,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site pain,Pharmacist,67,Years,Female,I,8/20/2019,8/8/2019,,,,CHRONIC PAIN,UNITED STATES,Application site pain,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0710,2019BDSI0710,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Pharmacist,67,Years,Female,I,8/20/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0711,2019BDSI0711,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,50,Years,Male,I,8/23/2019,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0712,2019BDSI0712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/22/2019,8/1/2019,,,,EXTREME NERVE PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0712,2019BDSI0712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/22/2019,8/1/2019,,,,EXTREME NERVE PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0712,2019BDSI0712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/22/2019,8/1/2019,,,,EXTREME NERVE PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0712,2019BDSI0712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/22/2019,8/1/2019,,,,EXTREME NERVE PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0712,2019BDSI0712,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/22/2019,8/21/2019,,,,EXTREME NERVE PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0713,2019BDSI0713,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mouth ulceration,Physician,,,Male,I,8/20/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2019BDSI0714,2019BDSI0714,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/22/2019,8/20/2019,,,,PAIN MANAGEMENT,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0715,2019BDSI0715,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,8/26/2019,8/23/2019,,,,TO GET OFF FROM OPIUM,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0715,2019BDSI0715,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,8/26/2019,8/23/2019,,,,TO GET OFF FROM OPIUM,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0716,2019BDSI0716,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Non-Health Professional,,,Male,I,8/25/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0716,2019BDSI0716,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Vomiting,Non-Health Professional,,,Male,I,8/25/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0717,2019BDSI0717,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Non-Health Professional,,,Female,I,8/26/2019,8/26/2019,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2019BDSI0717,2019BDSI0717,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/26/2019,8/26/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0718,2019BDSI0718,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Pharmacist,,,Female,I,8/23/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2019BDSI0718,2019BDSI0718,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/23/2019,8/19/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0718,2019BDSI0718,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Pharmacist,,,Female,I,8/23/2019,8/19/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,77,Years,Female,I,8/26/2019,8/20/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sedation,Non-Health Professional,77,Years,Female,I,8/26/2019,8/20/2019,,,,CHRONIC PAIN,UNITED STATES,Sedation,,NO,NO,Listed
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,77,Years,Female,I,8/26/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,77,Years,Female,I,8/26/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,77,Years,Female,I,8/26/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,77,Years,Female,I,8/26/2019,8/20/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2019BDSI0720,2019BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,77,Years,Female,I,8/26/2019,8/20/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0721,2019BDSI0721,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Female,I,8/27/2019,,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0722,2019BDSI0722,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,8/25/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0726,2019BDSI0726,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,8/27/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0726,2019BDSI0726,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,8/27/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0726,2019BDSI0726,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,8/27/2019,8/9/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0727,2019BDSI0727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dispensing error,Other Health Professional,,,Female,I,8/28/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product dispensing error,,YES,YES,Unlisted
2019BDSI0731,2019BDSI0731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dysphonia,Other Health Professional,,,Female,I,8/28/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dysphonia,,NO,NO,Unlisted
2019BDSI0732,2019BDSI0732,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/28/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0732,2019BDSI0732,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/28/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0734,2019BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,,,Male,I,8/29/2019,4/5/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0734,2019BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,,,Male,I,8/29/2019,5/5/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0735,2019BDSI0735,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/30/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0735,2019BDSI0735,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/30/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0736,2019BDSI0736,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,8/31/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0737,2019BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/29/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0738,2019BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/30/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0738,2019BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/30/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0738,2019BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/30/2019,8/7/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0738,2019BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/30/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0743,2019BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Physician,46,Years,Female,I,9/3/2019,8/1/2019,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0743,2019BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Bedridden,Physician,46,Years,Female,I,9/3/2019,8/1/2019,,,,PAIN,UNITED STATES,Bedridden,,NO,NO,Unlisted
2019BDSI0743,2019BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Vision blurred,Physician,46,Years,Female,I,9/3/2019,8/1/2019,,,,PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2019BDSI0743,2019BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Heart rate decreased,Physician,46,Years,Female,I,9/3/2019,9/3/2019,,,,PAIN,UNITED STATES,Heart rate decreased,,NO,NO,Unlisted
2019BDSI0743,2019BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Blood pressure increased,Physician,46,Years,Female,I,9/3/2019,9/3/2019,,,,PAIN,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2019BDSI0744,2019BDSI0744,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Chest discomfort,Other Health Professional,,,Male,I,8/28/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2019BDSI0744,2019BDSI0744,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Non-cardiac chest pain,Other Health Professional,,,Male,I,8/28/2019,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Non-cardiac chest pain,,NO,NO,Listed
2019BDSI0745,2019BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,9/2/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0747,2019BDSI0747,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Oesophageal oedema,Physician,,,Female,I,9/3/2019,8/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Oesophageal oedema,,YES,YES,Unlisted
2019BDSI0747,2019BDSI0747,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Hypersensitivity,Physician,,,Female,I,9/3/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hypersensitivity,,NO,YES,Listed
2019BDSI0747,2019BDSI0747,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Drug withdrawal syndrome,Physician,,,Female,I,9/3/2019,8/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0749,2019BDSI0749,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Male,I,9/3/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0749,2019BDSI0749,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,54,Years,Male,I,9/3/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2019BDSI0749,2019BDSI0749,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,54,Years,Male,I,9/3/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2019BDSI0750,2019BDSI0750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,9/3/2019,9/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0753,2019BDSI0753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Insomnia,Non-Health Professional,,,Male,I,9/3/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0754,2019BDSI0754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain of skin,Non-Health Professional,57,Years,Male,I,9/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain of skin,,NO,NO,Unlisted
2019BDSI0754,2019BDSI0754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus generalised,Non-Health Professional,57,Years,Male,I,9/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pruritus generalised,,NO,NO,Listed
2019BDSI0754,2019BDSI0754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,57,Years,Male,I,9/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2019BDSI0754,2019BDSI0754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,57,Years,Male,I,9/5/2019,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0755,2019BDSI0755,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Other Health Professional,,,Female,I,9/5/2019,1/1/2019,,,,PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Dementia,Non-Health Professional,70,Years,Male,I,10/24/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dementia,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,70,Years,Male,I,10/24/2019,9/3/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Dehydration,Non-Health Professional,70,Years,Male,I,10/24/2019,9/3/2019,,,,CHRONIC PAIN,UNITED STATES,Dehydration,,NO,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Syncope,Non-Health Professional,70,Years,Male,I,10/24/2019,9/3/2019,,,,CHRONIC PAIN,UNITED STATES,Syncope,,NO,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Drug interaction,Non-Health Professional,70,Years,Male,I,10/24/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug interaction,,YES,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Idiopathic intracranial hypertension,Non-Health Professional,70,Years,Male,I,10/24/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Idiopathic intracranial hypertension,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,70,Years,Male,I,10/24/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,10/24/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Off label use,Non-Health Professional,70,Years,Male,I,10/24/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Asthenia,Non-Health Professional,70,Years,Male,I,10/24/2019,10/24/2019,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,YES,Listed
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,70,Years,Male,I,10/24/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Malaise,Non-Health Professional,70,Years,Male,I,10/24/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Feeling hot,Non-Health Professional,70,Years,Male,I,10/24/2019,9/3/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,YES,Unlisted
2019BDSI0758,2019BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Dizziness,Non-Health Professional,70,Years,Male,I,10/24/2019,10/24/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,YES,Listed
2019BDSI0759,2019BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/9/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0759,2019BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/9/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0759,2019BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,9/9/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0759,2019BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/9/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0759,2019BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/9/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0762,2019BDSI0762,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Flatulence,Non-Health Professional,73,Years,Female,I,9/10/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Flatulence,,NO,NO,Unlisted
2019BDSI0762,2019BDSI0762,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,73,Years,Female,I,9/10/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2019BDSI0765,2019BDSI0765,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0765,2019BDSI0765,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,9/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0765,2019BDSI0765,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,9/9/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0765,2019BDSI0765,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/9/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0766,2019BDSI0766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,9/10/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0767,2019BDSI0767,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Male,I,9/12/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI0768,2019BDSI0768,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Depression,Other Health Professional,,,Female,I,9/12/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Depression,,NO,YES,Listed
2019BDSI0768,2019BDSI0768,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Suicidal ideation,Other Health Professional,,,Female,I,9/12/2019,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2019BDSI0769,2019BDSI0769,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urinary tract infection,Other Health Professional,63,Years,Male,I,9/18/2019,9/11/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Urinary tract infection,,NO,NO,Listed
2019BDSI0771,2019BDSI0771,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urinary tract infection,Other Health Professional,64,Years,Female,I,9/18/2019,5/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Urinary tract infection,,NO,NO,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,69,Years,Female,F,10/2/2019,,,,,DEPRESSION,UNITED STATES,Vomiting,,NO,YES,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Cardiac failure congestive,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,Other,DEPRESSION,UNITED STATES,Cardiac failure congestive,,YES,YES,Unlisted
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,,DEPRESSION,UNITED STATES,Blood pressure increased,,NO,YES,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Cerebrovascular accident,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,Hospitalisation,DEPRESSION,UNITED STATES,Cerebrovascular accident,,YES,YES,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood glucose increased,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,,DEPRESSION,UNITED STATES,Blood glucose increased,,NO,YES,Unlisted
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Carotid artery occlusion,Non-Health Professional,69,Years,Female,F,10/2/2019,,,,Hospitalisation,DEPRESSION,UNITED STATES,Carotid artery occlusion,,YES,YES,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pneumonia,Non-Health Professional,69,Years,Female,F,10/2/2019,,,,Other,DEPRESSION,UNITED STATES,Pneumonia,,YES,YES,Listed
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Thrombosis,Non-Health Professional,69,Years,Female,F,10/2/2019,,,,Hospitalisation,DEPRESSION,UNITED STATES,Thrombosis,,YES,YES,Unlisted
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mood altered,Non-Health Professional,69,Years,Female,F,10/2/2019,,,,,DEPRESSION,UNITED STATES,Mood altered,,NO,YES,Unlisted
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product use in unapproved indication,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,,DEPRESSION,UNITED STATES,Product use in unapproved indication,,NO,YES,Unlisted
2019BDSI0775,2019BDSI0775,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Ill-defined disorder,Non-Health Professional,69,Years,Female,F,10/2/2019,1/1/2016,,,,DEPRESSION,UNITED STATES,Ill-defined disorder,,NO,YES,Unlisted
2019BDSI0776,2019BDSI0776,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/13/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0776,2019BDSI0776,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,9/13/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0777,2019BDSI0777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,9/13/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0777,2019BDSI0777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/13/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0777,2019BDSI0777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/13/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0777,2019BDSI0777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,9/13/2019,8/5/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0777,2019BDSI0777,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/13/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0778,2019BDSI0778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,9/16/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0778,2019BDSI0778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,9/16/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0778,2019BDSI0778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/16/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0778,2019BDSI0778,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,,,Female,I,9/16/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral discomfort,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Glossodynia,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Glossodynia,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Glossitis,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Glossitis,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Taste disorder,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Taste disorder,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Neck pain,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Neck pain,,NO,NO,Listed
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Thyroid function test abnormal,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Thyroid function test abnormal,,NO,NO,Unlisted
2019BDSI0779,2019BDSI0779,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,9/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,45,Years,Male,I,9/17/2019,9/17/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,45,Years,Male,I,9/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,45,Years,Male,I,9/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,45,Years,Male,I,9/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,45,Years,Male,I,9/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0781,2019BDSI0781,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,45,Years,Male,I,9/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0783,2019BDSI0783,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Male,I,9/18/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2019BDSI0783,2019BDSI0783,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,9/18/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0786,2019BDSI0786,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Other Health Professional,49,Years,Male,I,9/19/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,YES,Listed
2019BDSI0786,2019BDSI0786,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Other Health Professional,49,Years,Male,I,9/19/2019,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0786,2019BDSI0786,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest discomfort,Other Health Professional,49,Years,Male,I,9/19/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Chest discomfort,,NO,YES,Unlisted
2019BDSI0789,2019BDSI0789,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,I,9/23/2019,9/20/2019,,,,CHRONIC GI PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0789,2019BDSI0789,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,46,Years,Female,I,9/23/2019,9/1/2019,,,,CHRONIC GI PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0789,2019BDSI0789,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,46,Years,Female,I,9/23/2019,9/1/2019,,,,CHRONIC GI PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0794,2019BDSI0794,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0794,2019BDSI0794,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0794,2019BDSI0794,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0794,2019BDSI0794,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0794,2019BDSI0794,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0795,2019BDSI0795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,56,Years,Female,I,9/23/2019,7/21/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0795,2019BDSI0795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,56,Years,Female,I,9/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0795,2019BDSI0795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Female,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0795,2019BDSI0795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,56,Years,Female,I,9/23/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0795,2019BDSI0795,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,56,Years,Female,I,9/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2019BDSI0796,2019BDSI0796,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Chest discomfort,Non-Health Professional,,,Male,I,9/25/2019,9/25/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2019BDSI0798,2019BDSI0798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,9/24/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0798,2019BDSI0798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/24/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0798,2019BDSI0798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,9/24/2019,9/24/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0798,2019BDSI0798,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/24/2019,9/24/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0799,2019BDSI0799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Other Health Professional,,,,I,9/25/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0800,2019BDSI0800,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,,,Female,I,9/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0800,2019BDSI0800,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Detoxification,Other Health Professional,,,Female,I,9/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Detoxification,,NO,NO,Unlisted
2019BDSI0800,2019BDSI0800,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,,,Female,I,9/24/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0804,2019BDSI0804,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,9/25/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0804,2019BDSI0804,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,9/25/2019,9/25/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0805,2019BDSI0805,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,9/25/2019,9/25/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0806,2019BDSI0806,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,9/26/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0806,2019BDSI0806,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,9/26/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0808,2019BDSI0808,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Non-Health Professional,,,Female,I,9/30/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0809,2019BDSI0809,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral candidiasis,Non-Health Professional,,,Female,I,9/27/2019,9/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral candidiasis,,NO,NO,Unlisted
2019BDSI0809,2019BDSI0809,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/27/2019,9/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0809,2019BDSI0809,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/27/2019,9/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0810,2019BDSI0810,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,43,Years,Female,I,9/30/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,YES,Unlisted
2019BDSI0810,2019BDSI0810,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Patient dissatisfaction with treatment,Non-Health Professional,43,Years,Female,I,9/30/2019,9/30/2019,,,,CHRONIC PAIN,UNITED STATES,Patient dissatisfaction with treatment,,NO,YES,Unlisted
2019BDSI0810,2019BDSI0810,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,43,Years,Female,I,9/30/2019,9/28/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2019BDSI0810,2019BDSI0810,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,43,Years,Female,I,9/30/2019,9/28/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0810,2019BDSI0810,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,43,Years,Female,I,9/30/2019,9/30/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0811,2019BDSI0811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Physician,,,Male,I,9/30/2019,9/29/2019,,,,CHRONIC PAIN IN RECTUM,UNITED STATES,Nausea,,NO,YES,Listed
2019BDSI0811,2019BDSI0811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Physician,,,Male,I,9/30/2019,9/29/2019,,,,CHRONIC PAIN IN RECTUM,UNITED STATES,Fatigue,,NO,YES,Listed
2019BDSI0811,2019BDSI0811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Physician,,,Male,I,9/30/2019,9/29/2019,,,,CHRONIC PAIN IN RECTUM,UNITED STATES,Depression,,NO,YES,Listed
2019BDSI0811,2019BDSI0811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Male,I,9/30/2019,9/29/2019,,,Other,CHRONIC PAIN IN RECTUM,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0814,2019BDSI0814,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,9/30/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0814,2019BDSI0814,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,9/30/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0814,2019BDSI0814,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,9/30/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0814,2019BDSI0814,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,9/30/2019,8/26/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0814,2019BDSI0814,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,9/30/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0815,2019BDSI0815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,69,Years,Female,I,9/27/2019,8/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2019BDSI0816,2019BDSI0816,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pollakiuria,Physician,69,Years,Male,I,10/2/2019,9/1/2019,,,,CHRONIC BACK PAIN,UNITED STATES,Pollakiuria,,NO,NO,Unlisted
2019BDSI0817,2019BDSI0817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,10/2/2019,10/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2019BDSI0817,2019BDSI0817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/2/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0817,2019BDSI0817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/2/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0818,2019BDSI0818,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Male,I,10/3/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0818,2019BDSI0818,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Male,I,10/3/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0818,2019BDSI0818,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Male,I,10/3/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0819,2019BDSI0819,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,69,Years,Female,I,10/3/2019,10/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Arthralgia,,NO,NO,Unlisted
2019BDSI0819,2019BDSI0819,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Flank pain,Non-Health Professional,69,Years,Female,I,10/3/2019,10/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Flank pain,,NO,NO,Unlisted
2019BDSI0819,2019BDSI0819,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,69,Years,Female,I,10/3/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Unlisted
2019BDSI0819,2019BDSI0819,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,69,Years,Female,I,10/3/2019,4/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0819,2019BDSI0819,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,69,Years,Female,I,10/3/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,NO,Listed
2019BDSI0822,2019BDSI0822,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0822,2019BDSI0822,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0822,2019BDSI0822,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0822,2019BDSI0822,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,57,Years,Female,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,57,Years,Female,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,57,Years,Female,I,10/4/2019,10/4/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Panic attack,Non-Health Professional,57,Years,Female,I,10/4/2019,10/4/2019,,,,CHRONIC PAIN,UNITED STATES,Panic attack,,NO,NO,Unlisted
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,57,Years,Female,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0823,2019BDSI0823,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,57,Years,Female,I,10/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,NO,Listed
2019BDSI0825,2019BDSI0825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0825,2019BDSI0825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0825,2019BDSI0825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0826,2019BDSI0826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,10/7/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2019BDSI0826,2019BDSI0826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/7/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0826,2019BDSI0826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/7/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0826,2019BDSI0826,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/7/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0827,2019BDSI0827,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,81,Years,Female,I,10/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0827,2019BDSI0827,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,81,Years,Female,I,10/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0827,2019BDSI0827,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,81,Years,Female,I,10/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0827,2019BDSI0827,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,81,Years,Female,I,10/7/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0828,2019BDSI0828,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Male,I,10/7/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0829,2019BDSI0829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,10/7/2019,10/4/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0830,2019BDSI0830,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Female,I,10/10/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0830,2019BDSI0830,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,10/10/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,58,Years,Female,I,10/10/2019,10/9/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Female,I,10/10/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,58,Years,Female,I,10/10/2019,10/9/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,I,10/10/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,58,Years,Female,I,10/10/2019,9/25/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0831,2019BDSI0831,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,I,10/10/2019,9/25/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0833,2019BDSI0833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,10/11/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0833,2019BDSI0833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/11/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0833,2019BDSI0833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,,,Female,I,10/11/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2019BDSI0833,2019BDSI0833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/11/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0833,2019BDSI0833,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/11/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0834,2019BDSI0834,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Pharmacist,,,Female,F,10/17/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2019BDSI0834,2019BDSI0834,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Surgery,Pharmacist,,,Female,F,10/17/2019,1/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Surgery,,YES,YES,Unlisted
2019BDSI0834,2019BDSI0834,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,F,10/17/2019,10/11/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,YES,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,10/14/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,67,Years,Female,I,10/14/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Female,I,10/14/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Female,I,10/14/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Mobility decreased,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Mobility decreased,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Amnesia,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Amnesia,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Discomfort,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Discomfort,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Feeling hot,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,NO,Unlisted
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Somnolence,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0835,2019BDSI0835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product administration error,Non-Health Professional,67,Years,Female,I,10/14/2019,10/10/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0836,2019BDSI0836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,41,Years,Male,F,11/15/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0836,2019BDSI0836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Pharmacist,41,Years,Male,F,11/15/2019,8/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0836,2019BDSI0836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,41,Years,Male,F,11/15/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0836,2019BDSI0836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Pharmacist,41,Years,Male,F,11/15/2019,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,YES,Listed
2019BDSI0837,2019BDSI0837,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,60,Years,Female,I,10/14/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0837,2019BDSI0837,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,10/14/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0837,2019BDSI0837,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,10/14/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,58,Years,Female,I,10/15/2019,10/8/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0838,2019BDSI0838,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,58,Years,Female,I,10/15/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0839,2019BDSI0839,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,10/16/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0839,2019BDSI0839,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Salivary hypersecretion,Non-Health Professional,68,Years,Female,I,10/16/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Salivary hypersecretion,,NO,NO,Unlisted
2019BDSI0839,2019BDSI0839,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,68,Years,Female,I,10/16/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0840,2019BDSI0840,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pain,Non-Health Professional,,,Female,I,10/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0840,2019BDSI0840,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,10/15/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0844,2019BDSI0844,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,10/18/2019,10/13/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0844,2019BDSI0844,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,10/18/2019,10/13/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0848,2019BDSI0848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0848,2019BDSI0848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0848,2019BDSI0848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0848,2019BDSI0848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Drug effective for unapproved indication,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Drug effective for unapproved indication,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Drug effective for unapproved indication,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Drug effective for unapproved indication,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Off label use,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Off label use,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Product use in unapproved indication,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0849,2019BDSI0849,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,dosage form,Buccal film,,Product use in unapproved indication,Non-Health Professional,60,Years,Male,I,10/22/2019,,,,,CHRONIC BODY PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,60,Years,Male,I,10/23/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0851,2019BDSI0851,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Other Health Professional,60,Years,Male,I,10/23/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0852,2019BDSI0852,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,10/24/2019,10/24/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,52,Years,Female,I,10/25/2019,10/2/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,52,Years,Female,I,10/25/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,52,Years,Female,I,10/25/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,52,Years,Female,I,10/25/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mobility decreased,Non-Health Professional,52,Years,Female,I,10/25/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Mobility decreased,,NO,NO,Unlisted
2019BDSI0857,2019BDSI0857,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,52,Years,Female,I,10/25/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0859,2019BDSI0859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,10/28/2019,10/1/2016,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0859,2019BDSI0859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,10/28/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0859,2019BDSI0859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/28/2019,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,10/28/2019,10/28/2019,,,,PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2019BDSI0860,2019BDSI0860,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,,,Female,I,10/28/2019,,,,,PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2019BDSI0861,2019BDSI0861,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/25/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0861,2019BDSI0861,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/25/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,47,Years,Female,I,10/29/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,47,Years,Female,I,10/29/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,47,Years,Female,I,10/29/2019,10/11/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,47,Years,Female,I,10/29/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,47,Years,Female,I,10/29/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,NO,Listed
2019BDSI0862,2019BDSI0862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,47,Years,Female,I,10/29/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0863,2019BDSI0863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,75,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0863,2019BDSI0863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0863,2019BDSI0863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0863,2019BDSI0863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,75,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2019BDSI0863,2019BDSI0863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Positive,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,10/30/2019,10/8/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0866,2019BDSI0866,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/30/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0866,2019BDSI0866,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/30/2019,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0866,2019BDSI0866,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,,Female,I,10/30/2019,6/27/2019,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2019BDSI0866,2019BDSI0866,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/30/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0866,2019BDSI0866,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,10/30/2019,6/27/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Immobile,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Immobile,,NO,NO,Unlisted
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fluid intake reduced,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Fluid intake reduced,,NO,NO,Unlisted
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Parosmia,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Parosmia,,NO,NO,Unlisted
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Painful respiration,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Painful respiration,,NO,NO,Unlisted
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,56,Years,Female,I,10/30/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,56,Years,Female,I,10/30/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Female,I,10/30/2019,10/14/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0867,2019BDSI0867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperacusis,Non-Health Professional,56,Years,Female,I,10/30/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperacusis,,NO,NO,Unlisted
2019BDSI0868,2019BDSI0868,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Other Health Professional,,,Male,I,11/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0868,2019BDSI0868,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Male,I,11/6/2019,10/25/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0869,2019BDSI0869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,52,Years,Male,I,11/1/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0869,2019BDSI0869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,52,Years,Male,I,11/1/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0869,2019BDSI0869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,52,Years,Male,I,11/1/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0869,2019BDSI0869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,52,Years,Male,I,11/1/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0869,2019BDSI0869,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,52,Years,Male,I,11/1/2019,10/29/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0873,2019BDSI0873,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,,,Male,I,11/1/2019,10/13/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0874,2019BDSI0874,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,,,Female,I,11/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0874,2019BDSI0874,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,,,Female,I,11/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0876,2019BDSI0876,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,36,Years,Male,I,11/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0876,2019BDSI0876,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,36,Years,Male,I,11/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0877,2019BDSI0877,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,54,Years,Male,I,11/4/2019,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI0878,2019BDSI0878,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Accidental exposure to product,Other Health Professional,,,,I,11/5/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Accidental exposure to product,,YES,YES,Unlisted
2019BDSI0879,2019BDSI0879,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,51,Years,Male,I,11/4/2019,10/25/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0880,2019BDSI0880,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,11/4/2019,11/3/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0881,2019BDSI0881,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,F,11/8/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0881,2019BDSI0881,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,F,11/8/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug effective for unapproved indication,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Drug effective for unapproved indication,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Fatigue,,NO,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Insomnia,,NO,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Product administration error,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,Other,RESTLESS LEGS,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Male,F,11/13/2019,1/1/2019,,,,RESTLESS LEGS,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Male,F,11/13/2019,1/1/2019,,,,RESTLESS LEGS,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,67,Years,Male,F,11/13/2019,1/1/2019,,,,RESTLESS LEGS,UNITED STATES,Product use complaint,,NO,YES,Unlisted
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Asthenia,,NO,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Abdominal discomfort,,NO,YES,Listed
2019BDSI0882,2019BDSI0882,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,67,Years,Male,F,11/13/2019,10/1/2019,,,,RESTLESS LEGS,UNITED STATES,Off label use,,NO,YES,Unlisted
2019BDSI0883,2019BDSI0883,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Reaction to food additive,Non-Health Professional,55,Years,Female,I,11/5/2019,10/30/2019,,,,CHRONIC PAIN,UNITED STATES,Reaction to food additive,,NO,NO,Unlisted
2019BDSI0883,2019BDSI0883,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Epigastric discomfort,Non-Health Professional,55,Years,Female,I,11/5/2019,10/30/2019,,,,CHRONIC PAIN,UNITED STATES,Epigastric discomfort,,NO,NO,Unlisted
2019BDSI0883,2019BDSI0883,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspepsia,Non-Health Professional,55,Years,Female,I,11/5/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dyspepsia,,NO,NO,Listed
2019BDSI0884,2019BDSI0884,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/4/2019,,,,,BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0886,2019BDSI0886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/5/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0886,2019BDSI0886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,11/5/2019,11/5/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0886,2019BDSI0886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,11/5/2019,11/5/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0886,2019BDSI0886,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/5/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,49,Years,Male,I,11/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,49,Years,Male,I,11/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,49,Years,Male,I,11/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,49,Years,Male,I,11/4/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,49,Years,Male,I,11/4/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0887,2019BDSI0887,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,49,Years,Male,I,11/4/2019,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI0888,2019BDSI0888,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/5/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0888,2019BDSI0888,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/5/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0889,2019BDSI0889,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/7/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0889,2019BDSI0889,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/7/2019,11/6/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0889,2019BDSI0889,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/7/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0891,2019BDSI0891,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,46,Years,Female,I,11/7/2019,4/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0891,2019BDSI0891,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,46,Years,Female,I,11/7/2019,10/15/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0891,2019BDSI0891,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,46,Years,Female,I,11/7/2019,10/15/2019,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2019BDSI0891,2019BDSI0891,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,46,Years,Female,I,11/7/2019,10/15/2019,,,,CHRONIC PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2019BDSI0895,2019BDSI0895,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,55,Years,Female,I,11/8/2019,11/4/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0899,2019BDSI0899,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,83,Years,Male,I,11/11/2019,11/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0899,2019BDSI0899,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,83,Years,Male,I,11/11/2019,11/8/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI0899,2019BDSI0899,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,83,Years,Male,I,11/11/2019,11/8/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI0900,2019BDSI0900,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,,,Female,I,11/27/2019,11/8/2019,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,YES,Unlisted
2019BDSI0900,2019BDSI0900,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,11/27/2019,11/8/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0900,2019BDSI0900,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle twitching,Non-Health Professional,,,Female,I,11/27/2019,11/8/2019,,,,CHRONIC PAIN,UNITED STATES,Muscle twitching,,NO,YES,Unlisted
2019BDSI0900,2019BDSI0900,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,,,Female,I,11/27/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,YES,Unlisted
2019BDSI0901,2019BDSI0901,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,42,Years,Male,I,11/8/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0901,2019BDSI0901,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,42,Years,Male,I,11/8/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2019BDSI0901,2019BDSI0901,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,42,Years,Male,I,11/8/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0901,2019BDSI0901,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,42,Years,Male,I,11/8/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0902,2019BDSI0902,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,45,Years,Female,I,11/11/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0902,2019BDSI0902,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Pre-existing condition improved,Non-Health Professional,45,Years,Female,I,11/11/2019,10/3/2019,,,,CHRONIC PAIN,UNITED STATES,Pre-existing condition improved,,NO,NO,Unlisted
2019BDSI0902,2019BDSI0902,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Feeling hot,Non-Health Professional,45,Years,Female,I,11/11/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,NO,Listed
2019BDSI0902,2019BDSI0902,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Nausea,Non-Health Professional,45,Years,Female,I,11/11/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0908,2019BDSI0908,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,45,Years,Female,I,11/13/2019,1/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2019BDSI0909,2019BDSI0909,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,52,Years,Female,I,11/13/2019,1/1/2016,,,,CHRONIC ABDOMEN PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0913,2019BDSI0913,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,11/14/2019,11/14/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0913,2019BDSI0913,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,11/14/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0913,2019BDSI0913,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Female,I,11/14/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0918,2019BDSI0918,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Surgery,Pharmacist,,,Female,I,11/15/2019,1/1/2019,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Surgery,,YES,YES,Unlisted
2019BDSI0919,2019BDSI0919,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0919,2019BDSI0919,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0922,2019BDSI0922,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0922,2019BDSI0922,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0922,2019BDSI0922,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,64,Years,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI0922,2019BDSI0922,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Female,I,11/18/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0923,2019BDSI0923,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood glucose decreased,Physician,57,Years,Female,I,11/19/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Blood glucose decreased,,NO,NO,Unlisted
2019BDSI0923,2019BDSI0923,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Physician,57,Years,Female,I,11/19/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0925,2019BDSI0925,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Male,I,11/20/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0926,2019BDSI0926,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Physician,,,Female,I,11/20/2019,10/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2019BDSI0928,2019BDSI0928,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,51,Years,Male,I,11/19/2019,,,,,CHRONIC BACK PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2019BDSI0929,2019BDSI0929,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,11/21/2019,11/18/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0929,2019BDSI0929,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Male,I,11/21/2019,11/18/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2019BDSI0930,2019BDSI0930,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Male,I,11/20/2019,7/2/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0930,2019BDSI0930,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,11/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0930,2019BDSI0930,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,11/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0930,2019BDSI0930,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Male,I,11/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0932,2019BDSI0932,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,59,Years,Female,I,11/22/2019,11/13/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI0932,2019BDSI0932,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,11/22/2019,11/13/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0933,2019BDSI0933,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,11/22/2019,,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0933,2019BDSI0933,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/22/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2019BDSI0933,2019BDSI0933,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/22/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2019BDSI0933,2019BDSI0933,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,11/22/2019,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0934,2019BDSI0934,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,11/22/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0934,2019BDSI0934,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,11/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0934,2019BDSI0934,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0934,2019BDSI0934,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/22/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0937,2019BDSI0937,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,8/1/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0937,2019BDSI0937,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,8/1/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0937,2019BDSI0937,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,8/1/2019,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0938,2019BDSI0938,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,11/25/2019,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Intentional product use issue,,NO,YES,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Presyncope,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Presyncope,,NO,YES,Listed
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Delirium,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Delirium,,NO,YES,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,YES,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,YES,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,11/26/2019,11/19/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,11/26/2019,11/19/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2019BDSI0943,2019BDSI0943,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/26/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2019BDSI0947,2019BDSI0947,SUBUTEX,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Overdose,Physician,48,Years,Female,F,12/19/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Overdose,,YES,YES,
2019BDSI0947,2019BDSI0947,SUBUTEX,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug ineffective,Physician,48,Years,Female,F,12/19/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug ineffective,,YES,YES,
2019BDSI0947,2019BDSI0947,SUBUTEX,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug abuse,Physician,48,Years,Female,F,12/19/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug abuse,,YES,YES,
2019BDSI0947,2019BDSI0947,SUBUTEX,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Miosis,Physician,48,Years,Female,F,12/19/2019,5/1/2017,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Miosis,,YES,YES,
2019BDSI0947,2019BDSI0947,SUBUTEX,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Coma,Physician,48,Years,Female,F,12/19/2019,5/1/2017,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Coma,,YES,YES,
2019BDSI0950,2019BDSI0950,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0950,2019BDSI0950,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,,,Female,I,11/27/2019,11/25/2019,,,,PAIN,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2019BDSI0951,2019BDSI0951,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,11/27/2019,11/27/2019,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2019BDSI0951,2019BDSI0951,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,11/27/2019,11/27/2019,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,YES,Listed
2019BDSI0953,2019BDSI0953,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,,66,Years,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0953,2019BDSI0953,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,,66,Years,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Headache,,NO,NO,Listed
2019BDSI0953,2019BDSI0953,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,,66,Years,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI0953,2019BDSI0953,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,,66,Years,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2019BDSI0953,2019BDSI0953,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,,66,Years,Female,I,11/27/2019,,,,,PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0957,2019BDSI0957,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/26/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI0964,2019BDSI0964,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,12/2/2019,12/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0965,2019BDSI0965,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,12/2/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0966,2019BDSI0966,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,58,Years,Female,I,12/2/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2019BDSI0966,2019BDSI0966,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,58,Years,Female,I,12/2/2019,12/2/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0966,2019BDSI0966,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,58,Years,Female,I,12/2/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI0968,2019BDSI0968,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,78,Years,Female,I,12/2/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0968,2019BDSI0968,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,78,Years,Female,I,12/2/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0968,2019BDSI0968,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,78,Years,Female,I,12/2/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Drug withdrawal syndrome neonatal,Other Health Professional,,,Male,I,12/6/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome neonatal,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Low set ears,Other Health Professional,,,Male,I,12/6/2019,,,,Congenital Anomaly,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Low set ears,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Sepsis,Other Health Professional,,,Male,I,12/6/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Sepsis,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Gastrooesophageal reflux disease,Other Health Professional,,,Male,I,12/6/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Gastrooesophageal reflux disease,,NO,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Foetal exposure during pregnancy,Other Health Professional,,,Male,I,12/6/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Foetal exposure during pregnancy,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Deafness bilateral,Other Health Professional,,,Male,I,12/6/2019,,,,Disability,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Deafness bilateral,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Blindness,Other Health Professional,,,Male,I,12/6/2019,,,,Disability,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blindness,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Micrognathia,Other Health Professional,,,Male,I,12/6/2019,,,,Congenital Anomaly,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Micrognathia,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Anal skin tags,Other Health Professional,,,Male,I,12/6/2019,,,,Congenital Anomaly,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Anal skin tags,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Hypoxic-ischaemic encephalopathy,Other Health Professional,,,Male,I,12/6/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypoxic-ischaemic encephalopathy,,YES,YES,Unlisted
2019BDSI0973,2019BDSI0973,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,High arched palate,Other Health Professional,,,Male,I,12/6/2019,,,,Congenital Anomaly,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,High arched palate,,YES,YES,Unlisted
2019BDSI0975,2019BDSI0975,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,12/5/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0982,2019BDSI0982,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,12/6/2019,12/5/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0983,2019BDSI0983,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Male,I,12/5/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI0992,2019BDSI0992,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,12/9/2019,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI0992,2019BDSI0992,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,12/9/2019,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI0992,2019BDSI0992,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,12/9/2019,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI0994,2019BDSI0994,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,12/6/2019,12/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI0995,2019BDSI0995,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling hot,Physician,40,Years,Male,I,12/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,NO,Listed
2019BDSI0995,2019BDSI0995,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Malaise,Physician,40,Years,Male,I,12/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2019BDSI0995,2019BDSI0995,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Physician,40,Years,Male,I,12/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI0995,2019BDSI0995,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal pain upper,Physician,40,Years,Male,I,12/6/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2019BDSI0996,2019BDSI0996,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,12/9/2019,12/9/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI1000,2019BDSI1000,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,12/9/2019,12/7/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI1000,2019BDSI1000,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,12/9/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1002,2019BDSI1002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Other Health Professional,60,Years,Female,I,12/10/2019,10/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2019BDSI1002,2019BDSI1002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,60,Years,Female,I,12/10/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Head discomfort,Non-Health Professional,34,Years,Male,I,12/11/2019,11/15/2019,,,,CHRONIC PAIN,UNITED STATES,Head discomfort,,NO,NO,Unlisted
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,34,Years,Male,I,12/11/2019,11/15/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hangover,Non-Health Professional,34,Years,Male,I,12/11/2019,11/15/2019,,,,CHRONIC PAIN,UNITED STATES,Hangover,,NO,NO,Unlisted
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,34,Years,Male,I,12/11/2019,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,34,Years,Male,I,12/11/2019,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2019BDSI1003,2019BDSI1003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,34,Years,Male,I,12/11/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2019BDSI1005,2019BDSI1005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,12/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1005,2019BDSI1005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,12/11/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,57,Years,Female,I,12/12/2019,12/10/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,57,Years,Female,I,12/12/2019,12/10/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,57,Years,Female,I,12/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,57,Years,Female,I,12/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,57,Years,Female,I,12/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI1006,2019BDSI1006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,57,Years,Female,I,12/12/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2019BDSI1007,2019BDSI1007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,55,Years,Female,I,12/12/2019,9/20/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2019BDSI1007,2019BDSI1007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Electrocardiogram QT prolonged,Physician,55,Years,Female,I,12/12/2019,10/1/2019,,,Other,CHRONIC PAIN,UNITED STATES,Electrocardiogram QT prolonged,,YES,YES,Listed
2019BDSI1008,2019BDSI1008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,89,Years,Female,I,12/13/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI1008,2019BDSI1008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,89,Years,Female,I,12/13/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI1009,2019BDSI1009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,,,Female,I,12/13/2019,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI1009,2019BDSI1009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Pharmacist,,,Female,I,12/13/2019,5/1/2018,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI1012,2019BDSI1012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Cystitis,Physician,59,Years,Female,I,12/16/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Cystitis,,NO,NO,Unlisted
2019BDSI1012,2019BDSI1012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Physician,59,Years,Female,I,12/16/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1012,2019BDSI1012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Physician,59,Years,Female,I,12/16/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI1013,2019BDSI1013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,72,Years,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry eye,Non-Health Professional,72,Years,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Dry eye,,NO,NO,Unlisted
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,72,Years,Female,I,12/16/2019,12/16/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling hot,Non-Health Professional,72,Years,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,NO,Unlisted
2019BDSI1014,2019BDSI1014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Erythema,Non-Health Professional,72,Years,Female,I,12/16/2019,12/15/2019,,,,CHRONIC PAIN,UNITED STATES,Erythema,,NO,NO,Unlisted
2019BDSI1016,2019BDSI1016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Colon operation,Other Health Professional,49,Years,Male,I,12/16/2019,1/1/2019,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Colon operation,,YES,YES,Unlisted
2019BDSI1016,2019BDSI1016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Renal surgery,Other Health Professional,49,Years,Male,I,12/16/2019,1/1/2019,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Renal surgery,,YES,YES,Unlisted
2019BDSI1016,2019BDSI1016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Portal vein thrombosis,Other Health Professional,49,Years,Male,I,12/16/2019,11/1/2019,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Portal vein thrombosis,,YES,YES,Unlisted
2019BDSI1016,2019BDSI1016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pancreatitis acute,Other Health Professional,49,Years,Male,I,12/16/2019,11/1/2019,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pancreatitis acute,,YES,YES,Listed
2019BDSI1017,2019BDSI1017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/17/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI1019,2019BDSI1019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,12/16/2019,11/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abnormal behaviour,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Abnormal behaviour,,NO,NO,Unlisted
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Balance disorder,,NO,NO,Unlisted
2019BDSI1022,2019BDSI1022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling drunk,Non-Health Professional,73,Years,Female,I,12/18/2019,12/16/2019,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Feeling drunk,,NO,NO,Unlisted
2019BDSI1024,2019BDSI1024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,63,Years,Female,I,12/19/2019,12/18/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2019BDSI1024,2019BDSI1024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,63,Years,Female,I,12/19/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI1024,2019BDSI1024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,63,Years,Female,I,12/19/2019,11/10/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure decreased,Non-Health Professional,,,,I,12/14/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Blood pressure decreased,,YES,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Respiratory depression,Non-Health Professional,,,,I,12/14/2019,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Respiratory depression,,YES,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest discomfort,,NO,YES,Unlisted
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,YES,Listed
2019BDSI1025,2019BDSI1025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypersensitivity,Non-Health Professional,,,,I,12/14/2019,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypersensitivity,,NO,YES,Listed
2019BDSI1027,2019BDSI1027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,51,Years,Male,I,12/20/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2019BDSI1027,2019BDSI1027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,51,Years,Male,I,12/20/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI1027,2019BDSI1027,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,51,Years,Male,I,12/20/2019,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Manufacturing product shipping issue,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Manufacturing product shipping issue,,NO,NO,Unlisted
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product distribution issue,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product distribution issue,,NO,NO,Unlisted
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2019BDSI1028,2019BDSI1028,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,12/20/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI1031,2019BDSI1031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,51,Years,Female,I,12/21/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2019BDSI1031,2019BDSI1031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,51,Years,Female,I,12/21/2019,11/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2019BDSI1037,2019BDSI1037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,81,Years,Female,I,12/27/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2019BDSI1037,2019BDSI1037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,81,Years,Female,I,12/27/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2019BDSI1037,2019BDSI1037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,81,Years,Female,I,12/27/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2019BDSI1037,2019BDSI1037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,81,Years,Female,I,12/27/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2019BDSI1037,2019BDSI1037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,81,Years,Female,I,12/27/2019,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0003,2020BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Male,I,1/2/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0003,2020BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,47,Years,Male,I,1/2/2020,12/12/2019,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0005,2020BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,62,Years,Female,I,1/2/2020,12/18/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0005,2020BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,62,Years,Female,I,1/2/2020,12/18/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0005,2020BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Female,I,1/2/2020,12/18/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0005,2020BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,62,Years,Female,I,1/2/2020,12/18/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0008,2020BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/3/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0009,2020BDSI0009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Alopecia,Non-Health Professional,55,Years,Female,I,1/2/2020,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2020BDSI0009,2020BDSI0009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,55,Years,Female,I,1/2/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0011,2020BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,,,Female,I,1/5/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0011,2020BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swelling face,Non-Health Professional,,,Female,I,1/5/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Swelling face,,NO,NO,Unlisted
2020BDSI0011,2020BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,,,Female,I,1/5/2020,1/5/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0014,2020BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,Buccal film,,Arthritis,Non-Health Professional,,,Female,I,1/6/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Arthritis,,NO,YES,Unlisted
2020BDSI0014,2020BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,milligram,Buccal film,,Disability,Non-Health Professional,,,Female,I,1/6/2020,,,,Disability,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Disability,,YES,YES,Unlisted
2020BDSI0015,2020BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Intentional product misuse,Pharmacist,39,Years,Male,I,1/8/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Intentional product misuse,,NO,NO,
2020BDSI0016,2020BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,74,Years,Female,I,1/6/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0016,2020BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,74,Years,Female,I,1/6/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2020BDSI0016,2020BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,74,Years,Female,I,1/6/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0016,2020BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait inability,Non-Health Professional,74,Years,Female,I,1/6/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gait inability,,NO,NO,Unlisted
2020BDSI0016,2020BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,74,Years,Female,I,1/6/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,NO,Unlisted
2020BDSI0017,2020BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/6/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0017,2020BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/6/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0017,2020BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/6/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0018,2020BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product administration error,Non-Health Professional,59,Years,Male,I,1/8/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0018,2020BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,59,Years,Male,I,1/8/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0018,2020BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,59,Years,Male,I,1/8/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0018,2020BDSI0018,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,59,Years,Male,I,1/8/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0019,2020BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Physician,,,,I,1/9/2020,12/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0019,2020BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Physician,,,,I,1/9/2020,12/1/2019,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0020,2020BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Male,I,1/9/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0020,2020BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,70,Years,Male,I,1/9/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0020,2020BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,1/9/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0022,2020BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,1/11/2020,1/11/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0022,2020BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Detoxification,Non-Health Professional,70,Years,Male,I,1/11/2020,1/11/2020,,,,CHRONIC PAIN,UNITED STATES,Detoxification,,NO,NO,Unlisted
2020BDSI0022,2020BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,1/11/2020,1/11/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0022,2020BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Infrequent bowel movements,Non-Health Professional,70,Years,Male,I,1/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Infrequent bowel movements,,NO,NO,Unlisted
2020BDSI0022,2020BDSI0022,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Micturition frequency decreased,Non-Health Professional,70,Years,Male,I,1/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Micturition frequency decreased,,NO,NO,Unlisted
2020BDSI0023,2020BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,1/13/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0035,2020BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,1/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,77,Years,Female,I,1/20/2020,1/1/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,77,Years,Female,I,1/20/2020,1/1/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,77,Years,Female,I,1/20/2020,1/1/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,77,Years,Female,I,1/20/2020,1/1/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,77,Years,Female,I,1/20/2020,1/15/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0036,2020BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,77,Years,Female,I,1/20/2020,1/1/2020,,,,SEVERE CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0040,2020BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/17/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0041,2020BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Male,I,1/20/2020,1/20/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0041,2020BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,71,Years,Male,I,1/20/2020,1/20/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0041,2020BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,71,Years,Male,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0041,2020BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response delayed,Non-Health Professional,71,Years,Male,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response delayed,,NO,NO,Unlisted
2020BDSI0042,2020BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,1/17/2020,,,,,PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0043,2020BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,1/20/2020,1/18/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0043,2020BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0043,2020BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0043,2020BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0044,2020BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0044,2020BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,1/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0045,2020BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hallucination,Other Health Professional,61,Years,Female,I,1/22/2020,1/17/2020,,,,CHRONIC PAIN,UNITED STATES,Hallucination,,NO,NO,Unlisted
2020BDSI0045,2020BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,61,Years,Female,I,1/22/2020,1/17/2020,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2020BDSI0046,2020BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,71,Years,Male,I,1/22/2020,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/22/2020,12/20/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,Other,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Hypertension,,YES,YES,Listed
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,1/22/2020,12/24/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Headache,,NO,YES,Listed
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Nausea,,NO,YES,Listed
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Vomiting,,NO,YES,Listed
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,,,Female,I,1/22/2020,,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Loss of personal independence in daily activities,,NO,YES,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Incorrect route of product administration,,NO,YES,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,1/22/2020,,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Product packaging difficult to open,,NO,YES,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/22/2020,,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0048,2020BDSI0048,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/22/2020,12/1/2019,,,,CHRONIC REGIONAL PAIN SYNDROME,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0049,2020BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Male,I,1/23/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0049,2020BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product primary packaging issue,Non-Health Professional,71,Years,Male,I,1/23/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product primary packaging issue,,NO,NO,Unlisted
2020BDSI0049,2020BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product complaint,Non-Health Professional,71,Years,Male,I,1/23/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product complaint,,NO,NO,Unlisted
2020BDSI0053,2020BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,66,Years,Male,I,1/16/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0054,2020BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,1/23/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0055,2020BDSI0055,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Male,I,1/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0060,2020BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,1/27/2020,1/7/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0061,2020BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,1/26/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0062,2020BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/27/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0062,2020BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/27/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0063,2020BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,57,Years,Female,I,1/28/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0063,2020BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,57,Years,Female,I,1/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2020BDSI0063,2020BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,57,Years,Female,I,1/28/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,NO,Listed
2020BDSI0063,2020BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site irritation,Non-Health Professional,57,Years,Female,I,1/28/2020,1/28/2020,,,,CHRONIC PAIN,UNITED STATES,Application site irritation,,NO,NO,Unlisted
2020BDSI0066,2020BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Pharmacist,37,Years,Female,I,1/29/2020,1/29/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0067,2020BDSI0067,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/29/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0072,2020BDSI0072,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Other Health Professional,,,Male,I,1/30/2020,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0073,2020BDSI0073,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/30/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0075,2020BDSI0075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Surgery,Pharmacist,,,Male,I,1/31/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Surgery,,YES,YES,Unlisted
2020BDSI0076,2020BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,1/30/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0076,2020BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,1/30/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0077,2020BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,1/31/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0079,2020BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,1/31/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0080,2020BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Adverse drug reaction,Non-Health Professional,,,Female,I,1/31/2020,,,,,CHRONIC PAIN,UNITED STATES,Adverse drug reaction,,NO,NO,Unlisted
2020BDSI0080,2020BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/31/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0082,2020BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Panic attack,Non-Health Professional,93,Years,Female,I,2/3/2020,2/2/2020,,,,CHRONIC PAIN,UNITED STATES,Panic attack,,NO,NO,Unlisted
2020BDSI0082,2020BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,93,Years,Female,I,2/3/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0082,2020BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,93,Years,Female,I,2/3/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0082,2020BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,93,Years,Female,I,2/3/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0083,2020BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,41,Years,Female,I,1/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0083,2020BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,41,Years,Female,I,1/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0083,2020BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product adhesion issue,Non-Health Professional,41,Years,Female,I,1/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0083,2020BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Oral administration complication,Non-Health Professional,41,Years,Female,I,1/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0083,2020BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product physical consistency issue,Non-Health Professional,41,Years,Female,I,1/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0084,2020BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/3/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Male,I,2/3/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Male,I,2/3/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Male,I,2/3/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,66,Years,Male,I,2/3/2020,1/28/2020,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Male,I,2/3/2020,1/28/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Male,I,2/3/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0085,2020BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Male,I,2/3/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0086,2020BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,2/3/2020,2/3/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0086,2020BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Male,I,2/3/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0087,2020BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tongue ulceration,Non-Health Professional,64,Years,Male,I,2/3/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Tongue ulceration,,NO,NO,Unlisted
2020BDSI0088,2020BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,71,Years,Female,I,2/4/2020,1/31/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0088,2020BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,71,Years,Female,I,2/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0088,2020BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Female,I,2/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0091,2020BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Female,I,2/4/2020,11/1/2019,,,,CHRONIC PAIN IN NECK,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0092,2020BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product availability issue,Non-Health Professional,,,Female,I,2/5/2020,1/1/2020,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2020BDSI0092,2020BDSI0092,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Product availability issue,Non-Health Professional,,,Female,I,2/5/2020,1/1/2020,,,,DEPENDENCE ON OPIATES,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2020BDSI0093,2020BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Suicidal ideation,Non-Health Professional,,,,I,2/5/2020,2/4/2020,,,Other,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Listed
2020BDSI0093,2020BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,,I,2/5/2020,2/3/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0093,2020BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,,I,2/5/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Nausea,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Listed
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Feeling drunk,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling drunk,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Visual impairment,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,67,Years,Female,I,2/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,NO,Listed
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Quality of life decreased,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Quality of life decreased,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,67,Years,Female,I,2/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Listed
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Malaise,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2020BDSI0096,2020BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,67,Years,Female,I,2/5/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Balance disorder,,NO,NO,Unlisted
2020BDSI0098,2020BDSI0098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,73,Years,Female,I,2/7/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2020BDSI0098,2020BDSI0098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,73,Years,Female,I,2/7/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0098,2020BDSI0098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Female,I,2/7/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0099,2020BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,2/8/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0100,2020BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,2/10/2020,2/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0100,2020BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Pharmacist,,,Female,I,2/10/2020,2/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Quality of life decreased,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Quality of life decreased,,NO,NO,Unlisted
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0101,2020BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,62,Years,Male,I,2/10/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0102,2020BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,60,Years,Female,I,2/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0102,2020BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,2/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0102,2020BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,2/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0102,2020BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,2/11/2020,2/5/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0103,2020BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,2/10/2020,,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0103,2020BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,,,Female,I,2/10/2020,,,,,CHRONIC PAIN,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2020BDSI0103,2020BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Back pain,Non-Health Professional,,,Female,I,2/10/2020,,,,,CHRONIC PAIN,UNITED STATES,Back pain,,NO,NO,Listed
2020BDSI0103,2020BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,,,Female,I,2/10/2020,,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Unlisted
2020BDSI0103,2020BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,,,Female,I,2/10/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,NO,Listed
2020BDSI0104,2020BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Other Health Professional,54,Years,Male,I,2/13/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0107,2020BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,46,Years,Male,I,2/11/2020,1/30/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0107,2020BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hepatic infection,Non-Health Professional,46,Years,Male,I,2/11/2020,1/30/2020,,,Other,CHRONIC PAIN,UNITED STATES,Hepatic infection,,YES,YES,Unlisted
2020BDSI0107,2020BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hepatic pain,Non-Health Professional,46,Years,Male,I,2/11/2020,1/30/2020,,,,CHRONIC PAIN,UNITED STATES,Hepatic pain,,NO,YES,Unlisted
2020BDSI0108,2020BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,,I,2/11/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0108,2020BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,,I,2/11/2020,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0109,2020BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,54,Years,Male,I,2/11/2020,5/21/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0109,2020BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Physician,54,Years,Male,I,2/11/2020,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2020BDSI0109,2020BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Skin exfoliation,Physician,54,Years,Male,I,2/11/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Skin exfoliation,,NO,NO,Unlisted
2020BDSI0110,2020BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pruritus,Other Health Professional,,,Female,I,2/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0111,2020BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,,,Headache,Other Health Professional,,,Female,I,2/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0112,2020BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pruritus,Physician,,,Female,I,2/12/2020,2/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0112,2020BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Glossitis,Physician,,,Female,I,2/12/2020,2/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Glossitis,,NO,NO,Unlisted
2020BDSI0112,2020BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Physician,,,Female,I,2/12/2020,2/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2020BDSI0113,2020BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Other Health Professional,,,Male,I,2/12/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0114,2020BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0114,2020BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,61,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0115,2020BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,74,Years,Male,I,2/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0115,2020BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Male,I,2/12/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0115,2020BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,74,Years,Male,I,2/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0115,2020BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,74,Years,Male,I,2/12/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0115,2020BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,74,Years,Male,I,2/12/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0118,2020BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,50,Years,Female,I,2/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0118,2020BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,50,Years,Female,I,2/18/2020,1/23/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0118,2020BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,50,Years,Female,I,2/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0118,2020BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,50,Years,Female,I,2/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0119,2020BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,56,Years,Male,I,2/13/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0119,2020BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Male,I,2/13/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0119,2020BDSI0119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,56,Years,Male,I,2/13/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0120,2020BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/13/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0120,2020BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,2/13/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0120,2020BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,2/13/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0122,2020BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,68,Years,Female,I,2/14/2020,2/14/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0123,2020BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,73,Years,Female,I,2/14/2020,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0123,2020BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,73,Years,Female,I,2/14/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0126,2020BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,2/18/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pancreatitis,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Pancreatitis,,YES,YES,Unlisted
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dizziness,,YES,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight increased,Non-Health Professional,50,Years,Female,I,2/18/2020,12/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Weight increased,,YES,YES,Unlisted
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,50,Years,Female,I,2/18/2020,2/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Hypertension,,YES,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,50,Years,Female,I,2/18/2020,2/1/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Chest pain,,YES,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,50,Years,Female,I,2/18/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,YES,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chills,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Chills,,YES,YES,Listed
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dehydration,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dehydration,,YES,YES,Unlisted
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2020BDSI0130,2020BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Amnesia,Non-Health Professional,50,Years,Female,I,2/18/2020,12/5/2019,,,,CHRONIC PAIN,UNITED STATES,Amnesia,,NO,YES,Unlisted
2020BDSI0134,2020BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypotension,Other Health Professional,,,Male,I,2/14/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypotension,,NO,NO,Listed
2020BDSI0134,2020BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Other Health Professional,,,Male,I,2/14/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0134,2020BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Other Health Professional,,,Male,I,2/14/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,NO,Listed
2020BDSI0134,2020BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Other Health Professional,,,Male,I,2/14/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Muscle spasms,,NO,NO,Listed
2020BDSI0135,2020BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,2/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product residue present,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product residue present,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hostility,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hostility,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0137,2020BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,2/14/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0138,2020BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/18/2020,2/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0138,2020BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/18/2020,2/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0138,2020BDSI0138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/18/2020,2/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0139,2020BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abnormal dreams,Non-Health Professional,78,Years,Female,I,2/18/2020,2/17/2020,,,,CHRONIC PAIN,UNITED STATES,Abnormal dreams,,NO,NO,Unlisted
2020BDSI0139,2020BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,78,Years,Female,I,2/18/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0139,2020BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,78,Years,Female,I,2/18/2020,2/18/2020,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0139,2020BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,78,Years,Female,I,2/18/2020,2/18/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,70,Years,Female,I,2/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0145,2020BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,2/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0146,2020BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,53,Years,Female,I,2/20/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0146,2020BDSI0146,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Female,I,2/20/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingival discomfort,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Gingival discomfort,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0147,2020BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,85,Years,Male,I,2/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0148,2020BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,44,Years,Female,I,2/19/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0151,2020BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ocular discomfort,Non-Health Professional,,,Male,I,2/20/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Ocular discomfort,,NO,NO,Unlisted
2020BDSI0151,2020BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0151,2020BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,2/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0151,2020BDSI0151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,2/20/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0153,2020BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Euphoric mood,Other Health Professional,,,Female,I,2/21/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Euphoric mood,,NO,NO,Unlisted
2020BDSI0153,2020BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Other Health Professional,,,Female,I,2/21/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2020BDSI0154,2020BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,2/24/2020,2/17/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0154,2020BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/24/2020,2/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0156,2020BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Other Health Professional,56,Years,Female,I,2/21/2020,2/21/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0156,2020BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,56,Years,Female,I,2/21/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0157,2020BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Male,I,2/21/2020,2/21/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0158,2020BDSI0158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,2/25/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0162,2020BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/24/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0162,2020BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/24/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0162,2020BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/24/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0162,2020BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/24/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0164,2020BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Seizure,Physician,,,Female,I,2/25/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Seizure,,YES,YES,Unlisted
2020BDSI0164,2020BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Agitation,Physician,,,Female,I,2/25/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Agitation,,NO,YES,Unlisted
2020BDSI0164,2020BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Crying,Physician,,,Female,I,2/25/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Crying,,NO,YES,Unlisted
2020BDSI0165,2020BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Alopecia,Other Health Professional,,,Female,I,2/26/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Alopecia,,NO,NO,Unlisted
2020BDSI0168,2020BDSI0168,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Aphthous ulcer,Physician,,,Female,I,2/25/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Aphthous ulcer,,NO,NO,Unlisted
2020BDSI0169,2020BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Aphthous ulcer,Physician,49,Years,Male,I,2/28/2020,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Aphthous ulcer,,NO,NO,Unlisted
2020BDSI0169,2020BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Physician,49,Years,Male,I,2/28/2020,1/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,45,Years,Female,I,2/26/2020,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,45,Years,Female,I,2/26/2020,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,General physical health deterioration,Non-Health Professional,45,Years,Female,I,2/26/2020,,,,,CHRONIC BACK PAIN,UNITED STATES,General physical health deterioration,,NO,NO,Unlisted
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,45,Years,Female,I,2/26/2020,1/1/2018,,,,CHRONIC BACK PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,45,Years,Female,I,2/26/2020,,,,,CHRONIC BACK PAIN,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,45,Years,Female,I,2/26/2020,,,,,CHRONIC BACK PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0172,2020BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight increased,Non-Health Professional,45,Years,Female,I,2/26/2020,,,,,CHRONIC BACK PAIN,UNITED STATES,Weight increased,,NO,NO,Unlisted
2020BDSI0180,2020BDSI0180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,2/27/2020,2/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Hypertension,Non-Health Professional,,,Male,I,2/28/2020,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Hypertension,Non-Health Professional,,,Male,I,2/28/2020,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Off label use,Non-Health Professional,,,Male,I,2/28/2020,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,Buccal film,,Off label use,Non-Health Professional,,,Male,I,2/28/2020,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0182,2020BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,,,Male,I,2/28/2020,1/1/2017,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2020BDSI0182,2020BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0182,2020BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,2/28/2020,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0183,2020BDSI0183,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pruritus,Other Health Professional,,,Female,I,2/28/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0186,2020BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/28/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0186,2020BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/28/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0187,2020BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Male,I,3/2/2020,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0187,2020BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,67,Years,Male,I,3/2/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0187,2020BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Male,I,3/2/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0187,2020BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Male,I,3/2/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0188,2020BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Pharmacist,55,Years,Female,I,3/3/2020,7/1/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0189,2020BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Female,I,3/3/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0189,2020BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,3/3/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0189,2020BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/3/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0189,2020BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,3/3/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0192,2020BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Exposure during pregnancy,Physician,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Exposure during pregnancy,,NO,NO,Unlisted
2020BDSI0193,2020BDSI0193,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash,Other Health Professional,60,Years,Female,I,3/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Rash,,NO,NO,Listed
2020BDSI0193,2020BDSI0193,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Other Health Professional,60,Years,Female,I,3/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,YES,YES,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dysstasia,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dysstasia,,YES,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Localised oedema,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Localised oedema,,YES,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Flank pain,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Flank pain,,YES,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Headache,,YES,YES,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,YES,Unlisted
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Constipation,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Constipation,,YES,YES,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Back pain,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Back pain,,YES,YES,Listed
2020BDSI0194,2020BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,70,Years,Male,F,3/5/2020,1/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Condition aggravated,,YES,YES,Unlisted
2020BDSI0195,2020BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swelling face,Other Health Professional,,,Male,I,3/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Swelling face,,NO,NO,Unlisted
2020BDSI0195,2020BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Skin irritation,Other Health Professional,,,Male,I,3/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Skin irritation,,NO,NO,Listed
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,50,Years,Female,I,3/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,50,Years,Female,I,3/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Staphylococcal infection,Non-Health Professional,50,Years,Female,I,3/5/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Staphylococcal infection,,NO,NO,Unlisted
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,50,Years,Female,I,3/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,50,Years,Female,I,3/5/2020,11/6/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0197,2020BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,50,Years,Female,I,3/5/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2020BDSI0198,2020BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,3/4/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Intentional overdose,Non-Health Professional,68,Years,Female,I,3/6/2020,2/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Intentional overdose,,YES,YES,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Suicide attempt,Non-Health Professional,68,Years,Female,I,3/6/2020,2/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Suicide attempt,,YES,YES,Listed
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,3/6/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mood altered,Non-Health Professional,68,Years,Female,I,3/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Mood altered,,NO,YES,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Aggression,Non-Health Professional,68,Years,Female,I,3/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Aggression,,NO,YES,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abnormal behaviour,Non-Health Professional,68,Years,Female,I,3/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abnormal behaviour,,NO,YES,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,68,Years,Female,I,3/6/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,68,Years,Female,I,3/6/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2020BDSI0204,2020BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Belligerence,Non-Health Professional,68,Years,Female,I,3/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Belligerence,,NO,YES,Unlisted
2020BDSI0205,2020BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0205,2020BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0205,2020BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0211,2020BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Headache,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0211,2020BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Malaise,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2020BDSI0211,2020BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,3/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Irritability,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Irritability,,NO,YES,Unlisted
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug dependence,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,NO,YES,Listed
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pain,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Personality change,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Personality change,,NO,YES,Unlisted
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Anger,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Anger,,NO,YES,Unlisted
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Visual impairment,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Visual impairment,,NO,YES,Unlisted
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug dependence,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,NO,YES,Listed
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Depressed mood,Non-Health Professional,,,Female,I,3/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Depressed mood,,NO,YES,Listed
2020BDSI0212,2020BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Amnesia,Non-Health Professional,,,Female,I,3/9/2020,,,,Disability,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Amnesia,,YES,YES,Unlisted
2020BDSI0218,2020BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,81,Years,Male,I,3/9/2020,3/7/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0218,2020BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,81,Years,Male,I,3/9/2020,3/7/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0218,2020BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,81,Years,Male,I,3/9/2020,3/8/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0218,2020BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vision blurred,Non-Health Professional,81,Years,Male,I,3/9/2020,3/9/2020,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2020BDSI0218,2020BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,81,Years,Male,I,3/9/2020,3/7/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0222,2020BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,67,Years,Female,F,1/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,NO,Unlisted
2020BDSI0222,2020BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dermatitis psoriasiform,Non-Health Professional,67,Years,Female,F,1/27/2021,4/19/2019,,,,CHRONIC PAIN,UNITED STATES,Dermatitis psoriasiform,,NO,NO,Unlisted
2020BDSI0222,2020BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Localised infection,Non-Health Professional,67,Years,Female,F,1/27/2021,4/19/2019,,,,CHRONIC PAIN,UNITED STATES,Localised infection,,NO,NO,Unlisted
2020BDSI0223,2020BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Lethargy,Other Health Professional,,,Female,I,3/9/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Lethargy,,NO,NO,Listed
2020BDSI0223,2020BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Chromaturia,Other Health Professional,,,Female,I,3/9/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chromaturia,,NO,NO,Unlisted
2020BDSI0223,2020BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Apathy,Other Health Professional,,,Female,I,3/9/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Apathy,,NO,NO,Unlisted
2020BDSI0227,2020BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blindness transient,Physician,83,Years,Male,I,3/12/2020,1/1/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Blindness transient,,YES,YES,Unlisted
2020BDSI0229,2020BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Female,I,3/13/2020,3/12/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0229,2020BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,67,Years,Female,I,3/13/2020,3/12/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0229,2020BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,67,Years,Female,I,3/13/2020,3/12/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0230,2020BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Gingival recession,Physician,,,Female,I,3/13/2020,,,,,CHRONIC PAIN,UNITED STATES,Gingival recession,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Off label use,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Off label use,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Drug interaction,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Hypersomnia,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypersomnia,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Drug interaction,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Mental impairment,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mental impairment,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Mental impairment,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mental impairment,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Condition aggravated,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Hypersomnia,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypersomnia,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Belligerence,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Belligerence,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Belligerence,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Belligerence,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Mental disorder,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mental disorder,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Mental disorder,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mental disorder,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Visual impairment,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Visual impairment,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Feeling cold,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling cold,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Feeling cold,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling cold,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Condition aggravated,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2020BDSI0232,2020BDSI0232,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,milligram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,3/13/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0233,2020BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,74,Years,Female,F,4/29/2020,,,,,PAIN,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0233,2020BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lethargy,Non-Health Professional,74,Years,Female,F,4/29/2020,,,,,PAIN,UNITED STATES,Lethargy,,NO,YES,Listed
2020BDSI0233,2020BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lymphoma,Non-Health Professional,74,Years,Female,F,4/29/2020,6/1/2019,,,Other,PAIN,UNITED STATES,Lymphoma,,YES,YES,Unlisted
2020BDSI0233,2020BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,74,Years,Female,F,4/29/2020,,,,,PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product primary packaging issue,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product primary packaging issue,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,64,Years,Male,I,3/17/2020,3/16/2020,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,64,Years,Male,I,3/17/2020,3/10/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disorientation,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Disorientation,,NO,NO,Unlisted
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0234,2020BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Heart rate irregular,Non-Health Professional,64,Years,Male,I,3/17/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Heart rate irregular,,NO,NO,Unlisted
2020BDSI0235,2020BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/17/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0236,2020BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Female,I,3/18/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0236,2020BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Female,I,3/18/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0236,2020BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,71,Years,Female,I,3/18/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0236,2020BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Female,I,3/18/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0237,2020BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,F,7/30/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0237,2020BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,F,7/30/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0238,2020BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,62,Years,Female,I,3/20/2020,3/17/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0238,2020BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,62,Years,Female,I,3/20/2020,3/18/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0243,2020BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,3/24/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0243,2020BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/24/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0243,2020BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,3/24/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0244,2020BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,3/25/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0244,2020BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/25/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0245,2020BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blood glucose increased,Non-Health Professional,68,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,53,Years,Female,I,3/24/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,53,Years,Female,I,3/24/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Retching,Non-Health Professional,53,Years,Female,I,3/24/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Retching,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,53,Years,Female,I,3/24/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Female,I,3/24/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,53,Years,Female,I,3/24/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0246,2020BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,53,Years,Female,I,3/24/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2020BDSI0248,2020BDSI0248,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pelvic fracture,Non-Health Professional,56,Years,Female,I,3/25/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Pelvic fracture,,NO,NO,Unlisted
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,69,Years,Female,I,3/26/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,69,Years,Female,I,3/26/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,69,Years,Female,I,3/26/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Female,I,3/26/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,3/26/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0249,2020BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,69,Years,Female,I,3/26/2020,3/25/2020,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0253,2020BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,76,Years,Female,I,3/31/2020,3/1/2020,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0253,2020BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,76,Years,Female,I,3/31/2020,3/19/2020,,,,CHRONIC BACK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0253,2020BDSI0253,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,76,Years,Female,I,3/31/2020,3/1/2020,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0256,2020BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,46,Years,Male,I,3/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Female,I,3/30/2020,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,47,Years,Female,I,3/30/2020,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,47,Years,Female,I,3/30/2020,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,47,Years,Female,I,3/30/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,47,Years,Female,I,3/30/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0257,2020BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,47,Years,Female,I,3/30/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0259,2020BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/31/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0261,2020BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,4/1/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0261,2020BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/1/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0262,2020BDSI0262,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0264,2020BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,70,Years,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2020BDSI0264,2020BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0264,2020BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0264,2020BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,70,Years,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0264,2020BDSI0264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,4/2/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0265,2020BDSI0265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,84,Years,Male,I,4/6/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0266,2020BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,4/6/2020,4/5/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0267,2020BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Positive,Positive,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,35,Years,Male,I,4/4/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0268,2020BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,4/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0269,2020BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,4/7/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0269,2020BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/7/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0269,2020BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/7/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0269,2020BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,4/7/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0269,2020BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,4/7/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0270,2020BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,60,Years,Male,I,4/3/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0270,2020BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Male,I,4/3/2020,12/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0275,2020BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral disorder,Other Health Professional,75,Years,Female,I,4/9/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral disorder,,NO,NO,Unlisted
2020BDSI0275,2020BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mouth ulceration,Other Health Professional,75,Years,Female,I,4/9/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2020BDSI0277,2020BDSI0277,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,I,4/9/2020,4/2/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,44,Years,Female,I,4/10/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,44,Years,Female,I,4/10/2020,4/10/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,44,Years,Female,I,4/10/2020,4/10/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,44,Years,Female,I,4/10/2020,4/10/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,44,Years,Female,I,4/10/2020,4/10/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0278,2020BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,44,Years,Female,I,4/10/2020,2/27/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0280,2020BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,32,Years,Female,I,4/13/2020,1/1/2020,,,,CHRONIC NECK PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0280,2020BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral swelling,Other Health Professional,32,Years,Female,I,4/13/2020,3/29/2020,,,,CHRONIC NECK PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2020BDSI0280,2020BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral swelling,Other Health Professional,32,Years,Female,I,4/13/2020,3/29/2020,,,,CHRONIC NECK PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,I,4/10/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drooling,Non-Health Professional,59,Years,Female,I,4/10/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drooling,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fear-related avoidance of activities,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Fear-related avoidance of activities,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urticaria,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Urticaria,,NO,NO,Listed
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vision blurred,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Memory impairment,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2020BDSI0281,2020BDSI0281,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,59,Years,Female,I,4/10/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0282,2020BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,4/13/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0282,2020BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/13/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0282,2020BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,4/13/2020,4/6/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0283,2020BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Physician,64,Years,Female,F,5/11/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,YES,YES,Listed
2020BDSI0283,2020BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Femur fracture,Physician,64,Years,Female,F,5/11/2020,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Femur fracture,,YES,YES,Unlisted
2020BDSI0283,2020BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Fall,Physician,64,Years,Female,F,5/11/2020,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Fall,,YES,YES,Listed
2020BDSI0283,2020BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Tremor,Physician,64,Years,Female,F,5/11/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tremor,,YES,YES,Listed
2020BDSI0284,2020BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,76,Years,Female,I,4/14/2020,4/14/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0284,2020BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,76,Years,Female,I,4/14/2020,4/14/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0285,2020BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Pharmacist,,,Male,I,4/15/2020,4/13/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0285,2020BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Male,I,4/15/2020,4/13/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,,,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,YES,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Male,I,4/16/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,4/16/2020,2/24/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2020BDSI0286,2020BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,4/16/2020,2/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,73,Years,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,73,Years,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Listed
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,73,Years,Male,I,4/16/2020,1/15/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia oral,Non-Health Professional,73,Years,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia oral,,NO,NO,Unlisted
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,73,Years,Male,I,4/16/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,73,Years,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0289,2020BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,73,Years,Male,I,4/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0292,2020BDSI0292,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,4/20/2020,4/20/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2020BDSI0293,2020BDSI0293,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,32,Years,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0294,2020BDSI0294,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,Female,I,4/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0297,2020BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,77,Years,Male,I,4/22/2020,4/6/2020,,,,CHRONIC KNEE PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0298,2020BDSI0298,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Blister,Non-Health Professional,59,Years,Female,I,4/22/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Blister,,NO,NO,Unlisted
2020BDSI0299,2020BDSI0299,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Other Health Professional,,,Female,I,4/23/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lower limb fracture,Non-Health Professional,61,Years,Female,I,4/22/2020,4/15/2020,,,Other,CHRONIC PAIN,UNITED STATES,Lower limb fracture,,YES,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dehydration,Non-Health Professional,61,Years,Female,I,4/22/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dehydration,,NO,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fall,Non-Health Professional,61,Years,Female,I,4/22/2020,4/15/2020,,,Other,CHRONIC PAIN,UNITED STATES,Fall,,YES,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,61,Years,Female,I,4/22/2020,4/15/2020,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,61,Years,Female,I,4/22/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,61,Years,Female,I,4/22/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrist fracture,Non-Health Professional,61,Years,Female,I,4/22/2020,4/15/2020,,,Other,CHRONIC PAIN,UNITED STATES,Wrist fracture,,YES,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,61,Years,Female,I,4/22/2020,4/10/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depressed level of consciousness,Non-Health Professional,61,Years,Female,I,4/22/2020,4/10/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Depressed level of consciousness,,YES,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pyrexia,Non-Health Professional,61,Years,Female,I,4/22/2020,4/10/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Pyrexia,,YES,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,61,Years,Female,I,4/22/2020,4/10/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dyspnoea,,YES,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,4/22/2020,4/9/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,61,Years,Female,I,4/22/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,YES,Listed
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of consciousness,Non-Health Professional,61,Years,Female,I,4/22/2020,4/15/2020,,,Other,CHRONIC PAIN,UNITED STATES,Loss of consciousness,,YES,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight increased,Non-Health Professional,61,Years,Female,I,4/22/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Weight increased,,NO,YES,Unlisted
2020BDSI0300,2020BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Metabolic surgery,Non-Health Professional,61,Years,Female,I,4/22/2020,11/11/2019,,,Other,CHRONIC PAIN,UNITED STATES,Metabolic surgery,,YES,YES,Unlisted
2020BDSI0301,2020BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Male,I,4/24/2020,4/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2020BDSI0301,2020BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,4/24/2020,4/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Off label use,,NO,YES,Unlisted
2020BDSI0301,2020BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,4/24/2020,4/1/2020,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0302,2020BDSI0302,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,4/24/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0304,2020BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inadequate analgesia,Physician,50,Years,Female,I,4/23/2020,4/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Inadequate analgesia,,NO,NO,Listed
2020BDSI0304,2020BDSI0304,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Physician,50,Years,Female,I,4/23/2020,4/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0306,2020BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,80,Years,Male,I,4/24/2020,4/24/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0306,2020BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,80,Years,Male,I,4/24/2020,4/24/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0307,2020BDSI0307,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,,,Non-cardiogenic pulmonary oedema,Other Health Professional,,,Male,I,4/25/2020,,,,,CANCER PAIN,PORTUGAL,Non-cardiogenic pulmonary oedema,,NO,NO,Unlisted
2020BDSI0307,2020BDSI0307,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,,,Application site erythema,Other Health Professional,,,Male,I,4/25/2020,4/20/2020,,,,CANCER PAIN,PORTUGAL,Application site erythema,,NO,NO,Unlisted
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Migraine,Non-Health Professional,37,Years,Male,F,6/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Sleep disorder,Non-Health Professional,37,Years,Male,F,6/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Sleep disorder,,NO,NO,Unlisted
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Insomnia,Non-Health Professional,37,Years,Male,F,6/18/2020,4/17/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Vomiting,Non-Health Professional,37,Years,Male,F,6/18/2020,4/17/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Visual impairment,Non-Health Professional,37,Years,Male,F,6/18/2020,4/17/2020,,,,CHRONIC PAIN,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Headache,Non-Health Professional,37,Years,Male,F,6/18/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0308,2020BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Dissociation,Non-Health Professional,37,Years,Male,F,6/18/2020,4/17/2020,,,,CHRONIC PAIN,UNITED STATES,Dissociation,,NO,NO,Unlisted
2020BDSI0309,2020BDSI0309,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Uterine cancer,Non-Health Professional,50,Years,Female,I,4/27/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Uterine cancer,,YES,YES,Unlisted
2020BDSI0309,2020BDSI0309,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Condition aggravated,Non-Health Professional,50,Years,Female,I,4/27/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Condition aggravated,,NO,YES,Unlisted
2020BDSI0309,2020BDSI0309,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Condition aggravated,Non-Health Professional,50,Years,Female,I,4/27/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Condition aggravated,,NO,YES,Unlisted
2020BDSI0309,2020BDSI0309,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Uterine cancer,Non-Health Professional,50,Years,Female,I,4/27/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Uterine cancer,,YES,YES,Unlisted
2020BDSI0310,2020BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,4/29/2020,4/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0310,2020BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,4/29/2020,4/29/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0310,2020BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/29/2020,4/29/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0312,2020BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,4/30/2020,3/1/2020,,,,CHRONIC NERVE PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0312,2020BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,4/30/2020,1/1/2020,,,,CHRONIC NERVE PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0312,2020BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,4/30/2020,1/1/2020,,,,CHRONIC NERVE PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0312,2020BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/30/2020,1/1/2020,,,,CHRONIC NERVE PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0312,2020BDSI0312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/30/2020,1/1/2020,,,,CHRONIC NERVE PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0313,2020BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/1/2020,1/1/2020,,,,CHRONIC HIP PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0313,2020BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Female,I,5/1/2020,5/1/2020,,,,CHRONIC HIP PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0313,2020BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/1/2020,5/1/2020,,,,CHRONIC HIP PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0313,2020BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/1/2020,1/1/2020,,,,CHRONIC HIP PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0313,2020BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,5/1/2020,1/1/2020,,,,CHRONIC HIP PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0314,2020BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Transient ischaemic attack,Non-Health Professional,68,Years,Female,I,5/8/2020,4/1/2020,,,Other,CHRONIC LOWER BACK,UNITED STATES,Transient ischaemic attack,,YES,YES,Listed
2020BDSI0315,2020BDSI0315,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Physician,72,Years,Female,I,5/4/2020,5/3/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0315,2020BDSI0315,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tachycardia,Physician,72,Years,Female,I,5/4/2020,5/3/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tachycardia,,NO,NO,Unlisted
2020BDSI0316,2020BDSI0316,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,5/4/2020,4/30/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0321,2020BDSI0321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0322,2020BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,51,Years,Male,I,5/7/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0323,2020BDSI0323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Male,I,5/7/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0323,2020BDSI0323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral pain,Non-Health Professional,,,Male,I,5/7/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral pain,,NO,NO,Unlisted
2020BDSI0323,2020BDSI0323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral discomfort,Non-Health Professional,,,Male,I,5/7/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral discomfort,,NO,NO,Unlisted
2020BDSI0324,2020BDSI0324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Female,I,5/8/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0324,2020BDSI0324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,5/8/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0324,2020BDSI0324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,63,Years,Female,I,5/8/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,YES,Listed
2020BDSI0324,2020BDSI0324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chronic obstructive pulmonary disease,Non-Health Professional,63,Years,Female,I,5/8/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Chronic obstructive pulmonary disease,,NO,YES,Unlisted
2020BDSI0324,2020BDSI0324,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oxygen saturation decreased,Non-Health Professional,63,Years,Female,I,5/8/2020,1/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Oxygen saturation decreased,,YES,YES,Unlisted
2020BDSI0331,2020BDSI0331,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,61,Years,Female,I,5/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0332,2020BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,5/12/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0332,2020BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,5/12/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0333,2020BDSI0333,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Headache,Non-Health Professional,,,Female,I,5/12/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0333,2020BDSI0333,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Malaise,Non-Health Professional,,,Female,I,5/12/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Malaise,,NO,NO,Unlisted
2020BDSI0333,2020BDSI0333,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Non-Health Professional,,,Female,I,5/12/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0334,2020BDSI0334,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,,,Male,I,5/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0334,2020BDSI0334,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Other Health Professional,,,Male,I,5/6/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2020BDSI0338,2020BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,68,Years,Female,I,5/13/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2020BDSI0338,2020BDSI0338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,68,Years,Female,I,5/13/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0342,2020BDSI0342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Male,I,5/15/2020,5/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0345,2020BDSI0345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,5/19/2020,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0346,2020BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/19/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0346,2020BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/19/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0346,2020BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,5/19/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0346,2020BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/19/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0346,2020BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,5/19/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2020BDSI0347,2020BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,67,Years,Female,I,5/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0347,2020BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,5/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0347,2020BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Female,I,5/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0347,2020BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Female,I,5/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0348,2020BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Pruritus,Non-Health Professional,63,Years,Female,I,5/19/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0349,2020BDSI0349,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,5/19/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0349,2020BDSI0349,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/19/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0353,2020BDSI0353,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Dyspnoea,Physician,,,Male,I,5/21/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0354,2020BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,5/22/2020,5/21/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastrointestinal pain,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Gastrointestinal pain,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Back pain,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Back pain,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest discomfort,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling hot,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Feeling hot,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling cold,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Feeling cold,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sinus disorder,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Sinus disorder,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Eye pruritus,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Eye pruritus,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nasal pruritus,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Nasal pruritus,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Non-Health Professional,63,Years,Female,I,5/22/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,63,Years,Female,I,5/22/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,63,Years,Female,I,5/22/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,63,Years,Female,I,5/22/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,63,Years,Female,I,5/22/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cold sweat,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Cold sweat,,NO,NO,Unlisted
2020BDSI0355,2020BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling of body temperature change,Non-Health Professional,63,Years,Female,I,5/22/2020,5/19/2020,,,,CHRONIC PAIN,UNITED STATES,Feeling of body temperature change,,NO,NO,Unlisted
2020BDSI0357,2020BDSI0357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Female,I,5/28/2020,5/6/2020,,,,CHRONIC HEADACHE ON THE SIDES OF THE NECK,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0357,2020BDSI0357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Female,I,5/28/2020,5/1/2020,,,,CHRONIC HEADACHE ON THE SIDES OF THE NECK,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0358,2020BDSI0358,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product contamination physical,Non-Health Professional,,,Male,I,5/26/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product contamination physical,,NO,NO,Unlisted
2020BDSI0359,2020BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Female,I,5/27/2020,5/5/2020,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0359,2020BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/27/2020,5/5/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0359,2020BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Female,I,5/27/2020,5/5/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0359,2020BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,,Female,I,5/27/2020,5/5/2020,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2020BDSI0359,2020BDSI0359,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,5/27/2020,5/5/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0360,2020BDSI0360,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Palpitations,Other Health Professional,,,,I,5/26/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0361,2020BDSI0361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/27/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0362,2020BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,40,Years,Female,I,5/27/2020,5/26/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0362,2020BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,40,Years,Female,I,5/27/2020,5/26/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0362,2020BDSI0362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,40,Years,Female,I,5/27/2020,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0364,2020BDSI0364,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,75,Years,Female,I,5/28/2020,5/27/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0364,2020BDSI0364,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,5/28/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0364,2020BDSI0364,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,75,Years,Female,I,5/28/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0364,2020BDSI0364,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,75,Years,Female,I,5/28/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0364,2020BDSI0364,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,5/28/2020,5/27/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0365,2020BDSI0365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/27/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0365,2020BDSI0365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/27/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0365,2020BDSI0365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,5/27/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0366,2020BDSI0366,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Male,I,5/29/2020,,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0367,2020BDSI0367,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,54,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0367,2020BDSI0367,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,54,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0367,2020BDSI0367,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,54,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0367,2020BDSI0367,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,54,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Overdose,Non-Health Professional,59,Years,Female,I,5/29/2020,,,,,CHRONIC PAIN,UNITED STATES,Overdose,,NO,NO,Listed
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Listed
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival disorder,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Gingival disorder,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Bone loss,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Bone loss,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Vision blurred,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Coordination abnormal,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Coordination abnormal,,NO,NO,Unlisted
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Balance disorder,,NO,NO,Listed
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dyspepsia,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Dyspepsia,,NO,NO,Listed
2020BDSI0368,2020BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,59,Years,Female,I,5/29/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,NO,NO,Listed
2020BDSI0369,2020BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0369,2020BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,64,Years,Female,I,5/29/2020,5/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,62,Years,Male,I,6/1/2020,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,62,Years,Male,I,6/1/2020,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,62,Years,Male,I,6/1/2020,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,62,Years,Male,I,6/1/2020,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,62,Years,Male,I,6/1/2020,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0370,2020BDSI0370,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,62,Years,Male,I,6/1/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0371,2020BDSI0371,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Other Health Professional,,,UNK,I,6/2/2020,,,,Other,UNCONTROLLED PAIN,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2020BDSI0371,2020BDSI0371,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Other Health Professional,,,UNK,I,6/2/2020,,,,Other,UNCONTROLLED PAIN,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2020BDSI0373,2020BDSI0373,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,61,Years,Male,I,6/4/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0373,2020BDSI0373,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,61,Years,Male,I,6/4/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0373,2020BDSI0373,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,6/4/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0374,2020BDSI0374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,67,Years,Female,I,6/4/2020,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0374,2020BDSI0374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,67,Years,Female,I,6/4/2020,,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2020BDSI0374,2020BDSI0374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,67,Years,Female,I,6/4/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0376,2020BDSI0376,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,32,Years,Male,I,6/5/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0376,2020BDSI0376,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,32,Years,Male,I,6/5/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0379,2020BDSI0379,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,6/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0380,2020BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug interaction,Other Health Professional,46,Years,Male,F,10/20/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,SPAIN,Drug interaction,,YES,YES,
2020BDSI0380,2020BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Anxiety,Other Health Professional,46,Years,Male,F,10/20/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,SPAIN,Anxiety,,YES,YES,
2020BDSI0380,2020BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hepatic enzyme increased,Other Health Professional,46,Years,Male,F,10/20/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,SPAIN,Hepatic enzyme increased,,YES,YES,
2020BDSI0380,2020BDSI0380,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Gamma-glutamyltransferase increased,Other Health Professional,46,Years,Male,F,10/20/2020,,,,Other,DRUG USE FOR UNKNOWN INDICATION,SPAIN,Gamma-glutamyltransferase increased,,YES,YES,
2020BDSI0382,2020BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urticaria,Other Health Professional,72,Years,Female,I,6/8/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Urticaria,,NO,NO,Listed
2020BDSI0382,2020BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Other Health Professional,72,Years,Female,I,6/8/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2020BDSI0384,2020BDSI0384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Other Health Professional,,,Female,I,6/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0384,2020BDSI0384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Other Health Professional,,,Female,I,6/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0384,2020BDSI0384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Other Health Professional,,,Female,I,6/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0385,2020BDSI0385,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,54,Years,Female,I,6/8/2020,6/6/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0386,2020BDSI0386,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,62,Years,Female,I,6/10/2020,6/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,48,Years,Female,I,6/10/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,48,Years,Female,I,6/10/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,48,Years,Female,I,6/10/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,48,Years,Female,I,6/10/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,48,Years,Female,I,6/10/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0387,2020BDSI0387,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,48,Years,Female,I,6/10/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product temperature excursion issue,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product temperature excursion issue,,NO,NO,Unlisted
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product measured potency issue,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product measured potency issue,,NO,NO,Unlisted
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug delivery system issue,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug delivery system issue,,NO,NO,Unlisted
2020BDSI0390,2020BDSI0390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Female,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0391,2020BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,54,Years,Female,I,6/12/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2020BDSI0391,2020BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Female,I,6/12/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0391,2020BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,54,Years,Female,I,6/12/2020,5/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Hypertension,,YES,YES,Listed
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Nausea,Non-Health Professional,60,Years,Female,I,6/12/2020,6/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,6/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,6/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Product administration error,Non-Health Professional,60,Years,Female,I,6/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,6/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0394,2020BDSI0394,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,Negative,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,6/12/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0395,2020BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Female,I,6/15/2020,6/9/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0395,2020BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,53,Years,Female,I,6/15/2020,6/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0395,2020BDSI0395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,53,Years,Female,I,6/15/2020,6/9/2020,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0400,2020BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,26,Years,Female,I,6/16/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0400,2020BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,26,Years,Female,I,6/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0400,2020BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,26,Years,Female,I,6/16/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Joint swelling,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Joint swelling,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Decreased appetite,,NO,NO,Listed
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Weight decreased,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Night sweats,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Night sweats,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Fatigue,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Somnolence,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Dizziness,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Feeling of body temperature change,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Feeling of body temperature change,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Asthenia,Non-Health Professional,80,Years,Female,I,6/17/2020,3/1/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Asthenia,,NO,NO,Listed
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Product size issue,Non-Health Professional,80,Years,Female,I,6/17/2020,6/17/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0401,2020BDSI0401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,80,Years,Female,I,6/17/2020,6/17/2020,,,,CHRONIC PAIN DUE TO ACROMEGALY,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0402,2020BDSI0402,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,6/18/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0402,2020BDSI0402,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,6/18/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0402,2020BDSI0402,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,,,Female,I,6/18/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2020BDSI0404,2020BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,6/18/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0404,2020BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,6/18/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0404,2020BDSI0404,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,6/18/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0406,2020BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/19/2020,6/19/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0406,2020BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,6/19/2020,6/19/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0406,2020BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,6/19/2020,6/19/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0409,2020BDSI0409,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,57,Years,Male,I,6/19/2020,2/1/2020,,,,CHRONIC PAIN DUE TO NEUROPATHY,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0410,2020BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission,Non-Health Professional,58,Years,Male,I,6/22/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product dose omission,,NO,NO,Unlisted
2020BDSI0410,2020BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,58,Years,Male,I,6/22/2020,6/22/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0411,2020BDSI0411,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,35,Years,Female,I,6/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2020BDSI0411,2020BDSI0411,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,35,Years,Female,I,6/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0411,2020BDSI0411,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,35,Years,Female,I,6/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0411,2020BDSI0411,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,35,Years,Female,I,6/19/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0414,2020BDSI0414,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Pharmacist,,,Female,I,6/24/2020,6/24/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0418,2020BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/25/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0423,2020BDSI0423,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Female,I,6/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Application site erythema,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Application site erythema,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Application site pain,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Application site pain,,NO,NO,Unlisted
2020BDSI0424,2020BDSI0424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Application site pruritus,Non-Health Professional,,,Female,I,7/1/2020,6/25/2020,,,,CHRONIC PAIN,UNITED STATES,Application site pruritus,,NO,NO,Unlisted
2020BDSI0425,2020BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect dose administered by product,Non-Health Professional,66,Years,Male,I,6/29/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect dose administered by product,,NO,NO,Unlisted
2020BDSI0425,2020BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Male,I,6/29/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0425,2020BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Male,I,6/29/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0425,2020BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Male,I,6/29/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0425,2020BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,66,Years,Male,I,6/29/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Female,I,6/30/2020,3/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0427,2020BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,63,Years,Female,I,6/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0428,2020BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,47,Years,Female,I,7/1/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0430,2020BDSI0430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,6/30/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0431,2020BDSI0431,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Other Health Professional,,,Male,I,7/1/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0432,2020BDSI0432,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth discolouration,Other Health Professional,53,Years,Female,I,7/1/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth discolouration,,NO,NO,Unlisted
2020BDSI0432,2020BDSI0432,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Other Health Professional,53,Years,Female,I,7/1/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dental caries,,NO,NO,Unlisted
2020BDSI0435,2020BDSI0435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,7/6/2020,1/1/2020,,,,CHRONIC PAIN DUE TO ARTHRITIS,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0435,2020BDSI0435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Female,I,7/6/2020,6/1/2020,,,,CHRONIC PAIN DUE TO ARTHRITIS,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0435,2020BDSI0435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/6/2020,6/1/2020,,,,CHRONIC PAIN DUE TO ARTHRITIS,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0435,2020BDSI0435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/6/2020,1/1/2020,,,,CHRONIC PAIN DUE TO ARTHRITIS,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0435,2020BDSI0435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/6/2020,6/1/2020,,,,CHRONIC PAIN DUE TO ARTHRITIS,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0436,2020BDSI0436,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,7/3/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0437,2020BDSI0437,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,40,Years,Female,I,7/7/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0438,2020BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,7/7/2020,7/3/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0440,2020BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Male,F,9/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0440,2020BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Male,F,9/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0440,2020BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Male,F,9/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0440,2020BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,72,Years,Male,F,9/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,75,Years,Female,I,7/7/2020,5/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Nausea,,YES,YES,Listed
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,7/7/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,75,Years,Female,I,7/7/2020,5/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Asthenia,,YES,YES,Listed
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,75,Years,Female,I,7/7/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,75,Years,Female,I,7/7/2020,5/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dizziness,,YES,YES,Listed
2020BDSI0441,2020BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,75,Years,Female,I,7/7/2020,5/1/2019,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2020BDSI0451,2020BDSI0451,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Cellulitis,Physician,40,Years,Female,I,7/13/2020,,,,Other,OPIOID USE DISORDER,UNITED STATES,Cellulitis,,YES,YES,Unlisted
2020BDSI0451,2020BDSI0451,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Abscess limb,Physician,40,Years,Female,I,7/13/2020,,,,Other,OPIOID USE DISORDER,UNITED STATES,Abscess limb,,YES,YES,Unlisted
2020BDSI0451,2020BDSI0451,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Abscess limb,Physician,40,Years,Female,I,7/13/2020,,,,Other,OPIOID USE DISORDER,UNITED STATES,Abscess limb,,YES,YES,Unlisted
2020BDSI0451,2020BDSI0451,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Cellulitis,Physician,40,Years,Female,I,7/13/2020,,,,Other,OPIOID USE DISORDER,UNITED STATES,Cellulitis,,YES,YES,Unlisted
2020BDSI0452,2020BDSI0452,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/15/2020,1/1/2016,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0452,2020BDSI0452,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,7/15/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0452,2020BDSI0452,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,7/15/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0452,2020BDSI0452,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Male,I,7/15/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0453,2020BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,53,Years,Female,I,7/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2020BDSI0453,2020BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Female,I,7/16/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0462,2020BDSI0462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,32,Years,Female,I,7/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0462,2020BDSI0462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,7/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0462,2020BDSI0462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,32,Years,Female,I,7/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0462,2020BDSI0462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,32,Years,Female,I,7/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0462,2020BDSI0462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,32,Years,Female,I,7/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,50,Years,Female,I,7/20/2020,1/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,50,Years,Female,I,7/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of product administration,Non-Health Professional,50,Years,Female,I,7/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Inappropriate schedule of product administration,,NO,YES,Unlisted
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,50,Years,Female,I,7/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,50,Years,Female,I,7/20/2020,3/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0463,2020BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,50,Years,Female,I,7/20/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Abdominal distension,Other Health Professional,62,Years,Male,F,1/24/2022,,,,,PAIN,CZECH REPUBLIC,Abdominal distension,,NO,YES,
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Mental impairment,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Mental impairment,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Weight increased,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Weight increased,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Constipation,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Constipation,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Application site hypersensitivity,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Application site hypersensitivity,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Headache,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Headache,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Sedation,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Sedation,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Flatulence,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Flatulence,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Functional gastrointestinal disorder,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Functional gastrointestinal disorder,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Dry mouth,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Dry mouth,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Nausea,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Nausea,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Abdominal pain,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Abdominal pain,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Condition aggravated,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Condition aggravated,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Vomiting,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Vomiting,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Intentional overdose,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Intentional overdose,,YES,YES,Listed
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug ineffective,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Drug ineffective,,YES,YES,Unlisted
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Quality of life decreased,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Quality of life decreased,,YES,YES,
2020BDSI0470,2020BDSI0470,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Major depression,Other Health Professional,62,Years,Male,F,1/24/2022,,,,Other,PAIN,CZECH REPUBLIC,Major depression,,YES,YES,
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oropharyngeal discomfort,Non-Health Professional,72,Years,Female,I,7/22/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oropharyngeal discomfort,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,72,Years,Female,I,7/22/2020,4/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,72,Years,Female,I,7/22/2020,,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,72,Years,Female,I,7/22/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,72,Years,Female,I,7/22/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Female,I,7/22/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Female,I,7/22/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0475,2020BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,72,Years,Female,I,7/22/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0476,2020BDSI0476,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug screen negative,Pharmacist,,,Male,I,7/22/2020,6/23/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0478,2020BDSI0478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Inappropriate schedule of product administration,Other Health Professional,,,Female,I,7/22/2020,7/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Inappropriate schedule of product administration,,NO,NO,Unlisted
2020BDSI0478,2020BDSI0478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Nausea,Other Health Professional,,,Female,I,7/22/2020,7/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0480,2020BDSI0480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alopecia,Non-Health Professional,65,Years,Female,I,7/23/2020,7/21/2020,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2020BDSI0483,2020BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/24/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0483,2020BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site haemorrhage,Non-Health Professional,,,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Application site haemorrhage,,NO,NO,Unlisted
2020BDSI0483,2020BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0483,2020BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/24/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0484,2020BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,7/24/2020,7/24/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0484,2020BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/24/2020,7/24/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0484,2020BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,7/24/2020,7/24/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0484,2020BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,7/24/2020,7/24/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0485,2020BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,49,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2020BDSI0485,2020BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sudden onset of sleep,Non-Health Professional,49,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Sudden onset of sleep,,NO,NO,Unlisted
2020BDSI0485,2020BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,49,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0485,2020BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,49,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0486,2020BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral pain,Non-Health Professional,89,Years,Female,I,7/24/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral pain,,NO,NO,Unlisted
2020BDSI0486,2020BDSI0486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Non-Health Professional,89,Years,Female,I,7/24/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2020BDSI0487,2020BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,81,Years,Male,I,7/27/2020,7/27/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0487,2020BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,81,Years,Male,I,7/27/2020,7/27/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0487,2020BDSI0487,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,81,Years,Male,I,7/27/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0488,2020BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0488,2020BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,64,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0488,2020BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,64,Years,Female,I,7/24/2020,5/1/2019,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0488,2020BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0488,2020BDSI0488,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,7/24/2020,7/23/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0489,2020BDSI0489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,7/24/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0490,2020BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/31/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0490,2020BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/31/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0490,2020BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/31/2020,7/31/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0490,2020BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/31/2020,7/31/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0490,2020BDSI0490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,7/31/2020,7/31/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0491,2020BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product commingling,Pharmacist,,,Female,I,8/3/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product commingling,,NO,NO,Unlisted
2020BDSI0492,2020BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/3/2020,7/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0492,2020BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/3/2020,7/29/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0492,2020BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/3/2020,7/29/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0492,2020BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/3/2020,7/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0492,2020BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/3/2020,7/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0493,2020BDSI0493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,8/4/2020,8/3/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0493,2020BDSI0493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,8/4/2020,8/3/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0493,2020BDSI0493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,8/4/2020,8/4/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0494,2020BDSI0494,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Male,I,8/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0497,2020BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,,,Female,I,8/5/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0499,2020BDSI0499,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,8/5/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0499,2020BDSI0499,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,8/5/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0500,2020BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,8/5/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0500,2020BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,8/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0500,2020BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,8/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0500,2020BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0500,2020BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,8/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0501,2020BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,32,Years,Female,I,8/7/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0501,2020BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,8/7/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0501,2020BDSI0501,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,32,Years,Female,I,8/7/2020,7/10/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0502,2020BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Pharmacist,,,Female,I,8/7/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0502,2020BDSI0502,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product contamination physical,Pharmacist,,,Female,I,8/7/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product contamination physical,,NO,NO,Unlisted
2020BDSI0504,2020BDSI0504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,64,Years,Male,F,12/3/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0504,2020BDSI0504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,64,Years,Male,F,12/3/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0504,2020BDSI0504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Pharmacist,64,Years,Male,F,12/3/2020,,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0506,2020BDSI0506,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Mouth haemorrhage,Pharmacist,,,Male,I,8/11/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mouth haemorrhage,,NO,NO,Unlisted
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dysuria,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,NO,Unlisted
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nightmare,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Nightmare,,NO,NO,Unlisted
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Palpitations,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tremor,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Energy increased,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Energy increased,,NO,NO,Unlisted
2020BDSI0507,2020BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nervousness,Non-Health Professional,65,Years,Female,I,8/11/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Nervousness,,NO,NO,Unlisted
2020BDSI0509,2020BDSI0509,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,62,Years,Female,F,11/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0509,2020BDSI0509,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Female,F,11/17/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0509,2020BDSI0509,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,62,Years,Female,F,11/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0510,2020BDSI0510,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,8/13/2020,8/12/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0513,2020BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Chest discomfort,Other Health Professional,,,Female,I,8/5/2020,1/1/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Chest discomfort,,YES,YES,Unlisted
2020BDSI0513,2020BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Swelling face,Other Health Professional,,,Female,I,8/5/2020,1/1/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Swelling face,,YES,YES,Unlisted
2020BDSI0513,2020BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Swollen tongue,Other Health Professional,,,Female,I,8/5/2020,1/1/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Swollen tongue,,YES,YES,Unlisted
2020BDSI0514,2020BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,8/13/2020,8/13/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0514,2020BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product primary packaging issue,Non-Health Professional,,,Female,I,8/13/2020,8/13/2020,,,,CHRONIC PAIN,UNITED STATES,Product primary packaging issue,,NO,NO,Unlisted
2020BDSI0514,2020BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product design issue,Non-Health Professional,,,Female,I,8/13/2020,8/13/2020,,,,CHRONIC PAIN,UNITED STATES,Product design issue,,NO,NO,Unlisted
2020BDSI0515,2020BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/13/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0515,2020BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/13/2020,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0515,2020BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product communication issue,Non-Health Professional,,,Female,I,8/13/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2020BDSI0518,2020BDSI0518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,75,Years,Female,I,8/14/2020,,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0518,2020BDSI0518,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,75,Years,Female,I,8/14/2020,8/11/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/13/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,8/13/2020,8/12/2020,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ageusia,Non-Health Professional,,,Female,I,8/13/2020,8/12/2020,,,,CHRONIC PAIN,UNITED STATES,Ageusia,,NO,NO,Unlisted
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,8/13/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/13/2020,8/12/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/13/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/13/2020,8/12/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0519,2020BDSI0519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysphagia,Non-Health Professional,,,Female,I,8/13/2020,8/13/2020,,,,CHRONIC PAIN,UNITED STATES,Dysphagia,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lip swelling,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Lip swelling,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lip pain,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Lip pain,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tongue ulceration,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Tongue ulceration,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mouth ulceration,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lip blister,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Lip blister,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral pustule,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral pustule,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lip haemorrhage,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Lip haemorrhage,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lip exfoliation,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Lip exfoliation,,NO,NO,Unlisted
2020BDSI0521,2020BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Cheilitis,Non-Health Professional,73,Years,Female,I,8/17/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Cheilitis,,NO,NO,Unlisted
2020BDSI0522,2020BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,67,Years,Male,I,8/17/2020,8/12/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0524,2020BDSI0524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/18/2020,,,,,NECK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0525,2020BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,34,Years,Female,I,8/18/2020,8/10/2020,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2020BDSI0525,2020BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,34,Years,Female,I,8/18/2020,8/10/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0525,2020BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,34,Years,Female,I,8/18/2020,8/10/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0525,2020BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,34,Years,Female,I,8/18/2020,8/10/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0526,2020BDSI0526,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,68,Years,Male,I,8/18/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0526,2020BDSI0526,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Male,I,8/18/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0527,2020BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,46,Years,Female,I,8/19/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0527,2020BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,I,8/19/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0527,2020BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,46,Years,Female,I,8/19/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0527,2020BDSI0527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,46,Years,Female,I,8/19/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0528,2020BDSI0528,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Other Health Professional,,,Male,I,8/18/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0528,2020BDSI0528,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Other Health Professional,,,Male,I,8/18/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0528,2020BDSI0528,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,,,Male,I,8/18/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0530,2020BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,63,Years,Female,I,8/19/2020,8/12/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2020BDSI0530,2020BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Female,I,8/19/2020,8/12/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0530,2020BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,63,Years,Female,I,8/19/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0530,2020BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Female,I,8/19/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0531,2020BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality sleep,Non-Health Professional,62,Years,Female,I,8/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality sleep,,NO,NO,Unlisted
2020BDSI0531,2020BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,62,Years,Female,I,8/20/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0532,2020BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,57,Years,Female,I,8/20/2020,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0532,2020BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,57,Years,Female,I,8/20/2020,7/26/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0532,2020BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,57,Years,Female,I,8/20/2020,8/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0532,2020BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Pharmacist,57,Years,Female,I,8/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0532,2020BDSI0532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oropharyngeal pain,Pharmacist,57,Years,Female,I,8/20/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oropharyngeal pain,,NO,NO,Listed
2020BDSI0539,2020BDSI0539,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,8/21/2020,8/20/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0539,2020BDSI0539,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,8/21/2020,8/20/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Transient ischaemic attack,Non-Health Professional,66,Years,Female,I,8/22/2020,8/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Transient ischaemic attack,,YES,YES,Listed
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,66,Years,Female,I,8/22/2020,8/14/2020,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,66,Years,Female,I,8/22/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,YES,Listed
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Female,I,8/22/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Female,I,8/22/2020,8/23/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Female,I,8/22/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,66,Years,Female,I,8/22/2020,8/24/2020,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,YES,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,66,Years,Female,I,8/22/2020,8/23/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Female,I,8/22/2020,8/6/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0540,2020BDSI0540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Female,I,8/22/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,39,Years,Female,I,8/24/2020,8/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,39,Years,Female,I,8/24/2020,8/21/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,39,Years,Female,I,8/24/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,39,Years,Female,I,8/24/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,39,Years,Female,I,8/24/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,39,Years,Female,I,8/24/2020,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,YES,Listed
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,39,Years,Female,I,8/24/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,YES,Unlisted
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,39,Years,Female,I,8/24/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2020BDSI0541,2020BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,39,Years,Female,I,8/24/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product measured potency issue,Non-Health Professional,71,Years,Female,I,8/24/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product measured potency issue,,NO,NO,Unlisted
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,71,Years,Female,I,8/24/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,71,Years,Female,I,8/24/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,71,Years,Female,I,8/24/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Female,I,8/24/2020,8/17/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0543,2020BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,71,Years,Female,I,8/24/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0544,2020BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,61,Years,Male,I,8/25/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0544,2020BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,I,8/25/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0544,2020BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,8/25/2020,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0544,2020BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,61,Years,Male,I,8/25/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0545,2020BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/25/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0545,2020BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,8/25/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0545,2020BDSI0545,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,8/25/2020,8/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0547,2020BDSI0547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Stomatitis,Other Health Professional,49,Years,Female,I,8/27/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2020BDSI0547,2020BDSI0547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Mucosa vesicle,Other Health Professional,49,Years,Female,I,8/27/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mucosa vesicle,,NO,NO,Unlisted
2020BDSI0548,2020BDSI0548,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,8/28/2020,8/1/2020,,,Other,PAIN AND IRRITATION CAUSED BY THE BOTOX,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0548,2020BDSI0548,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product use in unapproved indication,Non-Health Professional,,,Male,I,8/28/2020,8/1/2020,,,,PAIN AND IRRITATION CAUSED BY THE BOTOX,UNITED STATES,Product use in unapproved indication,,NO,YES,Unlisted
2020BDSI0550,2020BDSI0550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Incorrect route of product administration,Non-Health Professional,68,Years,Female,I,8/28/2020,1/1/2020,,,,NEUROPATHY,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0550,2020BDSI0550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Therapeutic response decreased,Non-Health Professional,68,Years,Female,I,8/28/2020,1/1/2020,,,,NEUROPATHY,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0550,2020BDSI0550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Product adhesion issue,Non-Health Professional,68,Years,Female,I,8/28/2020,1/1/2020,,,,NEUROPATHY,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0550,2020BDSI0550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal tablet,,Oral administration complication,Non-Health Professional,68,Years,Female,I,8/28/2020,1/1/2020,,,,NEUROPATHY,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0551,2020BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,8/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0551,2020BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,75,Years,Female,I,8/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0551,2020BDSI0551,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,75,Years,Female,I,8/28/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0552,2020BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,I,8/31/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0552,2020BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,46,Years,Female,I,8/31/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0552,2020BDSI0552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,46,Years,Female,I,8/31/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0553,2020BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Male,I,8/31/2020,8/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0554,2020BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,59,Years,Male,I,8/31/2020,,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2020BDSI0554,2020BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Male,I,8/31/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0554,2020BDSI0554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth extraction,Non-Health Professional,59,Years,Male,I,8/31/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Tooth extraction,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Female,I,9/3/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Throat irritation,Non-Health Professional,73,Years,Female,I,9/3/2020,8/30/2020,,,,CHRONIC PAIN,UNITED STATES,Throat irritation,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wheezing,Non-Health Professional,73,Years,Female,I,9/3/2020,8/30/2020,,,,CHRONIC PAIN,UNITED STATES,Wheezing,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cough,Non-Health Professional,73,Years,Female,I,9/3/2020,8/30/2020,,,,CHRONIC PAIN,UNITED STATES,Cough,,NO,NO,Listed
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Female,I,9/3/2020,8/30/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Female,I,9/3/2020,8/30/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0555,2020BDSI0555,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,73,Years,Female,I,9/3/2020,9/2/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0556,2020BDSI0556,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Other Health Professional,58,Years,Female,I,9/2/2020,8/10/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0556,2020BDSI0556,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vertigo,Other Health Professional,58,Years,Female,I,9/2/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Vertigo,,NO,NO,Unlisted
2020BDSI0557,2020BDSI0557,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Headache,Physician,,,,I,9/1/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0558,2020BDSI0558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Disorientation,Other Health Professional,76,Years,,I,9/2/2020,6/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Disorientation,,NO,NO,Unlisted
2020BDSI0558,2020BDSI0558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Nausea,Other Health Professional,76,Years,,I,9/2/2020,6/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0558,2020BDSI0558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Dizziness,Other Health Professional,76,Years,,I,9/2/2020,6/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0560,2020BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Dysarthria,Other Health Professional,46,Years,Female,I,9/1/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dysarthria,,NO,NO,Unlisted
2020BDSI0561,2020BDSI0561,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,,Buccal film,,Chest pain,Non-Health Professional,59,Years,Female,I,9/2/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Chest pain,,NO,NO,Listed
2020BDSI0561,2020BDSI0561,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,,Buccal film,,Hypersensitivity,Non-Health Professional,59,Years,Female,I,9/2/2020,1/1/2020,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2020BDSI0564,2020BDSI0564,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oropharyngeal pain,Non-Health Professional,43,Years,Female,I,9/5/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oropharyngeal pain,,NO,NO,Listed
2020BDSI0564,2020BDSI0564,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,43,Years,Female,I,9/5/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,NO,Listed
2020BDSI0564,2020BDSI0564,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,43,Years,Female,I,9/5/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2020BDSI0566,2020BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Other Health Professional,67,Years,Male,I,9/9/2020,8/12/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Male,I,9/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Male,I,9/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,73,Years,Male,I,9/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,73,Years,Male,I,9/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Male,I,9/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0568,2020BDSI0568,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,73,Years,Male,I,9/9/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0569,2020BDSI0569,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Other Health Professional,50,Years,Male,I,9/10/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0569,2020BDSI0569,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysphagia,Other Health Professional,50,Years,Male,I,9/10/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dysphagia,,NO,NO,Unlisted
2020BDSI0569,2020BDSI0569,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pharyngeal hypoaesthesia,Other Health Professional,50,Years,Male,I,9/10/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pharyngeal hypoaesthesia,,NO,NO,Unlisted
2020BDSI0569,2020BDSI0569,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,50,Years,Male,I,9/10/2020,7/14/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0570,2020BDSI0570,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,9/10/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0570,2020BDSI0570,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Female,I,9/10/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0571,2020BDSI0571,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urinary tract infection,Pharmacist,,,Female,I,9/11/2020,9/11/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Urinary tract infection,,YES,YES,Listed
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,30,Years,Female,I,9/10/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,30,Years,Female,I,9/10/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0572,2020BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,30,Years,Female,I,9/10/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0573,2020BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,9/11/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0574,2020BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Paralysis,Non-Health Professional,69,Years,Male,I,9/14/2020,9/11/2020,,,Other,CHRONIC PAIN,UNITED STATES,Paralysis,,YES,YES,Unlisted
2020BDSI0574,2020BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,69,Years,Male,I,9/14/2020,9/13/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0574,2020BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Male,I,9/14/2020,9/13/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2020BDSI0574,2020BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,69,Years,Male,I,9/14/2020,9/12/2020,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,YES,Unlisted
2020BDSI0575,2020BDSI0575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inappropriate schedule of product administration,Non-Health Professional,70,Years,Male,I,9/14/2020,9/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Inappropriate schedule of product administration,,NO,NO,Unlisted
2020BDSI0575,2020BDSI0575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Male,I,9/14/2020,9/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0575,2020BDSI0575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,70,Years,Male,I,9/14/2020,9/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0575,2020BDSI0575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Male,I,9/14/2020,9/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0575,2020BDSI0575,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,9/14/2020,9/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0577,2020BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Hallucination,Physician,,,Male,I,9/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hallucination,,NO,NO,Unlisted
2020BDSI0577,2020BDSI0577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response decreased,Physician,,,Male,I,9/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0579,2020BDSI0579,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/15/2020,9/15/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0580,2020BDSI0580,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,9/15/2020,9/14/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0581,2020BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/16/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0581,2020BDSI0581,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/16/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0582,2020BDSI0582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Other Health Professional,43,Years,Male,I,9/17/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2020BDSI0583,2020BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,9/16/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0583,2020BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,68,Years,Female,I,9/16/2020,9/11/2020,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product administration error,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Insomnia,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Confusional state,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Negative thoughts,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Negative thoughts,,NO,NO,Unlisted
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Emotional disorder,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Emotional disorder,,NO,NO,Unlisted
2020BDSI0584,2020BDSI0584,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,53,Years,Male,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2020BDSI0585,2020BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Physician,,,Male,I,9/18/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,YES,YES,Unlisted
2020BDSI0586,2020BDSI0586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Pharmacist,,,Female,I,9/17/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2020BDSI0587,2020BDSI0587,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,9/18/2020,9/18/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0587,2020BDSI0587,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Female,I,9/18/2020,9/18/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0588,2020BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,9/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0588,2020BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Skin irritation,Non-Health Professional,,,Male,I,9/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Skin irritation,,NO,NO,Unlisted
2020BDSI0589,2020BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chronic obstructive pulmonary disease,Physician,69,Years,Male,I,9/18/2020,9/18/2020,,,,CHRONIC PAIN,UNITED STATES,Chronic obstructive pulmonary disease,,NO,NO,Unlisted
2020BDSI0589,2020BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Physician,69,Years,Male,I,9/18/2020,9/18/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0591,2020BDSI0591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/21/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0593,2020BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mental status changes,Non-Health Professional,50,Years,Female,I,9/22/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Mental status changes,,NO,NO,Unlisted
2020BDSI0593,2020BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Personality change,Non-Health Professional,50,Years,Female,I,9/22/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Personality change,,NO,NO,Unlisted
2020BDSI0593,2020BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abnormal behaviour,Non-Health Professional,50,Years,Female,I,9/22/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abnormal behaviour,,NO,NO,Unlisted
2020BDSI0595,2020BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,88,Years,Female,I,9/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0595,2020BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,88,Years,Female,I,9/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0595,2020BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intercepted product administration error,Non-Health Professional,88,Years,Female,I,9/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Intercepted product administration error,,NO,NO,Unlisted
2020BDSI0595,2020BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,88,Years,Female,I,9/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0597,2020BDSI0597,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product contamination physical,Pharmacist,,,Female,I,9/23/2020,,,,,CHRONIC PAIN,UNITED STATES,Product contamination physical,,NO,NO,Unlisted
2020BDSI0599,2020BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood glucose increased,Physician,,,Female,F,9/30/2020,9/17/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,YES,YES,Unlisted
2020BDSI0599,2020BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dehydration,Physician,,,Female,F,9/30/2020,9/17/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dehydration,,YES,YES,Listed
2020BDSI0599,2020BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Urinary tract infection,Physician,,,Female,F,9/30/2020,9/17/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Urinary tract infection,,YES,YES,Listed
2020BDSI0599,2020BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Incoherent,Physician,,,Female,F,9/30/2020,9/17/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Incoherent,,YES,YES,Unlisted
2020BDSI0602,2020BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Staring,Non-Health Professional,72,Years,Male,I,9/28/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Staring,,NO,NO,Unlisted
2020BDSI0602,2020BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Irritability,Non-Health Professional,72,Years,Male,I,9/28/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Irritability,,NO,NO,Unlisted
2020BDSI0602,2020BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,72,Years,Male,I,9/28/2020,9/26/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0602,2020BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Memory impairment,Non-Health Professional,72,Years,Male,I,9/28/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Memory impairment,,NO,NO,Unlisted
2020BDSI0602,2020BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,,Confusional state,Non-Health Professional,72,Years,Male,I,9/28/2020,8/27/2020,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0604,2020BDSI0604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,9/28/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0604,2020BDSI0604,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/28/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0607,2020BDSI0607,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,88,Years,Female,I,9/29/2020,9/28/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0607,2020BDSI0607,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,88,Years,Female,I,9/29/2020,9/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0610,2020BDSI0610,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,10/1/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0610,2020BDSI0610,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,10/1/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0610,2020BDSI0610,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,10/1/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0610,2020BDSI0610,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,10/1/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0610,2020BDSI0610,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/1/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0611,2020BDSI0611,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,9/30/2020,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0612,2020BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/1/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0613,2020BDSI0613,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Male,I,10/1/2020,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0614,2020BDSI0614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,61,Years,Female,I,10/1/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2020BDSI0614,2020BDSI0614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Female,I,10/1/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0614,2020BDSI0614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,61,Years,Female,I,10/1/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2020BDSI0615,2020BDSI0615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Female,I,10/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0615,2020BDSI0615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,10/5/2020,,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0616,2020BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,65,Years,Male,I,10/5/2020,6/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0616,2020BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Male,I,10/5/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2020BDSI0616,2020BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental dysaesthesia,Non-Health Professional,65,Years,Male,I,10/5/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dental dysaesthesia,,NO,YES,Unlisted
2020BDSI0616,2020BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,65,Years,Male,I,10/5/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2020BDSI0616,2020BDSI0616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,65,Years,Male,I,10/5/2020,9/30/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,YES,Unlisted
2020BDSI0617,2020BDSI0617,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,No adverse event,Non-Health Professional,47,Years,Female,I,10/6/2020,,,,,CHRONIC PAIN,UNITED STATES,No adverse event,,NO,NO,Unlisted
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Chest pain,Other Health Professional,46,Years,Female,I,10/6/2020,4/5/2020,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,46,Years,Female,I,10/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,46,Years,Female,I,10/6/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,46,Years,Female,I,10/6/2020,4/5/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,46,Years,Female,I,10/6/2020,4/5/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0620,2020BDSI0620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Asthma,Other Health Professional,46,Years,Female,I,10/6/2020,4/5/2020,,,,CHRONIC PAIN,UNITED STATES,Asthma,,NO,NO,Unlisted
2020BDSI0621,2020BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,63,Years,Female,I,10/8/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2020BDSI0621,2020BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,63,Years,Female,I,10/8/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0621,2020BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,63,Years,Female,I,10/8/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0621,2020BDSI0621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,63,Years,Female,I,10/8/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0625,2020BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,65,Years,Female,I,10/7/2020,10/7/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0625,2020BDSI0625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,10/7/2020,10/7/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0626,2020BDSI0626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/7/2020,10/7/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0626,2020BDSI0626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/7/2020,10/7/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0627,2020BDSI0627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,56,Years,Female,I,10/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0627,2020BDSI0627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,56,Years,Female,I,10/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0627,2020BDSI0627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nodule,Non-Health Professional,56,Years,Female,I,10/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nodule,,NO,NO,Unlisted
2020BDSI0627,2020BDSI0627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,56,Years,Female,I,10/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2020BDSI0627,2020BDSI0627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Swelling face,Non-Health Professional,56,Years,Female,I,10/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Swelling face,,NO,NO,Unlisted
2020BDSI0630,2020BDSI0630,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response unexpected,Non-Health Professional,59,Years,Female,I,10/7/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2020BDSI0631,2020BDSI0631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Pharmacist,59,Years,Female,I,10/8/2020,10/7/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0633,2020BDSI0633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,51,Years,Male,I,10/9/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0634,2020BDSI0634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Peripheral swelling,Other Health Professional,,,Female,I,10/9/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2020BDSI0635,2020BDSI0635,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,90,Years,Female,I,10/12/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0635,2020BDSI0635,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,90,Years,Female,I,10/12/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0636,2020BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,80,Years,Female,I,10/12/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2020BDSI0636,2020BDSI0636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,80,Years,Female,I,10/12/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2020BDSI0638,2020BDSI0638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,10/13/2020,10/13/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0638,2020BDSI0638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,10/13/2020,10/13/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0638,2020BDSI0638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,10/13/2020,10/13/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0639,2020BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0639,2020BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,10/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dry mouth,,NO,NO,Listed
2020BDSI0639,2020BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,10/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0639,2020BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0639,2020BDSI0639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/9/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0640,2020BDSI0640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,69,Years,Male,I,10/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0641,2020BDSI0641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,78,Years,Female,I,10/14/2020,9/29/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0641,2020BDSI0641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,78,Years,Female,I,10/14/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0642,2020BDSI0642,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Male,I,10/13/2020,10/12/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0642,2020BDSI0642,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Manufacturing production issue,Non-Health Professional,,,Male,I,10/13/2020,10/12/2020,,,,CHRONIC PAIN,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2020BDSI0643,2020BDSI0643,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,73,Years,Female,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2020BDSI0643,2020BDSI0643,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hot flush,Non-Health Professional,73,Years,Female,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2020BDSI0643,2020BDSI0643,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Non-Health Professional,73,Years,Female,I,10/14/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2020BDSI0644,2020BDSI0644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Female,I,10/14/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0644,2020BDSI0644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,65,Years,Female,I,10/14/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Heart rate increased,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Heart rate increased,,NO,NO,Unlisted
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Peripheral swelling,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Unlisted
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Hypotension,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Hypotension,,NO,NO,Listed
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Urticaria,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Urticaria,,NO,NO,Listed
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Rhinorrhoea,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Rhinorrhoea,,NO,NO,Listed
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Anxiety,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2020BDSI0646,2020BDSI0646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Ear discomfort,Non-Health Professional,64,Years,Female,I,10/15/2020,10/8/2020,,,,CHRONIC PAIN,UNITED STATES,Ear discomfort,,NO,NO,Unlisted
2020BDSI0647,2020BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspepsia,Non-Health Professional,61,Years,Female,I,10/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspepsia,,NO,NO,Listed
2020BDSI0647,2020BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,61,Years,Female,I,10/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0647,2020BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,61,Years,Female,I,10/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0647,2020BDSI0647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,61,Years,Female,I,10/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0648,2020BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Female,I,10/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0648,2020BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,10/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0648,2020BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,10/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0648,2020BDSI0648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,10/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0649,2020BDSI0649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,10/16/2020,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0650,2020BDSI0650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/16/2020,10/16/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0652,2020BDSI0652,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Pharmacist,,,Female,I,10/19/2020,10/19/2020,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0652,2020BDSI0652,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Pharmacist,,,Female,I,10/19/2020,10/19/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,YES,Unlisted
2020BDSI0653,2020BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,23,Years,Female,I,10/19/2020,10/18/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0653,2020BDSI0653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,23,Years,Female,I,10/19/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0655,2020BDSI0655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Application site pain,Non-Health Professional,75,Years,Female,I,10/19/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Application site pain,,NO,NO,Unlisted
2020BDSI0656,2020BDSI0656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,10/20/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2020BDSI0656,2020BDSI0656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/20/2020,10/20/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0656,2020BDSI0656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,10/20/2020,10/20/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0656,2020BDSI0656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Female,I,10/20/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0657,2020BDSI0657,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,10/19/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0658,2020BDSI0658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,79,Years,Female,I,10/21/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0658,2020BDSI0658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,79,Years,Female,I,10/21/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,54,Years,Female,I,10/23/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,54,Years,Female,I,10/23/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,54,Years,Female,I,10/23/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,54,Years,Female,I,10/23/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,54,Years,Female,I,10/23/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0659,2020BDSI0659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,54,Years,Female,I,10/23/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,57,Years,Female,I,10/26/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,57,Years,Female,I,10/26/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,57,Years,Female,I,10/26/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,57,Years,Female,I,10/26/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Swollen tongue,Non-Health Professional,57,Years,Female,I,10/26/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Swollen tongue,,NO,NO,Unlisted
2020BDSI0661,2020BDSI0661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Palpitations,Non-Health Professional,57,Years,Female,I,10/26/2020,10/11/2020,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0662,2020BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Female,I,10/24/2020,10/23/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0662,2020BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,63,Years,Female,I,10/24/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0662,2020BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,63,Years,Female,I,10/24/2020,10/24/2020,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0662,2020BDSI0662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,63,Years,Female,I,10/24/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0663,2020BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Weight increased,Non-Health Professional,,,Male,I,10/28/2020,,,,,OPIOID DEPENDENCE,UNITED STATES,Weight increased,,NO,NO,Unlisted
2020BDSI0663,2020BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Weight increased,Non-Health Professional,,,Male,I,10/28/2020,,,,,OPIOID DEPENDENCE,UNITED STATES,Weight increased,,NO,NO,Unlisted
2020BDSI0663,2020BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Therapeutic response unexpected,Non-Health Professional,,,Male,I,10/28/2020,,,,,OPIOID DEPENDENCE,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2020BDSI0663,2020BDSI0663,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,Buccal film,,Therapeutic response unexpected,Non-Health Professional,,,Male,I,10/28/2020,,,,,OPIOID DEPENDENCE,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2020BDSI0665,2020BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,75,Years,Female,I,10/29/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0665,2020BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,75,Years,Female,I,10/29/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0665,2020BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,75,Years,Female,I,10/29/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0665,2020BDSI0665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,10/29/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0666,2020BDSI0666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Generalised oedema,Other Health Professional,,,Female,I,10/29/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Generalised oedema,,NO,NO,Unlisted
2020BDSI0666,2020BDSI0666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pruritus,Other Health Professional,,,Female,I,10/29/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0666,2020BDSI0666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Erythema,Other Health Professional,,,Female,I,10/29/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Erythema,,NO,NO,Unlisted
2020BDSI0667,2020BDSI0667,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,10/29/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0668,2020BDSI0668,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,10/30/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0669,2020BDSI0669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,59,Years,Female,I,10/30/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0669,2020BDSI0669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Female,I,10/30/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0669,2020BDSI0669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,59,Years,Female,I,10/30/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0669,2020BDSI0669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysgeusia,Non-Health Professional,59,Years,Female,I,10/30/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,32,Years,Female,I,10/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,32,Years,Female,I,10/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,32,Years,Female,I,10/31/2020,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pain,Non-Health Professional,32,Years,Female,I,10/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,32,Years,Female,I,10/31/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Suicidal ideation,Non-Health Professional,32,Years,Female,I,10/31/2020,1/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2020BDSI0671,2020BDSI0671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,10/31/2020,10/31/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2020BDSI0672,2020BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,62,Years,Female,I,11/3/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0672,2020BDSI0672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Aggression,Non-Health Professional,62,Years,Female,I,11/3/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Aggression,,NO,NO,Unlisted
2020BDSI0674,2020BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,,,Female,I,11/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2020BDSI0674,2020BDSI0674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,11/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0675,2020BDSI0675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Overdose,Other Health Professional,,,Male,F,11/20/2020,1/1/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Overdose,,YES,YES,Unlisted
2020BDSI0676,2020BDSI0676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Manufacturing production issue,Non-Health Professional,,,Female,I,11/5/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2020BDSI0678,2020BDSI0678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,11/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0678,2020BDSI0678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,68,Years,Female,I,11/4/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,YES,Unlisted
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastric disorder,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Gastric disorder,,NO,YES,Unlisted
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypotension,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hypotension,,NO,YES,Unlisted
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0679,2020BDSI0679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Non-Health Professional,62,Years,Male,I,11/6/2020,11/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Chest pain,,YES,YES,Listed
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental restoration failure,Non-Health Professional,66,Years,Male,I,2/22/2021,,,,,CHRONIC PAIN,UNITED STATES,Dental restoration failure,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,66,Years,Male,I,2/22/2021,11/7/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product availability issue,Non-Health Professional,66,Years,Male,I,2/22/2021,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Product availability issue,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Male,I,2/22/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fall,Non-Health Professional,66,Years,Male,I,2/22/2021,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Fall,,NO,NO,Listed
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Limb injury,Non-Health Professional,66,Years,Male,I,2/22/2021,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Limb injury,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rotator cuff syndrome,Non-Health Professional,66,Years,Male,I,2/22/2021,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Rotator cuff syndrome,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tendonitis,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Tendonitis,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Radiculopathy,Non-Health Professional,66,Years,Male,I,2/22/2021,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Radiculopathy,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Male,I,2/22/2021,5/30/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0680,2020BDSI0680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Male,I,2/22/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0685,2020BDSI0685,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,11/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,11/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,,,Male,I,11/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vertigo,Non-Health Professional,,,Male,I,11/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Vertigo,,NO,NO,Unlisted
2020BDSI0688,2020BDSI0688,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,,,Male,I,11/11/2020,2/1/2020,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0689,2020BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/11/2020,10/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0689,2020BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,,Female,I,11/11/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2020BDSI0689,2020BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,11/11/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0689,2020BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/11/2020,10/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0689,2020BDSI0689,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/11/2020,10/29/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0691,2020BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0691,2020BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0691,2020BDSI0691,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0692,2020BDSI0692,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,36,Years,Female,I,11/11/2020,11/6/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0694,2020BDSI0694,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,57,Years,Female,I,11/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0694,2020BDSI0694,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product prescribing error,Non-Health Professional,57,Years,Female,I,11/12/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0697,2020BDSI0697,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Euphoric mood,Physician,,,Male,I,11/16/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Euphoric mood,,NO,NO,Unlisted
2020BDSI0698,2020BDSI0698,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Aversion,Non-Health Professional,,,Male,I,11/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Aversion,,NO,NO,Unlisted
2020BDSI0699,2020BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,,,Female,I,11/17/2020,11/16/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2020BDSI0699,2020BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,,,Female,I,11/17/2020,11/16/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Palpitations,,NO,NO,Unlisted
2020BDSI0699,2020BDSI0699,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,11/17/2020,11/16/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0700,2020BDSI0700,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0700,2020BDSI0700,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0701,2020BDSI0701,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,38,Years,Female,I,11/16/2020,11/16/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0701,2020BDSI0701,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,38,Years,Female,I,11/16/2020,11/16/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0701,2020BDSI0701,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,38,Years,Female,I,11/16/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0702,2020BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Female,I,11/16/2020,11/12/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0702,2020BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Female,I,11/16/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0702,2020BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,63,Years,Female,I,11/16/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0702,2020BDSI0702,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Female,I,11/16/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0703,2020BDSI0703,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,11/17/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0704,2020BDSI0704,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,11/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0704,2020BDSI0704,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,11/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0704,2020BDSI0704,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0705,2020BDSI0705,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,74,Years,Female,I,11/17/2020,11/17/2020,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2020BDSI0705,2020BDSI0705,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,11/17/2020,11/17/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0705,2020BDSI0705,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,74,Years,Female,I,11/17/2020,11/17/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0707,2020BDSI0707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,11/20/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0707,2020BDSI0707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/20/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0707,2020BDSI0707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/20/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0707,2020BDSI0707,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,11/20/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0718,2020BDSI0718,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,12/1/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0720,2020BDSI0720,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Incorrect route of product administration,Other Health Professional,,,,I,12/2/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,I,12/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,51,Years,Female,I,12/9/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,51,Years,Female,I,12/9/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,51,Years,Female,I,12/9/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,51,Years,Female,I,12/9/2020,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2020BDSI0724,2020BDSI0724,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,51,Years,Female,I,12/9/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0726,2020BDSI0726,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,49,Years,Female,I,12/4/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0727,2020BDSI0727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Male,I,12/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0727,2020BDSI0727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,12/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0727,2020BDSI0727,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,12/4/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0729,2020BDSI0729,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,12/7/2020,11/23/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0729,2020BDSI0729,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/7/2020,11/23/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0729,2020BDSI0729,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,12/7/2020,11/23/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0730,2020BDSI0730,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/7/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0731,2020BDSI0731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Physician,88,Years,Female,I,12/7/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2020BDSI0731,2020BDSI0731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Physician,88,Years,Female,I,12/7/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0731,2020BDSI0731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,88,Years,Female,I,12/7/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0732,2020BDSI0732,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,73,Years,Male,I,12/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0733,2020BDSI0733,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Transcription medication error,Non-Health Professional,,,Female,I,12/8/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Transcription medication error,,NO,NO,Unlisted
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,I,12/8/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug hypersensitivity,Non-Health Professional,59,Years,Female,I,12/8/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug hypersensitivity,,NO,NO,Listed
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,59,Years,Female,I,12/8/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Insomnia,Non-Health Professional,59,Years,Female,I,12/8/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,59,Years,Female,I,12/8/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0734,2020BDSI0734,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product administration error,Non-Health Professional,59,Years,Female,I,12/8/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0735,2020BDSI0735,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,77,Years,Male,I,12/7/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0735,2020BDSI0735,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Pharmacist,77,Years,Male,I,12/7/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0735,2020BDSI0735,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Pharmacist,77,Years,Male,I,12/7/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0737,2020BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,49,Years,Male,I,12/9/2020,12/9/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0737,2020BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,49,Years,Male,I,12/9/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2020BDSI0737,2020BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,49,Years,Male,I,12/9/2020,12/8/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0737,2020BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,49,Years,Male,I,12/9/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2020BDSI0737,2020BDSI0737,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,49,Years,Male,I,12/9/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2020BDSI0738,2020BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,12/7/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0738,2020BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,70,Years,Male,I,12/7/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2020BDSI0738,2020BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,70,Years,Male,I,12/7/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0738,2020BDSI0738,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mental impairment,Non-Health Professional,70,Years,Male,I,12/7/2020,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Mental impairment,,NO,NO,Unlisted
2020BDSI0739,2020BDSI0739,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Manufacturing production issue,Pharmacist,,,Female,I,12/9/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Male,I,12/9/2020,9/22/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,65,Years,Male,I,12/9/2020,11/19/2020,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,65,Years,Male,I,12/9/2020,11/19/2020,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,65,Years,Male,I,12/9/2020,11/19/2020,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inhibitory drug interaction,Non-Health Professional,65,Years,Male,I,12/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Inhibitory drug interaction,,NO,NO,Unlisted
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Male,I,12/9/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0740,2020BDSI0740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,65,Years,Male,I,12/9/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2020BDSI0741,2020BDSI0741,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,65,Years,Female,I,12/11/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2020BDSI0743,2020BDSI0743,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Physician,,,Female,I,12/10/2020,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0744,2020BDSI0744,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,12/2/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0744,2020BDSI0744,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Male,I,12/2/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Asthenia,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tinnitus,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Tinnitus,,NO,YES,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Skin necrosis,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Skin necrosis,,NO,YES,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,12/11/2020,1/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,YES,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Irritability,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Irritability,,NO,YES,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anger,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Anger,,NO,YES,Unlisted
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,YES,Listed
2020BDSI0745,2020BDSI0745,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,,,Male,I,12/11/2020,,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,YES,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,49,Years,Female,I,12/15/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,49,Years,Female,I,12/15/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,49,Years,Female,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,49,Years,Female,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,49,Years,Female,I,12/15/2020,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect dose administered by product,Non-Health Professional,49,Years,Female,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect dose administered by product,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,49,Years,Female,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0746,2020BDSI0746,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,49,Years,Female,I,12/15/2020,7/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2020BDSI0749,2020BDSI0749,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,84,Years,Male,I,12/11/2020,12/11/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0750,2020BDSI0750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Female,I,12/11/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0750,2020BDSI0750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Female,I,12/11/2020,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0750,2020BDSI0750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Female,I,12/11/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0750,2020BDSI0750,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Female,I,12/11/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0751,2020BDSI0751,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product commingling,Pharmacist,,,Female,I,12/14/2020,9/3/2020,,,,CHRONIC PAIN,UNITED STATES,Product commingling,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Male,I,12/15/2020,11/24/2020,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,12/15/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2020BDSI0752,2020BDSI0752,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,,,Male,I,12/15/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,NO,NO,Listed
2020BDSI0753,2020BDSI0753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash,Non-Health Professional,,,Female,I,12/14/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2020BDSI0753,2020BDSI0753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,,,Female,I,12/14/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2020BDSI0753,2020BDSI0753,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Scab,Non-Health Professional,,,Female,I,12/14/2020,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Scab,,NO,NO,Unlisted
2020BDSI0758,2020BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malaise,Non-Health Professional,,,Female,I,12/17/2020,12/15/2020,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2020BDSI0758,2020BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,12/17/2020,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0758,2020BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,General symptom,Non-Health Professional,,,Female,I,12/17/2020,12/16/2020,,,,CHRONIC PAIN,UNITED STATES,General symptom,,NO,NO,Unlisted
2020BDSI0758,2020BDSI0758,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,12/17/2020,12/16/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2020BDSI0759,2020BDSI0759,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tongue discomfort,Other Health Professional,,,Female,I,12/17/2020,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tongue discomfort,,NO,NO,Unlisted
2020BDSI0760,2020BDSI0760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Male,I,12/16/2020,12/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2020BDSI0760,2020BDSI0760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Male,I,12/16/2020,12/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2020BDSI0760,2020BDSI0760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Male,I,12/16/2020,12/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0760,2020BDSI0760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,12/16/2020,12/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0761,2020BDSI0761,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Male,I,12/18/2020,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0761,2020BDSI0761,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,59,Years,Male,I,12/18/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2020BDSI0762,2020BDSI0762,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Female,I,12/21/2020,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Unlisted
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,,,Female,I,12/21/2020,12/20/2020,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,12/21/2020,12/9/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,12/21/2020,12/20/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0764,2020BDSI0764,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2020BDSI0766,2020BDSI0766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,55,Years,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2020BDSI0766,2020BDSI0766,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Other Health Professional,55,Years,Female,I,12/21/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2020BDSI0767,2020BDSI0767,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,12/22/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2020BDSI0767,2020BDSI0767,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Nausea,Non-Health Professional,,,Female,I,12/22/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2020BDSI0770,2020BDSI0770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Male,I,12/28/2020,12/15/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2020BDSI0770,2020BDSI0770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,47,Years,Male,I,12/28/2020,12/15/2020,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2020BDSI0770,2020BDSI0770,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,47,Years,Male,I,12/28/2020,12/22/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2020BDSI0771,2020BDSI0771,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,12/28/2020,12/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2020BDSI0774,2020BDSI0774,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Alopecia,Non-Health Professional,76,Years,Female,I,12/29/2020,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Alopecia,,NO,NO,Unlisted
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Male,I,1/4/2021,12/29/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Male,I,1/4/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,64,Years,Male,I,1/4/2021,12/29/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Male,I,1/4/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Male,I,1/4/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0002,2021BDSI0002,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,64,Years,Male,I,1/4/2021,12/29/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0003,2021BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,1/5/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0003,2021BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,1/5/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0003,2021BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,1/5/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0003,2021BDSI0003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/5/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0004,2021BDSI0004,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,1/6/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0005,2021BDSI0005,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,1/5/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0006,2021BDSI0006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,1/6/2021,1/6/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0007,2021BDSI0007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,68,Years,Female,I,1/6/2021,12/31/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0007,2021BDSI0007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,68,Years,Female,I,1/6/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0007,2021BDSI0007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,68,Years,Female,I,1/6/2021,12/31/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0007,2021BDSI0007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,68,Years,Female,I,1/6/2021,12/31/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0007,2021BDSI0007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,68,Years,Female,I,1/6/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0009,2021BDSI0009,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/9/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0011,2021BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,1/12/2021,1/1/2021,,,,CONSTANT DEBILITATING PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0012,2021BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Adverse drug reaction,Other Health Professional,,,Male,I,1/14/2021,10/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Adverse drug reaction,,NO,YES,Listed
2021BDSI0012,2021BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Atrioventricular block,Other Health Professional,,,Male,I,1/14/2021,1/1/2020,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Atrioventricular block,,YES,YES,Unlisted
2021BDSI0013,2021BDSI0013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Male,I,1/15/2021,10/21/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0014,2021BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/16/2021,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0015,2021BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/15/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0016,2021BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Suicidal ideation,Other Health Professional,43,Years,Female,I,1/19/2021,12/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2021BDSI0016,2021BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling abnormal,Other Health Professional,43,Years,Female,I,1/19/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2021BDSI0016,2021BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product communication issue,Other Health Professional,43,Years,Female,I,1/19/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,YES,Unlisted
2021BDSI0016,2021BDSI0016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Intentional self-injury,Other Health Professional,43,Years,Female,I,1/19/2021,12/1/2020,,,Other,CHRONIC PAIN,UNITED STATES,Intentional self-injury,,YES,YES,Unlisted
2021BDSI0017,2021BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use in unapproved indication,Non-Health Professional,,,Female,I,1/19/2021,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2021BDSI0017,2021BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,Female,I,1/19/2021,,,,,BREAKTHROUGH PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0017,2021BDSI0017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,1/19/2021,,,,,BREAKTHROUGH PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0020,2021BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Pharmacist,43,Years,Female,I,1/20/2021,1/20/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0024,2021BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,53,Years,Female,I,1/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0025,2021BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,59,Years,Female,I,1/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0025,2021BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,59,Years,Female,I,1/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0026,2021BDSI0026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,53,Years,Male,I,1/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0029,2021BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,1/22/2021,1/19/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0030,2021BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0030,2021BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0030,2021BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0031,2021BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,29,Years,Male,I,1/26/2021,1/1/2018,,,,PAIN POST DISCECTOMY,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0031,2021BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,29,Years,Male,I,1/26/2021,,,,,PAIN POST DISCECTOMY,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0031,2021BDSI0031,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,29,Years,Male,I,1/26/2021,,,,,PAIN POST DISCECTOMY,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2021BDSI0032,2021BDSI0032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Somnolence,Non-Health Professional,46,Years,Female,I,1/26/2021,,,,,BACK PAIN DUE TO SCOLIOSIS,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0034,2021BDSI0034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,39,Years,Female,I,1/28/2021,,,,,BACK PAIN DUE TO SPINE ABNORMALITY,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0034,2021BDSI0034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,39,Years,Female,I,1/28/2021,,,,,BACK PAIN DUE TO SPINE ABNORMALITY,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,51,Years,Female,I,1/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,51,Years,Female,I,1/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,51,Years,Female,I,1/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,51,Years,Female,I,1/28/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,I,1/28/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0035,2021BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,51,Years,Female,I,1/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0036,2021BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,53,Years,Male,I,1/29/2021,4/1/2020,,,,RSD PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0036,2021BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Male,I,1/29/2021,,,,,RSD PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2021BDSI0036,2021BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,53,Years,Male,I,1/29/2021,,,,,RSD PAIN,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2021BDSI0036,2021BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Toothache,Non-Health Professional,53,Years,Male,I,1/29/2021,,,,,RSD PAIN,UNITED STATES,Toothache,,NO,YES,Listed
2021BDSI0036,2021BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,53,Years,Male,I,1/29/2021,4/1/2020,,,Other,RSD PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0037,2021BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Male,I,1/29/2021,,,,,LOWER BACK PAIN AND NEUROPATHY DUE TO CHARCOT-MARIE-TOOTH,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0037,2021BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,59,Years,Male,I,1/29/2021,,,,,LOWER BACK PAIN AND NEUROPATHY DUE TO CHARCOT-MARIE-TOOTH,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0037,2021BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Male,I,1/29/2021,,,,,LOWER BACK PAIN AND NEUROPATHY DUE TO CHARCOT-MARIE-TOOTH,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0038,2021BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/29/2021,12/28/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0038,2021BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/29/2021,12/28/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0039,2021BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Withdrawal syndrome,Non-Health Professional,60,Years,Male,I,2/1/2021,,,,Other,PAIN DUE TO MULTIPLE SPINAL FRACTURES AND SUBSEQUENT SURGERIES AND NEUROPATHY IN HIS BACK AND ARMS,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
2021BDSI0039,2021BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Heart rate decreased,Non-Health Professional,60,Years,Male,I,2/1/2021,,,,,PAIN DUE TO MULTIPLE SPINAL FRACTURES AND SUBSEQUENT SURGERIES AND NEUROPATHY IN HIS BACK AND ARMS,UNITED STATES,Heart rate decreased,,NO,YES,Unlisted
2021BDSI0040,2021BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0040,2021BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Extrasystoles,Non-Health Professional,,,Female,I,2/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Extrasystoles,,NO,NO,Unlisted
2021BDSI0040,2021BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,,,Female,I,2/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2021BDSI0040,2021BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,2/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2021BDSI0041,2021BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product quality issue,Non-Health Professional,,,Male,I,2/1/2021,,,,,CHRONIC PAIN,UNITED STATES,Product quality issue,,NO,NO,Unlisted
2021BDSI0041,2021BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,2/1/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0041,2021BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,2/1/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0041,2021BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,2/1/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0041,2021BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/1/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0043,2021BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,2/3/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,,,Female,I,2/3/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,,,Female,I,2/3/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,NO,Listed
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/3/2021,10/23/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,,,Female,I,2/3/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,2/3/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Night sweats,Non-Health Professional,,,Female,I,2/3/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Night sweats,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Palpitations,Non-Health Professional,,,Female,I,2/3/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2021BDSI0044,2021BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Female,I,2/3/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0045,2021BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,51,Years,,I,2/3/2021,,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0046,2021BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,,,Female,I,2/4/2021,1/30/2021,,,,PAIN MANAGEMENT,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2021BDSI0046,2021BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,2/4/2021,1/30/2021,,,,PAIN MANAGEMENT,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0046,2021BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,2/4/2021,1/30/2021,,,,PAIN MANAGEMENT,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0046,2021BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,,,Female,I,2/4/2021,2/1/2021,,,,PAIN MANAGEMENT,UNITED STATES,Memory impairment,,NO,NO,Unlisted
2021BDSI0049,2021BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Knee operation,Non-Health Professional,78,Years,Female,I,2/6/2021,,,,,CHRONIC PAIN,UNITED STATES,Knee operation,,NO,NO,Unlisted
2021BDSI0049,2021BDSI0049,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,78,Years,Female,I,2/6/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,49,Years,Male,I,2/8/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,49,Years,Male,I,2/8/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,49,Years,Male,I,2/8/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,49,Years,Male,I,2/8/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,49,Years,Male,I,2/8/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,49,Years,Male,I,2/8/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0051,2021BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,49,Years,Male,I,2/8/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0052,2021BDSI0052,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Male,I,2/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2021BDSI0053,2021BDSI0053,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0054,2021BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,,Buccal film,,Radiculopathy,Non-Health Professional,,,Male,I,2/8/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Radiculopathy,,YES,YES,Unlisted
2021BDSI0054,2021BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,,Buccal film,,Gait inability,Non-Health Professional,,,Male,I,2/8/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Gait inability,,YES,YES,Unlisted
2021BDSI0057,2021BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,2/9/2021,,,,Other,SEVERE CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0059,2021BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,2/8/2021,1/19/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0059,2021BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0060,2021BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0060,2021BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Female,I,2/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2021BDSI0060,2021BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0061,2021BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Other Health Professional,,,Male,I,2/9/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0062,2021BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Body temperature fluctuation,Non-Health Professional,,,Female,I,2/10/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Body temperature fluctuation,,NO,NO,Unlisted
2021BDSI0062,2021BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Female,I,2/10/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2021BDSI0062,2021BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Chills,Non-Health Professional,,,Female,I,2/10/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Chills,,NO,NO,Listed
2021BDSI0063,2021BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,I,2/9/2021,1/27/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0063,2021BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,69,Years,Female,I,2/9/2021,2/4/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0063,2021BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,69,Years,Female,I,2/9/2021,2/3/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0065,2021BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,2/10/2021,9/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0065,2021BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,63,Years,Female,I,2/10/2021,2/7/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0067,2021BDSI0067,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/11/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0067,2021BDSI0067,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/11/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0068,2021BDSI0068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,45,Years,Male,I,2/11/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0069,2021BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,38,Years,Female,I,2/11/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0070,2021BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Female,I,2/12/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2021BDSI0070,2021BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,2/12/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,68,Years,Female,I,2/12/2021,2/12/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,68,Years,Female,I,2/12/2021,2/12/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,68,Years,Female,I,2/12/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,68,Years,Female,I,2/12/2021,2/12/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Illness,Non-Health Professional,68,Years,Female,I,2/12/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Illness,,NO,NO,Unlisted
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait inability,Non-Health Professional,68,Years,Female,I,2/12/2021,2/12/2021,,,,CHRONIC PAIN,UNITED STATES,Gait inability,,NO,NO,Unlisted
2021BDSI0071,2021BDSI0071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,68,Years,Female,I,2/12/2021,2/12/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0072,2021BDSI0072,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,54,Years,Female,I,2/12/2021,9/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0073,2021BDSI0073,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Off label use,Pharmacist,,,Female,I,2/16/2021,,,,,OPIOID WITHDRAWAL,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0074,2021BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/15/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0074,2021BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Male,I,2/15/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,52,Years,Female,I,2/18/2021,1/6/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,52,Years,Female,I,2/18/2021,2/17/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Procedural pain,Non-Health Professional,52,Years,Female,I,2/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Procedural pain,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug dependence,Non-Health Professional,52,Years,Female,I,2/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug dependence,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Irritability,Non-Health Professional,52,Years,Female,I,2/18/2021,1/6/2021,,,,CHRONIC PAIN,UNITED STATES,Irritability,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,52,Years,Female,I,2/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,52,Years,Female,I,2/18/2021,1/6/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Crying,Non-Health Professional,52,Years,Female,I,2/18/2021,1/6/2021,,,,CHRONIC PAIN,UNITED STATES,Crying,,NO,NO,Unlisted
2021BDSI0076,2021BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,52,Years,Female,I,2/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0077,2021BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/19/2021,2/19/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0077,2021BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/19/2021,2/19/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0077,2021BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/19/2021,2/19/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0077,2021BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/19/2021,2/19/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0078,2021BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,62,Years,Male,I,2/18/2021,11/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2021BDSI0078,2021BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dizziness,Other Health Professional,62,Years,Male,I,2/18/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0078,2021BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Chest pain,Other Health Professional,62,Years,Male,I,2/18/2021,11/23/2020,,,,CHRONIC PAIN,UNITED STATES,Chest pain,,NO,NO,Listed
2021BDSI0079,2021BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,79,Years,Female,I,2/19/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0079,2021BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,79,Years,Female,I,2/19/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0079,2021BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,79,Years,Female,I,2/19/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0079,2021BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,79,Years,Female,I,2/19/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0079,2021BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,79,Years,Female,I,2/19/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0080,2021BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product solubility abnormal,Physician,,,,I,2/18/2021,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Fine motor skill dysfunction,Non-Health Professional,52,Years,Female,I,2/19/2021,,,,,CHRONIC PAIN,UNITED STATES,Fine motor skill dysfunction,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Gait inability,Non-Health Professional,52,Years,Female,I,2/19/2021,,,,,CHRONIC PAIN,UNITED STATES,Gait inability,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Breakthrough pain,Non-Health Professional,52,Years,Female,I,2/19/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Insomnia,Non-Health Professional,52,Years,Female,I,2/19/2021,,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product packaging quantity issue,Non-Health Professional,52,Years,Female,I,2/19/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product solubility abnormal,Non-Health Professional,52,Years,Female,I,2/19/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Product prescribing error,Non-Health Professional,52,Years,Female,I,2/19/2021,1/15/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0082,2021BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Therapeutic response decreased,Non-Health Professional,52,Years,Female,I,2/19/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0083,2021BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/22/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0084,2021BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,56,Years,Female,I,2/23/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Male,I,2/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intervertebral disc injury,Non-Health Professional,63,Years,Male,I,2/24/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Intervertebral disc injury,,NO,NO,Unlisted
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Male,I,2/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Male,I,2/24/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,63,Years,Male,I,2/24/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2021BDSI0085,2021BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Male,I,2/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,42,Years,Female,I,2/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,42,Years,Female,I,2/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Decreased activity,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Decreased activity,,NO,NO,Unlisted
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Lethargy,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Lethargy,,NO,NO,Listed
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0086,2021BDSI0086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Malaise,Non-Health Professional,42,Years,Female,I,2/24/2021,2/22/2021,,,,CHRONIC PAIN,UNITED STATES,Malaise,,NO,NO,Unlisted
2021BDSI0087,2021BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,2/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0087,2021BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,63,Years,Female,I,2/25/2021,2/25/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0087,2021BDSI0087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,63,Years,Female,I,2/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,37,Years,Female,I,2/26/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,37,Years,Female,I,2/26/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,37,Years,Female,I,2/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,37,Years,Female,I,2/26/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,37,Years,Female,I,2/26/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0089,2021BDSI0089,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Discomfort,Non-Health Professional,37,Years,Female,I,2/26/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Discomfort,,NO,NO,Unlisted
2021BDSI0090,2021BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/25/2021,2/10/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0090,2021BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,2/25/2021,2/25/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0090,2021BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,2/25/2021,2/10/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0091,2021BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,68,Years,Male,I,2/25/2021,2/25/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0092,2021BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,2/26/2021,2/9/2021,,,,PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0092,2021BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,,,Female,I,2/26/2021,2/9/2021,,,,PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2021BDSI0092,2021BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,2/26/2021,2/1/2021,,,,PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0093,2021BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,2/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0093,2021BDSI0093,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0094,2021BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Female,I,2/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0094,2021BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Female,I,2/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0094,2021BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysuria,Non-Health Professional,66,Years,Female,I,2/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dysuria,,NO,NO,Unlisted
2021BDSI0094,2021BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Female,I,2/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0095,2021BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Sublingual use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,67,Years,Female,I,3/2/2021,2/28/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0095,2021BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Sublingual use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,67,Years,Female,I,3/2/2021,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0095,2021BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Sublingual use,,,,microgram,Buccal film,,Product use in unapproved indication,Non-Health Professional,67,Years,Female,I,3/2/2021,2/28/2021,,,,CHRONIC PAIN,UNITED STATES,Product use in unapproved indication,,NO,NO,Unlisted
2021BDSI0096,2021BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0096,2021BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0096,2021BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,3/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0096,2021BDSI0096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0097,2021BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth erosion,Non-Health Professional,50,Years,Male,I,3/3/2021,3/2/2021,,,,CHRONIC PAIN,UNITED STATES,Tooth erosion,,NO,NO,Unlisted
2021BDSI0099,2021BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product outer packaging issue,Non-Health Professional,,,Female,I,3/4/2021,3/2/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2021BDSI0099,2021BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Female,I,3/4/2021,3/2/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2021BDSI0099,2021BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,3/4/2021,3/2/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0099,2021BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,,,Female,I,3/4/2021,3/2/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2021BDSI0100,2021BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,78,Years,Female,I,3/4/2021,,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,NO,Unlisted
2021BDSI0100,2021BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,78,Years,Female,I,3/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0100,2021BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Non-Health Professional,78,Years,Female,I,3/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2021BDSI0100,2021BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,78,Years,Female,I,3/4/2021,,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2021BDSI0100,2021BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,78,Years,Female,I,3/4/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0101,2021BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Male,I,3/4/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0101,2021BDSI0101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,3/4/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0102,2021BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,84,Years,Female,I,3/5/2021,3/4/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0102,2021BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,84,Years,Female,I,3/5/2021,3/4/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0102,2021BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,84,Years,Female,I,3/5/2021,3/4/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0102,2021BDSI0102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,84,Years,Female,I,3/5/2021,3/4/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0103,2021BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,52,Years,Female,I,3/8/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2021BDSI0103,2021BDSI0103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,52,Years,Female,I,3/8/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Female,I,3/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,3/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,3/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,3/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,3/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0104,2021BDSI0104,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,3/8/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0105,2021BDSI0105,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Other Health Professional,19,Years,Female,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2021BDSI0106,2021BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission in error,Non-Health Professional,39,Years,Female,I,3/8/2021,3/8/2021,,,,CHRONIC PAIN,UNITED STATES,Product dose omission in error,,NO,NO,Unlisted
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Male,I,3/9/2021,11/26/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Male,I,3/9/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,3/9/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Male,I,3/9/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Male,I,3/9/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0107,2021BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,3/9/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,62,Years,Male,I,3/9/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product primary packaging issue,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product primary packaging issue,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0108,2021BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,62,Years,Male,I,3/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0109,2021BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,3/10/2021,3/1/2021,,,,CHRONIC NEUROPATHIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0109,2021BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/10/2021,3/1/2021,,,,CHRONIC NEUROPATHIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0109,2021BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/10/2021,3/1/2021,,,,CHRONIC NEUROPATHIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0110,2021BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,61,Years,Male,I,3/11/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Listed
2021BDSI0111,2021BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Off label use,Non-Health Professional,62,Years,Female,I,3/12/2021,1/1/2021,,,,TREATMENT-RESISTANT DEPRESSION,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0111,2021BDSI0111,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,62,Years,Female,I,3/12/2021,1/1/2021,,,,TREATMENT-RESISTANT DEPRESSION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0112,2021BDSI0112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Physician,36,Years,Female,I,3/12/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0113,2021BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Male,I,3/12/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0113,2021BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,59,Years,Male,I,3/12/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0113,2021BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,59,Years,Male,I,3/12/2021,2/9/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0113,2021BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,59,Years,Male,I,3/12/2021,2/9/2021,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0114,2021BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Restlessness,Non-Health Professional,39,Years,Female,I,3/15/2021,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Restlessness,,NO,NO,Unlisted
2021BDSI0114,2021BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Akathisia,Non-Health Professional,39,Years,Female,I,3/15/2021,10/1/2020,,,,CHRONIC PAIN,UNITED STATES,Akathisia,,NO,NO,Unlisted
2021BDSI0114,2021BDSI0114,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,39,Years,Female,I,3/15/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0115,2021BDSI0115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Male,I,3/16/2021,3/12/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0116,2021BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pain,Other Health Professional,58,Years,Female,I,3/16/2021,3/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Pain,,NO,YES,Listed
2021BDSI0116,2021BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Other Health Professional,58,Years,Female,I,3/16/2021,3/14/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2021BDSI0116,2021BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Suicidal ideation,Other Health Professional,58,Years,Female,I,3/16/2021,3/12/2021,,,Other,CHRONIC BACK PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2021BDSI0116,2021BDSI0116,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Depression,Other Health Professional,58,Years,Female,I,3/16/2021,3/11/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Depression,,NO,YES,Listed
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Female,I,3/16/2021,3/16/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Psychiatric symptom,Non-Health Professional,67,Years,Female,I,3/16/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Psychiatric symptom,,NO,NO,Unlisted
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Application site acne,Non-Health Professional,67,Years,Female,I,3/16/2021,3/20/2021,,,,CHRONIC PAIN,UNITED STATES,Application site acne,,NO,NO,Unlisted
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,67,Years,Female,I,3/16/2021,3/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,67,Years,Female,I,3/16/2021,3/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,67,Years,Female,I,3/16/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0117,2021BDSI0117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abnormal faeces,Non-Health Professional,67,Years,Female,I,3/16/2021,3/16/2021,,,,CHRONIC PAIN,UNITED STATES,Abnormal faeces,,NO,NO,Unlisted
2021BDSI0118,2021BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,3/16/2021,3/16/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0118,2021BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product communication issue,Non-Health Professional,,,Female,I,3/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0118,2021BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Anger,Non-Health Professional,,,Female,I,3/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Anger,,NO,NO,Unlisted
2021BDSI0118,2021BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0118,2021BDSI0118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/16/2021,3/16/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0120,2021BDSI0120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Respiratory depression,Physician,,,Female,I,3/17/2021,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Respiratory depression,,YES,YES,Listed
2021BDSI0121,2021BDSI0121,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/22/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0122,2021BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Suicidal ideation,Non-Health Professional,,,Female,I,3/22/2021,3/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2021BDSI0122,2021BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,"Hallucination, auditory",Non-Health Professional,,,Female,I,3/22/2021,3/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,"Hallucination, auditory",,YES,YES,Unlisted
2021BDSI0122,2021BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Anxiety,Non-Health Professional,,,Female,I,3/22/2021,3/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Anxiety,,YES,YES,Listed
2021BDSI0123,2021BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,3/23/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0123,2021BDSI0123,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/23/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0124,2021BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,74,Years,Female,I,3/22/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0125,2021BDSI0125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Application site reaction,Non-Health Professional,,,Female,I,3/23/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Application site reaction,,NO,NO,Unlisted
2021BDSI0126,2021BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,3/25/2021,3/5/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0126,2021BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Immobile,Non-Health Professional,,,Female,I,3/25/2021,3/5/2021,,,,CHRONIC PAIN,UNITED STATES,Immobile,,NO,NO,Unlisted
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Male,I,3/25/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Other Health Professional,,,Male,I,3/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Other Health Professional,,,Male,I,3/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Other Health Professional,,,Male,I,3/25/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Other Health Professional,,,Male,I,3/25/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0128,2021BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Other Health Professional,,,Male,I,3/25/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2021BDSI0129,2021BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/26/2021,3/26/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0129,2021BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/26/2021,3/26/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0130,2021BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,3/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0130,2021BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0130,2021BDSI0130,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,3/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0132,2021BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,35,Years,Female,I,3/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0132,2021BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug tolerance,Non-Health Professional,35,Years,Female,I,3/26/2021,,,,,CHRONIC PAIN,UNITED STATES,Drug tolerance,,NO,NO,Listed
2021BDSI0134,2021BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Male,I,3/29/2021,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0134,2021BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,3/29/2021,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0134,2021BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Manufacturing production issue,Non-Health Professional,,,Male,I,3/29/2021,1/10/2021,,,,CHRONIC PAIN,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2021BDSI0134,2021BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,,,Male,I,3/29/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2021BDSI0136,2021BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Unresponsive to stimuli,Other Health Professional,,,Female,I,3/29/2021,3/1/2021,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Unresponsive to stimuli,,YES,YES,Unlisted
2021BDSI0136,2021BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,,,Female,I,3/29/2021,3/1/2021,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,YES,YES,Listed
2021BDSI0137,2021BDSI0137,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/30/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0139,2021BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0139,2021BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0140,2021BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0140,2021BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Male,I,4/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2021BDSI0140,2021BDSI0140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,4/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0141,2021BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Other Health Professional,,,Female,I,3/31/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0141,2021BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Discomfort,Other Health Professional,,,Female,I,3/31/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Discomfort,,NO,NO,Unlisted
2021BDSI0141,2021BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Other Health Professional,,,Female,I,3/31/2021,10/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0141,2021BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeding disorder,Other Health Professional,,,Female,I,3/31/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeding disorder,,NO,NO,Unlisted
2021BDSI0141,2021BDSI0141,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth injury,Other Health Professional,,,Female,I,3/31/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2021BDSI0142,2021BDSI0142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,72,Years,Female,I,4/2/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sensory loss,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Sensory loss,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastrointestinal disorder,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Gastrointestinal disorder,,NO,NO,Unlisted
2021BDSI0145,2021BDSI0145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,59,Years,Female,I,4/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Arthralgia,,NO,NO,Listed
2021BDSI0147,2021BDSI0147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Manufacturing production issue,Other Health Professional,,,,I,4/9/2021,1/1/2020,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2021BDSI0149,2021BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0149,2021BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,4/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0149,2021BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0152,2021BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Female,I,4/13/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0152,2021BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,65,Years,Female,I,4/13/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0152,2021BDSI0152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Female,I,4/13/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0153,2021BDSI0153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,4/13/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2021BDSI0154,2021BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,78,Years,Female,I,4/13/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0154,2021BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,78,Years,Female,I,4/13/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0154,2021BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,78,Years,Female,I,4/13/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0154,2021BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,78,Years,Female,I,4/13/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0155,2021BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,4/14/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0155,2021BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,4/14/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0155,2021BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,4/14/2021,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0156,2021BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,4/15/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0157,2021BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,60,Years,Male,I,4/15/2021,4/14/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0157,2021BDSI0157,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Male,I,4/15/2021,4/13/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0158,2021BDSI0158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,,,,I,4/15/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2021BDSI0159,2021BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,4/16/2021,4/15/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0160,2021BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Male,I,4/16/2021,4/6/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0160,2021BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Male,I,4/16/2021,4/6/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0161,2021BDSI0161,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,40,Years,Female,I,4/16/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0162,2021BDSI0162,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,4/20/2021,3/29/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hepatic enzyme increased,Non-Health Professional,,,Female,I,4/21/2021,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hepatic enzyme increased,,NO,YES,Listed
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Non-Health Professional,,,Female,I,4/21/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hypoaesthesia,,NO,YES,Unlisted
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,4/21/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rheumatoid arthritis,Non-Health Professional,,,Female,I,4/21/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Rheumatoid arthritis,,NO,YES,Unlisted
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hepatitis A,Non-Health Professional,,,Female,I,4/21/2021,1/31/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hepatitis A,,YES,YES,Unlisted
2021BDSI0163,2021BDSI0163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Joint swelling,Non-Health Professional,,,Female,I,4/21/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Joint swelling,,NO,YES,Unlisted
2021BDSI0164,2021BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Angioedema,Physician,33,Years,Female,I,4/21/2021,4/20/2021,,,Other,CHRONIC PAIN,UNITED STATES,Angioedema,,YES,YES,Listed
2021BDSI0164,2021BDSI0164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Urticaria,Physician,33,Years,Female,I,4/21/2021,4/20/2021,,,,CHRONIC PAIN,UNITED STATES,Urticaria,,NO,YES,Listed
2021BDSI0165,2021BDSI0165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,82,Years,Female,I,4/21/2021,10/1/2020,,,,CHRONIC SEVERE BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0166,2021BDSI0166,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Peripheral swelling,Other Health Professional,50,Years,Female,I,4/20/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2021BDSI0167,2021BDSI0167,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,I,4/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0168,2021BDSI0168,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,4/21/2021,4/20/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0169,2021BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,33,Years,Female,I,4/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0171,2021BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,46,Years,Female,I,4/23/2021,3/31/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0171,2021BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Migraine,Non-Health Professional,46,Years,Female,I,4/23/2021,3/31/2021,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,YES,Listed
2021BDSI0171,2021BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,46,Years,Female,I,4/23/2021,3/31/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0172,2021BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,4/23/2021,4/22/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0172,2021BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/23/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0172,2021BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/23/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0173,2021BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Skin discolouration,Other Health Professional,,,Male,I,4/22/2021,4/16/2021,,,,CHRONIC PAIN,UNITED STATES,Skin discolouration,,NO,NO,Unlisted
2021BDSI0174,2021BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Physician,,,Female,I,4/26/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0175,2021BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intervertebral disc protrusion,Non-Health Professional,48,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Intervertebral disc protrusion,,NO,NO,Unlisted
2021BDSI0176,2021BDSI0176,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,61,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0176,2021BDSI0176,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,YES,Listed
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,YES,Listed
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stress,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Stress,,NO,YES,Unlisted
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ulcer haemorrhage,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Ulcer haemorrhage,,YES,YES,Unlisted
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gastrointestinal injury,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Gastrointestinal injury,,YES,YES,Unlisted
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2021BDSI0177,2021BDSI0177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,33,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0178,2021BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,4/28/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0179,2021BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,61,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2021BDSI0179,2021BDSI0179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0180,2021BDSI0180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Foot operation,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Foot operation,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Aphonia,Non-Health Professional,51,Years,Male,I,4/27/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Aphonia,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Foot fracture,Non-Health Professional,51,Years,Male,I,4/27/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Foot fracture,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Limb injury,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Limb injury,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Joint injury,Non-Health Professional,51,Years,Male,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Joint injury,,NO,YES,Unlisted
2021BDSI0181,2021BDSI0181,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Shoulder operation,Non-Health Professional,51,Years,Male,I,4/27/2021,1/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Shoulder operation,,YES,YES,Unlisted
2021BDSI0182,2021BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depression,Non-Health Professional,39,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Depression,,NO,NO,Listed
2021BDSI0182,2021BDSI0182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,39,Years,Female,I,4/27/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0184,2021BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,4/29/2021,4/28/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0184,2021BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,4/29/2021,4/28/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0184,2021BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Pharmacist,,,Female,I,4/29/2021,4/29/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0184,2021BDSI0184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,4/29/2021,5/3/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0185,2021BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,4/30/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0185,2021BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,4/30/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0185,2021BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,4/30/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0185,2021BDSI0185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/30/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0186,2021BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,5/3/2021,5/3/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0187,2021BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,64,Years,Male,I,5/3/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0188,2021BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0188,2021BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/4/2021,3/30/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0188,2021BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0189,2021BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Heart rate decreased,Physician,,,,I,5/4/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Heart rate decreased,,NO,NO,Unlisted
2021BDSI0191,2021BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia oral,Other Health Professional,61,Years,Male,I,5/4/2021,4/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypoaesthesia oral,,NO,NO,Unlisted
2021BDSI0191,2021BDSI0191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pharyngeal hypoaesthesia,Other Health Professional,61,Years,Male,I,5/4/2021,4/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pharyngeal hypoaesthesia,,NO,NO,Unlisted
2021BDSI0192,2021BDSI0192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Gingival recession,Physician,,,Female,I,5/3/2021,,,,,CHRONIC PAIN,UNITED STATES,Gingival recession,,NO,NO,Unlisted
2021BDSI0193,2021BDSI0193,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Other Health Professional,54,Years,Female,I,5/5/2021,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0193,2021BDSI0193,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hot flush,Other Health Professional,54,Years,Female,I,5/5/2021,5/1/2020,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2021BDSI0194,2021BDSI0194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Insomnia,Other Health Professional,58,Years,Male,I,5/5/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0195,2021BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Insomnia,Other Health Professional,38,Years,Female,I,5/5/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0197,2021BDSI0197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Male,I,5/6/2021,5/2/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0198,2021BDSI0198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Adverse drug reaction,Non-Health Professional,,,Female,I,5/6/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Adverse drug reaction,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Female,I,5/10/2021,4/27/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,64,Years,Female,I,5/10/2021,4/27/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Renal pain,Non-Health Professional,64,Years,Female,I,5/10/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Renal pain,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain upper,Non-Health Professional,64,Years,Female,I,5/10/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain upper,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,64,Years,Female,I,5/10/2021,4/27/2021,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,64,Years,Female,I,5/10/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Female,I,5/10/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingival recession,Non-Health Professional,64,Years,Female,I,5/10/2021,5/9/2021,,,,CHRONIC PAIN,UNITED STATES,Gingival recession,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,64,Years,Female,I,5/10/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,5/10/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0200,2021BDSI0200,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,64,Years,Female,I,5/10/2021,4/27/2021,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,NO,Unlisted
2021BDSI0201,2021BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,5/11/2021,5/10/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0201,2021BDSI0201,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Female,I,5/11/2021,5/10/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0202,2021BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Skin ulcer,Other Health Professional,,,Female,I,5/13/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Skin ulcer,,NO,NO,Unlisted
2021BDSI0203,2021BDSI0203,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product packaging difficult to open,Non-Health Professional,61,Years,Male,I,5/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0205,2021BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,39,Years,Female,I,5/17/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0205,2021BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,39,Years,Female,I,5/17/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0206,2021BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Migraine,Other Health Professional,54,Years,Male,I,5/17/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,NO,Listed
2021BDSI0206,2021BDSI0206,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Diarrhoea,Other Health Professional,54,Years,Male,I,5/17/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2021BDSI0207,2021BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/18/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0207,2021BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/18/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0207,2021BDSI0207,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/18/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0211,2021BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Non-Health Professional,58,Years,Female,I,5/20/2021,5/20/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2021BDSI0211,2021BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,58,Years,Female,I,5/20/2021,1/1/2020,,,,CHRONIC BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0211,2021BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,58,Years,Female,I,5/20/2021,5/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2021BDSI0211,2021BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,58,Years,Female,I,5/20/2021,5/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0212,2021BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0213,2021BDSI0213,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,33,Years,Male,I,5/19/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0214,2021BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,55,Years,Female,I,5/21/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0214,2021BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,55,Years,Female,I,5/21/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0214,2021BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,55,Years,Female,I,5/21/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0215,2021BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,48,Years,Male,I,5/21/2021,,,,,PAIN MANAGEMENT,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0215,2021BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,48,Years,Male,I,5/21/2021,,,,,PAIN MANAGEMENT,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0215,2021BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,48,Years,Male,I,5/21/2021,,,,,PAIN MANAGEMENT,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2021BDSI0216,2021BDSI0216,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Abdominal discomfort,Non-Health Professional,,,Female,I,5/21/2021,,,,,PAIN MANAGEMENT,UNITED STATES,Abdominal discomfort,,NO,NO,Unlisted
2021BDSI0217,2021BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0217,2021BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,5/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0218,2021BDSI0218,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,56,Years,Female,I,5/24/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0219,2021BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,77,Years,Male,I,5/25/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0219,2021BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,77,Years,Male,I,5/25/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0219,2021BDSI0219,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,77,Years,Male,I,5/25/2021,4/13/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0220,2021BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Intentional dose omission,Other Health Professional,50,Years,Female,I,5/24/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2021BDSI0220,2021BDSI0220,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Oedema peripheral,Other Health Professional,50,Years,Female,I,5/24/2021,4/8/2021,,,,CHRONIC PAIN,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2021BDSI0222,2021BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain in extremity,Non-Health Professional,55,Years,Male,I,5/27/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
2021BDSI0222,2021BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,55,Years,Male,I,5/27/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0223,2021BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/28/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0223,2021BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/28/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0224,2021BDSI0224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,6/1/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2021BDSI0224,2021BDSI0224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,6/1/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2021BDSI0224,2021BDSI0224,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oedema peripheral,Non-Health Professional,,,Female,I,6/1/2021,5/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,NO,NO,Listed
2021BDSI0225,2021BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0225,2021BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Male,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0225,2021BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0226,2021BDSI0226,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Pharmacist,,,Female,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0227,2021BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,50,Years,Female,I,6/2/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0227,2021BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Other Health Professional,50,Years,Female,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0227,2021BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Other Health Professional,50,Years,Female,I,6/2/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0227,2021BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Other Health Professional,50,Years,Female,I,6/2/2021,5/29/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0227,2021BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Other Health Professional,50,Years,Female,I,6/2/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0228,2021BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product identification number issue,Non-Health Professional,72,Years,Female,I,6/3/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product identification number issue,,NO,NO,Unlisted
2021BDSI0228,2021BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,72,Years,Female,I,6/3/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2021BDSI0228,2021BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,72,Years,Female,I,6/3/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2021BDSI0228,2021BDSI0228,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,72,Years,Female,I,6/3/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product solubility abnormal,Physician,60,Years,Female,I,6/4/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product adhesion issue,Physician,60,Years,Female,I,6/4/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,YES,Unlisted
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Decreased appetite,Physician,60,Years,Female,I,6/4/2021,5/28/2021,,,,CHRONIC PAIN,UNITED STATES,Decreased appetite,,NO,YES,Listed
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Gastrointestinal sounds abnormal,Physician,60,Years,Female,I,6/4/2021,5/28/2021,,,,CHRONIC PAIN,UNITED STATES,Gastrointestinal sounds abnormal,,NO,YES,Unlisted
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,60,Years,Female,I,6/4/2021,5/28/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0229,2021BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response decreased,Physician,60,Years,Female,I,6/4/2021,5/28/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0231,2021BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Confusional state,Non-Health Professional,67,Years,Female,I,6/7/2021,5/1/2021,,,,VERY BAD PAIN,UNITED STATES,Confusional state,,NO,YES,Unlisted
2021BDSI0231,2021BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,67,Years,Female,I,6/7/2021,5/1/2021,,,,VERY BAD PAIN,UNITED STATES,Headache,,NO,YES,Listed
2021BDSI0231,2021BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,67,Years,Female,I,6/7/2021,5/1/2021,,,Other,VERY BAD PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0231,2021BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,67,Years,Female,I,6/7/2021,5/1/2021,,,,VERY BAD PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2021BDSI0231,2021BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Hallucination,Non-Health Professional,67,Years,Female,I,6/7/2021,5/1/2021,,,,VERY BAD PAIN,UNITED STATES,Hallucination,,NO,YES,Unlisted
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,6/6/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,60,Years,Female,I,6/6/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,6/6/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,60,Years,Female,I,6/6/2021,6/2/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,60,Years,Female,I,6/6/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0232,2021BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,6/6/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0233,2021BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,69,Years,Female,I,6/7/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0233,2021BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,69,Years,Female,I,6/7/2021,6/6/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0233,2021BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Female,I,6/7/2021,6/6/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0233,2021BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,I,6/7/2021,6/6/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0233,2021BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,6/7/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0234,2021BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Seizure,Physician,,,Female,I,6/8/2021,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Seizure,,YES,YES,Unlisted
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Pain in jaw,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pain in jaw,,NO,YES,Unlisted
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Neck pain,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Neck pain,,NO,YES,Listed
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,YES,Listed
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Pharyngeal swelling,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pharyngeal swelling,,NO,YES,Unlisted
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Swelling face,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Swelling face,,NO,YES,Unlisted
2021BDSI0235,2021BDSI0235,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Pancreatitis,Non-Health Professional,,,Male,I,6/11/2021,3/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Pancreatitis,,YES,YES,Listed
2021BDSI0236,2021BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,I,6/8/2021,1/1/2020,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0236,2021BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,46,Years,Female,I,6/8/2021,5/1/2021,,,,CHRONIC PAIN DUE TO FIBROMYALGIA,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0237,2021BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Male,I,6/9/2021,4/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0238,2021BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,89,Years,Female,I,6/8/2021,6/8/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0239,2021BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,49,Years,Male,I,6/14/2021,6/12/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0239,2021BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Claustrophobia,Non-Health Professional,49,Years,Male,I,6/14/2021,6/12/2021,,,,CHRONIC PAIN,UNITED STATES,Claustrophobia,,NO,YES,Unlisted
2021BDSI0239,2021BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,49,Years,Male,I,6/14/2021,6/12/2021,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,YES,Listed
2021BDSI0239,2021BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,49,Years,Male,I,6/14/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,YES,Unlisted
2021BDSI0239,2021BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,49,Years,Male,I,6/14/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,YES,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Musculoskeletal stiffness,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Musculoskeletal stiffness,,NO,NO,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Headache,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tinnitus,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tinnitus,,NO,NO,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Hypersomnia,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypersomnia,,NO,NO,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Muscular weakness,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Muscular weakness,,NO,NO,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Asthenia,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Asthenia,,NO,NO,Listed
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Sciatica,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Sciatica,,NO,NO,Unlisted
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Decreased appetite,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Decreased appetite,,NO,NO,Listed
2021BDSI0240,2021BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Burning sensation,Non-Health Professional,64,Years,Female,I,6/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2021BDSI0241,2021BDSI0241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Toothache,Other Health Professional,,,Female,I,6/14/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Toothache,,NO,NO,Listed
2021BDSI0242,2021BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,6/14/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0242,2021BDSI0242,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/14/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0243,2021BDSI0243,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Physician,,,Female,I,6/3/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0244,2021BDSI0244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dyspnoea,Physician,,,Male,I,5/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dyspnoea,,NO,NO,Listed
2021BDSI0245,2021BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Weight decreased,Physician,,,Female,I,5/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2021BDSI0246,2021BDSI0246,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Urticaria,Physician,,,Female,I,5/1/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Urticaria,,NO,NO,Listed
2021BDSI0247,2021BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/11/2021,6/10/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0247,2021BDSI0247,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/11/2021,6/10/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0254,2021BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Back pain,Non-Health Professional,56,Years,Male,I,6/17/2021,6/1/2021,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Back pain,,NO,NO,Listed
2021BDSI0254,2021BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Neck pain,Non-Health Professional,56,Years,Male,I,6/17/2021,6/1/2021,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Neck pain,,NO,NO,Listed
2021BDSI0254,2021BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stress,Non-Health Professional,56,Years,Male,I,6/17/2021,6/1/2021,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Stress,,NO,NO,Unlisted
2021BDSI0256,2021BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/17/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0256,2021BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/17/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0256,2021BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Female,I,6/17/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2021BDSI0256,2021BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/17/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0256,2021BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/17/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,65,Years,Female,I,6/16/2021,6/13/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,65,Years,Female,I,6/16/2021,6/13/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,65,Years,Female,I,6/16/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,65,Years,Female,I,6/16/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,65,Years,Female,I,6/16/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0257,2021BDSI0257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,65,Years,Female,I,6/16/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,58,Years,Female,I,6/17/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,58,Years,Female,I,6/17/2021,5/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Abdominal pain,,YES,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,58,Years,Female,I,6/17/2021,5/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Nausea,,YES,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,58,Years,Female,I,6/17/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dehydration,Non-Health Professional,58,Years,Female,I,6/17/2021,6/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dehydration,,YES,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Decreased appetite,Non-Health Professional,58,Years,Female,I,6/17/2021,6/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Decreased appetite,,YES,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,58,Years,Female,I,6/17/2021,6/10/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Vomiting,,YES,YES,Listed
2021BDSI0259,2021BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Renal failure,Non-Health Professional,58,Years,Female,I,6/17/2021,6/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Renal failure,,YES,YES,Unlisted
2021BDSI0263,2021BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,84,Years,Female,I,6/21/2021,6/18/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0263,2021BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,84,Years,Female,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0263,2021BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,84,Years,Female,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0263,2021BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,84,Years,Female,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0263,2021BDSI0263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,84,Years,Female,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Male,I,6/21/2021,6/2/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic product effect increased,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic product effect increased,,NO,NO,Unlisted
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lethargy,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Lethargy,,NO,NO,Listed
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rash,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2021BDSI0266,2021BDSI0266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Male,I,6/21/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0267,2021BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,87,Years,Female,I,6/22/2021,6/8/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0267,2021BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,87,Years,Female,I,6/22/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0267,2021BDSI0267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,87,Years,Female,I,6/22/2021,6/8/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0268,2021BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,6/22/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0268,2021BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,61,Years,Female,I,6/22/2021,6/21/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0268,2021BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,61,Years,Female,I,6/22/2021,6/21/2021,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0268,2021BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,61,Years,Female,I,6/22/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0268,2021BDSI0268,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysstasia,Non-Health Professional,61,Years,Female,I,6/22/2021,6/21/2021,,,,CHRONIC PAIN,UNITED STATES,Dysstasia,,NO,NO,Unlisted
2021BDSI0269,2021BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,37,Years,Male,I,6/25/2021,6/1/2021,,,,CHRONIC LOWER BACK PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0270,2021BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Death,Physician,59,Years,Male,I,6/28/2021,6/18/2021,,,Death,CHRONIC PAIN,UNITED STATES,Death,,YES,YES,Unlisted
2021BDSI0271,2021BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/28/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0271,2021BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,6/28/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0272,2021BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Weight decreased,Non-Health Professional,41,Years,Female,I,6/28/2021,,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2021BDSI0272,2021BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response unexpected,Non-Health Professional,41,Years,Female,I,6/28/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2021BDSI0273,2021BDSI0273,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Surgery,Non-Health Professional,61,Years,Female,I,6/28/2021,6/23/2021,,,,CHRONIC PAIN,UNITED STATES,Surgery,,NO,NO,Unlisted
2021BDSI0274,2021BDSI0274,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Pain,Non-Health Professional,,,Female,I,6/18/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0275,2021BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/30/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0276,2021BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,52,Years,Male,I,7/2/2021,3/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2021BDSI0276,2021BDSI0276,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,52,Years,Male,I,7/2/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0278,2021BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,80,Years,Female,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0278,2021BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,80,Years,Female,I,7/6/2021,7/5/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0278,2021BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,80,Years,Female,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0280,2021BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Male,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0280,2021BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,65,Years,Male,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2021BDSI0280,2021BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,65,Years,Male,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2021BDSI0280,2021BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Male,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0280,2021BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,65,Years,Male,I,7/6/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0282,2021BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/7/2021,7/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0282,2021BDSI0282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,,,Male,I,7/7/2021,7/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2021BDSI0283,2021BDSI0283,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Other Health Professional,,,Male,I,7/8/2021,7/8/2021,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2021BDSI0284,2021BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/8/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0284,2021BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/8/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0285,2021BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0285,2021BDSI0285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0286,2021BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Other Health Professional,52,Years,Male,I,7/8/2021,1/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0287,2021BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0287,2021BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,,,Male,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0287,2021BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0287,2021BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,,Male,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0288,2021BDSI0288,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Contusion,Other Health Professional,51,Years,Female,I,7/8/2021,5/13/2021,,,,CHRONIC PAIN,UNITED STATES,Contusion,,NO,NO,Listed
2021BDSI0288,2021BDSI0288,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,,Mood altered,Other Health Professional,51,Years,Female,I,7/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Mood altered,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Toothache,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,NO,Listed
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Headache,Non-Health Professional,55,Years,Female,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Increased upper airway secretion,Non-Health Professional,55,Years,Female,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Increased upper airway secretion,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Tooth infection,Non-Health Professional,55,Years,Female,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Tooth infection,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Dental caries,Non-Health Professional,55,Years,Female,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Hyperaesthesia teeth,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Hyperaesthesia teeth,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,55,Years,Female,I,7/9/2021,1/1/2019,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0289,2021BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Tooth injury,Non-Health Professional,55,Years,Female,I,7/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2021BDSI0292,2021BDSI0292,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Physician,,,Female,I,7/8/2021,6/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0292,2021BDSI0292,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Physician,,,Female,I,7/8/2021,6/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0297,2021BDSI0297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0299,2021BDSI0299,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,7/15/2021,7/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0299,2021BDSI0299,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/15/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0300,2021BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,65,Years,Female,I,7/15/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0300,2021BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,65,Years,Female,I,7/15/2021,7/13/2021,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2021BDSI0300,2021BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pain,Non-Health Professional,65,Years,Female,I,7/15/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Unlisted
2021BDSI0300,2021BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Headache,Non-Health Professional,65,Years,Female,I,7/15/2021,7/10/2021,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2021BDSI0300,2021BDSI0300,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Female,I,7/15/2021,7/10/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0301,2021BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,78,Years,Female,I,7/16/2021,7/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0301,2021BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,78,Years,Female,I,7/16/2021,7/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0301,2021BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,78,Years,Female,I,7/16/2021,7/1/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0301,2021BDSI0301,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,78,Years,Female,I,7/16/2021,7/16/2021,,,,CHRONIC BACK PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0302,2021BDSI0302,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tooth loss,Physician,92,Years,Female,I,7/15/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth loss,,NO,NO,Unlisted
2021BDSI0305,2021BDSI0305,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,7/19/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0305,2021BDSI0305,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,64,Years,Female,I,7/19/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0306,2021BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeding disorder,Non-Health Professional,,,Male,I,7/19/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Feeding disorder,,NO,NO,Unlisted
2021BDSI0306,2021BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Male,I,7/19/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0306,2021BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,,,Male,I,7/19/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2021BDSI0306,2021BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,7/19/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0306,2021BDSI0306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/19/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0307,2021BDSI0307,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal blistering,Physician,,,Female,I,7/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2021BDSI0307,2021BDSI0307,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Physician,,,Female,I,7/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0308,2021BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,7/16/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0308,2021BDSI0308,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,7/16/2021,7/16/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0309,2021BDSI0309,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pruritus,Physician,,,Female,I,7/16/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2021BDSI0310,2021BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Negative,,,microgram,Buccal film,,Fall,Pharmacist,,,Male,I,7/20/2021,7/1/2021,,,Hospitalisation,CHRONIC PAIN FROM SICKLE CELL DISEASE,UNITED STATES,Fall,,YES,YES,Listed
2021BDSI0310,2021BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Negative,,,microgram,Buccal film,,Injury,Pharmacist,,,Male,I,7/20/2021,7/1/2021,,,Hospitalisation,CHRONIC PAIN FROM SICKLE CELL DISEASE,UNITED STATES,Injury,,YES,YES,Unlisted
2021BDSI0310,2021BDSI0310,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Negative,,,microgram,Buccal film,,Product prescribing error,Pharmacist,,,Male,I,7/20/2021,,,,,CHRONIC PAIN FROM SICKLE CELL DISEASE,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,71,Years,Female,I,7/21/2021,7/9/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0311,2021BDSI0311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,71,Years,Female,I,7/21/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2021BDSI0313,2021BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Intentional product use issue,Non-Health Professional,,,Female,I,7/22/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Intentional product use issue,,NO,NO,Unlisted
2021BDSI0313,2021BDSI0313,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/22/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,82,Years,Female,I,7/23/2021,7/19/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,82,Years,Female,I,7/23/2021,7/19/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,82,Years,Female,I,7/23/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,82,Years,Female,I,7/23/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,82,Years,Female,I,7/23/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0314,2021BDSI0314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,82,Years,Female,I,7/23/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0316,2021BDSI0316,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0316,2021BDSI0316,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,7/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0318,2021BDSI0318,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,7/26/2021,12/21/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0318,2021BDSI0318,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disorganised speech,Non-Health Professional,60,Years,Female,I,7/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Disorganised speech,,NO,NO,Unlisted
2021BDSI0318,2021BDSI0318,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Disturbance in attention,Non-Health Professional,60,Years,Female,I,7/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Disturbance in attention,,NO,NO,Unlisted
2021BDSI0319,2021BDSI0319,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,7/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0319,2021BDSI0319,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,7/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0319,2021BDSI0319,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,75,Years,Female,I,7/26/2021,6/4/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0319,2021BDSI0319,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,75,Years,Female,I,7/26/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0319,2021BDSI0319,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,7/26/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0320,2021BDSI0320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,42,Years,Female,I,7/24/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0322,2021BDSI0322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/26/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective for unapproved indication,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Drug ineffective for unapproved indication,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,53,Years,Female,I,7/28/2021,7/1/2021,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0325,2021BDSI0325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,53,Years,Female,I,7/28/2021,1/1/2020,,,,CHRONIC RESTLESS LEG SYNDROME,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood pressure increased,Non-Health Professional,65,Years,Male,F,8/10/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Blood pressure increased,,NO,YES,Listed
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,65,Years,Male,F,8/10/2021,8/5/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Heart rate decreased,Non-Health Professional,65,Years,Male,F,8/10/2021,1/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Heart rate decreased,,YES,YES,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,65,Years,Male,F,8/10/2021,7/27/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,YES,Listed
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,65,Years,Male,F,8/10/2021,7/27/2021,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,65,Years,Male,F,8/10/2021,7/27/2021,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,65,Years,Male,F,8/10/2021,7/27/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,YES,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,65,Years,Male,F,8/10/2021,7/27/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,YES,Unlisted
2021BDSI0328,2021BDSI0328,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Extrasystoles,Non-Health Professional,65,Years,Male,F,8/10/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Extrasystoles,,NO,YES,Unlisted
2021BDSI0329,2021BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,51,Years,Female,F,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0329,2021BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,51,Years,Female,F,10/7/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0329,2021BDSI0329,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,51,Years,Female,F,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0330,2021BDSI0330,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,8/2/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0332,2021BDSI0332,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Diarrhoea,Other Health Professional,,,Male,I,8/3/2021,7/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2021BDSI0334,2021BDSI0334,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,,,Stomatitis,Other Health Professional,,,Male,I,8/4/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0339,2021BDSI0339,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,8/6/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0345,2021BDSI0345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0345,2021BDSI0345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0345,2021BDSI0345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0346,2021BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,48,Years,Male,I,8/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0346,2021BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,48,Years,Male,I,8/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0346,2021BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Restlessness,Non-Health Professional,48,Years,Male,I,8/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Restlessness,,NO,NO,Unlisted
2021BDSI0346,2021BDSI0346,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,48,Years,Male,I,8/9/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,53,Years,Male,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,53,Years,Male,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pancreatitis,Non-Health Professional,53,Years,Male,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pancreatitis,,NO,NO,Listed
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mobility decreased,Non-Health Professional,53,Years,Male,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Mobility decreased,,NO,NO,Unlisted
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,53,Years,Male,I,8/9/2021,8/4/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,53,Years,Male,I,8/9/2021,8/4/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,53,Years,Male,I,8/9/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0347,2021BDSI0347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,53,Years,Male,I,8/9/2021,8/9/2021,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2021BDSI0348,2021BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Rash,Other Health Professional,56,Years,Female,I,8/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2021BDSI0348,2021BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tongue discolouration,Other Health Professional,56,Years,Female,I,8/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Tongue discolouration,,NO,NO,Unlisted
2021BDSI0348,2021BDSI0348,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pharyngeal swelling,Other Health Professional,56,Years,Female,I,8/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Pharyngeal swelling,,NO,NO,Unlisted
2021BDSI0350,2021BDSI0350,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Urinary tract infection,Physician,66,Years,Female,I,8/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Urinary tract infection,,NO,NO,Listed
2021BDSI0350,2021BDSI0350,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Physician,66,Years,Female,I,8/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0353,2021BDSI0353,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dental caries,Physician,,,Female,I,8/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pulmonary mass,Non-Health Professional,61,Years,Male,F,10/12/2021,2/1/2020,,,Death,CHRONIC PAIN,UNITED STATES,Pulmonary mass,,YES,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Respiratory arrest,Non-Health Professional,61,Years,Male,F,10/12/2021,3/18/2020,,,Other,CHRONIC PAIN,UNITED STATES,Respiratory arrest,,YES,YES,Listed
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Unresponsive to stimuli,Non-Health Professional,61,Years,Male,F,10/12/2021,3/19/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Unresponsive to stimuli,,YES,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Coma,Non-Health Professional,61,Years,Male,F,10/12/2021,3/19/2020,,,Other,CHRONIC PAIN,UNITED STATES,Coma,,YES,YES,Listed
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Respiratory failure,Non-Health Professional,61,Years,Male,F,10/12/2021,3/19/2020,,,Death,CHRONIC PAIN,UNITED STATES,Respiratory failure,,YES,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Respiratory distress,Non-Health Professional,61,Years,Male,F,10/12/2021,,,,Other,CHRONIC PAIN,UNITED STATES,Respiratory distress,,YES,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pneumonia aspiration,Non-Health Professional,61,Years,Male,F,10/12/2021,1/1/2020,,,Death,CHRONIC PAIN,UNITED STATES,Pneumonia aspiration,,YES,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tremor,Non-Health Professional,61,Years,Male,F,10/12/2021,3/14/2020,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,YES,Listed
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Depressed level of consciousness,Non-Health Professional,61,Years,Male,F,10/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Depressed level of consciousness,,NO,YES,Unlisted
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Male,F,10/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0354,2021BDSI0354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Chronic obstructive pulmonary disease,Non-Health Professional,61,Years,Male,F,10/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Chronic obstructive pulmonary disease,,NO,YES,Unlisted
2021BDSI0355,2021BDSI0355,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,,,Female,I,8/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2021BDSI0356,2021BDSI0356,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/13/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0357,2021BDSI0357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Migraine,Other Health Professional,51,Years,Female,I,8/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2021BDSI0358,2021BDSI0358,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,66,Years,Female,I,8/13/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0358,2021BDSI0358,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Female,I,8/13/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0358,2021BDSI0358,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Female,I,8/13/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0361,2021BDSI0361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,8/16/2021,8/7/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0361,2021BDSI0361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,8/16/2021,8/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0361,2021BDSI0361,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,60,Years,Female,I,8/16/2021,8/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0366,2021BDSI0366,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral disorder,Physician,50,Years,Female,I,8/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral disorder,,NO,NO,Unlisted
2021BDSI0367,2021BDSI0367,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/18/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0368,2021BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,70,Years,Female,I,8/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0368,2021BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,70,Years,Female,I,8/18/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2021BDSI0368,2021BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth injury,Non-Health Professional,70,Years,Female,I,8/18/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2021BDSI0368,2021BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth abscess,Non-Health Professional,70,Years,Female,I,8/18/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Tooth abscess,,NO,NO,Listed
2021BDSI0368,2021BDSI0368,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cardiovascular insufficiency,Non-Health Professional,70,Years,Female,I,8/18/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Cardiovascular insufficiency,,NO,NO,Unlisted
2021BDSI0369,2021BDSI0369,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Stomatitis,Other Health Professional,,,Female,I,8/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0372,2021BDSI0372,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,8/19/2021,8/19/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0381,2021BDSI0381,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product solubility abnormal,Physician,,,,I,8/20/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0382,2021BDSI0382,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dysphonia,Non-Health Professional,61,Years,Male,I,8/24/2021,8/23/2021,,,,CHRONIC PAIN,UNITED STATES,Dysphonia,,NO,NO,Unlisted
2021BDSI0391,2021BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,,,Male,I,8/24/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0391,2021BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Other Health Professional,,,Male,I,8/24/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2021BDSI0391,2021BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Male,I,8/24/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0391,2021BDSI0391,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Other Health Professional,,,Male,I,8/24/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0392,2021BDSI0392,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Palpitations,Physician,,,Female,I,8/24/2021,,,,,CHRONIC PAIN,UNITED STATES,Palpitations,,NO,NO,Unlisted
2021BDSI0397,2021BDSI0397,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Invasive breast carcinoma,Non-Health Professional,69,Years,Female,I,8/25/2021,8/12/2021,,,Other,CHRONIC PAIN,UNITED STATES,Invasive breast carcinoma,,YES,YES,Unlisted
2021BDSI0397,2021BDSI0397,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypersensitivity,Non-Health Professional,69,Years,Female,I,8/25/2021,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Hypersensitivity,,NO,YES,Listed
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/25/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/25/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,8/25/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional dose omission,Non-Health Professional,,,Female,I,8/25/2021,8/25/2021,,,,CHRONIC PAIN,UNITED STATES,Intentional dose omission,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Memory impairment,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Female,I,8/25/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Motion sickness,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Motion sickness,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Paraesthesia,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0398,2021BDSI0398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Female,I,8/25/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0400,2021BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival pain,Non-Health Professional,,,Female,I,8/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Gingival pain,,NO,NO,Unlisted
2021BDSI0400,2021BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Toothache,Non-Health Professional,,,Female,I,8/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,NO,Listed
2021BDSI0400,2021BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Oral pain,Non-Health Professional,,,Female,I,8/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral pain,,NO,NO,Unlisted
2021BDSI0400,2021BDSI0400,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,,Gingival bleeding,Non-Health Professional,,,Female,I,8/26/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Gingival bleeding,,NO,NO,Unlisted
2021BDSI0402,2021BDSI0402,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Pharmacist,,,Female,I,8/27/2021,8/26/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0406,2021BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Other Health Professional,,,Female,I,8/30/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2021BDSI0406,2021BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Other Health Professional,,,Female,I,8/30/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0406,2021BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Other Health Professional,,,Female,I,8/30/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0406,2021BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,,,Female,I,8/30/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0406,2021BDSI0406,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Other Health Professional,,,Female,I,8/30/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0407,2021BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Male,I,8/30/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0407,2021BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Male,I,8/30/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0407,2021BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,63,Years,Male,I,8/30/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0407,2021BDSI0407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Male,I,8/30/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0409,2021BDSI0409,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,8/31/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0410,2021BDSI0410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,,,Male,I,8/31/2021,,,,,CHRONIC PAIN,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0412,2021BDSI0412,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/1/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0416,2021BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,,,Female,I,9/3/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2021BDSI0416,2021BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mental impairment,Non-Health Professional,,,Female,I,9/3/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mental impairment,,NO,NO,Unlisted
2021BDSI0416,2021BDSI0416,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,9/3/2021,6/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0417,2021BDSI0417,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,56,Years,Female,I,9/7/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0417,2021BDSI0417,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,56,Years,Female,I,9/7/2021,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Libido decreased,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Libido decreased,,NO,NO,Unlisted
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Listed
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2021BDSI0418,2021BDSI0418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,9/7/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,70,Years,Female,I,9/10/2021,8/20/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,70,Years,Female,I,9/10/2021,8/20/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Female,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Female,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0419,2021BDSI0419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Female,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0420,2021BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pain,Non-Health Professional,54,Years,Female,I,9/9/2021,9/7/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0420,2021BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,54,Years,Female,I,9/9/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0420,2021BDSI0420,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,54,Years,Female,I,9/9/2021,9/7/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,35,Years,Male,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,35,Years,Male,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,35,Years,Male,I,9/10/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,35,Years,Male,I,9/10/2021,8/4/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,35,Years,Male,I,9/10/2021,8/4/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,35,Years,Male,I,9/10/2021,8/4/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,35,Years,Male,I,9/10/2021,8/4/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0422,2021BDSI0422,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,35,Years,Male,I,9/10/2021,8/4/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2021BDSI0423,2021BDSI0423,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,9/10/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0423,2021BDSI0423,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,74,Years,Female,I,9/10/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0423,2021BDSI0423,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,74,Years,Female,I,9/10/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0425,2021BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,9/13/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0425,2021BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,74,Years,Female,I,9/13/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0425,2021BDSI0425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,74,Years,Female,I,9/13/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0426,2021BDSI0426,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Vomiting,Non-Health Professional,59,Years,Female,I,9/13/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0426,2021BDSI0426,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,59,Years,Female,I,9/13/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0427,2021BDSI0427,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,COVID-19 pneumonia,Non-Health Professional,61,Years,Male,I,9/14/2021,1/1/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,COVID-19 pneumonia,,YES,YES,Unlisted
2021BDSI0428,2021BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,70,Years,Female,I,9/15/2021,8/5/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0428,2021BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Female,I,9/15/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0428,2021BDSI0428,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Female,I,9/15/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0429,2021BDSI0429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,,Buccal film,,Drug withdrawal syndrome,Physician,,,Female,I,9/15/2021,1/1/2021,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0430,2021BDSI0430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,9/15/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0430,2021BDSI0430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fall,Non-Health Professional,60,Years,Female,I,9/15/2021,,,,,CHRONIC PAIN,UNITED STATES,Fall,,NO,NO,Listed
2021BDSI0432,2021BDSI0432,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Mouth ulceration,Other Health Professional,,,Female,I,9/16/2021,,,,,CHRONIC PAIN,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,74,Years,Female,I,9/17/2021,9/10/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,74,Years,Female,I,9/17/2021,9/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,74,Years,Female,I,9/17/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,74,Years,Female,I,9/17/2021,9/16/2021,,,,CHRONIC PAIN,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,9/17/2021,9/17/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,74,Years,Female,I,9/17/2021,9/16/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,74,Years,Female,I,9/17/2021,9/8/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0433,2021BDSI0433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,74,Years,Female,I,9/17/2021,9/16/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0434,2021BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,65,Years,Male,I,9/17/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0434,2021BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,65,Years,Male,I,9/17/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0434,2021BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,65,Years,Male,I,9/17/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0434,2021BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Male,I,9/17/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0434,2021BDSI0434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,65,Years,Male,I,9/17/2021,9/10/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0438,2021BDSI0438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Hypersensitivity,Non-Health Professional,45,Years,Female,I,9/20/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypersensitivity,,NO,NO,Listed
2021BDSI0440,2021BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,68,Years,Female,I,9/21/2021,9/18/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0440,2021BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,68,Years,Female,I,9/21/2021,9/18/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0440,2021BDSI0440,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,68,Years,Female,I,9/21/2021,9/18/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0441,2021BDSI0441,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Mood altered,Other Health Professional,,,Male,I,9/21/2021,,,,,CHRONIC PAIN,UNITED STATES,Mood altered,,NO,NO,Unlisted
2021BDSI0442,2021BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dizziness,Other Health Professional,,,Female,I,9/21/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0442,2021BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Other Health Professional,,,Female,I,9/21/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0442,2021BDSI0442,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response increased,Other Health Professional,,,Female,I,9/21/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0443,2021BDSI0443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Blood pressure increased,Non-Health Professional,,,Female,I,9/22/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Blood pressure increased,,NO,NO,Listed
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,9/23/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fall,Non-Health Professional,,,Female,I,9/23/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Fall,,NO,YES,Listed
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrist fracture,Non-Health Professional,,,Female,I,9/23/2021,8/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Wrist fracture,,YES,YES,Unlisted
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrist surgery,Non-Health Professional,,,Female,I,9/23/2021,8/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Wrist surgery,,YES,YES,Unlisted
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,9/23/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2021BDSI0445,2021BDSI0445,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,9/23/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2021BDSI0446,2021BDSI0446,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Pharmacist,,,Male,I,9/23/2021,9/23/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2021BDSI0446,2021BDSI0446,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Male,I,9/23/2021,9/23/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0451,2021BDSI0451,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,49,Years,Male,I,9/27/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Hypertension,,NO,NO,Listed
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Psychomotor hyperactivity,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Psychomotor hyperactivity,,NO,NO,Unlisted
2021BDSI0453,2021BDSI0453,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Restlessness,Non-Health Professional,,,Male,I,9/28/2021,9/25/2021,,,,CHRONIC PAIN,UNITED STATES,Restlessness,,NO,NO,Listed
2021BDSI0455,2021BDSI0455,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,9/29/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0455,2021BDSI0455,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,9/29/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0456,2021BDSI0456,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,9/29/2021,9/29/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0459,2021BDSI0459,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Stem cell transplant,Pharmacist,,,Female,I,10/1/2021,9/23/2021,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Stem cell transplant,,YES,YES,Unlisted
2021BDSI0463,2021BDSI0463,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,10/6/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,75,Years,Female,I,10/7/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0464,2021BDSI0464,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,75,Years,Female,I,10/7/2021,10/6/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0465,2021BDSI0465,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Pharmacist,,,Female,I,10/8/2021,10/7/2021,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0467,2021BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Incorrect dose administered by product,Non-Health Professional,71,Years,Female,I,10/11/2021,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect dose administered by product,,NO,NO,Unlisted
2021BDSI0467,2021BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Female,I,10/11/2021,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0467,2021BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Female,I,10/11/2021,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0467,2021BDSI0467,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug ineffective,Non-Health Professional,71,Years,Female,I,10/11/2021,1/1/2019,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0468,2021BDSI0468,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Burning sensation,Other Health Professional,,,Male,I,10/12/2021,,,,,CHRONIC PAIN,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2021BDSI0475,2021BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,10/14/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0475,2021BDSI0475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,10/14/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0476,2021BDSI0476,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,10/15/2021,10/15/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0476,2021BDSI0476,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Female,I,10/15/2021,10/15/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0478,2021BDSI0478,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Hyperhidrosis,Other Health Professional,,,Female,I,10/18/2021,,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2021BDSI0479,2021BDSI0479,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Female,I,10/18/2021,10/16/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0479,2021BDSI0479,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ocular hyperaemia,Non-Health Professional,61,Years,Female,I,10/18/2021,10/18/2021,,,,CHRONIC PAIN,UNITED STATES,Ocular hyperaemia,,NO,NO,Unlisted
2021BDSI0479,2021BDSI0479,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,10/18/2021,10/16/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0482,2021BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,10/20/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0482,2021BDSI0482,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,10/20/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0483,2021BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Peripheral swelling,Other Health Professional,61,Years,Female,I,10/20/2021,,,,,CHRONIC PAIN,UNITED STATES,Peripheral swelling,,NO,NO,Listed
2021BDSI0483,2021BDSI0483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Rash,Other Health Professional,61,Years,Female,I,10/20/2021,,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2021BDSI0484,2021BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Female,I,10/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0484,2021BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,10/20/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0484,2021BDSI0484,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,10/20/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0485,2021BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Myalgia,Non-Health Professional,,,Female,I,10/21/2021,10/14/2021,,,,CHRONIC PAIN,UNITED STATES,Myalgia,,NO,NO,Listed
2021BDSI0485,2021BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,,,Female,I,10/21/2021,10/20/2021,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2021BDSI0485,2021BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Respiratory disorder,Non-Health Professional,,,Female,I,10/21/2021,10/14/2021,,,,CHRONIC PAIN,UNITED STATES,Respiratory disorder,,NO,NO,Unlisted
2021BDSI0485,2021BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,Female,I,10/21/2021,10/14/2021,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2021BDSI0485,2021BDSI0485,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Muscular weakness,Non-Health Professional,,,Female,I,10/21/2021,10/14/2021,,,,CHRONIC PAIN,UNITED STATES,Muscular weakness,,NO,NO,Listed
2021BDSI0487,2021BDSI0487,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Non-cardiogenic pulmonary oedema,Other Health Professional,56,Years,Female,I,10/25/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Non-cardiogenic pulmonary oedema,,YES,YES,Unlisted
2021BDSI0487,2021BDSI0487,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Non-cardiogenic pulmonary oedema,Other Health Professional,56,Years,Female,I,10/25/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Non-cardiogenic pulmonary oedema,,YES,YES,Unlisted
2021BDSI0487,2021BDSI0487,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Mental status changes,Other Health Professional,56,Years,Female,I,10/25/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Mental status changes,,YES,YES,Unlisted
2021BDSI0487,2021BDSI0487,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Mental status changes,Other Health Professional,56,Years,Female,I,10/25/2021,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Mental status changes,,YES,YES,Unlisted
2021BDSI0491,2021BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,95,Years,Female,I,10/26/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0491,2021BDSI0491,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,95,Years,Female,I,10/26/2021,10/25/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0492,2021BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,61,Years,Male,I,10/27/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0492,2021BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,61,Years,Male,I,10/27/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0492,2021BDSI0492,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Male,I,10/27/2021,10/26/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0493,2021BDSI0493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,73,Years,Female,I,10/27/2021,10/27/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Hyperhidrosis,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Chills,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Chills,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Paraesthesia,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Burning sensation,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Paraesthesia,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Burning sensation,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Heart rate decreased,Non-Health Professional,,,Female,I,10/28/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Heart rate decreased,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Blood pressure decreased,Non-Health Professional,,,Female,I,10/28/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Blood pressure decreased,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Dizziness,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Therapeutic response increased,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Tremor,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Feeling abnormal,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Paraesthesia,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Paraesthesia,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Oral administration complication,Non-Health Professional,,,Female,I,10/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Product adhesion issue,Non-Health Professional,,,Female,I,10/28/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Hot flush,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Therapeutic response unexpected,Non-Health Professional,,,Female,I,10/28/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,10/28/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Incorrect route of product administration,Non-Health Professional,,,Female,I,10/28/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/28/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Burning sensation,Non-Health Professional,,,Female,I,10/28/2021,2/27/2021,,,,CHRONIC PAIN,UNITED STATES,Burning sensation,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,10/28/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0497,2021BDSI0497,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,,,Product communication issue,Non-Health Professional,,,Female,I,10/28/2021,2/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vocal cord disorder,Non-Health Professional,63,Years,Male,I,12/8/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Vocal cord disorder,,NO,NO,Unlisted
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,63,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,63,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Adverse event following immunisation,Non-Health Professional,63,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Adverse event following immunisation,,NO,NO,Unlisted
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Productive cough,Non-Health Professional,63,Years,Male,I,12/8/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Productive cough,,NO,NO,Listed
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Aphasia,Non-Health Professional,63,Years,Male,I,12/8/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Aphasia,,NO,NO,Unlisted
2021BDSI0498,2021BDSI0498,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,63,Years,Male,I,12/8/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0499,2021BDSI0499,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Other Health Professional,73,Years,Male,I,10/29/2021,,,,Other,PAIN,SLOVAKIA,Drug dependence,,YES,YES,
2021BDSI0500,2021BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Infection,Pharmacist,,,Female,I,10/29/2021,,,,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Infection,,YES,YES,Unlisted
2021BDSI0500,2021BDSI0500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Pharmacist,,,Female,I,10/29/2021,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0504,2021BDSI0504,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,11/2/2021,10/9/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0506,2021BDSI0506,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,11/3/2021,10/21/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0506,2021BDSI0506,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,11/3/2021,10/24/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Coordination abnormal,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Coordination abnormal,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Memory impairment,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pollakiuria,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pollakiuria,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Myalgia,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Myalgia,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Rhinitis,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Rhinitis,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Conversion disorder,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Conversion disorder,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Agitation,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Agitation,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pallor,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pallor,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Retching,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Retching,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal discomfort,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal discomfort,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hallucination,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Hallucination,,YES,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,68,Years,Female,I,11/2/2021,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry eye,Non-Health Professional,68,Years,Female,I,11/2/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dry eye,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Lacrimation increased,Non-Health Professional,68,Years,Female,I,11/2/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Lacrimation increased,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Eye pain,Non-Health Professional,68,Years,Female,I,11/2/2021,9/1/2021,,,,CHRONIC PAIN,UNITED STATES,Eye pain,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,68,Years,Female,I,11/2/2021,10/1/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of personal independence in daily activities,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Loss of personal independence in daily activities,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Flatulence,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Flatulence,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nervousness,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Nervousness,,NO,YES,Unlisted
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,YES,Listed
2021BDSI0507,2021BDSI0507,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Agitation,Non-Health Professional,68,Years,Female,I,11/2/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Agitation,,NO,YES,Unlisted
2021BDSI0508,2021BDSI0508,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,11/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0508,2021BDSI0508,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/4/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0509,2021BDSI0509,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,11/4/2021,10/19/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product administration error,Non-Health Professional,56,Years,Female,I,11/8/2021,11/6/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Bone pain,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Bone pain,,NO,NO,Unlisted
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Somnolence,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Insomnia,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,56,Years,Female,I,11/8/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Memory impairment,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Memory impairment,,NO,NO,Unlisted
2021BDSI0511,2021BDSI0511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Confusional state,Non-Health Professional,56,Years,Female,I,11/8/2021,11/5/2021,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Listed
2021BDSI0513,2021BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,49,Years,Male,F,11/24/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0513,2021BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,49,Years,Male,F,11/24/2021,11/6/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0513,2021BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,49,Years,Male,F,11/24/2021,11/6/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0513,2021BDSI0513,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,49,Years,Male,F,11/24/2021,11/7/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0514,2021BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,11/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0514,2021BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,11/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0514,2021BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0514,2021BDSI0514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,11/9/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0515,2021BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,11/10/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0515,2021BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,61,Years,Female,I,11/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0515,2021BDSI0515,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,61,Years,Female,I,11/10/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0516,2021BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood glucose increased,Non-Health Professional,62,Years,Male,I,11/11/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Blood glucose increased,,NO,NO,Unlisted
2021BDSI0516,2021BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Blood glucose decreased,Non-Health Professional,62,Years,Male,I,11/11/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Blood glucose decreased,,NO,NO,Unlisted
2021BDSI0516,2021BDSI0516,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Dizziness,Non-Health Professional,62,Years,Male,I,11/11/2021,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2021BDSI0517,2021BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,70,Years,Male,I,11/11/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0517,2021BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,11/11/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0517,2021BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,70,Years,Male,I,11/11/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0517,2021BDSI0517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,70,Years,Male,I,11/11/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0521,2021BDSI0521,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,Female,I,12/8/2021,9/7/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0522,2021BDSI0522,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,11/12/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0525,2021BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,49,Years,Female,I,11/15/2021,4/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0525,2021BDSI0525,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,49,Years,Female,I,11/15/2021,5/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2021BDSI0530,2021BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product outer packaging issue,Non-Health Professional,,,Female,I,11/16/2021,11/12/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2021BDSI0530,2021BDSI0530,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,11/16/2021,11/12/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0531,2021BDSI0531,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,,Buccal film,,Toothache,Other Health Professional,,,Male,I,11/17/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Toothache,,NO,NO,Listed
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Malabsorption,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Malabsorption,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nephrolithiasis,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Nephrolithiasis,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Skin odour abnormal,Non-Health Professional,60,Years,Female,F,12/13/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Skin odour abnormal,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Renal stone removal,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Renal stone removal,,YES,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cholelithiasis,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Cholelithiasis,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,60,Years,Female,F,12/13/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Scar,Non-Health Professional,60,Years,Female,F,12/13/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Scar,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Calcinosis,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Calcinosis,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Renal impairment,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Renal impairment,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,F,12/13/2021,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,60,Years,Female,F,12/13/2021,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Renal stone removal,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Renal stone removal,,YES,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Non-Health Professional,60,Years,Female,F,12/13/2021,6/1/2020,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,YES,Listed
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gait disturbance,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Gait disturbance,,NO,YES,Unlisted
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,60,Years,Female,F,12/13/2021,8/1/2020,,,,CHRONIC PAIN,UNITED STATES,Muscle spasms,,NO,YES,Listed
2021BDSI0535,2021BDSI0535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Skin wrinkling,Non-Health Professional,60,Years,Female,F,12/13/2021,12/1/2020,,,,CHRONIC PAIN,UNITED STATES,Skin wrinkling,,NO,YES,Unlisted
2021BDSI0536,2021BDSI0536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,21,Years,Male,I,11/19/2021,11/18/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0536,2021BDSI0536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,21,Years,Male,I,11/19/2021,11/17/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0536,2021BDSI0536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,21,Years,Male,I,11/19/2021,11/17/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2021BDSI0537,2021BDSI0537,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Male,I,11/19/2021,11/19/2021,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2021BDSI0541,2021BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Pharmacist,,,Female,I,11/24/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0541,2021BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Pharmacist,,,Female,I,11/24/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0541,2021BDSI0541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Pharmacist,,,Female,I,11/24/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2021BDSI0543,2021BDSI0543,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Other Health Professional,73,Years,Male,I,11/24/2021,11/21/2021,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0544,2021BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,64,Years,Female,I,11/24/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0544,2021BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,11/24/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0544,2021BDSI0544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,64,Years,Female,I,11/24/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2021BDSI0553,2021BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/30/2021,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0553,2021BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,11/30/2021,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0553,2021BDSI0553,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/30/2021,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0559,2021BDSI0559,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypertensive emergency,Pharmacist,,,Male,I,12/2/2021,1/1/2021,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Hypertensive emergency,,YES,YES,Unlisted
2021BDSI0560,2021BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,12/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2021BDSI0560,2021BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,12/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2021BDSI0560,2021BDSI0560,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0561,2021BDSI0561,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Stomatitis,Physician,,,Female,I,12/2/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0562,2021BDSI0562,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oedema peripheral,Physician,60,Years,Female,I,12/2/2021,1/1/2021,,PER,Hospitalisation,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oedema peripheral,,YES,YES,Listed
2021BDSI0563,2021BDSI0563,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,61,Years,Female,I,12/9/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,YES,Unlisted
2021BDSI0563,2021BDSI0563,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Pharmacist,61,Years,Female,I,12/9/2021,12/6/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response unexpected,Non-Health Professional,67,Years,Male,I,12/8/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response unexpected,,NO,YES,Unlisted
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,67,Years,Male,I,12/8/2021,11/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,67,Years,Male,I,12/8/2021,11/24/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,67,Years,Male,I,12/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,YES,Unlisted
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,67,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,67,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,67,Years,Male,I,12/8/2021,,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,67,Years,Male,I,12/8/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,67,Years,Male,I,12/8/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response increased,,NO,YES,Listed
2021BDSI0566,2021BDSI0566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Euphoric mood,Non-Health Professional,67,Years,Male,I,12/8/2021,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Euphoric mood,,NO,YES,Unlisted
2021BDSI0572,2021BDSI0572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pruritus,Physician,54,Years,Male,I,12/8/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pruritus,,NO,NO,Listed
2021BDSI0573,2021BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,12/9/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0573,2021BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/9/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0573,2021BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Female,I,12/9/2021,12/9/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2021BDSI0573,2021BDSI0573,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,12/9/2021,11/16/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0574,2021BDSI0574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,,,Female,I,12/10/2021,11/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2021BDSI0578,2021BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/14/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0578,2021BDSI0578,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/14/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0580,2021BDSI0580,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,55,Years,Female,I,12/13/2021,12/13/2021,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0583,2021BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Migraine,Non-Health Professional,60,Years,Female,I,12/15/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,YES,Listed
2021BDSI0583,2021BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Condition aggravated,Non-Health Professional,60,Years,Female,I,12/15/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,YES,Unlisted
2021BDSI0583,2021BDSI0583,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Road traffic accident,Non-Health Professional,60,Years,Female,I,12/15/2021,10/22/2021,,,Other,CHRONIC PAIN,UNITED STATES,Road traffic accident,,YES,YES,Unlisted
2021BDSI0585,2021BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,,,Male,I,12/14/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Stomatitis,,NO,NO,Unlisted
2021BDSI0585,2021BDSI0585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Anxiety,Other Health Professional,,,Male,I,12/14/2021,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Anxiety,,NO,NO,Listed
2021BDSI0586,2021BDSI0586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/15/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0586,2021BDSI0586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,12/15/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2021BDSI0586,2021BDSI0586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/15/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0588,2021BDSI0588,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Cough,Other Health Professional,75,Years,Male,I,12/15/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Cough,,NO,NO,Listed
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Paranoia,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,,CHRONIC PAIN,UNITED STATES,Paranoia,,NO,YES,Unlisted
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Product prescribing error,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Cerebrovascular accident,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,Other,CHRONIC PAIN,UNITED STATES,Cerebrovascular accident,,YES,YES,Listed
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Delusion,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,,CHRONIC PAIN,UNITED STATES,Delusion,,NO,YES,Unlisted
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,83,Years,Female,I,12/15/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Transient ischaemic attack,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,Other,CHRONIC PAIN,UNITED STATES,Transient ischaemic attack,,YES,YES,Listed
2021BDSI0589,2021BDSI0589,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Amnesia,Pharmacist,83,Years,Female,I,12/15/2021,10/12/2021,,,,CHRONIC PAIN,UNITED STATES,Amnesia,,NO,YES,Unlisted
2021BDSI0591,2021BDSI0591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,70,Years,Female,I,12/17/2021,11/20/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2021BDSI0591,2021BDSI0591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product outer packaging issue,Non-Health Professional,70,Years,Female,I,12/17/2021,11/20/2021,,,,CHRONIC PAIN,UNITED STATES,Product outer packaging issue,,NO,NO,Unlisted
2021BDSI0593,2021BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,12/16/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0593,2021BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Male,I,12/16/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product size issue,,NO,NO,Unlisted
2021BDSI0593,2021BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Male,I,12/16/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2021BDSI0593,2021BDSI0593,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Male,I,12/16/2021,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0595,2021BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Vomiting,Other Health Professional,73,Years,Female,I,12/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2021BDSI0595,2021BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Chromaturia,Other Health Professional,73,Years,Female,I,12/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Chromaturia,,NO,NO,Unlisted
2021BDSI0595,2021BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Back pain,Other Health Professional,73,Years,Female,I,12/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Back pain,,NO,NO,Listed
2021BDSI0595,2021BDSI0595,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Chills,Other Health Professional,73,Years,Female,I,12/17/2021,,,,,CHRONIC PAIN,UNITED STATES,Chills,,NO,NO,Listed
2021BDSI0596,2021BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021BDSI0596,2021BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,12/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2021BDSI0596,2021BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,12/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0596,2021BDSI0596,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,12/20/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0599,2021BDSI0599,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Pharmacist,,,Female,I,12/20/2021,12/16/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2021BDSI0602,2021BDSI0602,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Manufacturing production issue,Non-Health Professional,,,Male,I,12/27/2021,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Manufacturing production issue,,NO,NO,Unlisted
2021BDSI0606,2021BDSI0606,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,,,Female,I,12/22/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2021BDSI0608,2021BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug abuse,Non-Health Professional,,,Male,I,12/28/2021,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug abuse,,YES,YES,
2021BDSI0608,2021BDSI0608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Non-Health Professional,,,Male,I,12/28/2021,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Drug dependence,,YES,YES,
2021BDSI0612,2021BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Male,I,12/29/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2021BDSI0612,2021BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,73,Years,Male,I,12/29/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2021BDSI0612,2021BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,Buccal film,,Off label use,Non-Health Professional,73,Years,Male,I,12/29/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2021BDSI0612,2021BDSI0612,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,Positive,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Male,I,12/29/2021,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2021CGM01157,2021CGM01157,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,UNKNOWN,,,microgram,,,Pruritus,Other Health Professional,20,Years,Female,I,10/26/2021,6/22/2021,,,,Post operative pain control,AUSTRALIA,Pruritus,,YES,YES,
2021CGM01157,2021CGM01157,TEMGESIC,BUPRENORPHINE HYDROCHLORIDE,,UNKNOWN,,,microgram,,,Flushing,Other Health Professional,20,Years,Female,I,10/26/2021,6/22/2021,,,,Post operative pain control,AUSTRALIA,Flushing,,YES,YES,
20220700042,20220700042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,,I,7/22/2022,7/22/2022,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220700042,20220700042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,,,,I,7/22/2022,7/22/2022,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220700042,20220700042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,,I,7/22/2022,7/22/2022,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220700042,20220700042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,,I,7/22/2022,7/22/2022,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220700042,20220700042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Consumer,,,,I,7/22/2022,7/22/2022,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220700045,20220700045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Dental caries,Nurse,31,Years,Female,I,7/22/2022,5/15/2022,,PER,,Chronic Pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20220700047,20220700047,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,UNKNOWN,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,I,7/22/2022,6/15/2022,,PER,,pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220700048,20220700048,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,I,7/26/2022,7/24/2022,,PER,,pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220700049,20220700049,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,,Malaise,Consumer,78,Years,,I,7/26/2022,,,PER,,Product used for unknown indication,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Loss of consciousness,Non-Health Professional,41,Years,Male,I,7/28/2022,7/27/2022,EXP,,,Pain,UNITED STATES,Loss of consciousness,Collegium Pharmaceutical,YES,YES,Unlisted
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Head injury,Non-Health Professional,41,Years,Male,I,7/28/2022,7/27/2022,EXP,,,Pain,UNITED STATES,Head injury,Collegium Pharmaceutical,NO,YES,Unlisted
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Nausea,Non-Health Professional,41,Years,Male,I,7/28/2022,7/15/2022,EXP,,,Pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,YES,Listed
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Fatigue,Non-Health Professional,41,Years,Male,I,7/28/2022,7/15/2022,EXP,,,Pain,UNITED STATES,Fatigue,Collegium Pharmaceutical,NO,YES,Listed
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Vision blurred,Non-Health Professional,41,Years,Male,I,7/28/2022,7/27/2022,EXP,,,Pain,UNITED STATES,Vision blurred,Collegium Pharmaceutical,NO,YES,Unlisted
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Asthenia,Non-Health Professional,41,Years,Male,I,7/28/2022,7/27/2022,EXP,,,Pain,UNITED STATES,Asthenia,Collegium Pharmaceutical,NO,YES,Listed
20220800062,20220800062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Dizziness,Non-Health Professional,41,Years,Male,I,7/28/2022,7/15/2022,EXP,,,Pain,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,YES,Listed
20220800077,20220800077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,F,8/1/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800077,20220800077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,F,8/1/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800077,20220800077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,F,8/1/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800077,20220800077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,,,Female,F,8/1/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20220800080,20220800080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,,,Female,F,8/3/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product size issue,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product use complaint,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Diarrhoea,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Diarrhoea,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Nausea,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Migraine,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Migraine,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Swelling face,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Swelling face,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Vomiting,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging issue,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800081,20220800081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging difficult to open,Consumer,53,Years,Female,F,8/3/2022,,,PER,,Chronic pain,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20220800084,20220800084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Consumer,,,Female,F,8/4/2022,,,PER,,Drug use for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800084,20220800084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Consumer,,,Female,F,8/4/2022,,,PER,,Drug use for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800085,20220800085,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,,Urticaria,Consumer,,,Female,F,8/5/2022,6/15/2022,,PER,,Drug use for unknown indication,UNITED STATES,Urticaria,Collegium Pharmaceutical,NO,NO,Listed
20220800085,20220800085,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,,Burning sensation,Consumer,,,Female,F,8/5/2022,6/15/2022,,PER,,Drug use for unknown indication,UNITED STATES,Burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20220800086,20220800086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Rash macular,Consumer,74,Years,Female,I,8/4/2022,7/18/2022,,PER,,Pain,UNITED STATES,Rash macular,Collegium Pharmaceutical,NO,NO,Listed
20220800086,20220800086,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Rash pruritic,Consumer,74,Years,Female,I,8/4/2022,7/18/2022,,PER,,Pain,UNITED STATES,Rash pruritic,Collegium Pharmaceutical,NO,NO,Listed
20220800087,20220800087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Toothache,Nurse,48,Years,Female,F,8/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,NO,Listed
20220800087,20220800087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Bone loss,Nurse,48,Years,Female,F,8/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Bone loss,Collegium Pharmaceutical,NO,NO,Unlisted
20220800087,20220800087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dental caries,Nurse,48,Years,Female,F,8/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Unlisted
20220800088,20220800088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dental caries,Nurse,,,,F,8/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Unlisted
20220800088,20220800088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Toothache,Nurse,,,,F,8/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,NO,Listed
20220800095,20220800095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Consumer,,,Female,I,8/5/2022,8/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800095,20220800095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Consumer,,,Female,I,8/5/2022,8/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800098,20220800098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Stomatitis,Other Health Professional,35,Years,Female,F,8/5/2022,,,PER,,product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20220800100,20220800100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Male,I,8/5/2022,,,PER,,product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800101,20220800101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,60,Years,Female,F,8/8/2022,6/15/2022,,PER,,,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20220800101,20220800101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,60,Years,Female,F,8/8/2022,6/15/2022,,PER,,,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800101,20220800101,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Consumer,60,Years,Female,F,8/8/2022,1/15/2022,,PER,,,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20220800102,20220800102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,54,Years,Female,F,8/8/2022,6/15/2022,,PER,,,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800102,20220800102,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Gait inability,Consumer,54,Years,Female,F,8/8/2022,7/15/2022,,PER,,,UNITED STATES,Gait inability,Collegium Pharmaceutical,NO,NO,Unlisted
20220800106,20220800106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,Female,I,8/8/2022,8/15/2022,,PER,,product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800106,20220800106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,8/8/2022,8/15/2022,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800107,20220800107,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Incorrect route of product administration,Consumer,63,Years,Female,I,8/8/2022,8/8/2022,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20220800111,20220800111,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug screen negative,Physician,,,Male,F,8/10/2022,,,PER,,Product used for unknown indication,UNITED STATES,Drug screen negative,Collegium Pharmaceutical,NO,NO,Unlisted
20220800111,20220800111,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug screen negative,Physician,,,Male,F,8/10/2022,,,PER,,Product used for unknown indication,UNITED STATES,Drug screen negative,Collegium Pharmaceutical,NO,NO,Unlisted
20220800115,20220800115,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Pharmacist,,,Female,I,8/11/2022,6/15/2022,,PER,,chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800117,20220800117,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Tooth disorder,Nurse,,,Male,I,8/12/2022,,,PER,,Product used for unknown indication,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20220800118,20220800118,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Dental caries,Nurse,57,Years,Female,I,8/11/2022,,,PER,,Lower extremity neuropathy,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20220800119,20220800119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Exposed bone in jaw,Nurse,57,Years,Male,I,8/11/2022,,EXP,,,Lumbar radiculopathy,UNITED STATES,Exposed bone in jaw,Collegium Pharmaceutical,YES,YES,Unlisted
20220800120,20220800120,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Hypersensitivity,Consumer,,,Female,F,8/15/2022,7/15/2022,,PER,,Chronic Pain,UNITED STATES,Hypersensitivity,Collegium Pharmaceutical,NO,NO,Listed
20220800126,20220800126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,Unknown,Headache,Consumer,66,Years,Female,I,8/17/2022,6/15/2022,,,,product used for unknown indication,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20220800126,20220800126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,Unknown,Nausea,Consumer,66,Years,Female,I,8/17/2022,8/3/2022,,,,product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20220800127,20220800127,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Non-Health Professional,,,Female,I,8/16/2022,8/13/2022,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800127,20220800127,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Non-Health Professional,,,Female,I,8/16/2022,8/13/2022,,PER,,Chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800131,20220800131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Dental caries,Physician,65,Years,Female,F,9/1/2022,11/15/2021,,PER,,,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,YES,Listed
20220800131,20220800131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Tooth abscess,Physician,65,Years,Female,F,9/1/2022,11/15/2021,,PER,Intervention Required,,UNITED STATES,Tooth abscess,Collegium Pharmaceutical,YES,YES,Listed
20220800132,20220800132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,55,Years,Female,F,8/17/2022,1/15/2022,,PER,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800133,20220800133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,bid,Somnolence,Other Health Professional,,,Female,F,8/18/2022,6/15/2022,,PER,,Pain,UNITED STATES,Somnolence,Collegium Pharmaceutical,NO,NO,Listed
20220800133,20220800133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,bid,Drug ineffective,Other Health Professional,,,Female,F,8/18/2022,6/15/2022,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220800135,20220800135,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Unknown,Unknown,Dental caries,Physician,,,Female,F,8/18/2022,5/15/2022,,PER,,product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20220800145,20220800145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging issue,Consumer,39,Years,Female,I,8/18/2022,6/15/2022,,PER,,Multiple chronic illness,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800145,20220800145,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,39,Years,Female,I,8/18/2022,6/15/2022,,PER,,Multiple chronic illness,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800146,20220800146,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Stomatitis,Nurse,,,Female,F,8/19/2022,,,PER,,product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20220800147,20220800147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Hyperhidrosis,Nurse,,,Female,I,8/19/2022,,,PER,,pain,UNITED STATES,Hyperhidrosis,Collegium Pharmaceutical,NO,NO,Listed
20220800150,20220800150,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,Unknown,Eye discharge,Other Health Professional,53,Years,Male,I,8/22/2022,8/12/2022,,PER,,product used for unknown indication,UNITED STATES,Eye discharge,Collegium Pharmaceutical,NO,NO,Unlisted
20220800151,20220800151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Pharmacist,,,Male,I,8/22/2022,5/15/2022,,PER,,Chronic pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,YES,Listed
20220800151,20220800151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug withdrawal syndrome,Pharmacist,,,Male,I,8/22/2022,5/15/2022,,PER,,Chronic pain,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20220800154,20220800154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Mental disorder,Nurse,,,Male,I,8/23/2022,,EXP,,Hospitalisation,product used for unknown indication,UNITED STATES,Mental disorder,Collegium Pharmaceutical,YES,YES,Unlisted
20220800158,20220800158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,I,8/23/2022,6/15/2022,,PER,,Pain Relief,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800158,20220800158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,I,8/23/2022,6/15/2022,,PER,,Pain Relief,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20220800158,20220800158,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,8/23/2022,6/15/2022,,PER,,Pain Relief,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Urticaria,Consumer,37,Years,Female,F,10/22/2022,1/15/2021,EXP,,Hospitalisation,Chronic pain,UNITED STATES,Urticaria,Collegium Pharmaceutical,YES,YES,Listed
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Heart rate increased,Consumer,37,Years,Female,F,10/22/2022,1/15/2021,EXP,,,Chronic pain,UNITED STATES,Heart rate increased,Collegium Pharmaceutical,NO,YES,Listed
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Blister,Consumer,37,Years,Female,F,10/22/2022,1/15/2021,EXP,,Hospitalisation,Chronic pain,UNITED STATES,Blister,Collegium Pharmaceutical,YES,YES,Unlisted
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Pain,Consumer,37,Years,Female,F,10/22/2022,,EXP,,,Chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,YES,Listed
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Arthralgia,Consumer,37,Years,Female,F,10/22/2022,,EXP,,,Chronic pain,UNITED STATES,Arthralgia,Collegium Pharmaceutical,NO,YES,Listed
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Scar,Consumer,37,Years,Female,F,10/22/2022,,EXP,,,Chronic pain,UNITED STATES,Scar,Collegium Pharmaceutical,NO,YES,Unlisted
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Cardiac disorder,Consumer,37,Years,Female,F,10/22/2022,,EXP,,,Chronic pain,UNITED STATES,Cardiac disorder,Collegium Pharmaceutical,NO,YES,Unlisted
20220800163,20220800163,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,qd,Drug interaction,Consumer,37,Years,Female,F,10/22/2022,,EXP,,,Chronic pain,UNITED STATES,Drug interaction,Collegium Pharmaceutical,NO,YES,Listed
20220800164,20220800164,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Pruritus,Physician,,,Female,I,8/24/2022,,,PER,,product used for unknown indication,UNITED STATES,Pruritus,Collegium Pharmaceutical,NO,NO,Listed
20220800165,20220800165,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Exposure during pregnancy,Physician,,,Female,I,8/24/2022,,,PER,,product used for unknown indication,UNITED STATES,Exposure during pregnancy,Collegium Pharmaceutical,NO,NO,Unlisted
20220800170,20220800170,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Oral administration complication,Consumer,,,Male,I,8/26/2022,,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800171,20220800171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Non-Health Professional,,,Male,F,11/26/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800171,20220800171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Non-Health Professional,,,Male,F,11/26/2022,,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220800171,20220800171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Non-Health Professional,,,Male,F,11/26/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220800173,20220800173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Off label use,Non-Health Professional,,,Female,I,8/30/2022,8/15/2022,,PER,,Chronic Pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20220800173,20220800173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product solubility abnormal,Non-Health Professional,,,Female,I,8/30/2022,8/15/2022,,PER,,Chronic Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220800173,20220800173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Wrong technique in product usage process,Non-Health Professional,,,Female,I,8/30/2022,8/15/2022,,PER,,Chronic Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20220900177,20220900177,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,8/31/2022,8/15/2022,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900179,20220900179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product communication issue,Consumer,,,Female,I,8/31/2022,8/31/2022,,PER,,Chronic pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900180,20220900180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Blood glucose increased,Consumer,,,Female,I,8/31/2022,,,PER,,Chronic pain,UNITED STATES,Blood glucose increased,Collegium Pharmaceutical,NO,NO,Unlisted
20220900182,20220900182,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,Unknown,Euphoric mood,Nurse,,,Female,F,9/8/2022,,,PER,,,UNITED STATES,Euphoric mood,Collegium Pharmaceutical,NO,NO,Unlisted
20220900183,20220900183,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug screen negative,Physician,,,Female,F,9/7/2022,5/17/2022,,PER,,Product used for unknown indication,UNITED STATES,Drug screen negative,Collegium Pharmaceutical,NO,NO,Unlisted
20220900183,20220900183,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Blood test abnormal,Physician,,,Female,F,9/7/2022,6/28/2022,,PER,,Product used for unknown indication,UNITED STATES,Blood test abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220900185,20220900185,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Ageusia,Physician,,,Male,I,9/2/2022,6/15/2022,,PER,,Product use for unknown indication,UNITED STATES,Ageusia,Collegium Pharmaceutical,NO,NO,Unlisted
20220900186,20220900186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,62,Years,Female,I,9/2/2022,,,PER,,Chronic Pain in lower back and both knees,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220900186,20220900186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product communication issue,Consumer,62,Years,Female,I,9/2/2022,9/1/2022,,PER,,Chronic Pain in lower back and both knees,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900187,20220900187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Hyperhidrosis,Physician,,,Male,I,9/1/2022,,,PER,,product used for unknown indication,UNITED STATES,Hyperhidrosis,Collegium Pharmaceutical,NO,NO,Listed
20220900187,20220900187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Off label use,Physician,,,Male,I,9/1/2022,,,PER,,product used for unknown indication,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20220900196,20220900196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Non-Health Professional,,,Female,F,9/12/2022,,,PER,,back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900196,20220900196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product size issue,Non-Health Professional,,,Female,F,9/12/2022,,,PER,,back pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900196,20220900196,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Non-Health Professional,,,Female,F,9/12/2022,,,PER,,back pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20220900197,20220900197,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Non-Health Professional,,,Female,I,9/2/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900197,20220900197,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Oral administration complication,Non-Health Professional,,,Female,I,9/2/2022,,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Therapeutic product effect decreased,Physician,47,Years,Male,F,12/15/2022,11/15/2021,,,,indication not reported,SPAIN,Therapeutic product effect decreased,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Constipation,Physician,47,Years,Male,F,12/15/2022,,,,,indication not reported,SPAIN,Constipation,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Drug interaction,Physician,47,Years,Male,F,12/15/2022,,,,,indication not reported,SPAIN,Drug interaction,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Restlessness,Physician,47,Years,Male,F,12/15/2022,11/15/2021,,,,indication not reported,SPAIN,Restlessness,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Vomiting,Physician,47,Years,Male,F,12/15/2022,11/15/2021,,,,indication not reported,SPAIN,Vomiting,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Thinking abnormal,Physician,47,Years,Male,F,12/15/2022,11/15/2021,,,,indication not reported,SPAIN,Thinking abnormal,,NO,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Withdrawal syndrome,Physician,47,Years,Male,F,12/15/2022,,,,,indication not reported,SPAIN,Withdrawal syndrome,,YES,YES,
20220900212,20220900212,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,,,Staring,Physician,47,Years,Male,F,12/15/2022,11/15/2021,,,,indication not reported,SPAIN,Staring,,NO,YES,
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging difficult to open,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product use complaint,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Chest discomfort,Consumer,,,Female,F,9/13/2022,9/15/2022,,PER,,Pain,UNITED STATES,Chest discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Rhinorrhoea,Consumer,,,Female,F,9/13/2022,9/15/2022,,PER,,Pain,UNITED STATES,Rhinorrhoea,Collegium Pharmaceutical,NO,NO,Listed
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Hypopnoea,Consumer,,,Female,F,9/13/2022,9/15/2022,,PER,,Pain,UNITED STATES,Hypopnoea,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220900215,20220900215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,F,9/13/2022,9/7/2022,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900222,20220900222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Female,F,10/17/2022,,,PER,,product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900251,20220900251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,64,Years,Male,F,9/27/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20220900251,20220900251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,64,Years,Male,F,9/27/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900251,20220900251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,64,Years,Male,F,9/27/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220900256,20220900256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,9/15/2022,,,PER,,chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900256,20220900256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Male,I,9/15/2022,,,PER,,chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220900257,20220900257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Tardive dyskinesia,Nurse,72,Years,Female,F,9/27/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Tardive dyskinesia,Collegium Pharmaceutical,YES,YES,Unlisted
20220900257,20220900257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Therapeutic response decreased,Nurse,72,Years,Female,F,9/27/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,YES,Listed
20220900258,20220900258,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Therapeutic response decreased,Consumer,49,Years,Male,F,9/23/2022,,,PER,,chronic pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20220900261,20220900261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,9/16/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900261,20220900261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Male,I,9/16/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20220900263,20220900263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,9/19/2022,,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900263,20220900263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Pain,Consumer,,,Female,I,9/19/2022,,,PER,,Pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20220900263,20220900263,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,9/19/2022,,,PER,,Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220900264,20220900264,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product container issue,Company Representative,,,,I,9/14/2022,9/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product container issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900265,20220900265,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,Unknown,Therapeutic product effect variable,Consumer,,,Female,F,9/20/2022,9/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic product effect variable,Collegium Pharmaceutical,NO,NO,Listed
20220900266,20220900266,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,9/17/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900269,20220900269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product communication issue,Consumer,,,Female,I,9/20/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900269,20220900269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,9/20/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20220900274,20220900274,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Malaise,Consumer,,,Female,F,9/22/2022,,,PER,,Chronic Pain,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20220900274,20220900274,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Blood pressure increased,Consumer,,,Female,F,9/22/2022,,,PER,,Chronic Pain,UNITED STATES,Blood pressure increased,Collegium Pharmaceutical,NO,NO,Listed
20220900275,20220900275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Other,,,Female,I,9/20/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900282,20220900282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product availability issue,Consumer,45,Years,Female,F,9/23/2022,9/15/2022,,PER,,chronic pain,UNITED STATES,Product availability issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900282,20220900282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Breakthrough pain,Consumer,45,Years,Female,F,9/23/2022,9/15/2022,,PER,,chronic pain,UNITED STATES,Breakthrough pain,Collegium Pharmaceutical,NO,NO,Listed
20220900282,20220900282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,45,Years,Female,F,9/23/2022,9/15/2022,,PER,,chronic pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20220900282,20220900282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Hypertension,Consumer,45,Years,Female,F,9/23/2022,9/15/2022,,PER,,chronic pain,UNITED STATES,Hypertension,Collegium Pharmaceutical,NO,NO,Listed
20220900284,20220900284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Negative,,,,Buccal film,Unknown,Dental caries,Other Health Professional,47,Years,Female,F,9/23/2022,,,PER,,pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20220900285,20220900285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Lacrimation increased,Nurse,64,Years,Male,I,9/22/2022,9/15/2022,,PER,,Pain,UNITED STATES,Lacrimation increased,Collegium Pharmaceutical,NO,NO,Unlisted
20220900285,20220900285,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Vision blurred,Nurse,64,Years,Male,I,9/22/2022,9/15/2022,,PER,,Pain,UNITED STATES,Vision blurred,Collegium Pharmaceutical,NO,NO,Unlisted
20220900302,20220900302,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Dental caries,Nurse,,,Female,I,9/28/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20221000309,20221000309,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Other Health Professional,,,Male,I,9/28/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221000312,20221000312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Swollen tongue,Consumer,66,Years,Female,F,1/4/2023,,,PER,,Chronic low back pain,UNITED STATES,Swollen tongue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000312,20221000312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,66,Years,Female,F,1/4/2023,6/15/2022,,PER,,Chronic low back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221000312,20221000312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Dry mouth,Consumer,66,Years,Female,F,1/4/2023,7/15/2022,,PER,,Chronic low back pain,UNITED STATES,Dry mouth,Collegium Pharmaceutical,NO,NO,Listed
20221000312,20221000312,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,66,Years,Female,F,1/4/2023,6/15/2022,,PER,,Chronic low back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221000314,20221000314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,9/29/2022,9/15/2022,,PER,,Back Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221000314,20221000314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product communication issue,Consumer,,,Female,I,9/29/2022,9/15/2022,,PER,,Back Pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000314,20221000314,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,I,9/29/2022,9/15/2022,,PER,,Back Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221000315,20221000315,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Male,F,10/7/2022,9/30/2022,,PER,,Chronic Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221000317,20221000317,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Malaise,Consumer,,,Female,F,10/4/2022,,,PER,,Product used for unknown indication,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20221000317,20221000317,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Dental caries,Consumer,,,Female,F,10/4/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20221000318,20221000318,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Psychotic disorder,Consumer,40,Years,Female,I,10/6/2022,9/4/2022,EXP,,Life Threatening,Chronic pain,UNITED KINGDOM,Psychotic disorder,,YES,YES,
20221000318,20221000318,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug interaction,Consumer,40,Years,Female,I,10/6/2022,,EXP,,Life Threatening,Chronic pain,UNITED KINGDOM,Drug interaction,,YES,YES,
20221000318,20221000318,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Serotonin syndrome,Consumer,40,Years,Female,I,10/6/2022,,EXP,,Life Threatening,Chronic pain,UNITED KINGDOM,Serotonin syndrome,,YES,YES,
20221000318,20221000318,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Medication error,Consumer,40,Years,Female,I,10/6/2022,,EXP,,,Chronic pain,UNITED KINGDOM,Medication error,,NO,YES,
20221000321,20221000321,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Other Health Professional,,,Female,I,10/5/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000323,20221000323,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Tooth erosion,Physician,,,Female,F,10/7/2022,,,PER,,Product used for unknown indication,UNITED STATES,Tooth erosion,Collegium Pharmaceutical,NO,NO,Listed
20221000325,20221000325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,67,Years,Female,F,10/11/2022,10/7/2022,,PER,,Chronic Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221000325,20221000325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,67,Years,Female,F,10/11/2022,10/7/2022,,PER,,Chronic Pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221000325,20221000325,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product administration error,Consumer,67,Years,Female,F,10/11/2022,6/15/2022,,PER,,Chronic Pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Drug abuse,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Drug abuse,Collegium Pharmaceutical,YES,YES,Listed
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Drug abuse,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Drug abuse,Collegium Pharmaceutical,YES,YES,Listed
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Costochondritis,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,Hospitalisation,Product used for unknown indication,UNITED STATES,Costochondritis,Collegium Pharmaceutical,YES,YES,Unlisted
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Pseudomonas infection,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,Hospitalisation,Product used for unknown indication,UNITED STATES,Pseudomonas infection,Collegium Pharmaceutical,YES,YES,Unlisted
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Pseudomonas infection,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,Hospitalisation,Product used for unknown indication,UNITED STATES,Pseudomonas infection,Collegium Pharmaceutical,YES,YES,Unlisted
20221000334,20221000334,Bunavail," NALOXONE,BUPRENORPHINE",Intravenous use,,,,,Buccal film,Unknown,Costochondritis,Other Health Professional,44,Years,Male,I,10/10/2022,,EXP,,Hospitalisation,Product used for unknown indication,UNITED STATES,Costochondritis,Collegium Pharmaceutical,YES,YES,Unlisted
20221000337,20221000337,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Tremor,Other Health Professional,58,Years,Male,F,10/12/2022,10/10/2022,,PER,,Product used for unknown indication,UNITED STATES,Tremor,Collegium Pharmaceutical,NO,NO,Listed
20221000337,20221000337,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Anxiety,Other Health Professional,58,Years,Male,F,10/12/2022,10/10/2022,,PER,,Product used for unknown indication,UNITED STATES,Anxiety,Collegium Pharmaceutical,NO,NO,Listed
20221000341,20221000341,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,UNKNOWN,,,Buccal film,Unknown,Bradycardia,Physician,40,Years,Female,F,10/27/2022,,,PER,,Product used for unknown indication,UNITED STATES,Bradycardia,Collegium Pharmaceutical,NO,NO,Unlisted
20221000341,20221000341,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,UNKNOWN,,,Buccal film,Unknown,Arrhythmia,Physician,40,Years,Female,F,10/27/2022,,,PER,,Product used for unknown indication,UNITED STATES,Arrhythmia,Collegium Pharmaceutical,NO,NO,Unlisted
20221000343,20221000343,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product physical issue,Consumer,,,Female,I,10/10/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000353,20221000353,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,Unknown,Cardiac disorder,Consumer,,,Female,I,10/17/2022,2/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Cardiac disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20221000354,20221000354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Dental caries,Consumer,,,Female,I,10/18/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20221000357,20221000357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Male,F,10/18/2022,,,PER,,Back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221000360,20221000360,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Pharmacist,,,Female,I,10/18/2022,,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000363,20221000363,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,10/17/2022,6/15/2022,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000363,20221000363,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,I,10/17/2022,6/15/2022,,PER,,Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221000365,20221000365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Stomatitis,Nurse,,,Female,I,10/19/2022,,,PER,,Product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20221000369,20221000369,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Delirium,Other Health Professional,39,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Delirium,Collegium Pharmaceutical,YES,YES,Unlisted
20221000369,20221000369,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Delirium,Other Health Professional,39,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Delirium,Collegium Pharmaceutical,YES,YES,Unlisted
20221000369,20221000369,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Exposure during pregnancy,Other Health Professional,39,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Exposure during pregnancy,Collegium Pharmaceutical,NO,YES,Listed
20221000369,20221000369,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Exposure during pregnancy,Other Health Professional,39,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Exposure during pregnancy,Collegium Pharmaceutical,NO,YES,Listed
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Exposure during pregnancy,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Exposure during pregnancy,Collegium Pharmaceutical,NO,YES,Listed
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Agitation,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Agitation,Collegium Pharmaceutical,YES,YES,Unlisted
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Exposure during pregnancy,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Exposure during pregnancy,Collegium Pharmaceutical,NO,YES,Listed
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Delirium,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Delirium,Collegium Pharmaceutical,YES,YES,Unlisted
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Delirium,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Delirium,Collegium Pharmaceutical,YES,YES,Unlisted
20221000370,20221000370,Bunavail," NALOXONE,BUPRENORPHINE",Unknown,,,,,Buccal film,Unknown,Agitation,Other Health Professional,27,Years,Female,I,10/17/2022,,EXP,,,Product used for unknown indication,UNITED STATES,Agitation,Collegium Pharmaceutical,YES,YES,Unlisted
20221000377,20221000377,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect route of product administration,Non-Health Professional,,,Female,I,10/21/2022,,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221000377,20221000377,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Non-Health Professional,,,Female,I,10/21/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000384,20221000384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product taste abnormal,Consumer,,,Male,I,10/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Product taste abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221000384,20221000384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Euphoric mood,Consumer,,,Male,I,10/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Euphoric mood,Collegium Pharmaceutical,NO,NO,Unlisted
20221000384,20221000384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Paraesthesia oral,Consumer,,,Male,I,10/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Paraesthesia oral,Collegium Pharmaceutical,NO,NO,Unlisted
20221000386,20221000386,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,10/26/2022,10/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221000386,20221000386,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,I,10/26/2022,10/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20221000389,20221000389,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Male,I,10/27/2022,10/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221000389,20221000389,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product label confusion,Consumer,,,Male,I,10/27/2022,10/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product label confusion,Collegium Pharmaceutical,NO,NO,Unlisted
20221000389,20221000389,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug tolerance,Consumer,,,Male,I,10/27/2022,,,PER,,Product used for unknown indication,UNITED STATES,Drug tolerance,Collegium Pharmaceutical,NO,NO,Listed
20221100395,20221100395,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Male,I,10/26/2022,10/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100398,20221100398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product size issue,Physician,,,,F,11/1/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100398,20221100398,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Physician,,,,F,11/1/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100401,20221100401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Vomiting,Consumer,60,Years,Female,I,11/1/2022,10/15/2022,,PER,,Chronic pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20221100401,20221100401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug interaction,Consumer,60,Years,Female,I,11/1/2022,10/15/2022,,PER,,Chronic pain,UNITED STATES,Drug interaction,Collegium Pharmaceutical,NO,NO,Listed
20221100401,20221100401,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Nausea,Consumer,60,Years,Female,I,11/1/2022,10/15/2022,,PER,,Chronic pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20221100407,20221100407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,Unknown,Dental caries,Nurse,,,Female,I,11/3/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20221100407,20221100407,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,Unknown,Tooth loss,Nurse,,,Female,I,11/3/2022,,,PER,,Product used for unknown indication,UNITED STATES,Tooth loss,Collegium Pharmaceutical,NO,NO,Listed
20221100408,20221100408,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product label issue,Consumer,,,Female,I,11/3/2022,,,PER,,Chronic pain,UNITED STATES,Product label issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100408,20221100408,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product adhesion issue,Consumer,,,Female,I,11/3/2022,,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100408,20221100408,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Oral administration complication,Consumer,,,Female,I,11/3/2022,,,PER,,Chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221100415,20221100415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,11/7/2022,,,PER,,severe back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100415,20221100415,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Male,I,11/7/2022,,,PER,,severe back pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221100418,20221100418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,11/7/2022,9/8/2022,,PER,,Chronic back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100418,20221100418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,I,11/7/2022,9/8/2022,,PER,,Chronic back pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221100418,20221100418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Female,I,11/7/2022,9/8/2022,,PER,,Chronic back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221100418,20221100418,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,11/7/2022,9/8/2022,,PER,,Chronic back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100419,20221100419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Tremor,Consumer,56,Years,Female,I,11/8/2022,11/8/2022,,PER,,Severe chronic pain,UNITED STATES,Tremor,Collegium Pharmaceutical,NO,NO,Listed
20221100419,20221100419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Head discomfort,Consumer,56,Years,Female,I,11/8/2022,11/8/2022,,PER,,Severe chronic pain,UNITED STATES,Head discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20221100419,20221100419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Pain,Consumer,56,Years,Female,I,11/8/2022,6/15/2022,,PER,,Severe chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20221100419,20221100419,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Palpitations,Consumer,56,Years,Female,I,11/8/2022,11/8/2022,,PER,,Severe chronic pain,UNITED STATES,Palpitations,Collegium Pharmaceutical,NO,NO,Unlisted
20221100425,20221100425,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Dental caries,Physician,,,Female,I,11/9/2022,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,YES,YES,Listed
20221100429,20221100429,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Nausea,Nurse,37,Years,Male,I,11/8/2022,,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20221100430,20221100430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,,,Male,I,11/10/2022,11/10/2022,,PER,,back pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221100430,20221100430,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,11/10/2022,11/10/2022,,PER,,back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100431,20221100431,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qid,Drug ineffective,Consumer,62,Years,Male,F,1/26/2023,6/15/2020,,PER,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221100431,20221100431,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qid,Off label use,Consumer,62,Years,Male,F,1/26/2023,6/15/2020,,PER,,chronic pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Frontal sinus operation,Consumer,51,Years,Female,F,11/21/2022,11/19/2022,,PER,,Nerve pain,UNITED STATES,Frontal sinus operation,Collegium Pharmaceutical,NO,NO,Unlisted
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Sinus congestion,Consumer,51,Years,Female,F,11/21/2022,11/17/2022,,PER,,Nerve pain,UNITED STATES,Sinus congestion,Collegium Pharmaceutical,NO,NO,Listed
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,51,Years,Female,F,11/21/2022,11/9/2022,,PER,,Nerve pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Pyrexia,Consumer,51,Years,Female,F,11/21/2022,11/17/2022,,PER,,Nerve pain,UNITED STATES,Pyrexia,Collegium Pharmaceutical,NO,NO,Listed
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,51,Years,Female,F,11/21/2022,11/9/2022,,PER,,Nerve pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,51,Years,Female,F,11/21/2022,11/9/2022,,PER,,Nerve pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221100433,20221100433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,51,Years,Female,F,11/21/2022,11/9/2022,,PER,,Nerve pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221100435,20221100435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Burning sensation,Consumer,,,Female,I,11/14/2022,,,PER,,Chronic Pain,UNITED STATES,Burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20221100435,20221100435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Electric shock sensation,Consumer,,,Female,I,11/14/2022,,,PER,,Chronic Pain,UNITED STATES,Electric shock sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20221100435,20221100435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,,,Female,I,11/14/2022,10/15/2022,,PER,,Chronic Pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100438,20221100438,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product use complaint,Physician,22,Years,Female,I,11/14/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20221100454,20221100454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Off label use,Consumer,,,Female,I,11/18/2022,11/15/2022,,PER,,chronic pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20221100454,20221100454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Pain,Consumer,,,Female,I,11/18/2022,,,PER,,chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20221100454,20221100454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,I,11/18/2022,11/15/2022,,PER,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221100456,20221100456,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,F,11/30/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100456,20221100456,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,F,11/30/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100456,20221100456,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,F,11/30/2022,9/15/2022,,PER,,Chronic pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221100459,20221100459,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic product effect incomplete,Consumer,,,Male,I,11/21/2022,,,PER,,chronic pain,UNITED STATES,Therapeutic product effect incomplete,Collegium Pharmaceutical,NO,NO,Listed
20221100459,20221100459,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product use complaint,Consumer,,,Male,I,11/21/2022,,,PER,,chronic pain,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20221100462,20221100462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product size issue,Consumer,,,Female,I,11/21/2022,11/15/2022,,PER,,back pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100462,20221100462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,11/21/2022,11/15/2022,,PER,,back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100462,20221100462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,11/21/2022,11/15/2022,,PER,,back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100462,20221100462,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,Female,I,11/21/2022,11/15/2022,,PER,,back pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221100472,20221100472,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Skin burning sensation,Nurse,,,Female,I,11/23/2022,,,PER,,Product used for unknown indication,UNITED STATES,Skin burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20221100473,20221100473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,11/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221100473,20221100473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Female,I,11/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100473,20221100473,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Abdominal discomfort,Consumer,,,Female,I,11/23/2022,,,PER,,product used for unknown indication,UNITED STATES,Abdominal discomfort,Collegium Pharmaceutical,NO,NO,Listed
20221100480,20221100480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Female,I,11/28/2022,11/26/2022,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221100483,20221100483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Consumer,,,Male,I,11/29/2022,,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20221100483,20221100483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response increased,Consumer,,,Male,I,11/29/2022,,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response increased,Collegium Pharmaceutical,NO,NO,Listed
20221200486,20221200486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Nurse,,,Female,I,11/30/2022,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200486,20221200486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Oral administration complication,Nurse,,,Female,I,11/30/2022,,,PER,,product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221200494,20221200494,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging difficult to open,Consumer,,,Male,I,12/2/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Thinking abnormal,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Thinking abnormal,,NO,NO,
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Restlessness,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Restlessness,,NO,NO,
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Drug interaction,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Drug interaction,,NO,NO,
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Vomiting,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Vomiting,,NO,NO,
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Constipation,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Constipation,,NO,NO,
20221200500,20221200500,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Staring,Pharmacist,,,Male,I,12/5/2022,,,,,Pain,SPAIN,Staring,,NO,NO,
20221200506,20221200506,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Pharmacist,,,,I,12/6/2022,11/2/2022,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200511,20221200511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,58,Years,Female,F,12/9/2022,6/15/2022,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221200511,20221200511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral herpes,Consumer,58,Years,Female,F,12/9/2022,11/15/2022,,PER,,product used for unknown indication,UNITED STATES,Oral herpes,Collegium Pharmaceutical,NO,NO,Unlisted
20221200511,20221200511,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,58,Years,Female,F,12/9/2022,6/15/2022,,PER,,product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221200512,20221200512,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Taste disorder,Consumer,,,Male,I,12/8/2022,,,PER,,Product used for unknown indication,UNITED STATES,Taste disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20221200512,20221200512,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Headache,Consumer,,,Male,I,12/8/2022,11/27/2022,,PER,,Product used for unknown indication,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20221200512,20221200512,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Consumer,,,Male,I,12/8/2022,11/27/2022,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging quantity issue,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product size issue,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221200514,20221200514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,74,Years,Female,I,12/9/2022,6/15/2022,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200517,20221200517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,,,Female,I,12/12/2022,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200523,20221200523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Dental caries,Consumer,92,Years,Female,I,12/15/2022,,,PER,,pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,YES,Listed
20221200523,20221200523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Drug withdrawal syndrome,Consumer,92,Years,Female,I,12/15/2022,,,PER,,pain,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20221200523,20221200523,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Off label use,Consumer,92,Years,Female,I,12/15/2022,,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,YES,Unlisted
20221200524,20221200524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug-induced liver injury,Nurse,43,Years,Male,I,12/15/2022,8/25/2022,EXP,,Life Threatening,Product used for unknown indication,UNITED STATES,Drug-induced liver injury,Collegium Pharmaceutical,YES,YES,Unlisted
20221200524,20221200524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Appetite disorder,Nurse,43,Years,Male,I,12/15/2022,6/15/2022,EXP,,,Product used for unknown indication,UNITED STATES,Appetite disorder,Collegium Pharmaceutical,NO,YES,Unlisted
20221200524,20221200524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Gastritis,Nurse,43,Years,Male,I,12/15/2022,6/15/2022,EXP,,,Product used for unknown indication,UNITED STATES,Gastritis,Collegium Pharmaceutical,NO,YES,Unlisted
20221200524,20221200524,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Weight decreased,Nurse,43,Years,Male,I,12/15/2022,6/15/2022,EXP,,,Product used for unknown indication,UNITED STATES,Weight decreased,Collegium Pharmaceutical,NO,YES,Unlisted
20221200527,20221200527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,,,Female,I,12/16/2022,6/15/2022,,PER,,muscular dystrophy,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200527,20221200527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,I,12/16/2022,,,PER,,muscular dystrophy,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200527,20221200527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,12/16/2022,,,PER,,muscular dystrophy,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221200527,20221200527,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,12/16/2022,,,PER,,muscular dystrophy,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200532,20221200532,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Therapeutic response unexpected,Consumer,,,Female,I,12/19/2022,,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response unexpected,Collegium Pharmaceutical,NO,NO,Unlisted
20221200534,20221200534,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Pharmacist,,,Female,I,12/20/2022,12/20/2022,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200534,20221200534,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Pharmacist,,,Female,I,12/20/2022,,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20221200534,20221200534,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Pharmacist,,,Female,I,12/20/2022,12/20/2022,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200536,20221200536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Skin odour abnormal,Consumer,,,Female,I,12/20/2022,,,PER,,pain,UNITED STATES,Skin odour abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20221200536,20221200536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Inappropriate schedule of product administration,Consumer,,,Female,I,12/20/2022,,,PER,,pain,UNITED STATES,Inappropriate schedule of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20221200538,20221200538,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Female,I,12/21/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20221200538,20221200538,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,Female,I,12/21/2022,,,PER,,Product used for unknown indication,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20221200538,20221200538,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,12/21/2022,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
2022BDSI0006,2022BDSI0006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dysgeusia,Other Health Professional,71,Years,Female,I,1/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dysgeusia,,NO,NO,Unlisted
2022BDSI0006,2022BDSI0006,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Ageusia,Other Health Professional,71,Years,Female,I,1/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Ageusia,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intentional product misuse,Non-Health Professional,60,Years,Female,I,1/5/2022,12/27/2021,,,,CHRONIC PAIN,UNITED STATES,Intentional product misuse,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,60,Years,Female,I,1/5/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging issue,Non-Health Professional,60,Years,Female,I,1/5/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,60,Years,Female,I,1/5/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,1/5/2022,12/27/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,1/5/2022,12/27/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,1/5/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0008,2022BDSI0008,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,1/5/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0010,2022BDSI0010,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,61,Years,Female,I,1/4/2022,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0010,2022BDSI0010,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,61,Years,Female,I,1/4/2022,1/1/2020,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0011,2022BDSI0011,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Female,I,1/5/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0012,2022BDSI0012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Death,Physician,,,Male,I,1/6/2022,,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Death,,YES,YES,Unlisted
2022BDSI0013,2022BDSI0013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,,,Female,I,1/6/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2022BDSI0013,2022BDSI0013,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral pain,Other Health Professional,,,Female,I,1/6/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral pain,,NO,NO,Unlisted
2022BDSI0014,2022BDSI0014,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/7/2022,11/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,,,Female,I,1/6/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/6/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,1/6/2022,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product use complaint,Non-Health Professional,,,Female,I,1/6/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,1/6/2022,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0015,2022BDSI0015,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/6/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0019,2022BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Chest discomfort,Other Health Professional,50,Years,Male,I,1/10/2022,12/28/2021,,,,CHRONIC PAIN,UNITED STATES,Chest discomfort,,NO,NO,Unlisted
2022BDSI0019,2022BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Fatigue,Other Health Professional,50,Years,Male,I,1/10/2022,12/28/2021,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2022BDSI0019,2022BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dyspnoea,Other Health Professional,50,Years,Male,I,1/10/2022,12/28/2021,,,,CHRONIC PAIN,UNITED STATES,Dyspnoea,,NO,NO,Listed
2022BDSI0019,2022BDSI0019,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Headache,Other Health Professional,50,Years,Male,I,1/10/2022,1/2/2022,,,,CHRONIC PAIN,UNITED STATES,Headache,,NO,NO,Listed
2022BDSI0020,2022BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Ejaculation failure,Other Health Professional,53,Years,Male,I,1/11/2022,,,,,CHRONIC PAIN,UNITED STATES,Ejaculation failure,,NO,NO,Unlisted
2022BDSI0020,2022BDSI0020,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product administration error,Other Health Professional,53,Years,Male,I,1/11/2022,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0021,2022BDSI0021,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,I,1/12/2022,1/12/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0021,2022BDSI0021,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,58,Years,Female,I,1/12/2022,1/12/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0021,2022BDSI0021,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Female,I,1/12/2022,1/11/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0023,2022BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hot flush,Other Health Professional,62,Years,Female,I,1/18/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Hot flush,,NO,NO,Listed
2022BDSI0023,2022BDSI0023,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Migraine,Other Health Professional,62,Years,Female,I,1/18/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Migraine,,NO,NO,Listed
2022BDSI0024,2022BDSI0024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dental caries,Physician,,,Male,I,1/17/2022,,,,,CHRONIC PAIN,UNITED STATES,Dental caries,,NO,NO,Unlisted
2022BDSI0025,2022BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dyspnoea,Pharmacist,51,Years,Female,I,1/18/2022,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dyspnoea,,YES,YES,Listed
2022BDSI0025,2022BDSI0025,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Chest pain,Pharmacist,51,Years,Female,I,1/18/2022,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Chest pain,,YES,YES,Listed
2022BDSI0026,2022BDSI0026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Testicular pain,Physician,41,Years,Male,I,1/18/2022,,,,,CHRONIC PAIN,UNITED STATES,Testicular pain,,NO,NO,Unlisted
2022BDSI0026,2022BDSI0026,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product administration error,Physician,41,Years,Male,I,1/18/2022,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0028,2022BDSI0028,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Cardiomyopathy,Physician,64,Years,Female,I,1/21/2022,,,,Hospitalisation,OPIOID SUBSTITUTION TREATMENT,GREECE,Cardiomyopathy,,YES,YES,Unlisted
2022BDSI0028,2022BDSI0028,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Cardiomyopathy,Physician,64,Years,Female,I,1/21/2022,,,,Hospitalisation,OPIOID SUBSTITUTION TREATMENT,GREECE,Cardiomyopathy,,YES,YES,Unlisted
2022BDSI0028,2022BDSI0028,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Ischaemic stroke,Physician,64,Years,Female,I,1/21/2022,,,,,OPIOID SUBSTITUTION TREATMENT,GREECE,Ischaemic stroke,,YES,YES,Unlisted
2022BDSI0028,2022BDSI0028,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Ischaemic stroke,Physician,64,Years,Female,I,1/21/2022,,,,,OPIOID SUBSTITUTION TREATMENT,GREECE,Ischaemic stroke,,YES,YES,Unlisted
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,52,Years,Female,I,1/21/2022,6/1/2021,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Musculoskeletal discomfort,Non-Health Professional,52,Years,Female,I,1/21/2022,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Musculoskeletal discomfort,,NO,YES,Unlisted
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug titration error,Non-Health Professional,52,Years,Female,I,1/21/2022,6/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug titration error,,NO,YES,Unlisted
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intestinal mass,Non-Health Professional,52,Years,Female,I,1/21/2022,11/15/2021,,,,CHRONIC PAIN,UNITED STATES,Intestinal mass,,NO,YES,Unlisted
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,52,Years,Female,I,1/21/2022,1/2/2022,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,YES,Unlisted
2022BDSI0029,2022BDSI0029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Sensory disturbance,Non-Health Professional,52,Years,Female,I,1/21/2022,7/1/2021,,,,CHRONIC PAIN,UNITED STATES,Sensory disturbance,,NO,YES,Unlisted
2022BDSI0030,2022BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,1/21/2022,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0030,2022BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/21/2022,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0030,2022BDSI0030,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/21/2022,1/1/2018,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0032,2022BDSI0032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,1/25/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0033,2022BDSI0033,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral mucosal blistering,Physician,,,Male,I,1/25/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2022BDSI0034,2022BDSI0034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,1/25/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0034,2022BDSI0034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,1/25/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0034,2022BDSI0034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,1/25/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0035,2022BDSI0035,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tooth infection,Non-Health Professional,,,Female,I,1/26/2022,,,,,CHRONIC PAIN,UNITED STATES,Tooth infection,,NO,NO,Unlisted
2022BDSI0036,2022BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tremor,Physician,,,Male,I,1/28/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Tremor,,NO,NO,Listed
2022BDSI0036,2022BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Anxiety,Physician,,,Male,I,1/28/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Anxiety,,NO,NO,Listed
2022BDSI0036,2022BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Staphylococcal infection,Physician,,,Male,I,1/28/2022,,,,,CHRONIC PAIN,UNITED STATES,Staphylococcal infection,,NO,NO,Unlisted
2022BDSI0036,2022BDSI0036,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug interaction,Physician,,,Male,I,1/28/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Listed
2022BDSI0037,2022BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral mucosal blistering,Other Health Professional,78,Years,Female,I,1/6/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2022BDSI0037,2022BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral mucosal erythema,Other Health Professional,78,Years,Female,I,1/6/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral mucosal erythema,,NO,NO,Unlisted
2022BDSI0037,2022BDSI0037,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Tongue blistering,Other Health Professional,78,Years,Female,I,1/6/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Tongue blistering,,NO,NO,Unlisted
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,64,Years,Female,I,1/31/2022,7/26/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Confusional state,Non-Health Professional,64,Years,Female,I,1/31/2022,9/27/2021,,,,CHRONIC PAIN,UNITED STATES,Confusional state,,NO,NO,Listed
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,64,Years,Female,I,1/31/2022,9/27/2021,,,,CHRONIC PAIN,UNITED STATES,Fatigue,,NO,NO,Listed
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Non-Health Professional,64,Years,Female,I,1/31/2022,9/27/2021,,,,CHRONIC PAIN,UNITED STATES,Somnolence,,NO,NO,Listed
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,1/31/2022,9/27/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0038,2022BDSI0038,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,64,Years,Female,I,1/31/2022,1/27/2022,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0039,2022BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,1/31/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0039,2022BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,1/31/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0039,2022BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,1/31/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0039,2022BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Male,I,1/31/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0039,2022BDSI0039,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,1/31/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,66,Years,Female,I,2/1/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Female,I,2/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Female,I,2/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,66,Years,Female,I,2/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,66,Years,Female,I,2/1/2022,8/1/2021,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypervigilance,Non-Health Professional,66,Years,Female,I,2/1/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Hypervigilance,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Female,I,2/1/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,66,Years,Female,I,2/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Depressed mood,Non-Health Professional,66,Years,Female,I,2/1/2022,1/31/2022,,,,CHRONIC PAIN,UNITED STATES,Depressed mood,,NO,NO,Listed
2022BDSI0040,2022BDSI0040,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Irritability,Non-Health Professional,66,Years,Female,I,2/1/2022,1/31/2022,,,,CHRONIC PAIN,UNITED STATES,Irritability,,NO,NO,Listed
2022BDSI0041,2022BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,40,Years,Male,I,2/1/2022,1/31/2022,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0041,2022BDSI0041,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Feeling abnormal,Non-Health Professional,40,Years,Male,I,2/1/2022,1/31/2022,,,,CHRONIC PAIN,UNITED STATES,Feeling abnormal,,NO,NO,Unlisted
2022BDSI0042,2022BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/1/2022,11/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0042,2022BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypotension,Non-Health Professional,,,Female,I,2/1/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Hypotension,,NO,NO,Listed
2022BDSI0042,2022BDSI0042,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/1/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0043,2022BDSI0043,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Loss of consciousness,Other Health Professional,77,Years,Female,I,2/1/2022,12/23/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Loss of consciousness,,NO,NO,Unlisted
2022BDSI0044,2022BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dizziness,Other Health Professional,62,Years,Female,I,2/1/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2022BDSI0044,2022BDSI0044,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Loss of consciousness,Other Health Professional,62,Years,Female,I,2/1/2022,9/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Loss of consciousness,,NO,NO,Unlisted
2022BDSI0045,2022BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Headache,Non-Health Professional,59,Years,Female,I,2/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2022BDSI0045,2022BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pain,Non-Health Professional,59,Years,Female,I,2/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2022BDSI0045,2022BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tremor,Non-Health Professional,59,Years,Female,I,2/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tremor,,NO,NO,Listed
2022BDSI0045,2022BDSI0045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Hyperhidrosis,Non-Health Professional,59,Years,Female,I,2/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,NO,Listed
2022BDSI0046,2022BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/9/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0046,2022BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/9/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0046,2022BDSI0046,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/9/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0047,2022BDSI0047,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,2/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0051,2022BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,Male,I,2/10/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0051,2022BDSI0051,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/10/2022,1/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0052,2022BDSI0052,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,2/11/2022,2/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0054,2022BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,2/14/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0054,2022BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,2/14/2022,,,,,CHRONIC PAIN,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2022BDSI0054,2022BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,2/14/2022,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0054,2022BDSI0054,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,2/14/2022,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0057,2022BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,2/15/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0057,2022BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,2/15/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0057,2022BDSI0057,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,2/15/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Female,I,2/17/2022,2/13/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,72,Years,Female,I,2/17/2022,2/13/2022,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,72,Years,Female,I,2/17/2022,2/15/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,72,Years,Female,I,2/17/2022,2/13/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Female,I,2/17/2022,2/13/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,72,Years,Female,I,2/17/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2022BDSI0058,2022BDSI0058,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,72,Years,Female,I,2/17/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2022BDSI0059,2022BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Incorrect route of product administration,Non-Health Professional,63,Years,Female,I,2/16/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0059,2022BDSI0059,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Product adhesion issue,Non-Health Professional,63,Years,Female,I,2/16/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0060,2022BDSI0060,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,2/18/2022,2/18/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0061,2022BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,63,Years,Male,I,2/18/2022,2/1/2022,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0061,2022BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,63,Years,Male,I,2/18/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2022BDSI0061,2022BDSI0061,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Male,I,2/18/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0062,2022BDSI0062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,2/17/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0063,2022BDSI0063,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,2/18/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0064,2022BDSI0064,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pruritus,Physician,,,Female,I,2/20/2022,,,,,CHRONIC PAIN,UNITED STATES,Pruritus,,NO,NO,Listed
2022BDSI0065,2022BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,2/28/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0065,2022BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Night sweats,Non-Health Professional,,,Male,I,2/28/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Night sweats,,NO,YES,Unlisted
2022BDSI0065,2022BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Arthralgia,Non-Health Professional,,,Male,I,2/28/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Arthralgia,,NO,YES,Unlisted
2022BDSI0065,2022BDSI0065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Joint injury,Non-Health Professional,,,Male,I,2/28/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Joint injury,,YES,YES,Unlisted
2022BDSI0066,2022BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Male,I,2/23/2022,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0066,2022BDSI0066,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,63,Years,Male,I,2/23/2022,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0069,2022BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,54,Years,Female,I,2/25/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0069,2022BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,54,Years,Female,I,2/25/2022,12/1/2021,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0069,2022BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,54,Years,Female,I,2/25/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0069,2022BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,54,Years,Female,I,2/25/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0069,2022BDSI0069,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,54,Years,Female,I,2/25/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0070,2022BDSI0070,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Hernia,Pharmacist,,,Male,I,2/25/2022,2/22/2022,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Hernia,,YES,YES,Unlisted
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,66,Years,Female,I,3/1/2022,2/21/2022,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,66,Years,Female,I,3/1/2022,10/8/2021,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,66,Years,Female,I,3/1/2022,2/21/2022,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,66,Years,Female,I,3/1/2022,2/21/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,66,Years,Female,I,3/1/2022,2/21/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0074,2022BDSI0074,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,66,Years,Female,I,3/1/2022,2/21/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0076,2022BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Tooth injury,Nurse,36,Years,Female,F,1/20/2023,6/15/2021,,PER,,CHRONIC PAIN,UNITED STATES,Tooth injury,,NO,YES,Listed
2022BDSI0076,2022BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Tooth discolouration,Nurse,36,Years,Female,F,1/20/2023,6/15/2021,,PER,,CHRONIC PAIN,UNITED STATES,Tooth discolouration,,NO,YES,Unlisted
2022BDSI0076,2022BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Dental caries,Nurse,36,Years,Female,F,1/20/2023,6/15/2021,,PER,,CHRONIC PAIN,UNITED STATES,Dental caries,,YES,YES,Listed
2022BDSI0076,2022BDSI0076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Tooth disorder,Nurse,36,Years,Female,F,1/20/2023,6/15/2021,,PER,,CHRONIC PAIN,UNITED STATES,Tooth disorder,,NO,YES,Unlisted
2022BDSI0077,2022BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,59,Years,Male,I,4/21/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0077,2022BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,59,Years,Male,I,4/21/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0077,2022BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,59,Years,Male,I,4/21/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0077,2022BDSI0077,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,59,Years,Male,I,4/21/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0078,2022BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,3/2/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0078,2022BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,3/2/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0078,2022BDSI0078,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,3/2/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0079,2022BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/2/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0079,2022BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/2/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0079,2022BDSI0079,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,3/2/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0080,2022BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,68,Years,Male,I,3/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0080,2022BDSI0080,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Non-Health Professional,68,Years,Male,I,3/3/2022,2/22/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical issue,,NO,NO,Unlisted
2022BDSI0081,2022BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,3/4/2022,3/4/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0081,2022BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/4/2022,3/4/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0081,2022BDSI0081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,3/4/2022,3/4/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0082,2022BDSI0082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral mucosal blistering,Physician,,,Female,I,3/3/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral mucosal blistering,,NO,NO,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dyskinesia,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dyskinesia,,NO,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Sensory disturbance,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Sensory disturbance,,NO,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Visual impairment,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Visual impairment,,NO,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tremor,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tremor,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Constipation,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Constipation,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Hypertension,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hypertension,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Muscle spasms,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Muscle spasms,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Insomnia,,NO,YES,Listed
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Inhibitory drug interaction,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Inhibitory drug interaction,,NO,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,,,,I,3/4/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Multiple fractures,Non-Health Professional,,,,I,3/4/2022,12/1/2019,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Multiple fractures,,YES,YES,Unlisted
2022BDSI0083,2022BDSI0083,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drop attacks,Non-Health Professional,,,,I,3/4/2022,12/1/2019,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drop attacks,,YES,YES,Unlisted
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,54,Years,Male,I,3/7/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,54,Years,Male,I,3/7/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,54,Years,Male,I,3/7/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,54,Years,Male,I,3/7/2022,3/6/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,54,Years,Male,I,3/7/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0084,2022BDSI0084,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,54,Years,Male,I,3/7/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0085,2022BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Lymphadenopathy,Physician,59,Years,Female,I,3/7/2022,,,,,CHRONIC PAIN,UNITED STATES,Lymphadenopathy,,NO,NO,Unlisted
2022BDSI0085,2022BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Toothache,Physician,59,Years,Female,I,3/7/2022,,,,,CHRONIC PAIN,UNITED STATES,Toothache,,NO,NO,Listed
2022BDSI0085,2022BDSI0085,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,,Gingival bleeding,Physician,59,Years,Female,I,3/7/2022,,,,,CHRONIC PAIN,UNITED STATES,Gingival bleeding,,NO,NO,Unlisted
2022BDSI0088,2022BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,3/11/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0088,2022BDSI0088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,3/11/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0090,2022BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,73,Years,Female,I,3/14/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0090,2022BDSI0090,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,73,Years,Female,I,3/14/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0091,2022BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,69,Years,Female,I,3/14/2022,2/24/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0091,2022BDSI0091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,3/14/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0092,2022BDSI0092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product complaint,Non-Health Professional,70,Years,Female,I,3/14/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product complaint,,NO,NO,Unlisted
2022BDSI0094,2022BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,3/17/2022,3/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0094,2022BDSI0094,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Weight decreased,Non-Health Professional,,,Female,I,3/17/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Weight decreased,,NO,NO,Unlisted
2022BDSI0095,2022BDSI0095,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/18/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0097,2022BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,75,Years,Female,I,3/23/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0097,2022BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,75,Years,Female,I,3/23/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0097,2022BDSI0097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,75,Years,Female,I,3/23/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2022BDSI0099,2022BDSI0099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tooth discolouration,Other Health Professional,,,Female,I,3/23/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth discolouration,,NO,NO,Unlisted
2022BDSI0100,2022BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,63,Years,Male,I,3/25/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,YES,Unlisted
2022BDSI0100,2022BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,63,Years,Male,I,3/25/2022,3/1/2022,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0100,2022BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,63,Years,Male,I,3/25/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,YES,Unlisted
2022BDSI0100,2022BDSI0100,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,63,Years,Male,I,3/25/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0106,2022BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,3/28/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0106,2022BDSI0106,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,3/28/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0107,2022BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,3/25/2022,3/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0107,2022BDSI0107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Male,I,3/25/2022,3/1/2022,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0108,2022BDSI0108,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,54,Years,Female,I,3/28/2022,3/27/2022,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2022BDSI0109,2022BDSI0109,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,,,,,I,3/29/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,72,Years,Male,I,3/28/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,72,Years,Male,I,3/28/2022,3/26/2022,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,72,Years,Male,I,3/28/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Male,I,3/28/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Male,I,3/28/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0110,2022BDSI0110,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,72,Years,Male,I,3/28/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0113,2022BDSI0113,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Constipation,Non-Health Professional,62,Years,Male,I,3/30/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Constipation,,NO,NO,Listed
2022BDSI0122,2022BDSI0122,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Mouth ulceration,Other Health Professional,,,Female,I,3/31/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
2022BDSI0124,2022BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,55,Years,Male,I,3/31/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0124,2022BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,55,Years,Male,I,3/31/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0124,2022BDSI0124,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,55,Years,Male,I,3/31/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0125,2022BDSI0125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Serotonin syndrome,Other Health Professional,,,,I,4/8/2022,,,,Other,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Serotonin syndrome,,YES,YES,
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Inhibitory drug interaction,Non-Health Professional,61,Years,Female,I,4/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Inhibitory drug interaction,,NO,NO,Unlisted
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,61,Years,Female,I,4/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abdominal pain,Non-Health Professional,61,Years,Female,I,4/1/2022,3/26/2022,,,,CHRONIC PAIN,UNITED STATES,Abdominal pain,,NO,NO,Listed
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Non-Health Professional,61,Years,Female,I,4/1/2022,3/30/2022,,,,CHRONIC PAIN,UNITED STATES,Vomiting,,NO,NO,Listed
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,61,Years,Female,I,4/1/2022,3/30/2022,,,,CHRONIC PAIN,UNITED STATES,Diarrhoea,,NO,NO,Listed
2022BDSI0126,2022BDSI0126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,61,Years,Female,I,4/1/2022,3/28/2022,,,,CHRONIC PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0128,2022BDSI0128,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,64,Years,Female,I,4/5/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0129,2022BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,64,Years,Female,I,4/4/2022,3/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0129,2022BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,64,Years,Female,I,4/4/2022,3/2/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0129,2022BDSI0129,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,64,Years,Female,I,4/4/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2022BDSI0131,2022BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,65,Years,Male,I,4/5/2022,3/22/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0131,2022BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,65,Years,Male,I,4/5/2022,3/19/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,YES,Listed
2022BDSI0131,2022BDSI0131,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,65,Years,Male,I,4/5/2022,3/22/2022,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0132,2022BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral administration complication,Other Health Professional,,,,I,4/5/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0132,2022BDSI0132,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product solubility abnormal,Other Health Professional,,,,I,4/5/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0133,2022BDSI0133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Gingival pain,Other Health Professional,,,Male,I,3/25/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Gingival pain,,NO,NO,Unlisted
2022BDSI0133,2022BDSI0133,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Dental caries,Other Health Professional,,,Male,I,3/25/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dental caries,,NO,NO,Unlisted
2022BDSI0134,2022BDSI0134,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Rash,Non-Health Professional,38,Years,Male,I,4/6/2022,4/5/2022,,,,CHRONIC PAIN,UNITED STATES,Rash,,NO,NO,Listed
2022BDSI0135,2022BDSI0135,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dental caries,Physician,,,Female,I,3/30/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dental caries,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product label confusion,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product label confusion,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect dose administered by product,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Incorrect dose administered by product,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0136,2022BDSI0136,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,72,Years,Male,I,4/8/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Off label use,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Visual impairment,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Visual impairment,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Balance disorder,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Balance disorder,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Throat irritation,Non-Health Professional,,,Male,I,4/19/2022,4/19/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Throat irritation,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Therapeutic response increased,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Male,I,4/19/2022,4/18/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Headache,,NO,NO,Listed
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,4/19/2022,4/6/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,,,Male,I,4/19/2022,4/1/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2022BDSI0139,2022BDSI0139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dizziness,Non-Health Professional,,,Male,I,4/19/2022,4/5/2022,,,,SEVERE PUDENDAL NERVE PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Stress cardiomyopathy,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Life Threatening,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Stress cardiomyopathy,,YES,YES,Unlisted
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Pulmonary oedema,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Pulmonary oedema,,YES,YES,Unlisted
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Pulmonary oedema,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Pulmonary oedema,,YES,YES,Unlisted
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Abdominal pain,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Abdominal pain,,YES,YES,Listed
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Abdominal pain,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Abdominal pain,,YES,YES,Listed
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Vomiting,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Vomiting,,YES,YES,Listed
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Vomiting,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Hospitalisation,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Vomiting,,YES,YES,Listed
2022BDSI0141,2022BDSI0141,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Stress cardiomyopathy,Other Health Professional,25,Years,Male,I,4/6/2022,,,,Life Threatening,SUSPECTED OPIOID WITHDRAWAL,UNITED STATES,Stress cardiomyopathy,,YES,YES,Unlisted
2022BDSI0142,2022BDSI0142,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Ankle operation,Non-Health Professional,,,Male,I,4/12/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Ankle operation,,YES,YES,Unlisted
2022BDSI0143,2022BDSI0143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Male,I,4/11/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0144,2022BDSI0144,Subutex,BUPRENORPHINE HYDROCHLORIDE,,,,,,Injection,,Toxicity to various agents,Other Health Professional,42,Years,Male,I,5/13/2022,,,,Death,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Toxicity to various agents,,YES,YES,
2022BDSI0144,2022BDSI0144,Subutex,BUPRENORPHINE HYDROCHLORIDE,,,,,,Injection,,Intentional product misuse,Other Health Professional,42,Years,Male,I,5/13/2022,,,,Death,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Intentional product misuse,,YES,YES,
2022BDSI0144,2022BDSI0144,Subutex,BUPRENORPHINE HYDROCHLORIDE,,,,,,Injection,,Asphyxia,Other Health Professional,42,Years,Male,I,5/13/2022,,,,Death,DRUG USE FOR UNKNOWN INDICATION,FRANCE,Asphyxia,,YES,YES,
2022BDSI0148,2022BDSI0148,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tooth injury,Non-Health Professional,,,Female,I,4/18/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth injury,,NO,NO,Unlisted
2022BDSI0149,2022BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,69,Years,Male,I,4/14/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0149,2022BDSI0149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,69,Years,Male,I,4/14/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0150,2022BDSI0150,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Unevaluable event,Non-Health Professional,,,Female,I,4/15/2022,4/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Unevaluable event,,NO,NO,Unlisted
2022BDSI0154,2022BDSI0154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,44,Years,Female,I,4/20/2022,3/18/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Dry mouth,,NO,NO,Listed
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0155,2022BDSI0155,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,69,Years,Female,I,4/18/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0156,2022BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,4/21/2022,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0156,2022BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,4/21/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0156,2022BDSI0156,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,,,Female,I,4/21/2022,,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0159,2022BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Physician,,,Female,I,4/21/2022,11/21/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0159,2022BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Vomiting,Physician,,,Female,I,4/21/2022,11/21/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Vomiting,,NO,NO,Listed
2022BDSI0159,2022BDSI0159,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product use complaint,Physician,,,Female,I,4/21/2022,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product use complaint,,NO,NO,Unlisted
2022BDSI0160,2022BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Amnesia,Physician,65,Years,Female,I,4/22/2022,4/20/2022,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Amnesia,,YES,YES,Unlisted
2022BDSI0160,2022BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Confusional state,Physician,65,Years,Female,I,4/22/2022,4/20/2022,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Confusional state,,YES,YES,Unlisted
2022BDSI0160,2022BDSI0160,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Dizziness,Physician,65,Years,Female,I,4/22/2022,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Dizziness,,YES,YES,Listed
2022BDSI0169,2022BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Drug ineffective for unapproved indication,Other Health Professional,18,Years,Female,I,5/2/2022,,,,Hospitalisation,HYPERMOBILE EHLERS-DANLOS SYNDROME,UNITED KINGDOM,Drug ineffective for unapproved indication,,YES,YES,
2022BDSI0169,2022BDSI0169,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Transdermal patch,,Off label use,Other Health Professional,18,Years,Female,I,5/2/2022,,,,Hospitalisation,HYPERMOBILE EHLERS-DANLOS SYNDROME,UNITED KINGDOM,Off label use,,YES,YES,
2022BDSI0171,2022BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dental caries,Non-Health Professional,63,Years,Female,F,11/21/2022,1/15/2022,,PER,,CHRONIC PAIN,UNITED STATES,Dental caries,,YES,YES,Listed
2022BDSI0171,2022BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,63,Years,Female,F,11/21/2022,1/15/2022,,PER,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,YES,Unlisted
2022BDSI0171,2022BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tooth abscess,Non-Health Professional,63,Years,Female,F,11/21/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Tooth abscess,,YES,YES,Listed
2022BDSI0171,2022BDSI0171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,63,Years,Female,F,11/21/2022,1/15/2022,,PER,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,YES,Unlisted
2022BDSI0172,2022BDSI0172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Exposure during pregnancy,Physician,,,Female,I,5/3/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Exposure during pregnancy,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Non-Health Professional,47,Years,Female,I,5/3/2022,3/20/2022,,,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,47,Years,Female,I,5/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,47,Years,Female,I,5/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,47,Years,Female,I,5/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,47,Years,Female,I,5/3/2022,3/20/2022,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,47,Years,Female,I,5/3/2022,4/20/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,47,Years,Female,I,5/3/2022,4/19/2022,,,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,47,Years,Female,I,5/3/2022,,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0173,2022BDSI0173,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Non-Health Professional,47,Years,Female,I,5/3/2022,3/20/2022,,,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2022BDSI0174,2022BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wound,Pharmacist,69,Years,Female,I,5/4/2022,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Wound,,YES,YES,Unlisted
2022BDSI0174,2022BDSI0174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Cellulitis,Pharmacist,69,Years,Female,I,5/4/2022,,,,Hospitalisation,CHRONIC PAIN,UNITED STATES,Cellulitis,,YES,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,YES,Unlisted
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Off label use,,NO,YES,Unlisted
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pyrexia,Non-Health Professional,70,Years,Male,I,5/3/2022,4/29/2022,,,,CHRONIC PAIN,UNITED STATES,Pyrexia,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,70,Years,Male,I,5/3/2022,4/29/2022,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chills,Non-Health Professional,70,Years,Male,I,5/3/2022,4/29/2022,,,,CHRONIC PAIN,UNITED STATES,Chills,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Myalgia,Non-Health Professional,70,Years,Male,I,5/3/2022,4/29/2022,,,,CHRONIC PAIN,UNITED STATES,Myalgia,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,Other,CHRONIC PAIN,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2022BDSI0175,2022BDSI0175,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product prescribing error,Non-Health Professional,70,Years,Male,I,5/3/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product prescribing error,,NO,YES,Unlisted
2022BDSI0178,2022BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/2/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0178,2022BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,5/2/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0178,2022BDSI0178,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,,,Male,I,5/2/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0186,2022BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,5/9/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0186,2022BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/9/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0186,2022BDSI0186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/9/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0187,2022BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Male,I,5/10/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0187,2022BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/10/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0187,2022BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Male,I,5/10/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0187,2022BDSI0187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,5/10/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0188,2022BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,57,Years,Female,I,5/10/2022,2/1/2022,,,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0188,2022BDSI0188,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,57,Years,Female,I,5/10/2022,5/5/2022,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0189,2022BDSI0189,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,37,Years,Female,I,5/11/2022,,,,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0195,2022BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,71,Years,Female,I,5/12/2022,5/12/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0195,2022BDSI0195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Female,I,5/12/2022,5/12/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0196,2022BDSI0196,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Altered state of consciousness,Other Health Professional,38,Years,Male,I,5/12/2022,,,,Other,OPIOID USE DISORDER,AUSTRALIA,Altered state of consciousness,,YES,YES,Unlisted
2022BDSI0196,2022BDSI0196,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Maculopathy,Other Health Professional,38,Years,Male,I,5/12/2022,,,,Other,OPIOID USE DISORDER,AUSTRALIA,Maculopathy,,YES,YES,Unlisted
2022BDSI0196,2022BDSI0196,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Maculopathy,Other Health Professional,38,Years,Male,I,5/12/2022,,,,Other,OPIOID USE DISORDER,AUSTRALIA,Maculopathy,,YES,YES,Unlisted
2022BDSI0196,2022BDSI0196,Bunavail,"BUPRENORPHINE,NALOXONE",Unknown,,,,,,,Altered state of consciousness,Other Health Professional,38,Years,Male,I,5/12/2022,,,,Other,OPIOID USE DISORDER,AUSTRALIA,Altered state of consciousness,,YES,YES,Unlisted
2022BDSI0202,2022BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,54,Years,Female,I,5/17/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0202,2022BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Incorrect route of product administration,Non-Health Professional,54,Years,Female,I,5/17/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Incorrect route of product administration,,NO,NO,Unlisted
2022BDSI0202,2022BDSI0202,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,54,Years,Female,I,5/17/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0203,2022BDSI0203,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product dose omission issue,Non-Health Professional,,,Female,I,5/17/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product dose omission issue,,NO,NO,Unlisted
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Migraine,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Migraine,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Headache,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Headache,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Nausea,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Diarrhoea,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Diarrhoea,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Abdominal discomfort,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Abdominal discomfort,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pain,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0204,2022BDSI0204,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Asthenia,Non-Health Professional,,,Female,I,5/16/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Asthenia,,NO,NO,Listed
2022BDSI0205,2022BDSI0205,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,,,,I,5/17/2022,5/13/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0208,2022BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug screen negative,Non-Health Professional,,,Female,I,5/18/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0208,2022BDSI0208,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/18/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0211,2022BDSI0211,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,5/23/2022,1/1/2021,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0212,2022BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,5/23/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0212,2022BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,5/23/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0212,2022BDSI0212,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,5/23/2022,5/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0214,2022BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,5/26/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0214,2022BDSI0214,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,5/26/2022,,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0215,2022BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Dizziness,Non-Health Professional,,,Male,I,5/26/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Dizziness,,NO,NO,Listed
2022BDSI0215,2022BDSI0215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Vision blurred,Non-Health Professional,,,Male,I,5/26/2022,5/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Vision blurred,,NO,NO,Unlisted
2022BDSI0217,2022BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Suicidal ideation,Other Health Professional,,,Female,I,5/26/2022,,,,Other,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Suicidal ideation,,YES,YES,Unlisted
2022BDSI0217,2022BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Therapeutic response decreased,Other Health Professional,,,Female,I,5/26/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
2022BDSI0217,2022BDSI0217,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Breakthrough pain,Other Health Professional,,,Female,I,5/26/2022,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Breakthrough pain,,NO,YES,Listed
2022BDSI0221,2022BDSI0221,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Male,I,5/31/2022,4/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Joint stiffness,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Joint stiffness,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Gait inability,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Gait inability,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Insomnia,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Drug interaction,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Drug interaction,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Condition aggravated,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Condition aggravated,,NO,NO,Unlisted
2022BDSI0222,2022BDSI0222,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Pyrexia,Non-Health Professional,71,Years,Female,I,6/1/2022,1/1/2022,,,,CHRONIC PAIN,UNITED STATES,Pyrexia,,NO,NO,Listed
2022BDSI0223,2022BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,58,Years,Female,I,6/1/2022,6/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0223,2022BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,58,Years,Female,I,6/1/2022,6/1/2022,,,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0223,2022BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,58,Years,Female,I,6/1/2022,6/1/2022,,,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0223,2022BDSI0223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,58,Years,Female,I,6/1/2022,6/1/2022,,,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0225,2022BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Pain,Non-Health Professional,,,Female,I,6/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,NO,YES,Listed
2022BDSI0225,2022BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Nephrolithiasis,Non-Health Professional,,,Female,I,6/2/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nephrolithiasis,,NO,YES,Unlisted
2022BDSI0225,2022BDSI0225,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Surgery,Non-Health Professional,,,Female,I,6/2/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Surgery,,YES,YES,Unlisted
2022BDSI0226,2022BDSI0226,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product administration error,Non-Health Professional,,,Female,I,6/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Product administration error,,NO,NO,Unlisted
2022BDSI0226,2022BDSI0226,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/1/2022,,,,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0227,2022BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,74,Years,Female,I,6/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0227,2022BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,74,Years,Female,I,6/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0227,2022BDSI0227,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,74,Years,Female,I,6/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0229,2022BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,6/7/2022,1/1/2022,,PER,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0229,2022BDSI0229,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product dose omission issue,Non-Health Professional,,,Female,I,6/7/2022,1/1/2022,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product dose omission issue,,NO,YES,Unlisted
2022BDSI0230,2022BDSI0230,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug screen negative,Non-Health Professional,,,Male,I,6/7/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0231,2022BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral pain,Non-Health Professional,,,,I,6/9/2022,1/1/2022,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral pain,,NO,NO,Unlisted
2022BDSI0231,2022BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Pain in jaw,Non-Health Professional,,,,I,6/9/2022,1/1/2022,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain in jaw,,NO,NO,Unlisted
2022BDSI0231,2022BDSI0231,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Toothache,Non-Health Professional,,,,I,6/9/2022,1/1/2022,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Toothache,,NO,NO,Listed
2022BDSI0232,2022BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product communication issue,Non-Health Professional,,,Female,I,6/6/2022,,,PER,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product communication issue,,NO,NO,Unlisted
2022BDSI0232,2022BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/6/2022,,,PER,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0232,2022BDSI0232,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response increased,Non-Health Professional,,,Female,I,6/6/2022,,,PER,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response increased,,NO,NO,Listed
2022BDSI0233,2022BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Physician,,,Female,I,6/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0233,2022BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Physician,,,Female,I,6/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
2022BDSI0233,2022BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Physician,,,Female,I,6/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0233,2022BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Physician,,,Female,I,6/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0233,2022BDSI0233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Gingival discomfort,Physician,,,Female,I,6/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Gingival discomfort,,NO,NO,Unlisted
2022BDSI0234,2022BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical consistency issue,Other Health Professional,,,Female,I,6/8/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical consistency issue,,NO,YES,Unlisted
2022BDSI0234,2022BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Other Health Professional,,,Female,I,6/8/2022,,,PER,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0234,2022BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Feeling abnormal,Other Health Professional,,,Female,I,6/8/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Feeling abnormal,,NO,YES,Unlisted
2022BDSI0234,2022BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Poor quality product administered,Other Health Professional,,,Female,I,6/8/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Poor quality product administered,,NO,YES,Unlisted
2022BDSI0234,2022BDSI0234,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product physical issue,Other Health Professional,,,Female,I,6/8/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product physical issue,,NO,YES,Unlisted
2022BDSI0236,2022BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tooth disorder,Physician,,,Female,I,6/7/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth disorder,,NO,NO,Unlisted
2022BDSI0236,2022BDSI0236,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Gingival disorder,Physician,,,Female,I,6/7/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Gingival disorder,,NO,NO,Unlisted
2022BDSI0237,2022BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Tooth disorder,Physician,,,Male,I,6/7/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth disorder,,NO,NO,Unlisted
2022BDSI0237,2022BDSI0237,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Gingival disorder,Physician,,,Male,I,6/7/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Gingival disorder,,NO,NO,Unlisted
2022BDSI0238,2022BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,6/9/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0238,2022BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,6/9/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0238,2022BDSI0238,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,6/9/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0239,2022BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Gingival discolouration,Non-Health Professional,,,Female,I,6/9/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Gingival discolouration,,NO,NO,Unlisted
2022BDSI0239,2022BDSI0239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Tooth discolouration,Non-Health Professional,,,Female,I,6/9/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Tooth discolouration,,NO,NO,Unlisted
2022BDSI0240,2022BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Alopecia,Physician,,,Female,I,6/10/2022,1/1/2022,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Alopecia,,NO,YES,Unlisted
2022BDSI0240,2022BDSI0240,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Surgery,Physician,,,Female,I,6/10/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Surgery,,YES,YES,Unlisted
2022BDSI0241,2022BDSI0241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product prescribing error,Non-Health Professional,,,Female,I,6/8/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product prescribing error,,NO,NO,Unlisted
2022BDSI0245,2022BDSI0245,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging difficult to open,Non-Health Professional,,,Female,I,6/15/2022,1/1/2021,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2022BDSI0249,2022BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product size issue,Non-Health Professional,,,Male,I,6/18/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product size issue,,NO,NO,Unlisted
2022BDSI0249,2022BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,6/18/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0249,2022BDSI0249,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,6/18/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0250,2022BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Incorrect dose administered by product,Non-Health Professional,,,Female,I,6/20/2022,6/1/2022,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Incorrect dose administered by product,,NO,YES,Listed
2022BDSI0250,2022BDSI0250,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,6/20/2022,6/1/2022,,PER,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0251,2022BDSI0251,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product packaging quantity issue,Pharmacist,37,Years,Female,I,6/17/2022,6/16/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0254,2022BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,90,Years,Female,I,6/21/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0254,2022BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,90,Years,Female,I,6/21/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0254,2022BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,90,Years,Female,I,6/21/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0254,2022BDSI0254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product packaging difficult to open,Non-Health Professional,90,Years,Female,I,6/21/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product packaging difficult to open,,NO,NO,Unlisted
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0255,2022BDSI0255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Breakthrough pain,Non-Health Professional,60,Years,Female,I,6/23/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Breakthrough pain,,NO,NO,Listed
2022BDSI0256,2022BDSI0256,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,6/24/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0259,2022BDSI0259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Deep vein thrombosis,Other Health Professional,,,Female,I,6/27/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Deep vein thrombosis,,YES,YES,Unlisted
2022BDSI0261,2022BDSI0261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,6/27/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0262,2022BDSI0262,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,54,Years,Female,I,6/24/2022,4/18/2022,,PER,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0262,2022BDSI0262,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Non-Health Professional,54,Years,Female,I,6/24/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Pain,,NO,NO,Listed
2022BDSI0262,2022BDSI0262,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Insomnia,Non-Health Professional,54,Years,Female,I,6/24/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Insomnia,,NO,NO,Listed
2022BDSI0269,2022BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product colour issue,Pharmacist,83,Years,Female,I,7/6/2022,6/13/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product colour issue,,NO,NO,Unlisted
2022BDSI0269,2022BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Poor quality product administered,Pharmacist,83,Years,Female,I,7/6/2022,6/13/2022,,PER,,CHRONIC PAIN,UNITED STATES,Poor quality product administered,,NO,NO,Unlisted
2022BDSI0269,2022BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,83,Years,Female,I,7/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0269,2022BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,83,Years,Female,I,7/6/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0269,2022BDSI0269,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Pharmacist,83,Years,Female,I,7/6/2022,6/13/2022,,PER,,CHRONIC PAIN,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0270,2022BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,46,Years,Female,I,7/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0270,2022BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,46,Years,Female,I,7/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0270,2022BDSI0270,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,46,Years,Female,I,7/6/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0271,2022BDSI0271,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug screen negative,Non-Health Professional,52,Years,Male,I,7/1/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Drug screen negative,,NO,NO,Unlisted
2022BDSI0272,2022BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/5/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0272,2022BDSI0272,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Female,I,7/5/2022,1/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0274,2022BDSI0274,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Oral herpes,Other Health Professional,,,Male,I,7/7/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral herpes,,NO,NO,Unlisted
2022BDSI0275,2022BDSI0275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug screen false positive,Non-Health Professional,,,Female,I,7/5/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug screen false positive,,NO,NO,Unlisted
2022BDSI0278,2022BDSI0278,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,,,Female,I,7/13/2022,,,PER,,CHRONIC PAIN,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
2022BDSI0279,2022BDSI0279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,Male,I,7/14/2022,6/1/2022,,PER,,CHRONIC PAIN,UNITED STATES,Therapeutic response decreased,,NO,NO,Listed
2022BDSI0280,2022BDSI0280,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product packaging quantity issue,Non-Health Professional,,,Female,I,7/15/2022,7/14/2022,,PER,,SEVERE FACIAL PAIN,UNITED STATES,Product packaging quantity issue,,NO,NO,Unlisted
2022BDSI0284,2022BDSI0284,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/19/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0286,2022BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Female,I,7/20/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
2022BDSI0286,2022BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,7/20/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
2022BDSI0286,2022BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product taste abnormal,Non-Health Professional,,,Female,I,7/20/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product taste abnormal,,NO,NO,Unlisted
2022BDSI0286,2022BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Female,I,7/20/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Wrong technique in product usage process,,NO,NO,Unlisted
2022BDSI0286,2022BDSI0286,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Female,I,7/20/2022,,,PER,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
2022BDSI0287,2022BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Pulmonary embolism,Other Health Professional,,,Female,I,7/21/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pulmonary embolism,,YES,YES,Unlisted
2022BDSI0287,2022BDSI0287,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Cerebrovascular accident,Other Health Professional,,,Female,I,7/21/2022,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Cerebrovascular accident,,YES,YES,Listed
2022BDSI0288,2022BDSI0288,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,7/21/2022,7/1/2022,,PER,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
2022BDSI0289,2022BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,I,7/22/2022,7/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
2022BDSI0289,2022BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,,,Male,I,7/22/2022,7/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
2022BDSI0289,2022BDSI0289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,Male,I,7/22/2022,7/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230100003,20230100003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Fatigue,Consumer,,,Female,I,12/28/2022,9/15/2022,,PER,,pain,UNITED STATES,Fatigue,Collegium Pharmaceutical,NO,NO,Listed
20230100003,20230100003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Breakthrough pain,Consumer,,,Female,I,12/28/2022,9/15/2022,,PER,,pain,UNITED STATES,Breakthrough pain,Collegium Pharmaceutical,NO,NO,Listed
20230100003,20230100003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Off label use,Consumer,,,Female,I,12/28/2022,6/15/2022,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230100003,20230100003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Dyspnoea,Consumer,,,Female,I,12/28/2022,5/15/2022,,PER,,pain,UNITED STATES,Dyspnoea,Collegium Pharmaceutical,NO,NO,Listed
20230100003,20230100003,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Dizziness,Consumer,,,Female,I,12/28/2022,9/15/2022,,PER,,pain,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230100007,20230100007,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Peripheral swelling,Other Health Professional,58,Years,Male,F,1/6/2023,12/1/2022,,PER,,Pain,UNITED STATES,Peripheral swelling,Collegium Pharmaceutical,NO,NO,Listed
20230100012,20230100012,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Pharmacist,,,,I,1/2/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100016,20230100016,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,1/3/2023,,,PER,,pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100017,20230100017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,Buccal film,bid,Suicidal ideation,Consumer,,,Female,F,1/3/2023,12/24/2022,EXP,,,Pain,UNITED STATES,Suicidal ideation,Collegium Pharmaceutical,YES,YES,Unlisted
20230100017,20230100017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,Buccal film,bid,Tremor,Consumer,,,Female,F,1/3/2023,,EXP,,,Pain,UNITED STATES,Tremor,Collegium Pharmaceutical,NO,YES,Listed
20230100017,20230100017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,Buccal film,bid,Vomiting,Consumer,,,Female,F,1/3/2023,12/24/2022,EXP,,,Pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,YES,Listed
20230100017,20230100017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,Buccal film,bid,Nasal discharge discolouration,Consumer,,,Female,F,1/3/2023,12/24/2022,EXP,,,Pain,UNITED STATES,Nasal discharge discolouration,Collegium Pharmaceutical,NO,YES,Unlisted
20230100017,20230100017,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,Negative,,,microgram,Buccal film,bid,Pain,Consumer,,,Female,F,1/3/2023,,EXP,,,Pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,YES,Listed
20230100024,20230100024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Swelling face,Physician,,,Female,F,1/6/2023,,,PER,,Product used for unknown indication,UNITED STATES,Swelling face,Collegium Pharmaceutical,NO,NO,Unlisted
20230100024,20230100024,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Drug hypersensitivity,Physician,,,Female,F,1/6/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug hypersensitivity,Collegium Pharmaceutical,NO,NO,Listed
20230100029,20230100029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Periodontitis,Nurse,65,Years,Female,I,1/5/2023,,,PER,,Product used for unknown indication,UNITED STATES,Periodontitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230100029,20230100029,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Tooth disorder,Nurse,65,Years,Female,I,1/5/2023,,,PER,,Product used for unknown indication,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20230100032,20230100032,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Insomnia,Physician,51,Years,Female,I,1/5/2023,6/15/2022,,PER,,Product used for unknown indication,UNITED STATES,Insomnia,Collegium Pharmaceutical,NO,NO,Listed
20230100033,20230100033,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Stomatitis,Other Health Professional,,,Female,I,1/5/2023,6/15/2022,,PER,,product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230100034,20230100034,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging quantity issue,Pharmacist,,,Female,I,1/6/2023,,,PER,,Pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Oral administration complication,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Burning sensation,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Oral administration complication,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Burning sensation,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Tooth loss,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Tooth loss,Collegium Pharmaceutical,NO,NO,Unlisted
20230100037,20230100037,Bunavail," NALOXONE,BUPRENORPHINE",Buccal use,,,,milligram,Buccal film,,Tooth loss,Other Health Professional,,,,I,1/10/2023,,,,,chronic bone pain,UNITED STATES,Tooth loss,Collegium Pharmaceutical,NO,NO,Unlisted
20230100045,20230100045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,45,Years,Female,I,1/10/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100045,20230100045,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Condition aggravated,Consumer,45,Years,Female,I,1/10/2023,,,PER,,Product used for unknown indication,UNITED STATES,Condition aggravated,Collegium Pharmaceutical,NO,NO,Unlisted
20230100062,20230100062,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Consumer,77,Years,Female,I,1/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230100064,20230100064,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging quantity issue,Pharmacist,,,Male,I,1/17/2023,1/13/2023,,PER,,Pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100065,20230100065,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Therapeutic response decreased,Consumer,,,Male,I,1/17/2023,,,PER,,pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Salivary hypersecretion,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Salivary hypersecretion,Collegium Pharmaceutical,NO,NO,Unlisted
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100068,20230100068,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product communication issue,Consumer,65,Years,Male,I,1/17/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100071,20230100071,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Other Health Professional,,,UNK,I,1/19/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100076,20230100076,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Non-Health Professional,,,Male,I,1/20/2023,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100081,20230100081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Stomatitis,Nurse,,,Female,I,1/20/2023,12/15/2022,,PER,,Chronic pain,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230100081,20230100081,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Dental caries,Nurse,,,Female,I,1/20/2023,12/15/2022,,PER,,Chronic pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20230100082,20230100082,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Hepatic enzyme increased,Other Health Professional,,,Male,I,1/23/2023,,,PER,,pain,UNITED STATES,Hepatic enzyme increased,Collegium Pharmaceutical,NO,NO,Listed
20230100087,20230100087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product administration interrupted,Consumer,,,Male,I,1/23/2023,,,PER,,product used for unknown indication,UNITED STATES,Product administration interrupted,Collegium Pharmaceutical,NO,NO,Unlisted
20230100087,20230100087,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Pain,Consumer,,,Male,I,1/23/2023,,,PER,,product used for unknown indication,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230100088,20230100088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,qd,Product adhesion issue,Consumer,91,Years,Male,I,1/23/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100088,20230100088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,qd,Oral administration complication,Consumer,91,Years,Male,I,1/23/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100088,20230100088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,qd,Product communication issue,Consumer,91,Years,Male,I,1/23/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100088,20230100088,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,Positive,,,microgram,Buccal film,qd,Somnolence,Consumer,91,Years,Male,I,1/23/2023,1/23/2023,,PER,,Back pain,UNITED STATES,Somnolence,Collegium Pharmaceutical,NO,NO,Listed
20230100091,20230100091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product odour abnormal,Consumer,90,Years,Female,I,1/24/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product odour abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100091,20230100091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product taste abnormal,Consumer,90,Years,Female,I,1/24/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product taste abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100091,20230100091,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,90,Years,Female,I,1/24/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100092,20230100092,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Male,I,1/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230100096,20230100096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,I,1/25/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100096,20230100096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,1/25/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100096,20230100096,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,1/25/2023,1/15/2023,,PER,,Chronic Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100097,20230100097,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging issue,Other Health Professional,,,,I,1/26/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Oral administration complication,Consumer,,,Male,I,1/25/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Wrong technique in product usage process,Consumer,,,Male,I,1/25/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Therapeutic response decreased,Consumer,,,Male,I,1/25/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product adhesion issue,Consumer,,,Male,I,1/25/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Off label use,Consumer,,,Male,I,1/25/2023,1/24/2023,,PER,,Back pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230100098,20230100098,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Drug ineffective,Consumer,,,Male,I,1/25/2023,1/15/2023,,PER,,Back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230100099,20230100099,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Other Health Professional,50,Years,Male,I,1/25/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Stomatitis,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Stomatitis,Collegium Pharmaceutical,YES,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Glossitis,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Glossitis,Collegium Pharmaceutical,YES,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Hypoaesthesia oral,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Hypoaesthesia oral,Collegium Pharmaceutical,YES,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Dental caries,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,YES,YES,Listed
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Gingival disorder,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Gingival disorder,Collegium Pharmaceutical,YES,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Electric shock sensation,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Electric shock sensation,Collegium Pharmaceutical,YES,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,75,Years,Female,I,1/30/2023,,EXP,,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,75,Years,Female,I,1/30/2023,,EXP,,,Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,YES,Unlisted
20230100103,20230100103,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Gingival swelling,Consumer,75,Years,Female,I,1/30/2023,6/15/2022,EXP,,,Pain,UNITED STATES,Gingival swelling,Collegium Pharmaceutical,YES,YES,Unlisted
20230200107,20230200107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Drug ineffective,Physician,,,Female,I,1/31/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230200107,20230200107,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Drug intolerance,Physician,,,Female,I,1/31/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug intolerance,Collegium Pharmaceutical,NO,NO,Listed
20230200112,20230200112,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,2/1/2023,,,PER,,pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230200119,20230200119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Pain,Consumer,62,Years,Female,I,2/1/2023,,,PER,,chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230200119,20230200119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,62,Years,Female,I,2/1/2023,6/15/2023,,PER,,chronic pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200119,20230200119,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging issue,Consumer,62,Years,Female,I,2/1/2023,6/15/2023,,PER,,chronic pain,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tooth fracture,Consumer,68,Years,Female,F,4/20/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Tooth fracture,Collegium Pharmaceutical,YES,YES,Listed
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Stomatitis,Consumer,68,Years,Female,F,4/20/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,YES,Unlisted
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Loose tooth,Consumer,68,Years,Female,F,4/20/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Loose tooth,Collegium Pharmaceutical,NO,YES,Unlisted
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,68,Years,Female,F,4/20/2023,8/15/2022,,PER,,Chronic pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,YES,Listed
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Toothache,Consumer,68,Years,Female,F,4/20/2023,2/2/2023,,PER,,Chronic pain,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,YES,Listed
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Nausea,Consumer,68,Years,Female,F,4/20/2023,6/15/2022,,PER,,Chronic pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,YES,Listed
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tooth infection,Consumer,68,Years,Female,F,4/20/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Tooth infection,Collegium Pharmaceutical,NO,YES,Listed
20230200125,20230200125,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Dental caries,Consumer,68,Years,Female,F,4/20/2023,2/15/2023,,PER,,Chronic pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,YES,YES,Listed
20230200126,20230200126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug withdrawal syndrome,Consumer,,,Female,I,2/6/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20230200126,20230200126,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Inability to afford medication,Consumer,,,Female,I,2/6/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Inability to afford medication,Collegium Pharmaceutical,NO,YES,Unlisted
20230200127,20230200127,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Positive,,microgram,Buccal film,Unknown,Rash,Consumer,,,Male,I,2/7/2023,,,PER,,Pain,UNITED STATES,Rash,Collegium Pharmaceutical,NO,NO,Listed
20230200138,20230200138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Tooth disorder,Consumer,,,Female,I,2/10/2023,,,PER,,pain,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,NO,NO,Listed
20230200138,20230200138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Constipation,Consumer,,,Female,I,2/10/2023,,,PER,,pain,UNITED STATES,Constipation,Collegium Pharmaceutical,NO,NO,Listed
20230200138,20230200138,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Therapeutic response decreased,Consumer,,,Female,I,2/10/2023,,,PER,,pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230200139,20230200139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,,,Female,F,2/14/2023,2/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230200139,20230200139,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,F,2/14/2023,2/10/2023,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230200140,20230200140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Product physical consistency issue,Consumer,73,Years,Female,F,2/9/2023,2/15/2023,,PER,,pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200140,20230200140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Off label use,Consumer,73,Years,Female,F,2/9/2023,2/15/2023,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230200140,20230200140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Incorrect route of product administration,Consumer,73,Years,Female,F,2/9/2023,2/15/2023,,PER,,pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230200140,20230200140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Product solubility abnormal,Consumer,73,Years,Female,F,2/9/2023,2/15/2023,,PER,,pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230200140,20230200140,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Oral administration complication,Consumer,73,Years,Female,F,2/9/2023,2/15/2023,,PER,,pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230200143,20230200143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,2/11/2023,6/15/2023,,PER,,Chronic Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230200143,20230200143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Oral administration complication,Consumer,,,Female,I,2/11/2023,6/15/2023,,PER,,Chronic Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230200143,20230200143,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,I,2/11/2023,6/15/2023,,PER,,Chronic Pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200147,20230200147,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response increased,Non-Health Professional,,,Female,I,2/14/2023,,,PER,,product used for unknown indication,UNITED STATES,Therapeutic response increased,Collegium Pharmaceutical,NO,NO,Listed
20230200149,20230200149,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Stomatitis,Physician,,,Female,I,2/14/2023,,,PER,,product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230200151,20230200151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug withdrawal syndrome,Pharmacist,40,Years,Female,I,2/14/2023,1/15/2023,,PER,,Mononeuropathy,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20230200151,20230200151,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Pharmacist,40,Years,Female,I,2/14/2023,1/15/2023,,PER,,Mononeuropathy,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,YES,Listed
20230200152,20230200152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Sexual dysfunction,Physician,,,Male,I,2/15/2023,,,PER,,Pain,UNITED STATES,Sexual dysfunction,Collegium Pharmaceutical,NO,NO,Unlisted
20230200152,20230200152,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Irritability,Physician,,,Male,I,2/15/2023,,,PER,,Pain,UNITED STATES,Irritability,Collegium Pharmaceutical,NO,NO,Unlisted
20230200153,20230200153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,2/15/2023,2/15/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200153,20230200153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,I,2/15/2023,2/15/2023,,PER,,Chronic Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230200153,20230200153,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Oral administration complication,Consumer,,,Female,I,2/15/2023,2/15/2023,,PER,,Chronic Pain,UNITED STATES,Oral administration complication,Collegium Pharmaceutical,NO,NO,Unlisted
20230200154,20230200154,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,,,Female,I,2/15/2023,1/24/2023,,PER,,Chronic pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200168,20230200168,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Other Health Professional,,,Female,I,2/17/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200170,20230200170,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Respiratory depression,Nurse,50,Years,Female,I,2/17/2023,2/5/2023,,PER,,Product used for unknown indication,UNITED STATES,Respiratory depression,Collegium Pharmaceutical,YES,YES,Listed
20230200171,20230200171,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,Unknown,Product packaging issue,Consumer,,,UNK,I,2/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200172,20230200172,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Male,I,2/17/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200174,20230200174,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,,,Female,I,2/23/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Nausea,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Decreased appetite,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Decreased appetite,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Asthenia,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Asthenia,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Dizziness,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Feeling hot,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Feeling hot,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Bedridden,Consumer,70,Years,Female,F,8/17/2023,,,PER,,Pain,UNITED STATES,Bedridden,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Dyspnoea,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Dyspnoea,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Malaise,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Drug intolerance,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Drug intolerance,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Headache,Consumer,70,Years,Female,F,8/17/2023,2/19/2023,,PER,,Pain,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Hyperhidrosis,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Hyperhidrosis,Collegium Pharmaceutical,NO,NO,Listed
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Feeling cold,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Feeling cold,Collegium Pharmaceutical,NO,NO,Unlisted
20230200179,20230200179,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Drug hypersensitivity,Consumer,70,Years,Female,F,8/17/2023,2/15/2023,,PER,,Pain,UNITED STATES,Drug hypersensitivity,Collegium Pharmaceutical,NO,NO,Listed
20230200180,20230200180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Off label use,Consumer,76,Years,Female,F,3/30/2023,10/15/2022,,PER,,extreme chronic pain from arthritis,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230200180,20230200180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Product dose omission issue,Consumer,76,Years,Female,F,3/30/2023,2/23/2023,,PER,,extreme chronic pain from arthritis,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230200180,20230200180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Intentional product misuse,Consumer,76,Years,Female,F,3/30/2023,2/23/2023,,PER,,extreme chronic pain from arthritis,UNITED STATES,Intentional product misuse,Collegium Pharmaceutical,NO,NO,Unlisted
20230200180,20230200180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Wrong technique in product usage process,Consumer,76,Years,Female,F,3/30/2023,2/23/2023,,PER,,extreme chronic pain from arthritis,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230200180,20230200180,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Application site irritation,Consumer,76,Years,Female,F,3/30/2023,6/15/2023,,PER,,extreme chronic pain from arthritis,UNITED STATES,Application site irritation,Collegium Pharmaceutical,NO,NO,Unlisted
20230200182,20230200182,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Drug withdrawal syndrome,Non-Health Professional,64,Years,Female,I,2/24/2023,2/7/2023,,PER,,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20230300184,20230300184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,2/24/2023,2/23/2023,,PER,,back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300184,20230300184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,2/24/2023,2/24/2023,,PER,,back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300184,20230300184,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,I,2/24/2023,2/24/2023,,PER,,back pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230300185,20230300185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,2/27/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300185,20230300185,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,2/27/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300186,20230300186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Drug ineffective,Consumer,,,Male,I,2/27/2023,2/15/2023,,PER,,Chronic Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230300186,20230300186,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product adhesion issue,Consumer,,,Male,I,2/27/2023,2/15/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300187,20230300187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Consumer,,,Male,I,2/25/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300187,20230300187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Male,I,2/25/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300187,20230300187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging issue,Consumer,,,Male,I,2/25/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300187,20230300187,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging difficult to open,Consumer,,,Male,I,2/25/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20230300190,20230300190,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging difficult to open,Consumer,,,Female,I,2/27/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20230300191,20230300191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Periorbital swelling,Consumer,,,Female,I,2/28/2023,,,PER,,product used for unknown indication,UNITED STATES,Periorbital swelling,Collegium Pharmaceutical,NO,NO,Unlisted
20230300191,20230300191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Upper-airway cough syndrome,Consumer,,,Female,I,2/28/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Upper-airway cough syndrome,Collegium Pharmaceutical,NO,NO,Unlisted
20230300191,20230300191,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Dark circles under eyes,Consumer,,,Female,I,2/28/2023,,,PER,,product used for unknown indication,UNITED STATES,Dark circles under eyes,Collegium Pharmaceutical,NO,NO,Unlisted
20230300192,20230300192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,54,Years,Female,F,3/1/2023,,,PER,,pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230300192,20230300192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,54,Years,Female,F,3/1/2023,,,PER,,pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300192,20230300192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product taste abnormal,Consumer,54,Years,Female,F,3/1/2023,,,PER,,pain,UNITED STATES,Product taste abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300192,20230300192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,54,Years,Female,F,3/1/2023,,,PER,,pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230300192,20230300192,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,54,Years,Female,F,3/1/2023,,,PER,,pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300194,20230300194,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug ineffective,Consumer,70,Years,Male,I,3/2/2023,,,PER,,Back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230300195,20230300195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Male,I,3/2/2023,3/15/2023,,PER,,product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230300195,20230300195,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Male,I,3/2/2023,3/15/2023,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300197,20230300197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,60,Years,Male,I,3/3/2023,6/15/2023,,PER,,Severe chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300197,20230300197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product communication issue,Consumer,60,Years,Male,I,3/3/2023,2/1/2023,,PER,,Severe chronic pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300197,20230300197,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,60,Years,Male,I,3/3/2023,6/15/2023,,PER,,Severe chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product administration error,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging issue,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300198,20230300198,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product temperature excursion issue,Consumer,,,Female,F,3/13/2023,,,PER,,Pain,UNITED STATES,Product temperature excursion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300201,20230300201,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Adverse event,Physician,74,Years,Female,I,3/7/2023,,,,,Pain,SPAIN,Adverse event,,NO,NO,
20230300201,20230300201,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Dizziness,Physician,74,Years,Female,I,3/7/2023,,,,,Pain,SPAIN,Dizziness,,NO,NO,
20230300201,20230300201,BUPRENORPHINE,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,Unknown,Nausea,Physician,74,Years,Female,I,3/7/2023,,,,,Pain,SPAIN,Nausea,,NO,NO,
20230300203,20230300203,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Male,I,3/6/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300203,20230300203,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug ineffective,Consumer,,,Male,I,3/6/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230300215,20230300215,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Pharmacist,,,Female,I,3/9/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300223,20230300223,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Mouth ulceration,Nurse,4,Decades,Male,I,3/14/2023,,,PER,,product used for unknown indication,UNITED STATES,Mouth ulceration,Collegium Pharmaceutical,NO,NO,Unlisted
20230300233,20230300233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Incorrect route of product administration,Nurse,,,Male,I,3/16/2023,,,PER,,Chronic Moderate to Severe Pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230300233,20230300233,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Product adhesion issue,Nurse,,,Male,I,3/16/2023,,,PER,,Chronic Moderate to Severe Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300239,20230300239,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Pharmacist,,,UNK,F,3/22/2023,3/16/2023,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300241,20230300241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Female,I,3/20/2023,,,PER,,product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230300241,20230300241,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Off label use,Consumer,,,Female,I,3/20/2023,,,PER,,product used for unknown indication,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230300244,20230300244,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Male,I,3/21/2023,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300254,20230300254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,69,Years,Male,F,3/23/2023,3/20/2023,,PER,,Back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230300254,20230300254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Extra dose administered,Consumer,69,Years,Male,F,3/23/2023,,,PER,,Back pain,UNITED STATES,Extra dose administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230300254,20230300254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product taste abnormal,Consumer,69,Years,Male,F,3/23/2023,3/20/2023,,PER,,Back pain,UNITED STATES,Product taste abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300254,20230300254,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Somnolence,Consumer,69,Years,Male,F,3/23/2023,,,PER,,Back pain,UNITED STATES,Somnolence,Collegium Pharmaceutical,NO,NO,Listed
20230300255,20230300255,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Headache,Physician,,,Female,I,3/23/2023,,,PER,,product used for unknown indication,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230300257,20230300257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Hyperaesthesia teeth,Other Health Professional,,,Female,I,3/23/2023,,,PER,,Product used for unknown indication,UNITED STATES,Hyperaesthesia teeth,Collegium Pharmaceutical,NO,NO,Unlisted
20230300257,20230300257,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Mouth ulceration,Other Health Professional,,,Female,I,3/23/2023,,,PER,,Product used for unknown indication,UNITED STATES,Mouth ulceration,Collegium Pharmaceutical,NO,NO,Unlisted
20230300259,20230300259,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,,Buccal film,bid,Tooth disorder,Other Health Professional,,,Male,I,3/22/2023,,,,Intervention Required,Product used for unknown indication,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,YES,YES,Unlisted
20230300261,20230300261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Male,I,3/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300261,20230300261,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Consumer,,,Male,I,3/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300267,20230300267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Vomiting,Consumer,61,Years,Female,I,3/27/2023,3/17/2023,,PER,,pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230300267,20230300267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Thinking abnormal,Consumer,61,Years,Female,I,3/27/2023,3/15/2023,,PER,,pain,UNITED STATES,Thinking abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230300267,20230300267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tachycardia,Consumer,61,Years,Female,I,3/27/2023,3/17/2023,,PER,,pain,UNITED STATES,Tachycardia,Collegium Pharmaceutical,NO,NO,Unlisted
20230300267,20230300267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Nausea,Consumer,61,Years,Female,I,3/27/2023,3/17/2023,,PER,,pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230300267,20230300267,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Dyspnoea,Consumer,61,Years,Female,I,3/27/2023,3/15/2023,,PER,,pain,UNITED STATES,Dyspnoea,Collegium Pharmaceutical,NO,NO,Listed
20230300275,20230300275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Pharmacist,,,Male,I,3/29/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230300275,20230300275,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Drug ineffective,Pharmacist,,,Male,I,3/29/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400279,20230400279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Non-Health Professional,,,Female,I,3/31/2023,3/31/2023,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400279,20230400279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Mydriasis,Non-Health Professional,,,Female,I,3/31/2023,3/31/2023,,PER,,Product used for unknown indication,UNITED STATES,Mydriasis,Collegium Pharmaceutical,NO,NO,Listed
20230400279,20230400279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Vomiting,Non-Health Professional,,,Female,I,3/31/2023,3/31/2023,,PER,,Product used for unknown indication,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230400279,20230400279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Hyperhidrosis,Non-Health Professional,,,Female,I,3/31/2023,3/31/2023,,PER,,Product used for unknown indication,UNITED STATES,Hyperhidrosis,Collegium Pharmaceutical,NO,NO,Listed
20230400279,20230400279,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect route of product administration,Non-Health Professional,,,Female,I,3/31/2023,3/31/2023,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230400282,20230400282,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,74,Years,Male,I,4/3/2023,4/1/2023,,PER,,Pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Wrong technique in product usage process,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Nausea,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Abdominal discomfort,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Abdominal discomfort,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Product use complaint,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Musculoskeletal stiffness,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Musculoskeletal stiffness,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Pain in extremity,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Pain in extremity,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Dyspnoea,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Dyspnoea,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Chest discomfort,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Chest discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Drug ineffective,Non-Health Professional,59,Years,Female,F,4/21/2023,4/15/2023,,PER,,for pain from sclerosis,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Fall,Non-Health Professional,59,Years,Female,F,4/21/2023,4/5/2023,,PER,,for pain from sclerosis,UNITED STATES,Fall,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Costochondritis,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Costochondritis,Collegium Pharmaceutical,NO,NO,Unlisted
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Breakthrough pain,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Breakthrough pain,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Abdominal pain,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Abdominal pain,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Headache,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Vomiting,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230400289,20230400289,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Dizziness,Non-Health Professional,59,Years,Female,F,4/21/2023,4/3/2023,,PER,,for pain from sclerosis,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Off label use,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Erythema,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Erythema,Collegium Pharmaceutical,NO,NO,Unlisted
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Drug ineffective,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Feeling hot,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Feeling hot,Collegium Pharmaceutical,NO,NO,Unlisted
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Pruritus,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Pruritus,Collegium Pharmaceutical,NO,NO,Listed
20230400296,20230400296,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Product solubility abnormal,Consumer,33,Years,Female,I,4/5/2023,4/5/2023,,PER,,chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230400297,20230400297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,80,Years,Female,I,4/6/2023,6/15/2023,,PER,,constant pain/back pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230400297,20230400297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,80,Years,Female,I,4/6/2023,6/15/2023,,PER,,constant pain/back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400297,20230400297,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,80,Years,Female,I,4/6/2023,6/15/2023,,PER,,constant pain/back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230400305,20230400305,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,59,Years,Male,I,4/7/2023,4/15/2023,,PER,,product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400305,20230400305,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Pain,Consumer,59,Years,Male,I,4/7/2023,4/15/2023,,PER,,product used for unknown indication,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Diarrhoea,Consumer,,,Male,I,4/7/2023,4/5/2023,,PER,,Product used for unknown indication,UNITED STATES,Diarrhoea,Collegium Pharmaceutical,NO,NO,Listed
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Application site irritation,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Application site irritation,Collegium Pharmaceutical,NO,NO,Unlisted
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Pollakiuria,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Pollakiuria,Collegium Pharmaceutical,NO,NO,Unlisted
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Insomnia,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Insomnia,Collegium Pharmaceutical,NO,NO,Listed
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Oral pain,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Oral pain,Collegium Pharmaceutical,NO,NO,Unlisted
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Stomatitis,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Oral mucosal erythema,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Oral mucosal erythema,Collegium Pharmaceutical,NO,NO,Unlisted
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Nausea,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400306,20230400306,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Mouth swelling,Consumer,,,Male,I,4/7/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Mouth swelling,Collegium Pharmaceutical,NO,NO,Unlisted
20230400309,20230400309,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Male,F,4/11/2023,,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400309,20230400309,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Male,F,4/11/2023,4/15/2023,,PER,,Chronic Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230400311,20230400311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Nausea,Non-Health Professional,70,Years,Male,I,4/10/2023,4/8/2023,,PER,,bad headache,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400311,20230400311,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Off label use,Non-Health Professional,70,Years,Male,I,4/10/2023,4/8/2023,,PER,,bad headache,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230400318,20230400318,TRANSTEC,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,Transdermal patch,,Pneumonia,Physician,,,Male,I,4/14/2023,2/10/2023,EXP,,Other,Indication not reported,CROATIA,Pneumonia,,YES,YES,
20230400318,20230400318,TRANSTEC,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,Transdermal patch,,Somnolence,Physician,,,Male,I,4/14/2023,2/10/2023,EXP,,Other,Indication not reported,CROATIA,Somnolence,,YES,YES,
20230400318,20230400318,TRANSTEC,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,Transdermal patch,,Suicide attempt,Physician,,,Male,I,4/14/2023,2/10/2023,EXP,,Other,Indication not reported,CROATIA,Suicide attempt,,YES,YES,
20230400318,20230400318,TRANSTEC,BUPRENORPHINE HYDROCHLORIDE,Transdermal use,,,,,Transdermal patch,,Intentional overdose,Physician,,,Male,I,4/14/2023,2/10/2023,EXP,,Other,Indication not reported,CROATIA,Intentional overdose,,YES,YES,
20230400320,20230400320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Fatigue,Physician,54,Years,Female,I,4/12/2023,6/15/2020,,PER,,Chronic pain,UNITED STATES,Fatigue,Collegium Pharmaceutical,NO,NO,Listed
20230400320,20230400320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Cognitive disorder,Physician,54,Years,Female,I,4/12/2023,6/15/2020,,PER,,Chronic pain,UNITED STATES,Cognitive disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20230400320,20230400320,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Oedema peripheral,Physician,54,Years,Female,I,4/12/2023,6/15/2020,,PER,,Chronic pain,UNITED STATES,Oedema peripheral,Collegium Pharmaceutical,NO,NO,Listed
20230400322,20230400322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Dizziness,Non-Health Professional,,,Female,I,4/13/2023,2/15/2023,,PER,,pain,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230400322,20230400322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Drug ineffective,Non-Health Professional,,,Female,I,4/13/2023,2/15/2023,,PER,,pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400322,20230400322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Breakthrough pain,Non-Health Professional,,,Female,I,4/13/2023,2/15/2023,,PER,,pain,UNITED STATES,Breakthrough pain,Collegium Pharmaceutical,NO,NO,Listed
20230400322,20230400322,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Nausea,Non-Health Professional,,,Female,I,4/13/2023,2/15/2023,,PER,,pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400327,20230400327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Extra dose administered,Non-Health Professional,65,Years,Female,I,4/17/2023,4/17/2023,,PER,,Pain,UNITED STATES,Extra dose administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230400327,20230400327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Non-Health Professional,65,Years,Female,I,4/17/2023,4/17/2023,,PER,,Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230400327,20230400327,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Non-Health Professional,65,Years,Female,I,4/17/2023,4/17/2023,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400333,20230400333,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,4/15/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400333,20230400333,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,I,4/15/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230400338,20230400338,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging quantity issue,Non-Health Professional,,,Female,I,4/19/2023,4/19/2023,,PER,,Chronic pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400341,20230400341,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Urinary retention,Nurse,,,Male,I,4/20/2023,,,,,product used for unknown indication,UNITED STATES,Urinary retention,Collegium Pharmaceutical,YES,YES,Unlisted
20230400342,20230400342,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Orgasm abnormal,Other Health Professional,,,Male,I,4/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Orgasm abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230400345,20230400345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,65,Years,Female,F,2/5/2024,4/19/2023,,PER,,Occipital Neuralgia,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230400345,20230400345,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Drug ineffective,Consumer,65,Years,Female,F,2/5/2024,4/19/2023,,PER,,Occipital Neuralgia,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Therapeutic response decreased,Consumer,54,Years,Female,I,4/21/2023,2/4/2021,,PER,,Chronic pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Fluid retention,Consumer,54,Years,Female,I,4/21/2023,4/10/2023,,PER,,Chronic pain,UNITED STATES,Fluid retention,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Vision blurred,Consumer,54,Years,Female,I,4/21/2023,4/10/2023,,PER,,Chronic pain,UNITED STATES,Vision blurred,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Myalgia,Consumer,54,Years,Female,I,4/21/2023,6/15/2021,,PER,,Chronic pain,UNITED STATES,Myalgia,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Weight increased,Consumer,54,Years,Female,I,4/21/2023,4/10/2023,,PER,,Chronic pain,UNITED STATES,Weight increased,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Nightmare,Consumer,54,Years,Female,I,4/21/2023,4/10/2023,,PER,,Chronic pain,UNITED STATES,Nightmare,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Headache,Consumer,54,Years,Female,I,4/21/2023,2/4/2021,,PER,,Chronic pain,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Eye swelling,Consumer,54,Years,Female,I,4/21/2023,1/15/2021,,PER,,Chronic pain,UNITED STATES,Eye swelling,Collegium Pharmaceutical,NO,NO,Unlisted
20230400347,20230400347,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,qd,Drug ineffective,Consumer,54,Years,Female,I,4/21/2023,1/15/2021,,PER,,Chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230400351,20230400351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Ageusia,Nurse,55,Years,Female,I,4/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Ageusia,Collegium Pharmaceutical,NO,NO,Unlisted
20230400351,20230400351,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Dysgeusia,Nurse,55,Years,Female,I,4/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Dysgeusia,Collegium Pharmaceutical,NO,NO,Unlisted
20230400352,20230400352,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,4/22/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230400352,20230400352,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Female,I,4/22/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400354,20230400354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Vomiting,Consumer,,,Female,I,4/27/2023,,,PER,,Pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230400354,20230400354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Inappropriate schedule of product administration,Consumer,,,Female,I,4/27/2023,,,PER,,Pain,UNITED STATES,Inappropriate schedule of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230400354,20230400354,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Nausea,Consumer,,,Female,I,4/27/2023,,,PER,,Pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230400357,20230400357,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Therapeutic response decreased,Consumer,78,Years,Female,I,4/25/2023,4/15/2023,,PER,,Back pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230400362,20230400362,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Pharmacist,,,Male,I,4/26/2023,4/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400365,20230400365,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,44,Years,Female,I,4/27/2023,4/15/2023,,PER,,Pain due to Spinal cord surgery,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400366,20230400366,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product communication issue,Consumer,,,Male,I,4/27/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230400366,20230400366,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Male,I,4/27/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500371,20230500371,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging issue,Consumer,66,Years,Female,I,5/1/2023,6/15/2023,,PER,,Pain,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500374,20230500374,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,60,Years,Female,F,5/10/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230500384,20230500384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Vomiting,Other Health Professional,,,Male,I,5/5/2023,,,PER,,Product used for unknown indication,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230500384,20230500384,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Other Health Professional,,,Male,I,5/5/2023,,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230500385,20230500385,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product outer packaging issue,Physician,,,Female,I,5/8/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product outer packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500385,20230500385,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Physician,,,Female,I,5/8/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230500386,20230500386,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Drug ineffective,Consumer,80,Years,Male,I,5/8/2023,5/6/2023,,PER,,Pain management,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230500386,20230500386,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Dizziness,Consumer,80,Years,Male,I,5/8/2023,5/15/2023,,PER,,Pain management,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230500388,20230500388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product administration error,Consumer,,,Female,F,5/5/2023,5/5/2023,,PER,,Product used for unknown indication,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230500388,20230500388,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,F,5/5/2023,5/5/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500389,20230500389,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Swelling face,Other Health Professional,,,Female,I,5/8/2023,5/8/2023,,PER,,Product used for unknown indication,UNITED STATES,Swelling face,Collegium Pharmaceutical,NO,NO,Unlisted
20230500390,20230500390,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging quantity issue,Consumer,,,Female,F,5/12/2023,5/6/2023,,PER,,Pain management,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500410,20230500410,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Dental restoration failure,Consumer,,,Female,I,5/12/2023,5/11/2023,,PER,,Product used for unknown indication,UNITED STATES,Dental restoration failure,Collegium Pharmaceutical,YES,YES,Listed
20230500423,20230500423,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Male,I,5/17/2023,,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230500424,20230500424,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,,,Female,I,5/17/2023,5/14/2023,,PER,,Bursitis in buttocks,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500432,20230500432,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product storage error,Pharmacist,,,Female,F,5/22/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product storage error,Collegium Pharmaceutical,NO,NO,Unlisted
20230500432,20230500432,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Pharmacist,,,Female,F,5/22/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230500433,20230500433,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,61,Years,Female,I,5/18/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500434,20230500434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,65,Years,Male,I,5/19/2023,5/19/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500434,20230500434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product size issue,Consumer,65,Years,Male,I,5/19/2023,5/19/2023,,PER,,Chronic Pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500434,20230500434,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product administration error,Consumer,65,Years,Male,I,5/19/2023,5/19/2023,,PER,,Chronic Pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230500435,20230500435,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Off label use,Pharmacist,,,Male,I,5/19/2023,,,PER,,Product used for unknown indication,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230500436,20230500436,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,74,Years,Female,I,5/23/2023,5/17/2023,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230500436,20230500436,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,74,Years,Female,I,5/23/2023,5/17/2023,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230500443,20230500443,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,5/24/2023,,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230500451,20230500451,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product dose omission issue,Consumer,,,Female,I,5/30/2023,5/24/2023,,PER,,Product used for unknown indication,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600454,20230600454,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Constipation,Physician,,,Female,I,5/31/2023,,,PER,,Product used for unknown indication,UNITED STATES,Constipation,Collegium Pharmaceutical,NO,NO,Listed
20230600464,20230600464,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",Unknown,,,,,,Unknown,Off label use,Physician,,,Female,I,6/5/2023,,,,,Drug used for unknown indication,AUSTRALIA,Off label use,,NO,NO,
20230600464,20230600464,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",Unknown,,,,,,Unknown,Off label use,Physician,,,Female,I,6/5/2023,,,,,Drug used for unknown indication,AUSTRALIA,Off label use,,NO,NO,
20230600475,20230600475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,67,Years,Female,I,6/5/2023,5/15/2023,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600475,20230600475,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,67,Years,Female,I,6/5/2023,5/15/2023,,PER,,Chronic pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230600480,20230600480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,F,6/7/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230600480,20230600480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect route of product administration,Consumer,,,Female,F,6/7/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230600480,20230600480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Female,F,6/7/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600480,20230600480,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,F,6/7/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230600483,20230600483,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Dental caries,Other Health Professional,,,Female,I,6/7/2023,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20230600486,20230600486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Inability to afford medication,Consumer,,,Male,I,6/8/2023,,,PER,,product used for unknown indication,UNITED STATES,Inability to afford medication,Collegium Pharmaceutical,NO,NO,Unlisted
20230600486,20230600486,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Intentional product use issue,Consumer,,,Male,I,6/8/2023,,,PER,,product used for unknown indication,UNITED STATES,Intentional product use issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600489,20230600489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Off label use,Consumer,,,Male,I,6/8/2023,6/15/2023,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,YES,Unlisted
20230600489,20230600489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Drug withdrawal syndrome,Consumer,,,Male,I,6/8/2023,6/15/2023,,PER,,pain,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20230600489,20230600489,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,tid,Wrong technique in product usage process,Consumer,,,Male,I,6/8/2023,6/15/2023,,PER,,pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,YES,Unlisted
20230600490,20230600490,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,6/8/2023,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600493,20230600493,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Hallucination,Consumer,,,Female,I,6/9/2023,6/4/2023,EXP,,,pain,UNITED STATES,Hallucination,Collegium Pharmaceutical,YES,YES,Unlisted
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,General physical health deterioration,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,General physical health deterioration,,NO,YES,
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Marital problem,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Marital problem,,NO,YES,
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Homeless,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Homeless,,NO,YES,
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Loss of employment,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Loss of employment,,NO,YES,
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Depression,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Depression,,NO,YES,
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Erectile dysfunction,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Erectile dysfunction,,YES,YES,
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,General physical health deterioration,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,General physical health deterioration,Collegium Pharmaceutical,NO,YES,Unlisted
20230600500,20230600500,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Dependence,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Dependence,,YES,YES,
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Marital problem,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Marital problem,Collegium Pharmaceutical,NO,YES,Unlisted
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Homeless,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Homeless,Collegium Pharmaceutical,NO,YES,Unlisted
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Loss of employment,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Loss of employment,Collegium Pharmaceutical,NO,YES,Unlisted
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Depression,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Depression,Collegium Pharmaceutical,NO,YES,Listed
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Erectile dysfunction,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Erectile dysfunction,Collegium Pharmaceutical,YES,YES,Unlisted
20230600500,20230600500,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Dependence,Consumer,,,Male,I,6/14/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Dependence,Collegium Pharmaceutical,YES,YES,Listed
20230600501,20230600501,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug dependence,Consumer,,,Male,I,6/14/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug dependence,,YES,YES,
20230600501,20230600501,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Overdose,Consumer,,,Male,I,6/14/2023,,,PER,,Product used for unknown indication,UNITED STATES,Overdose,,NO,YES,
20230600501,20230600501,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug detoxification,Consumer,,,Male,I,6/14/2023,,,PER,,Product used for unknown indication,UNITED STATES,Drug detoxification,,NO,YES,
20230600514,20230600514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug titration error,Pharmacist,,,Male,I,6/14/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Drug titration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230600514,20230600514,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Pain,Pharmacist,,,Male,I,6/14/2023,6/15/2023,,PER,,product used for unknown indication,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230600517,20230600517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging difficult to open,Consumer,,,Female,F,2/5/2024,6/15/2023,,PER,,chronic pain,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20230600517,20230600517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dose omission issue,Consumer,,,Female,F,2/5/2024,5/15/2023,,PER,,chronic pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600517,20230600517,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical issue,Consumer,,,Female,F,2/5/2024,6/15/2023,,PER,,chronic pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600519,20230600519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Dental caries,Physician,6,Decades,Male,I,6/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20230600519,20230600519,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Inappropriate schedule of product discontinuation,Physician,6,Decades,Male,I,6/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Inappropriate schedule of product discontinuation,Collegium Pharmaceutical,NO,NO,Unlisted
20230600520,20230600520,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,,,Female,I,6/20/2023,,,PER,,product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230600520,20230600520,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,6/20/2023,,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230600533,20230600533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Off label use,Consumer,71,Years,Female,F,11/28/2023,,,PER,,Chronic pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230600533,20230600533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug screen negative,Consumer,71,Years,Female,F,11/28/2023,,,PER,,Chronic pain,UNITED STATES,Drug screen negative,Collegium Pharmaceutical,NO,NO,Unlisted
20230600533,20230600533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Pain,Consumer,71,Years,Female,F,11/28/2023,,,PER,,Chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230600533,20230600533,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,71,Years,Female,F,11/28/2023,1/15/2022,,PER,,Chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Drug ineffective,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Product prescribing error,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Product prescribing error,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Vomiting,Consumer,79,Years,Female,I,6/23/2023,,,PER,,pain,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Headache,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Nausea,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Malaise,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Decreased appetite,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Decreased appetite,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Weight decreased,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Weight decreased,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Dyspnoea,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Dyspnoea,Collegium Pharmaceutical,NO,NO,Listed
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Off label use,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Product administration error,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Expired product administered,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Expired product administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230600535,20230600535,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,bid,Asthenia,Consumer,79,Years,Female,I,6/23/2023,6/15/2023,,PER,,pain,UNITED STATES,Asthenia,Collegium Pharmaceutical,NO,NO,Listed
20230600536,20230600536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Female,I,6/23/2023,6/15/2023,,PER,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230600536,20230600536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Consumer,,,Female,I,6/23/2023,6/15/2023,,PER,,chronic pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600536,20230600536,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,6/23/2023,6/15/2023,,PER,,chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230600540,20230600540,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Swelling,Physician,,,UNK,I,6/26/2023,,,PER,,Product used for unknown indication,UNITED STATES,Swelling,Collegium Pharmaceutical,NO,NO,Unlisted
20230600541,20230600541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,6/26/2023,,,PER,,chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230600541,20230600541,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product administration error,Consumer,,,Male,I,6/26/2023,,,PER,,chronic pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230600544,20230600544,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Toothache,Physician,7,Decades,Female,I,6/27/2023,,,PER,,pain,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,NO,Listed
20230600547,20230600547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Constipation,Consumer,62,Years,Female,F,7/5/2023,6/15/2023,,PER,,Chronic pain in shoulder,UNITED STATES,Constipation,Collegium Pharmaceutical,NO,NO,Listed
20230600547,20230600547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Abdominal pain,Consumer,62,Years,Female,F,7/5/2023,6/15/2023,,PER,,Chronic pain in shoulder,UNITED STATES,Abdominal pain,Collegium Pharmaceutical,NO,NO,Listed
20230600547,20230600547,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Nausea,Consumer,62,Years,Female,F,7/5/2023,6/15/2023,,PER,,Chronic pain in shoulder,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Tooth loss,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Tooth loss,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Hypertension,Consumer,62,Years,Female,F,10/29/2023,11/15/2022,EXP,,,chronic pain,UNITED STATES,Hypertension,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Infection,Consumer,62,Years,Female,F,10/29/2023,11/15/2022,EXP,,Hospitalisation,chronic pain,UNITED STATES,Infection,Collegium Pharmaceutical,YES,YES,Unlisted
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Abscess oral,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Abscess oral,Collegium Pharmaceutical,NO,YES,Unlisted
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Dental caries,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Tooth fracture,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Tooth fracture,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Panic attack,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Panic attack,Collegium Pharmaceutical,NO,YES,Unlisted
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Drug ineffective,Consumer,62,Years,Female,F,10/29/2023,9/15/2022,EXP,,,chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Fear of death,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Fear of death,Collegium Pharmaceutical,NO,YES,Unlisted
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Toothache,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Constipation,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Constipation,Collegium Pharmaceutical,NO,YES,Listed
20230700550,20230700550,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,microgram,Buccal film,bid,Emotional distress,Consumer,62,Years,Female,F,10/29/2023,,EXP,,,chronic pain,UNITED STATES,Emotional distress,Collegium Pharmaceutical,NO,YES,Unlisted
20230700552,20230700552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,6/29/2023,6/28/2023,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230700552,20230700552,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,6/29/2023,6/28/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700554,20230700554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,86,Years,Female,I,7/5/2023,6/15/2023,,PER,,Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230700554,20230700554,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,86,Years,Female,I,7/5/2023,6/15/2023,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700558,20230700558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,64,Years,Female,I,7/6/2023,7/6/2023,,PER,,back pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230700558,20230700558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,64,Years,Female,I,7/6/2023,7/5/2023,,PER,,back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700558,20230700558,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,64,Years,Female,I,7/6/2023,7/5/2023,,PER,,back pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230700566,20230700566,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,54,Years,Male,I,7/11/2023,7/7/2023,,PER,,Product used for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230700572,20230700572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product packaging issue,Pharmacist,,,UNK,I,7/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700572,20230700572,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product packaging difficult to open,Pharmacist,,,UNK,I,7/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product packaging difficult to open,Collegium Pharmaceutical,NO,NO,Unlisted
20230700574,20230700574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,qd,Tooth disorder,Physician,49,Years,Female,I,7/12/2023,,,PER,,Chronic pain,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,NO,NO,Listed
20230700574,20230700574,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,Negative,,microgram,Buccal film,qd,Product administration error,Physician,49,Years,Female,I,7/12/2023,,,PER,,Chronic pain,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230700577,20230700577,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Pain,Consumer,,,Female,I,7/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect route of product administration,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product administration error,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product administration error,Collegium Pharmaceutical,NO,NO,Unlisted
20230700582,20230700582,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Retching,Consumer,,,Female,I,7/12/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Retching,Collegium Pharmaceutical,NO,NO,Unlisted
20230700585,20230700585,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Female,I,7/13/2023,6/15/2023,,PER,,Pain management,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700586,20230700586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,74,Years,Female,F,7/21/2023,,,PER,,extreme lower back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230700586,20230700586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,74,Years,Female,F,7/21/2023,7/14/2023,,PER,,extreme lower back pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230700586,20230700586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,74,Years,Female,F,7/21/2023,,,PER,,extreme lower back pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700586,20230700586,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,74,Years,Female,F,7/21/2023,,,PER,,extreme lower back pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230700591,20230700591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product solubility abnormal,Consumer,80,Years,,I,7/20/2023,7/19/2023,,PER,,Pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230700591,20230700591,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Wrong technique in product usage process,Consumer,80,Years,,I,7/20/2023,7/19/2023,,PER,,Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230700600,20230700600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Urinary incontinence,Physician,50,Years,Female,I,7/27/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Urinary incontinence,Collegium Pharmaceutical,NO,NO,Unlisted
20230700600,20230700600,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Micturition urgency,Physician,50,Years,Female,I,7/27/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Micturition urgency,Collegium Pharmaceutical,NO,NO,Unlisted
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Product use in unapproved indication,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Product use in unapproved indication,Collegium Pharmaceutical,NO,NO,Unlisted
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Off label use,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Intentional product use issue,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Intentional product use issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Wrong technique in product usage process,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Nausea,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230700601,20230700601,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Headache,Consumer,60,Years,Male,I,7/21/2023,7/19/2023,,PER,,restless leg syndrome,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230700608,20230700608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tooth disorder,Consumer,54,Years,Female,I,7/25/2023,,EXP,,,Back pain,UNITED STATES,Tooth disorder,Collegium Pharmaceutical,YES,YES,Unlisted
20230700608,20230700608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Pain,Consumer,54,Years,Female,I,7/25/2023,,EXP,,,Back pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,YES,Listed
20230700608,20230700608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tongue injury,Consumer,54,Years,Female,I,7/25/2023,7/24/2023,EXP,,,Back pain,UNITED STATES,Tongue injury,Collegium Pharmaceutical,NO,YES,Unlisted
20230700608,20230700608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Glossodynia,Consumer,54,Years,Female,I,7/25/2023,7/24/2023,EXP,,,Back pain,UNITED STATES,Glossodynia,Collegium Pharmaceutical,NO,YES,Unlisted
20230700608,20230700608,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Tooth fracture,Consumer,54,Years,Female,I,7/25/2023,7/24/2023,EXP,,,Back pain,UNITED STATES,Tooth fracture,Collegium Pharmaceutical,NO,YES,Listed
20230700616,20230700616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,61,Years,Male,I,7/31/2023,7/15/2023,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230700616,20230700616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Malaise,Consumer,61,Years,Male,I,7/31/2023,7/15/2023,,PER,,Pain,UNITED STATES,Malaise,Collegium Pharmaceutical,NO,NO,Unlisted
20230800623,20230800623,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product packaging quantity issue,Consumer,,,Female,I,7/31/2023,7/29/2023,,PER,,Chronic Pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800627,20230800627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,,Buccal film,Unknown,Asthma,Physician,,,Female,I,8/1/2023,,,PER,,product used for unknown indication,UNITED STATES,Asthma,Collegium Pharmaceutical,NO,NO,Unlisted
20230800628,20230800628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Burning sensation,Nurse,,,Male,I,8/1/2023,,,PER,,Product used for unknown indication,UNITED STATES,Burning sensation,Collegium Pharmaceutical,NO,NO,Unlisted
20230800630,20230800630,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,Unknown,Vomiting,Physician,,,Male,I,8/1/2023,,,PER,,Product used for unknown indication,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230800632,20230800632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Inappropriate schedule of product discontinuation,Pharmacist,65,Years,Male,I,8/2/2023,8/1/2023,,PER,,Chronic pain,UNITED STATES,Inappropriate schedule of product discontinuation,Collegium Pharmaceutical,NO,NO,Unlisted
20230800632,20230800632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Oral mucosal eruption,Pharmacist,65,Years,Male,I,8/2/2023,7/30/2023,,PER,,Chronic pain,UNITED STATES,Oral mucosal eruption,Collegium Pharmaceutical,NO,NO,Unlisted
20230800632,20230800632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Stomatitis,Pharmacist,65,Years,Male,I,8/2/2023,7/30/2023,,PER,,Chronic pain,UNITED STATES,Stomatitis,Collegium Pharmaceutical,NO,NO,Unlisted
20230800633,20230800633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Tongue discomfort,Other Health Professional,,,Female,I,8/2/2023,7/27/2023,,PER,,Pain management,UNITED STATES,Tongue discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20230800636,20230800636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Physician,,,Female,I,8/4/2023,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Oral pain,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Oral pain,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Application site pain,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Application site pain,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Gingival pain,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Gingival pain,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Discomfort,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Swelling face,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Swelling face,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Wrong technique in product usage process,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Pain,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Product adhesion issue,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Panic attack,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Panic attack,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Oral discomfort,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Oral discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20230800638,20230800638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Negative,,,,Buccal film,bid,Hypoaesthesia,Consumer,41,Years,Female,F,8/11/2023,8/3/2023,,PER,,chronic pain,UNITED STATES,Hypoaesthesia,Collegium Pharmaceutical,NO,NO,Unlisted
20230800640,20230800640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Accidental exposure to product,Consumer,77,Years,Female,I,8/4/2023,7/15/2023,,PER,,Pain relief,UNITED STATES,Accidental exposure to product,Collegium Pharmaceutical,NO,NO,Unlisted
20230800640,20230800640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,77,Years,Female,I,8/4/2023,7/15/2023,,PER,,Pain relief,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230800640,20230800640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,77,Years,Female,I,8/4/2023,7/28/2023,,PER,,Pain relief,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230800640,20230800640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,77,Years,Female,I,8/4/2023,7/15/2023,,PER,,Pain relief,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800641,20230800641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,8/7/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800641,20230800641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,I,8/7/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230800641,20230800641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,,,Female,I,8/7/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230800655,20230800655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,85,Years,Female,I,8/10/2023,,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800655,20230800655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Drug ineffective,Consumer,85,Years,Female,I,8/10/2023,,,PER,,pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230800655,20230800655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,85,Years,Female,I,8/10/2023,,,PER,,pain,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230800658,20230800658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,,,Female,I,8/11/2023,7/15/2023,,PER,,pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230800658,20230800658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Tongue discomfort,Consumer,,,Female,I,8/11/2023,7/15/2023,,PER,,pain,UNITED STATES,Tongue discomfort,Collegium Pharmaceutical,NO,NO,Unlisted
20230800658,20230800658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,8/11/2023,7/15/2023,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800666,20230800666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,,,Male,I,8/16/2023,6/15/2023,,PER,,failed back surgery syndrome,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800666,20230800666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Poor quality product administered,Consumer,,,Male,I,8/16/2023,6/15/2023,,PER,,failed back surgery syndrome,UNITED STATES,Poor quality product administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230800666,20230800666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Manufacturing production issue,Consumer,,,Male,I,8/16/2023,6/15/2023,,PER,,failed back surgery syndrome,UNITED STATES,Manufacturing production issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800666,20230800666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Male,I,8/16/2023,6/15/2023,,PER,,failed back surgery syndrome,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800673,20230800673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,47,Years,Female,I,8/17/2023,6/15/2023,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800674,20230800674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Consumer,,,Male,I,8/17/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800676,20230800676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,8/17/2023,8/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800676,20230800676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product physical consistency issue,Consumer,,,Female,I,8/17/2023,8/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800677,20230800677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Headache,Consumer,41,Years,Female,I,8/18/2023,7/15/2023,,PER,,"problem in spine, arms, shoulder and neck",UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230800677,20230800677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product solubility abnormal,Consumer,41,Years,Female,I,8/18/2023,7/15/2023,,PER,,"problem in spine, arms, shoulder and neck",UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230800677,20230800677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,41,Years,Female,I,8/18/2023,7/15/2023,,PER,,"problem in spine, arms, shoulder and neck",UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230800693,20230800693,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Vomiting,Physician,,,Female,I,8/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230800693,20230800693,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect dosage administered,Physician,,,Female,I,8/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Incorrect dosage administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230800693,20230800693,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product dispensing error,Physician,,,Female,I,8/24/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product dispensing error,Collegium Pharmaceutical,NO,NO,Unlisted
20230800700,20230800700,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product use issue,Non-Health Professional,76,Years,Male,I,8/25/2023,8/25/2023,,PER,,pain,UNITED STATES,Product use issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230800700,20230800700,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Non-Health Professional,76,Years,Male,I,8/25/2023,7/15/2023,,PER,,pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230800703,20230800703,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,prn,Inappropriate schedule of product administration,Consumer,,,Male,I,8/22/2023,,,PER,,chronic back pain,UNITED STATES,Inappropriate schedule of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230800703,20230800703,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,prn,Product storage error,Consumer,,,Male,I,8/22/2023,,,PER,,chronic back pain,UNITED STATES,Product storage error,Collegium Pharmaceutical,NO,NO,Unlisted
20230800703,20230800703,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,prn,Wrong technique in product usage process,Consumer,,,Male,I,8/22/2023,,,PER,,chronic back pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230800705,20230800705,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug screen negative,Consumer,55,Years,Female,I,8/29/2023,6/28/2023,,PER,,Refractory pain,UNITED STATES,Drug screen negative,Collegium Pharmaceutical,NO,NO,Unlisted
20230800706,20230800706,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Blood pressure decreased,Other Health Professional,70,Years,Female,I,8/29/2023,,,PER,,Product used for unknown indication,UNITED STATES,Blood pressure decreased,Collegium Pharmaceutical,NO,NO,Listed
20230900731,20230900731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical consistency issue,Consumer,,,Female,I,9/1/2023,,,PER,,pain due to muscular dystrophy,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,YES,Unlisted
20230900731,20230900731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,9/1/2023,,,PER,,pain due to muscular dystrophy,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,YES,Unlisted
20230900731,20230900731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product use issue,Consumer,,,Female,I,9/1/2023,,,PER,,pain due to muscular dystrophy,UNITED STATES,Product use issue,Collegium Pharmaceutical,NO,YES,Unlisted
20230900731,20230900731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Female,I,9/1/2023,,,PER,,pain due to muscular dystrophy,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,YES,Unlisted
20230900731,20230900731,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug withdrawal syndrome,Consumer,,,Female,I,9/1/2023,6/15/2023,,PER,,pain due to muscular dystrophy,UNITED STATES,Drug withdrawal syndrome,Collegium Pharmaceutical,YES,YES,Listed
20230900740,20230900740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product communication issue,Consumer,,,Female,I,9/6/2023,9/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900740,20230900740,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,9/6/2023,9/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230900754,20230900754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Sensitive skin,Consumer,,,Female,I,9/7/2023,5/15/2023,,PER,,Back pain,UNITED STATES,Sensitive skin,Collegium Pharmaceutical,NO,NO,Unlisted
20230900754,20230900754,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Off label use,Consumer,,,Female,I,9/7/2023,6/15/2022,,PER,,Back pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20230900756,20230900756,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Male,I,9/8/2023,,,PER,,drug use for unknown indication,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230900760,20230900760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,I,9/8/2023,9/3/2023,,PER,,Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20230900760,20230900760,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Inappropriate schedule of product administration,Consumer,,,Female,I,9/8/2023,9/3/2023,,PER,,Pain,UNITED STATES,Inappropriate schedule of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230900765,20230900765,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product packaging quantity issue,Consumer,,,Male,F,9/22/2023,9/5/2023,,PER,,Pain,UNITED STATES,Product packaging quantity issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900767,20230900767,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Fatigue,Non-Health Professional,79,Years,Male,I,9/11/2023,9/15/2023,,PER,,knee pain,UNITED STATES,Fatigue,Collegium Pharmaceutical,NO,NO,Listed
20230900767,20230900767,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Circumstance or information capable of leading to medication error,Non-Health Professional,79,Years,Male,I,9/11/2023,9/15/2023,,PER,,knee pain,UNITED STATES,Circumstance or information capable of leading to medication error,Collegium Pharmaceutical,NO,NO,Unlisted
20230900768,20230900768,Belbuca unspecified,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Unknown,Unknown,Feeling abnormal,Non-Health Professional,,,Female,I,9/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Feeling abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230900769,20230900769,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,9/12/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Feeling hot,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Feeling hot,Collegium Pharmaceutical,NO,NO,Unlisted
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Vomiting,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Vomiting,Collegium Pharmaceutical,NO,NO,Listed
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Anxiety,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Anxiety,Collegium Pharmaceutical,NO,NO,Listed
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Headache,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Headache,Collegium Pharmaceutical,NO,NO,Listed
20230900784,20230900784,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Dizziness,Consumer,69,Years,Female,I,9/16/2023,,,PER,,Product used for unknown indication,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20230900787,20230900787,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Pharmacist,,,Female,I,9/20/2023,9/18/2023,,PER,,Chronic Pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900787,20230900787,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Pharmacist,,,Female,I,9/20/2023,9/18/2023,,PER,,Chronic Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product storage error,Pharmacist,36,Years,Male,F,9/29/2023,9/15/2023,,PER,,pain,UNITED STATES,Product storage error,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product packaging issue,Pharmacist,36,Years,Male,F,9/29/2023,9/15/2023,,PER,,pain,UNITED STATES,Product packaging issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Pharmacist,36,Years,Male,F,9/29/2023,9/13/2023,,PER,,pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Pharmacist,36,Years,Male,F,9/29/2023,9/15/2023,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Poor quality product administered,Pharmacist,36,Years,Male,F,9/29/2023,9/15/2023,,PER,,pain,UNITED STATES,Poor quality product administered,Collegium Pharmaceutical,NO,NO,Unlisted
20230900791,20230900791,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product physical issue,Pharmacist,36,Years,Male,F,9/29/2023,9/15/2023,,PER,,pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900793,20230900793,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Male,I,9/21/2023,,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230900793,20230900793,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,9/21/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900799,20230900799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Mouth swelling,Consumer,68,Years,Male,I,9/22/2023,9/15/2023,EXP,,Hospitalisation,Chronic Pain,UNITED STATES,Mouth swelling,Collegium Pharmaceutical,YES,YES,Unlisted
20230900799,20230900799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Swollen tongue,Consumer,68,Years,Male,I,9/22/2023,9/15/2023,EXP,,Hospitalisation,Chronic Pain,UNITED STATES,Swollen tongue,Collegium Pharmaceutical,YES,YES,Unlisted
20230900799,20230900799,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Therapeutic response decreased,Consumer,68,Years,Male,I,9/22/2023,9/15/2023,EXP,,,Chronic Pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,YES,Listed
20230900801,20230900801,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,9/25/2023,9/15/2023,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900805,20230900805,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,9/26/2023,9/15/2023,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900805,20230900805,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,I,9/26/2023,9/15/2023,,PER,,pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230900806,20230900806,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,9/25/2023,,,PER,,product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20230900806,20230900806,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,9/25/2023,,,PER,,product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900806,20230900806,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Incorrect route of product administration,Consumer,,,Female,I,9/25/2023,,,PER,,product used for unknown indication,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20230900811,20230900811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Toothache,Other Health Professional,65,Years,Female,I,9/27/2023,,,PER,,chronic pain,UNITED STATES,Toothache,Collegium Pharmaceutical,NO,NO,Listed
20230900811,20230900811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Hyperaesthesia teeth,Other Health Professional,65,Years,Female,I,9/27/2023,,,PER,,chronic pain,UNITED STATES,Hyperaesthesia teeth,Collegium Pharmaceutical,NO,NO,Unlisted
20230900811,20230900811,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,Unknown,Dental caries,Other Health Professional,65,Years,Female,I,9/27/2023,,,PER,,chronic pain,UNITED STATES,Dental caries,Collegium Pharmaceutical,NO,NO,Listed
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Therapeutic response decreased,Consumer,86,Years,Female,I,9/28/2023,9/15/2023,,PER,,Extreme pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,86,Years,Female,I,9/28/2023,9/15/2023,,PER,,Extreme pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,86,Years,Female,I,9/28/2023,9/15/2023,,PER,,Extreme pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Pain,Consumer,86,Years,Female,I,9/28/2023,9/15/2023,,PER,,Extreme pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Somnolence,Consumer,86,Years,Female,I,9/28/2023,9/15/2023,,PER,,Extreme pain,UNITED STATES,Somnolence,Collegium Pharmaceutical,NO,NO,Listed
20230900815,20230900815,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product dose omission issue,Consumer,86,Years,Female,I,9/28/2023,9/28/2023,,PER,,Extreme pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000816,20231000816,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Nausea,Other Health Professional,60,Years,Male,I,9/29/2023,,,PER,,Product used for unknown indication,UNITED STATES,Nausea,Collegium Pharmaceutical,NO,NO,Listed
20231000817,20231000817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product communication issue,Consumer,,,Female,I,9/29/2023,9/28/2023,,PER,,Product used for unknown indication,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000817,20231000817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product solubility abnormal,Consumer,,,Female,I,9/29/2023,9/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,Collegium Pharmaceutical,NO,NO,Unlisted
20231000817,20231000817,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Wrong technique in product usage process,Consumer,,,Female,I,9/29/2023,9/28/2023,,PER,,Product used for unknown indication,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20231000821,20231000821,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product communication issue,Consumer,66,Years,Male,I,10/3/2023,9/15/2023,,PER,,chronic pain,UNITED STATES,Product communication issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Drug ineffective,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Pain,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Pain,Collegium Pharmaceutical,NO,NO,Listed
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Therapy cessation,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Therapy cessation,Collegium Pharmaceutical,NO,NO,Unlisted
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Product size issue,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Product size issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Inability to afford medication,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Inability to afford medication,Collegium Pharmaceutical,NO,NO,Unlisted
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Product dose omission issue,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Product dose omission issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000825,20231000825,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,UNKNOWN,,,microgram,Buccal film,,Gait disturbance,Consumer,75,Years,Female,F,11/13/2023,6/15/2023,,PER,,Chronic Spine Pain,UNITED STATES,Gait disturbance,Collegium Pharmaceutical,NO,NO,Unlisted
20231000829,20231000829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,tid,Therapeutic response decreased,Consumer,,,Female,I,10/4/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Therapeutic response decreased,Collegium Pharmaceutical,NO,NO,Listed
20231000829,20231000829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,tid,Wrong technique in product usage process,Consumer,,,Female,I,10/4/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20231000829,20231000829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,tid,Off label use,Consumer,,,Female,I,10/4/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20231000829,20231000829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,tid,Incorrect route of product administration,Consumer,,,Female,I,10/4/2023,8/15/2023,,PER,,Chronic pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20231000829,20231000829,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,tid,Product adhesion issue,Consumer,,,Female,I,10/4/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000832,20231000832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Off label use,Consumer,,,Male,I,10/6/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,YES,Unlisted
20231000832,20231000832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Delusion,Consumer,,,Male,I,10/6/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Delusion,Collegium Pharmaceutical,YES,YES,Unlisted
20231000832,20231000832,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,qd,Paranoia,Consumer,,,Male,I,10/6/2023,,EXP,,,Product used for unknown indication,UNITED STATES,Paranoia,Collegium Pharmaceutical,YES,YES,Unlisted
20231000834,20231000834,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Dizziness,Nurse,,,Male,I,10/10/2023,,,PER,,Product used for unknown indication,UNITED STATES,Dizziness,Collegium Pharmaceutical,NO,NO,Listed
20231000835,20231000835,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,10/10/2023,10/15/2023,,PER,,pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000836,20231000836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Pruritus,Physician,,,Male,I,10/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Pruritus,Collegium Pharmaceutical,NO,NO,Listed
20231000836,20231000836,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Skin irritation,Physician,,,Male,I,10/11/2023,,,PER,,Product used for unknown indication,UNITED STATES,Skin irritation,Collegium Pharmaceutical,NO,NO,Unlisted
20231000837,20231000837,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Feeling abnormal,Other Health Professional,,,Female,I,10/11/2023,9/15/2023,EXP,,,pain,UNITED STATES,Feeling abnormal,Collegium Pharmaceutical,NO,YES,Unlisted
20231000837,20231000837,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Loss of consciousness,Other Health Professional,,,Female,I,10/11/2023,9/15/2023,EXP,,,pain,UNITED STATES,Loss of consciousness,Collegium Pharmaceutical,YES,YES,Unlisted
20231000848,20231000848,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Female,I,10/16/2023,10/15/2023,,PER,,Chronic Back Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000854,20231000854,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Adverse event,Consumer,,,Female,I,10/17/2023,9/28/2023,EXP,,,Chronic Back pain,UNITED STATES,Adverse event,Collegium Pharmaceutical,YES,YES,Unlisted
20231000854,20231000854,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Drug ineffective,Consumer,,,Female,I,10/17/2023,,EXP,,,Chronic Back pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,YES,Listed
20231000855,20231000855,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Diarrhoea,Other Health Professional,63,Years,Female,I,10/16/2023,1/30/2023,,PER,,Chronic Pain,UNITED STATES,Diarrhoea,Collegium Pharmaceutical,NO,NO,Listed
20231000855,20231000855,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,bid,Anal incontinence,Other Health Professional,63,Years,Female,I,10/16/2023,1/30/2023,,PER,,Chronic Pain,UNITED STATES,Anal incontinence,Collegium Pharmaceutical,NO,NO,Unlisted
20231000859,20231000859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,81,Years,Male,I,10/18/2023,10/15/2023,,PER,,Chronic pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000859,20231000859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Drug ineffective,Consumer,81,Years,Male,I,10/18/2023,6/15/2023,,PER,,Chronic pain,UNITED STATES,Drug ineffective,Collegium Pharmaceutical,NO,NO,Listed
20231000859,20231000859,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Incorrect route of product administration,Consumer,81,Years,Male,I,10/18/2023,10/15/2023,,PER,,Chronic pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20231000861,20231000861,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,10/18/2023,6/15/2023,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000862,20231000862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product adhesion issue,Consumer,,,Female,I,10/19/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000862,20231000862,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,Unknown,Product use complaint,Consumer,,,Female,I,10/19/2023,,,PER,,Product used for unknown indication,UNITED STATES,Product use complaint,Collegium Pharmaceutical,NO,NO,Unlisted
20231000863,20231000863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Off label use,Physician,,,Female,I,10/19/2023,2/15/2023,,PER,,pain,UNITED STATES,Off label use,Collegium Pharmaceutical,NO,NO,Unlisted
20231000863,20231000863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Incorrect route of product administration,Physician,,,Female,I,10/19/2023,6/15/2023,,PER,,pain,UNITED STATES,Incorrect route of product administration,Collegium Pharmaceutical,NO,NO,Unlisted
20231000863,20231000863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Product physical issue,Physician,,,Female,I,10/19/2023,10/15/2023,,PER,,pain,UNITED STATES,Product physical issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000863,20231000863,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,prn,Product physical consistency issue,Physician,,,Female,I,10/19/2023,10/15/2023,,PER,,pain,UNITED STATES,Product physical consistency issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000864,20231000864,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Wrong technique in product usage process,Consumer,,,Male,I,10/19/2023,10/18/2023,,PER,,Pain,UNITED STATES,Wrong technique in product usage process,Collegium Pharmaceutical,NO,NO,Unlisted
20231000864,20231000864,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Product adhesion issue,Consumer,,,Male,I,10/19/2023,10/15/2023,,PER,,Pain,UNITED STATES,Product adhesion issue,Collegium Pharmaceutical,NO,NO,Unlisted
20231000867,20231000867,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,bid,Constipation,Consumer,67,Years,Male,I,10/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Constipation,Collegium Pharmaceutical,NO,NO,Listed
20231000868,20231000868,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Cholelithiasis,Consumer,,,Female,I,10/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Cholelithiasis,Collegium Pharmaceutical,NO,NO,Unlisted
20231000868,20231000868,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Sleep disorder,Consumer,,,Female,I,10/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Sleep disorder,Collegium Pharmaceutical,NO,NO,Unlisted
20231000868,20231000868,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,Unknown,Poor quality sleep,Consumer,,,Female,I,10/20/2023,,,PER,,Product used for unknown indication,UNITED STATES,Poor quality sleep,Collegium Pharmaceutical,NO,NO,Unlisted
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug withdrawal syndrome,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Anxiety,,YES,YES,Listed
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Anxiety,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Anxiety,,YES,YES,Listed
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Restlessness,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Restlessness,,YES,YES,Listed
E2B_00000001,E2B_00000001,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Restlessness,Non-Health Professional,37,Years,Female,I,12/8/2015,12/8/2015,,,Other,Drug dependence,UNITED STATES,Restlessness,,YES,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Insomnia,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Insomnia,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Restlessness,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Restlessness,,NO,YES,Unlisted
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Restlessness,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Restlessness,,NO,YES,Unlisted
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Insomnia,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Insomnia,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Diarrhoea,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Diarrhoea,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hyperhidrosis,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Bone pain,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Bone pain,,NO,YES,Unlisted
E2B_00000002,E2B_00000002,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Bone pain,Non-Health Professional,38,Years,Male,F,12/10/2015,,,,,Product used for unknown indication,UNITED STATES,Bone pain,,NO,YES,Unlisted
E2B_00000003,E2B_00000003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Overdose,Pharmacist,31,Years,Female,F,1/8/2016,12/8/2015,,,Death,Drug dependence,UNITED STATES,Overdose,,YES,YES,Unlisted
E2B_00000003,E2B_00000003,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Overdose,Pharmacist,31,Years,Female,F,1/8/2016,12/8/2015,,,Death,Drug dependence,UNITED STATES,Overdose,,YES,YES,Unlisted
E2B_00000004,E2B_00000004,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Malaise,Non-Health Professional,,,,F,12/14/2015,1/1/2015,,,,Product used for unknown indication,UNITED STATES,Malaise,,NO,NO,Unlisted
E2B_00000004,E2B_00000004,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Malaise,Non-Health Professional,,,,F,12/14/2015,1/1/2015,,,,Product used for unknown indication,UNITED STATES,Malaise,,NO,NO,Unlisted
E2B_00000005,E2B_00000005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Activities of daily living impaired,Non-Health Professional,,,Female,I,12/15/2015,12/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Activities of daily living impaired,,NO,NO,Unlisted
E2B_00000005,E2B_00000005,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Activities of daily living impaired,Non-Health Professional,,,Female,I,12/15/2015,12/1/2015,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Activities of daily living impaired,,NO,NO,Unlisted
E2B_00000006,E2B_00000006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Non-Health Professional,,,,F,1/4/2016,,,,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000006,E2B_00000006,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Non-Health Professional,,,,F,1/4/2016,,,,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Toxicity to various agents,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Toxicity to various agents,,YES,YES,
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Toxicity to various agents,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Toxicity to various agents,,YES,YES,
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Cardio-respiratory arrest,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Cardio-respiratory arrest,,YES,YES,
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Cardio-respiratory arrest,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Cardio-respiratory arrest,,YES,YES,
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Completed suicide,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Completed suicide,,YES,YES,
E2B_00000007,E2B_00000007,BUPRENORPHINE/NALOXONE,"BUPRENORPHINE,NALOXONE",,,,,,,,Completed suicide,Pharmacist,41,Years,Female,I,1/27/2016,1/1/2014,,,Death,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Completed suicide,,YES,YES,
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug withdrawal syndrome,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Hyperhidrosis,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Hyperhidrosis,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Hyperhidrosis,,NO,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Myalgia,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Myalgia,,NO,YES,Unlisted
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Myalgia,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Myalgia,,NO,YES,Unlisted
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Nausea,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Nausea,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Nausea,,NO,YES,Listed
E2B_00000008,E2B_00000008,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Therapeutic response decreased,Non-Health Professional,,,Female,I,2/1/2016,11/1/2015,,,,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Therapeutic response decreased,,NO,YES,Listed
E2B_00000009,E2B_00000009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Anger,Non-Health Professional,,,Female,I,2/10/2016,1/1/2016,,,Other,Product used for unknown indication,UNITED STATES,Anger,,YES,YES,Unlisted
E2B_00000009,E2B_00000009,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Anger,Non-Health Professional,,,Female,I,2/10/2016,1/1/2016,,,Other,Product used for unknown indication,UNITED STATES,Anger,,YES,YES,Unlisted
E2B_00000010,E2B_00000010,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Oedema peripheral,Non-Health Professional,27,Years,Male,I,1/21/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
E2B_00000010,E2B_00000010,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Oedema peripheral,Non-Health Professional,27,Years,Male,I,1/21/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
E2B_00000011,E2B_00000011,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug effect variable,Non-Health Professional,,,Male,I,2/1/2016,7/1/2015,,,,DRUG DEPENDENCE,UNITED STATES,Drug effect variable,,NO,NO,Listed
E2B_00000011,E2B_00000011,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug effect variable,Non-Health Professional,,,Male,I,2/1/2016,7/1/2015,,,,DRUG DEPENDENCE,UNITED STATES,Drug effect variable,,NO,NO,Listed
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Palpitations,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Palpitations,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Retching,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Retching,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Retching,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Retching,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Mental impairment,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Mental impairment,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Mental impairment,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Mental impairment,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Pruritus,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Pruritus,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Pruritus,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Pruritus,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Nausea,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Tachyphrenia,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Tachyphrenia,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Tachyphrenia,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Tachyphrenia,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Palpitations,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Palpitations,,NO,NO,Unlisted
E2B_00000012,E2B_00000012,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,,,,,,Nausea,Non-Health Professional,50,Years,Female,F,2/3/2016,2/1/2016,,,,Drug dependence,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000013,E2B_00000013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Non-Health Professional,,,Female,F,2/5/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000013,E2B_00000013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Non-Health Professional,,,Female,F,2/5/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000013,E2B_00000013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,F,2/5/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000013,E2B_00000013,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,F,2/5/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000014,E2B_00000014,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Oral administration complication,Non-Health Professional,,,Male,I,2/8/2016,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000014,E2B_00000014,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Oral administration complication,Non-Health Professional,,,Male,I,2/8/2016,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000015,E2B_00000015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product physical consistency issue,Non-Health Professional,,,Male,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000015,E2B_00000015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product physical consistency issue,Non-Health Professional,,,Male,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000015,E2B_00000015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000015,E2B_00000015,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Male,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000016,E2B_00000016,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000016,E2B_00000016,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product adhesion issue,Non-Health Professional,,,Female,I,2/9/2016,1/1/2016,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000017,E2B_00000017,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product packaging issue,Other Health Professional,,,,I,1/6/2016,1/6/2016,,,,Product used for unknown indication,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
E2B_00000017,E2B_00000017,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Product packaging issue,Other Health Professional,,,,I,1/6/2016,1/6/2016,,,,Product used for unknown indication,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
E2B_00000018,E2B_00000018,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug ineffective,Physician,,,,I,1/18/2016,,,,,Product used for unknown indication,UNITED STATES,Drug ineffective,,NO,NO,Listed
E2B_00000018,E2B_00000018,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,milligram,,,Drug ineffective,Physician,,,,I,1/18/2016,,,,,Product used for unknown indication,UNITED STATES,Drug ineffective,,NO,NO,Listed
E2B_00000019,E2B_00000019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product packaging issue,Pharmacist,,,,I,1/19/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
E2B_00000019,E2B_00000019,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product packaging issue,Pharmacist,,,,I,1/19/2016,1/1/2016,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Product packaging issue,,NO,NO,Unlisted
E2B_00000020,E2B_00000020,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,Negative,,,,,Nausea,Non-Health Professional,39,Years,Male,I,1/20/2016,1/20/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000020,E2B_00000020,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,Negative,,,,,Nausea,Non-Health Professional,39,Years,Male,I,1/20/2016,1/20/2016,,,,PAIN,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000020,E2B_00000020,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,Negative,,,,,Dizziness,Non-Health Professional,39,Years,Male,I,1/20/2016,1/20/2016,,,,PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
E2B_00000020,E2B_00000020,Bunavail,"BUPRENORPHINE,NALOXONE",,Negative,Negative,,,,,Dizziness,Non-Health Professional,39,Years,Male,I,1/20/2016,1/20/2016,,,,PAIN,UNITED STATES,Dizziness,,NO,NO,Listed
E2B_00000021,E2B_00000021,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,,,,Drug withdrawal syndrome,Non-Health Professional,30,Years,Female,I,2/1/2016,1/29/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000021,E2B_00000021,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,,,,Drug withdrawal syndrome,Non-Health Professional,30,Years,Female,I,2/1/2016,1/29/2016,,,Other,DEPENDENCE ON OPIATES,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000021,E2B_00000021,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,,,,Malaise,Non-Health Professional,30,Years,Female,I,2/1/2016,1/29/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,YES,Unlisted
E2B_00000021,E2B_00000021,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,Negative,,,,,,Malaise,Non-Health Professional,30,Years,Female,I,2/1/2016,1/29/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Malaise,,NO,YES,Unlisted
E2B_00000022,E2B_00000022,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,55,Years,Male,I,1/8/2016,1/7/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000022,E2B_00000022,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Nausea,Non-Health Professional,55,Years,Male,I,1/8/2016,1/7/2016,,,,DEPENDENCE ON OPIATES,UNITED STATES,Nausea,,NO,NO,Listed
E2B_00000023,E2B_00000023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Physician,,,,I,1/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
E2B_00000023,E2B_00000023,Bunavail,"BUPRENORPHINE,NALOXONE",Buccal use,,,,,,,Drug ineffective,Physician,,,,I,1/18/2016,,,,,DRUG USE FOR UNKNOWN INDICATION,UNITED STATES,Drug ineffective,,NO,NO,Listed
E2B_00000109,E2B_00000109,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/29/2015,10/28/2015,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000109,E2B_00000109,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Female,I,10/29/2015,10/28/2015,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000109,E2B_00000109,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,10/29/2015,10/28/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000109,E2B_00000109,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Female,I,10/29/2015,10/28/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000110,E2B_00000110,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Non-Health Professional,38,Years,Female,I,10/30/2015,10/26/2015,,,Other,Drug dependence,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
E2B_00000110,E2B_00000110,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Withdrawal syndrome,Non-Health Professional,38,Years,Female,I,10/30/2015,10/26/2015,,,Other,Drug dependence,UNITED STATES,Withdrawal syndrome,,YES,YES,Listed
E2B_00000111,E2B_00000111,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Aggression,Non-Health Professional,,,Male,I,10/30/2015,,,,,Product used for unknown indication,UNITED STATES,Aggression,,NO,NO,Unlisted
E2B_00000111,E2B_00000111,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Aggression,Non-Health Professional,,,Male,I,10/30/2015,,,,,Product used for unknown indication,UNITED STATES,Aggression,,NO,NO,Unlisted
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Insomnia,Non-Health Professional,35,Years,Female,I,11/4/2015,10/28/2015,,,,Drug dependence,UNITED STATES,Insomnia,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Insomnia,Non-Health Professional,35,Years,Female,I,11/4/2015,10/28/2015,,,,Drug dependence,UNITED STATES,Insomnia,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Headache,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dizziness,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Dizziness,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dizziness,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Dizziness,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Diarrhoea,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Diarrhoea,,NO,NO,Listed
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Malaise,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Malaise,,NO,NO,Unlisted
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Malaise,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Malaise,,NO,NO,Unlisted
E2B_00000112,E2B_00000112,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Non-Health Professional,35,Years,Female,I,11/4/2015,11/2/2015,,,,Drug dependence,UNITED STATES,Headache,,NO,NO,Listed
E2B_00000113,E2B_00000113,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,,,Male,I,11/4/2015,1/1/2015,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000113,E2B_00000113,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,,,Male,I,11/4/2015,1/1/2015,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000114,E2B_00000114,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/6/2015,11/5/2015,,,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000114,E2B_00000114,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product solubility abnormal,Non-Health Professional,,,Male,I,11/6/2015,11/5/2015,,,,Product used for unknown indication,UNITED STATES,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000114,E2B_00000114,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/6/2015,11/5/2015,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000114,E2B_00000114,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,,,Male,I,11/6/2015,11/5/2015,,,,Product used for unknown indication,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000115,E2B_00000115,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,11/13/2015,1/1/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000115,E2B_00000115,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,11/13/2015,1/1/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000116,E2B_00000116,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Eye pain,Non-Health Professional,27,Years,Male,I,11/16/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Eye pain,,NO,NO,Listed
E2B_00000116,E2B_00000116,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Migraine,Non-Health Professional,27,Years,Male,I,11/16/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Migraine,,NO,NO,Unlisted
E2B_00000116,E2B_00000116,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Eye pain,Non-Health Professional,27,Years,Male,I,11/16/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Eye pain,,NO,NO,Listed
E2B_00000116,E2B_00000116,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Migraine,Non-Health Professional,27,Years,Male,I,11/16/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Migraine,,NO,NO,Unlisted
E2B_00000117,E2B_00000117,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,27,Years,Male,I,11/16/2015,11/13/2015,,,,Drug dependence,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000117,E2B_00000117,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,27,Years,Male,I,11/16/2015,11/13/2015,,,,Drug dependence,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000117,E2B_00000117,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,27,Years,Male,I,11/16/2015,11/13/2015,,,,Drug dependence,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000117,E2B_00000117,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,27,Years,Male,I,11/16/2015,11/13/2015,,,,Drug dependence,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000123,E2B_00000123,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,Female,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000123,E2B_00000123,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Physician,,,Female,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,NO,Unlisted
E2B_00000124,E2B_00000124,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,30,Years,Male,I,11/17/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000124,E2B_00000124,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Non-Health Professional,30,Years,Male,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
E2B_00000124,E2B_00000124,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Oral administration complication,Non-Health Professional,30,Years,Male,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Oral administration complication,,NO,YES,Unlisted
E2B_00000124,E2B_00000124,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,30,Years,Male,I,11/17/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000125,E2B_00000125,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling of despair,Non-Health Professional,31,Years,Female,I,11/18/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Feeling of despair,,NO,NO,Unlisted
E2B_00000125,E2B_00000125,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Depression,Non-Health Professional,31,Years,Female,I,11/18/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Depression,,NO,NO,Listed
E2B_00000125,E2B_00000125,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Depression,Non-Health Professional,31,Years,Female,I,11/18/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Depression,,NO,NO,Listed
E2B_00000125,E2B_00000125,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Feeling of despair,Non-Health Professional,31,Years,Female,I,11/18/2015,11/14/2015,,,,Drug dependence,UNITED STATES,Feeling of despair,,NO,NO,Unlisted
E2B_00000126,E2B_00000126,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Mouth ulceration,Non-Health Professional,,,Male,I,11/30/2015,,,,,Product used for unknown indication,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
E2B_00000126,E2B_00000126,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Mouth ulceration,Non-Health Professional,,,Male,I,11/30/2015,,,,,Product used for unknown indication,UNITED STATES,Mouth ulceration,,NO,NO,Unlisted
E2B_00000127,E2B_00000127,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Tremor,Non-Health Professional,54,Years,Male,I,11/30/2015,11/25/2015,,,,Drug dependence,UNITED STATES,Tremor,,NO,NO,Unlisted
E2B_00000127,E2B_00000127,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Tremor,Non-Health Professional,54,Years,Male,I,11/30/2015,11/25/2015,,,,Drug dependence,UNITED STATES,Tremor,,NO,NO,Unlisted
E2B_00000127,E2B_00000127,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,54,Years,Male,I,11/30/2015,11/25/2015,,,,Drug dependence,UNITED STATES,Diarrhoea,,NO,NO,Listed
E2B_00000127,E2B_00000127,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Diarrhoea,Non-Health Professional,54,Years,Male,I,11/30/2015,11/25/2015,,,,Drug dependence,UNITED STATES,Diarrhoea,,NO,NO,Listed
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,11/30/2015,11/1/2015,,,,Drug dependence,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,32,Years,Female,I,11/30/2015,11/1/2015,,,,Drug dependence,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,32,Years,Female,I,11/30/2015,11/1/2015,,,,Drug dependence,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product physical consistency issue,Non-Health Professional,32,Years,Female,I,11/30/2015,11/1/2015,,,,Drug dependence,UNITED STATES,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypoaesthesia,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Hypoaesthesia,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Hypoaesthesia,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pyrexia,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Pyrexia,,NO,NO,Listed
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pyrexia,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Pyrexia,,NO,NO,Listed
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Limb discomfort,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Limb discomfort,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Limb discomfort,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Limb discomfort,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Limb discomfort,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Limb discomfort,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Limb discomfort,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Limb discomfort,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pain in extremity,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
E2B_00000128,E2B_00000128,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pain in extremity,Non-Health Professional,32,Years,Female,I,11/30/2015,11/27/2015,,,,Drug dependence,UNITED STATES,Pain in extremity,,NO,NO,Unlisted
E2B_00000129,E2B_00000129,Bunavail,"BUPRENORPHINE,NALOXONE",,,Negative,,,,,Oedema peripheral,Physician,,,Female,I,12/4/2015,,,,,Product used for unknown indication,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
E2B_00000129,E2B_00000129,Bunavail,"BUPRENORPHINE,NALOXONE",,,Negative,,,,,Oedema peripheral,Physician,,,Female,I,12/4/2015,,,,,Product used for unknown indication,UNITED STATES,Oedema peripheral,,NO,NO,Unlisted
E2B_00000131,E2B_00000131,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,12/4/2015,10/1/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000131,E2B_00000131,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Product adhesion issue,Non-Health Professional,,,Male,I,12/4/2015,10/1/2015,,,,Product used for unknown indication,UNITED STATES,Product adhesion issue,,NO,NO,Unlisted
E2B_00000144,E2B_00000144,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Vomiting,Non-Health Professional,,,,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Vomiting,,NO,NO,Listed
E2B_00000144,E2B_00000144,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Vomiting,Non-Health Professional,,,,I,11/17/2015,,,,,Product used for unknown indication,UNITED STATES,Vomiting,,NO,NO,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pain,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,YES,YES,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,YES,YES,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fear,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Fear,,YES,YES,Unlisted
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Fear,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Fear,,YES,YES,Unlisted
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug dependence,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Drug dependence,,YES,YES,Listed
E2B_00000247,E2B_00000247,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Pain,Other Health Professional,40,Years,Male,I,11/30/2015,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,UNITED STATES,Pain,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug withdrawal syndrome,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Night sweats,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Night sweats,,YES,YES,Unlisted
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Night sweats,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Night sweats,,YES,YES,Unlisted
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Headache,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Headache,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Headache,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug ineffective,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Tremor,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Tremor,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Abdominal pain upper,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Abdominal pain upper,,YES,YES,Unlisted
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Abdominal pain upper,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Abdominal pain upper,,YES,YES,Unlisted
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dependence,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Dependence,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Dependence,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Dependence,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Drug ineffective,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Drug ineffective,,YES,YES,Listed
E2B_00000597,E2B_00000597,Bunavail,"BUPRENORPHINE,NALOXONE",,,,,,,,Tremor,Non-Health Professional,,,,I,12/4/2015,,,,Other,Product used for unknown indication,UNITED STATES,Tremor,,YES,YES,Listed
E2B_00000614,E2B_00000614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug intolerance,Physician,,,Female,I,3/14/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug intolerance,,NO,NO,Listed
E2B_00000614,E2B_00000614,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug ineffective,Physician,,,Female,I,3/14/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000615,E2B_00000615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Physician,53,Years,Female,I,3/23/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Dry mouth,,NO,NO,Listed
E2B_00000615,E2B_00000615,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,53,Years,Female,I,3/23/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000616,E2B_00000616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Loss of libido,Non-Health Professional,,,Male,I,3/23/2018,3/19/2018,,,,Pain,CANADA,Loss of libido,,NO,NO,Listed
E2B_00000616,E2B_00000616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Fatigue,Non-Health Professional,,,Male,I,3/23/2018,3/19/2018,,,,Pain,CANADA,Fatigue,,NO,NO,Listed
E2B_00000616,E2B_00000616,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Erectile dysfunction,Non-Health Professional,,,Male,I,3/23/2018,3/19/2018,,,,Pain,CANADA,Erectile dysfunction,,NO,NO,Unlisted
E2B_00000617,E2B_00000617,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypoaesthesia,Physician,,,Female,I,3/28/2018,3/1/2018,,,,DRUG USE FOR UNKNOWN INDICATION,CANADA,Hypoaesthesia,,NO,NO,Unlisted
E2B_00000618,E2B_00000618,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Physician,60,Years,Female,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Anxiety,,NO,NO,Listed
E2B_00000618,E2B_00000618,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Physician,60,Years,Female,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Chest pain,,NO,NO,Listed
E2B_00000618,E2B_00000618,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Physician,60,Years,Female,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Somnolence,,NO,NO,Listed
E2B_00000618,E2B_00000618,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Physician,60,Years,Female,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Off label use,,NO,NO,Unlisted
E2B_00000619,E2B_00000619,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Physician,55,Years,Male,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Anxiety,,NO,NO,Listed
E2B_00000619,E2B_00000619,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Physician,55,Years,Male,I,4/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Chest pain,,NO,NO,Listed
E2B_00000620,E2B_00000620,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Intercepted drug prescribing error,Pharmacist,,,,I,4/10/2018,4/4/2018,,,,Product used for unknown indication,CANADA,Intercepted drug prescribing error,,NO,NO,Unlisted
E2B_00000621,E2B_00000621,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response shortened,Physician,,,Female,I,4/13/2018,1/1/2018,,,,Pain,CANADA,Therapeutic response shortened,,NO,NO,Listed
E2B_00000622,E2B_00000622,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response shortened,Physician,,,,I,4/13/2018,1/1/2018,,,,Pain,CANADA,Therapeutic response shortened,,NO,NO,Listed
E2B_00000623,E2B_00000623,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,Male,I,4/20/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000623,E2B_00000623,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dry mouth,Physician,,,Male,I,4/20/2018,9/1/2018,,,,Product used for unknown indication,CANADA,Dry mouth,,NO,NO,Listed
E2B_00000624,E2B_00000624,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Off label use,Physician,,,,I,4/13/2018,,,,,Pain,CANADA,Off label use,,NO,NO,Unlisted
E2B_00000625,E2B_00000625,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Off label use,Physician,,,,I,4/13/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Off label use,,NO,NO,Unlisted
E2B_00000626,E2B_00000626,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Physician,,,Female,I,4/16/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,Listed
E2B_00000627,E2B_00000627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response decreased,Physician,,,Male,I,4/27/2018,4/18/2018,,,,Pain,CANADA,Therapeutic response decreased,,NO,NO,Listed
E2B_00000627,E2B_00000627,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product physical consistency issue,Physician,,,Male,I,4/27/2018,4/18/2018,,,,Pain,CANADA,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000628,E2B_00000628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Physician,,,Female,I,4/27/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000628,E2B_00000628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Physician,,,Female,I,4/27/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Unlisted
E2B_00000628,E2B_00000628,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Physician,,,Female,I,4/27/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Vomiting,,NO,NO,Unlisted
E2B_00000629,E2B_00000629,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,5/2/2018,1/1/2018,,,,Pain,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000630,E2B_00000630,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,5/7/2018,,,,,Pain,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000631,E2B_00000631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Anxiety,Physician,72,Years,Male,I,5/7/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Anxiety,,NO,NO,Listed
E2B_00000631,E2B_00000631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Chest pain,Physician,72,Years,Male,I,5/7/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Chest pain,,NO,NO,Listed
E2B_00000631,E2B_00000631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Physician,72,Years,Male,I,5/7/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000631,E2B_00000631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Eye pruritus,Physician,72,Years,Male,I,5/7/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Eye pruritus,,NO,NO,Unlisted
E2B_00000631,E2B_00000631,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Dyspnoea,Physician,72,Years,Male,I,5/7/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Dyspnoea,,NO,NO,Listed
E2B_00000632,E2B_00000632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Off label use,Physician,,,Female,I,5/8/2018,4/1/2018,,,,Back pain,CANADA,Off label use,,NO,NO,Unlisted
E2B_00000632,E2B_00000632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response decreased,Physician,,,Female,I,5/8/2018,4/1/2018,,,,Back pain,CANADA,Therapeutic response decreased,,NO,NO,Listed
E2B_00000632,E2B_00000632,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Exposure during pregnancy,Physician,,,Female,I,5/8/2018,4/1/2018,,,,Back pain,CANADA,Exposure during pregnancy,,NO,NO,Unlisted
E2B_00000633,E2B_00000633,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,,,Drug ineffective,Pharmacist,39,Years,Female,I,5/14/2018,1/1/2018,,,,Back pain,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000634,E2B_00000634,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,,Female,I,5/24/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,Listed
E2B_00000635,E2B_00000635,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Headache,Physician,,,Female,I,5/28/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,Listed
E2B_00000636,E2B_00000636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,,,Male,I,5/25/2018,1/1/2018,,,Other,Arthralgia,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000636,E2B_00000636,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Vomiting,Physician,,,Male,I,5/25/2018,1/1/2018,,,,Arthralgia,CANADA,Vomiting,,NO,YES,Listed
E2B_00000637,E2B_00000637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,No adverse event,Physician,,,Female,I,5/29/2018,,,,,Product used for unknown indication,CANADA,No adverse event,,NO,NO,Listed
E2B_00000637,E2B_00000637,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hypersensitivity,Physician,,,Female,I,5/29/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Hypersensitivity,,NO,NO,Listed
E2B_00000638,E2B_00000638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product physical consistency issue,Physician,50,Years,Male,I,5/30/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product physical consistency issue,,NO,YES,Unlisted
E2B_00000638,E2B_00000638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug ineffective,Physician,50,Years,Male,I,5/30/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,YES,Listed
E2B_00000638,E2B_00000638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Physician,50,Years,Male,I,5/30/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product solubility abnormal,,NO,YES,Unlisted
E2B_00000638,E2B_00000638,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,50,Years,Male,I,5/30/2018,1/1/2018,,,Other,Product used for unknown indication,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Pain,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,,Pain,CANADA,Pain,,NO,YES,
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Syncope,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,Other,Pain,CANADA,Syncope,,YES,YES,Listed
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Malaise,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,,Pain,CANADA,Malaise,,NO,YES,Unlisted
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Musculoskeletal chest pain,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,,Pain,CANADA,Musculoskeletal chest pain,,NO,YES,Listed
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Nausea,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,,Pain,CANADA,Nausea,,NO,YES,Listed
E2B_00000639,E2B_00000639,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Non-Health Professional,,,Male,F,6/13/2018,1/1/2018,,,,Pain,CANADA,Drug ineffective,,NO,YES,Listed
E2B_00000640,E2B_00000640,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,,,Drug ineffective,Physician,54,Years,Male,I,6/4/2018,1/1/2018,,,,Pain,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000641,E2B_00000641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Non-Health Professional,93,Years,Female,I,5/30/2018,5/1/2018,,,,Neuropathy peripheral,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000641,E2B_00000641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product physical consistency issue,Non-Health Professional,93,Years,Female,I,5/30/2018,5/1/2018,,,,Neuropathy peripheral,CANADA,Product physical consistency issue,,NO,NO,Unlisted
E2B_00000641,E2B_00000641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Non-Health Professional,93,Years,Female,I,5/30/2018,5/23/2018,,,,Neuropathy peripheral,CANADA,Nausea,,NO,NO,Listed
E2B_00000641,E2B_00000641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug ineffective,Non-Health Professional,93,Years,Female,I,5/30/2018,5/23/2018,,,,Neuropathy peripheral,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000641,E2B_00000641,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Night sweats,Non-Health Professional,93,Years,Female,I,5/30/2018,5/23/2018,,,,Neuropathy peripheral,CANADA,Night sweats,,NO,NO,Listed
E2B_00000642,E2B_00000642,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000642,E2B_00000642,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Male,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000643,E2B_00000643,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Male,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000643,E2B_00000643,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Male,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000644,E2B_00000644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Suicidal ideation,Physician,,,,I,6/6/2018,1/1/2018,,,Other,Product used for unknown indication,CANADA,Suicidal ideation,,YES,YES,Unlisted
E2B_00000644,E2B_00000644,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Depressed mood,Physician,,,,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Depressed mood,,NO,YES,Listed
E2B_00000645,E2B_00000645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000645,E2B_00000645,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000646,E2B_00000646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000646,E2B_00000646,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000647,E2B_00000647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000647,E2B_00000647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Drug ineffective,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Drug ineffective,,NO,NO,Listed
E2B_00000647,E2B_00000647,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Mood altered,Pharmacist,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Mood altered,,NO,NO,Unlisted
E2B_00000648,E2B_00000648,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Hypersomnia,Physician,,,,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Hypersomnia,,NO,NO,Unlisted
E2B_00000649,E2B_00000649,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Therapeutic response decreased,Physician,,,Female,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Therapeutic response decreased,,NO,NO,Listed
E2B_00000650,E2B_00000650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Physician,,,Male,I,6/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Wrong technique in product usage process,,NO,NO,Unlisted
E2B_00000650,E2B_00000650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product adhesion issue,Physician,,,Male,I,6/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000650,E2B_00000650,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product solubility abnormal,Physician,,,Male,I,6/5/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000651,E2B_00000651,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Dizziness,Physician,,,,I,6/6/2018,,,,,Product used for unknown indication,CANADA,Dizziness,,NO,NO,Listed
E2B_00000652,E2B_00000652,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Headache,Physician,,,,I,6/6/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,Listed
E2B_00000653,E2B_00000653,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Drug withdrawal syndrome,Physician,,,Female,I,6/12/2018,1/1/2018,,,Other,Product used for unknown indication,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000654,E2B_00000654,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Off label use,Physician,,,Male,I,6/12/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Off label use,,NO,NO,Unlisted
E2B_00000655,E2B_00000655,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Headache,Physician,,,,I,6/6/2018,9/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,
E2B_00000655,E2B_00000655,SUBOXONE,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Headache,Physician,,,,I,6/6/2018,9/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,
E2B_00000655,E2B_00000655,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Headache,Physician,,,,I,6/6/2018,9/1/2018,,,,Product used for unknown indication,CANADA,Headache,,NO,NO,
E2B_00000656,E2B_00000656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000656,E2B_00000656,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000657,E2B_00000657,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,,,,Male,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000657,E2B_00000657,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,,,,Male,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000658,E2B_00000658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Pharmacist,,,,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000658,E2B_00000658,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Product adhesion issue,Pharmacist,,,,I,6/11/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000659,E2B_00000659,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,37,Years,Male,I,6/14/2018,1/1/2018,,,,Pain,CANADA,Therapeutic response decreased,,NO,NO,Listed
E2B_00000660,E2B_00000660,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Hypersensitivity,Physician,,,Male,I,6/12/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Hypersensitivity,,NO,NO,Listed
E2B_00000661,E2B_00000661,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Off label use,Pharmacist,47,Years,Female,I,6/19/2018,6/1/2018,,,,Product used for unknown indication,CANADA,Off label use,,NO,NO,Listed
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Breakthrough pain,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Breakthrough pain,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Dyspnoea,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Dyspnoea,,NO,YES,Listed
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral administration complication,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Oral administration complication,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Hot flush,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Hot flush,,NO,YES,Listed
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Intentional product misuse,Physician,53,Years,Female,I,7/26/2018,1/1/2018,,,,Pain,CANADA,Intentional product misuse,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Medication residue present,Physician,53,Years,Female,I,7/26/2018,1/1/2018,,,,Pain,CANADA,Medication residue present,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product use complaint,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Product use complaint,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Physician,53,Years,Female,I,7/26/2018,6/28/2018,,,,Pain,CANADA,Product adhesion issue,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Product solubility abnormal,,NO,YES,Unlisted
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal headache,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Drug withdrawal headache,,NO,YES,Listed
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,Other,Pain,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000662,E2B_00000662,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Chest pain,Physician,53,Years,Female,I,7/26/2018,6/1/2018,,,,Pain,CANADA,Chest pain,,NO,YES,Listed
E2B_00000663,E2B_00000663,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Non-Health Professional,40,Years,Male,I,7/6/2018,1/1/2018,,,,Back pain,CANADA,Product adhesion issue,,NO,YES,Unlisted
E2B_00000663,E2B_00000663,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,40,Years,Male,I,7/6/2018,1/1/2018,,,Other,Back pain,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000664,E2B_00000664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,,,Female,I,7/31/2018,6/1/2018,,,,Pain,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000664,E2B_00000664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,,,Female,I,7/31/2018,,,,,Pain,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000664,E2B_00000664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Nausea,Pharmacist,,,Female,I,7/31/2018,6/1/2018,,,,Pain,CANADA,Nausea,,NO,NO,Listed
E2B_00000664,E2B_00000664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,,,Female,I,7/31/2018,,,,,Pain,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000664,E2B_00000664,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug administration error,Pharmacist,,,Female,I,7/31/2018,,,,,Pain,CANADA,Drug administration error,,NO,NO,
E2B_00000665,E2B_00000665,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Palpitations,Physician,50,Years,Female,I,8/7/2018,7/3/2018,,,,Pain,CANADA,Palpitations,,NO,NO,Listed
E2B_00000666,E2B_00000666,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,Positive,,,microgram,Buccal film,,Gastrooesophageal reflux disease,Physician,59,Years,Male,I,8/7/2018,6/23/2018,,,,Pain,CANADA,Gastrooesophageal reflux disease,,NO,NO,Unlisted
E2B_00000667,E2B_00000667,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Drug withdrawal syndrome,Pharmacist,,,,I,9/17/2018,,,,Other,Product used for unknown indication,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000667,E2B_00000667,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Off label use,Pharmacist,,,,I,9/17/2018,,,,Other,Product used for unknown indication,CANADA,Off label use,,YES,YES,Unlisted
E2B_00000668,E2B_00000668,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Headache,Pharmacist,48,Years,Female,I,9/21/2018,9/1/2018,,,,Pain,CANADA,Headache,,NO,NO,Listed
E2B_00000668,E2B_00000668,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,48,Years,Female,I,9/21/2018,9/1/2018,,,,Pain,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000669,E2B_00000669,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,Buccal film,,Product solubility abnormal,Physician,,Years,Female,I,10/3/2018,1/1/2018,,,,Product used for unknown indication,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000670,E2B_00000670,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product adhesion issue,Pharmacist,53,Years,Female,I,9/27/2018,1/1/2018,,,,Pain,CANADA,Product adhesion issue,,NO,NO,Unlisted
E2B_00000670,E2B_00000670,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Oral administration complication,Pharmacist,53,Years,Female,I,9/27/2018,1/1/2018,,,,Pain,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000670,E2B_00000670,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Product solubility abnormal,Pharmacist,53,Years,Female,I,9/27/2018,1/1/2018,,,,Pain,CANADA,Product solubility abnormal,,NO,NO,Unlisted
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Wrong technique in product usage process,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Wrong technique in product usage process,,NO,NO,
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Malaise,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Malaise,,NO,NO,
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Lethargy,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Lethargy,,NO,NO,
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product solubility abnormal,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Product solubility abnormal,,NO,NO,
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Product use complaint,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Product use complaint,,NO,NO,
E2B_00000671,E2B_00000671,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,Buccal film,,Therapeutic response decreased,Non-Health Professional,,,,I,11/7/2018,2/1/2018,,,,Product used for unknown indication,CANADA,Therapeutic response decreased,,NO,NO,
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pruritus,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Pruritus,,NO,NO,Listed
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Somnolence,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Somnolence,,NO,NO,Listed
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Tremor,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Tremor,,NO,NO,Listed
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Abnormal faeces,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Abnormal faeces,,NO,NO,Unlisted
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Faeces pale,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Faeces pale,,NO,NO,Unlisted
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Thinking abnormal,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Thinking abnormal,,NO,NO,Unlisted
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Pain,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Pain,,NO,NO,Unlisted
E2B_00000672,E2B_00000672,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Negative thoughts,Pharmacist,64,Years,Female,I,11/30/2018,,,,,Pain,CANADA,Negative thoughts,,NO,NO,Unlisted
E2B_00000673,E2B_00000673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Therapeutic response shortened,Pharmacist,55,Years,Male,I,12/12/2018,,,,,Pain,CANADA,Therapeutic response shortened,,NO,NO,Listed
E2B_00000673,E2B_00000673,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Hot flush,Pharmacist,55,Years,Male,I,12/12/2018,,,,,Pain,CANADA,Hot flush,,NO,NO,Listed
E2B_00000674,E2B_00000674,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Therapeutic response shortened,Pharmacist,67,Years,Male,I,12/18/2018,,,,,Pain,CANADA,Therapeutic response shortened,,NO,NO,Listed
E2B_00000675,E2B_00000675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Tooth discolouration,Non-Health Professional,,,Female,I,12/10/2018,1/1/2018,,,,Pain,CANADA,Tooth discolouration,,NO,NO,Unlisted
E2B_00000675,E2B_00000675,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,,Buccal film,,Oral administration complication,Non-Health Professional,,,Female,I,12/10/2018,1/1/2018,,,,Pain,CANADA,Oral administration complication,,NO,NO,Unlisted
E2B_00000676,E2B_00000676,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,microgram,Buccal film,,Therapeutic response decreased,Pharmacist,37,Years,Male,I,2/14/2019,,,,,Pain,CANADA,Therapeutic response decreased,,NO,NO,Listed
E2B_00000677,E2B_00000677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product preparation error,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product preparation error,,NO,YES,Unlisted
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug abuse,Physician,21,Years,Female,I,2/14/2019,,,,Other,Drug dependence,CANADA,Drug abuse,,YES,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Drug abuse,Physician,21,Years,Female,I,2/14/2019,,,,Other,Drug dependence,CANADA,Drug abuse,,YES,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hyperemesis gravidarum,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Hyperemesis gravidarum,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Hyperemesis gravidarum,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Hyperemesis gravidarum,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product use issue,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product use issue,,NO,YES,
E2B_00000677,E2B_00000677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Nausea,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Nausea,,NO,YES,Listed
E2B_00000677,E2B_00000677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Product use issue,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product use issue,,NO,YES,Unlisted
E2B_00000677,E2B_00000677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Hyperemesis gravidarum,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Hyperemesis gravidarum,,NO,YES,Unlisted
E2B_00000677,E2B_00000677,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug abuse,Physician,21,Years,Female,I,2/14/2019,,,,Other,Drug dependence,CANADA,Drug abuse,,YES,YES,Unlisted
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product use issue,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product use issue,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product preparation error,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product preparation error,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Product preparation error,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Product preparation error,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Nausea,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Nausea,,NO,YES,
E2B_00000677,E2B_00000677,BUPRENORPHINE HYDROCHLORIDE W/NALOXONE HCL,"BUPRENORPHINE HYDROCHLORIDE,NALOXONE HYDROCHLORIDE",,,,,,,,Nausea,Physician,21,Years,Female,I,2/14/2019,,,,,Drug dependence,CANADA,Nausea,,NO,YES,
E2B_00000678,E2B_00000678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Drug abuse,Non-Health Professional,38,Years,Female,I,2/13/2019,,,,Other,Product used for unknown indication,CANADA,Drug abuse,,YES,YES,Listed
E2B_00000678,E2B_00000678,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Unknown,,,,,,,Drug dependence,Non-Health Professional,38,Years,Female,I,2/13/2019,,,,Other,Product used for unknown indication,CANADA,Drug dependence,,YES,YES,Listed
E2B_00000679,E2B_00000679,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Buccal use,,,,microgram,Buccal film,,Drug withdrawal syndrome,Non-Health Professional,,,,I,4/2/2019,,,,Other,Arthralgia,CANADA,Drug withdrawal syndrome,,YES,YES,Listed
E2B_00000680,E2B_00000680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Exposure via breast milk,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,CANADA,Exposure via breast milk,,YES,YES,Listed
E2B_00000680,E2B_00000680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug withdrawal syndrome neonatal,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,CANADA,Drug withdrawal syndrome neonatal,,YES,YES,Listed
E2B_00000680,E2B_00000680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Poor feeding infant,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,CANADA,Poor feeding infant,,YES,YES,Unlisted
E2B_00000680,E2B_00000680,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Foetal exposure during pregnancy,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,Product used for unknown indication,CANADA,Foetal exposure during pregnancy,,YES,YES,
E2B_00000680,E2B_00000680,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Foetal exposure during pregnancy,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,DRUG USE FOR UNKNOWN INDICATION,CANADA,Foetal exposure during pregnancy,,YES,YES,Listed
E2B_00000680,E2B_00000680,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Drug withdrawal syndrome neonatal,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,Product used for unknown indication,CANADA,Drug withdrawal syndrome neonatal,,YES,YES,
E2B_00000680,E2B_00000680,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Poor feeding infant,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,Product used for unknown indication,CANADA,Poor feeding infant,,YES,YES,
E2B_00000680,E2B_00000680,BUPRENORPHINE HYDROCHLORIDE,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Exposure via breast milk,Non-Health Professional,,,Male,I,4/2/2019,,,,Hospitalisation,Product used for unknown indication,CANADA,Exposure via breast milk,,YES,YES,
E2B_00001075,E2B_00001075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,,"Tablet, film coated",,Squamous cell carcinoma of lung,Physician,86,Years,Male,I,9/17/2019,7/21/2019,,,Death,CONSTIPATION,JAPAN,Squamous cell carcinoma of lung,,YES,YES,Unlisted
E2B_00001075,E2B_00001075,Belbuca,BUPRENORPHINE HYDROCHLORIDE,Oral use,,,,,"Tablet, film coated",,Diarrhoea,Physician,86,Years,Male,I,9/17/2019,6/16/2019,,,,CONSTIPATION,JAPAN,Diarrhoea,,NO,YES,Listed
E2B_00001335,E2B_00001335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Urinary retention,Physician,,,,I,7/7/2021,,,,Other,PRODUCT USED FOR UNKNOWN INDICATION,JAPAN,Urinary retention,,YES,YES,
E2B_00001335,E2B_00001335,Belbuca,BUPRENORPHINE HYDROCHLORIDE,,,,,,,,Off label use,Physician,,,,I,7/7/2021,,,,,PRODUCT USED FOR UNKNOWN INDICATION,JAPAN,Off label use,,NO,YES,
